Abstracts cont.  by unknown
Health care issues, public health, pharmaco-economics
R1949
Malaria problem in Afghanistan: malaria
scanning results of the Turkish medical aid group
after the war
Y.A. O¨ner, S.E. Okutan, E. Artinyan, B. Kocazeybek (Istanbul,
TR)
Objectives: Malaria is a parasitic infection caused by Plasmo-
dium species and it is especially seen in tropical and
subtropical areas. We aimed to evaluate the effects of the
infection in Afghanistan, which is an endemic place for
malaria and had severe socio-economical lost after the war.
We also compared these data with the ones that were
recorded before the war.
Methods: Blood samples were taken from 376 malaria suspec-
ted patients who come to the health centre, established by the
medical group of Istanbul Medical Faculty in 2002, Afghanistan.
Blood samples were screened using the OPTIMAL Rapid
Malaria Test and Giemsa staining method.
Results: In 95 (25.3%) patients diagnosis was malaria. In 65
patients (17.3%) the agent of the infection was P. falciparum and
in 30 patients (8%) agents were other Plasmodium species.
Conclusions: Reported data of malaria in Afghanistan are
limited by the only studies carried on Afghan refugees in
bordering countries. In this study given data were collected
from the present Afghan people living in their home country
even after the war. We emphasized the increasing importance of
the infection in Afghanistan where malaria is endemic and there
is severe socio-economic damage after the war.
R1950
Prevalence of Salmonella carriers among food
handlers in Hamadan, western Iran
R. Youseﬁ Mashouf, M. Ranjbar (Hamadan, IR)
Objectives: Salmonella is one of the major causes of human
diseases related to food consumption. Some infected individuals
recovering from this infection become temporary or permanent
carriers, harbouring the organisms in the gallbladder, biliary
tract, or rarely in their intestine. The objective of this study was
prevalence of S. typhi and S. para-typhi carriers among food
handlers.
Method: In this study, 210 persons who were working in
supplying and distribution of the food-stuffs were investigated.
The fecal samples from food handlers were collected and
cultured on a suitable media. The organisms were identiﬁed by
relevant antisera. The data was gathered through questionnaire
and analysed using EPI6 statistical software.
Results: Of 210 stool cultures, 5 cases (2.38%) were positive
for Salmonella species. Two (0.94%) were S. typhi, two (0.94%)
S. para-typhi B, and one (0.47%) Salmonella non-typhi. Positive
cases were tested again after one month and one of them
(non-typhi) was negative in culture. So, the rate of infection
was 0.19%.
Conclusion: Our results showed that prevalence of S. typhi and
S. para-typhi carriers among food handlers in Hamadan was
approximately similar to those in the third world countries.
Since food handler carriers are at high risk for transition of
organisms, which involved in foodborne diseases, they must be
checked regularly for health.
R1951
Seroprevalence of Haemophilus inﬂuenzae Type B
in children aged 1–5 years old in the region of a
primary health care unit in Antalya, Turkey
F. Unlu, G. Mutlu, L. Donmez, O. Yigitbasi (Antalya, TR)
Objectives: Aim of this study was to determine the natural
immunity to Haemophilus inﬂuenzae type b (Hib) and contributed
factors in children because there is limited data about the
seroprevalence of Hib in Turkey.
Methods: Presented study was performed in healthy children
aged 13–60 months living in the region of Primary Health Care
Unit Number 17, Antalya. A total of 378 children were selected
for sampling. No child had been vaccinated before against Hib.
Probable factors were asked to parents of the children affecting
Hib natural immunity. Questionnaire forms were ﬁlled by us.
Blood samples were taken from those children. Capsular
polysaccharide speciﬁc IgG antibody (anti-PRP) levels were
determined in the sera by EIA methods. 0.15 microgram/ml is
accepted as positive limit level of anti-PRP IgG antibody.
Dependent and independent variables were evaluated by
statistical methods.
Results: Antibody levels were below 0.15 l/ml in 10 (2.6%) and
antibody levels were above 0.15 l/ml in 368 (97.4%) of children
in the study group. No signiﬁcant relationships were found
geometric mean titres of antibodies with year’s intervals
(p > 0.05). Relationships were established between the Hib
natural immunity and frequency of upper respiratory tract
infection and bronchopneumonia (p < 0.05). No signiﬁcant
relationships were found between the natural immunity and
age, gender, breastfeeding, socioeconomic level, attendance day
care center, number of siblings, exposure to otitis media and
sinusitis (p > 0.05).
Conclusion: In our study we determined the natural immu-
nity rate was high even in very early ages in Antalya. This
fact should be evaluated by nation wide surveillance pro-
gramme of invasive Hib diseases and nasopharyngeal coloni-





Determination of the quantity of Aﬂatoxin M1
contamination in traditional and UF cheese in
Shiraz, Iran
S. Alborzi, B. Pourabbas, M.A. Hanifpour, M. Rashidi (Shiraz,
IR)
Objectives: Aﬂatoxins are toxic mold metabolites produced by
toxigenic strains of Aspergillus species. They have an important
role in the occurrence of some human diseases such as liver
cancer, chronic hepatitis and cirrhosis. When animals eat food-
stuffs containing aﬂatoxin B1, these toxins will be metabolized
and excreted as aﬂatoxin M1 in their milk. A aﬂatoxin M1 is
resistant to thermal inactivation and is not destroyed completely
by pasteurization, autoclaving or the other food processing
procedures. The aim of this study was to evaluate the quantity
of aﬂatoxin M1 contamination in UF and traditional cheeses in
comparison with the primary milk contamination in Shiraz city
(Iran).
Methods: Forty-eight UF cheese, 48 traditional cheese and 48
milk samples which were used to produce those cheeses were
collected from one of the cheese factories in Shiraz. The amount
of aﬂatoxin M1 in these samples was determined by ELISA test
Using Ridascreen Aﬂatoxin M1 kit (r-biopharm, Germany).
Aﬂatoxins are Soluble in polar compounds so water phase of
centrifuged milk samples and methanol phase of cheese sam-
ples, which were prepared with solvents such as methanol, PBS
buffer and heptan were used to determine the quantity of
aﬂatoxin M1.
Results: Thirty per cent of milk samples had contamination
more than maximum tolerated level (50 ng/kg). The range of
aﬂatoxin M1 contamination in UF cheese samples was
27–137 ng/kg and that of traditional cheese samples was
25–88 ng/kg. So none of the UF and traditional cheese samples
have contamination more than maximum tolerated level, which
has been accepted by European countries (250 ng/kg). This
study showed that in transforming the milk to UF and
traditional Cheeses 61.9% and 77.1% of aﬂotoxins were
eradicated in whey, respectively while 38.1% and 22.9% of
aﬂatoxins remained respectively, which shows no statistical
differences between UF and traditional cheeses in contamin-
ation with aﬂatoxins.
Conclusion: Although 30% of pasteurized milk had contamin-
ation more than maximum tolerated level with aﬂatoxin M1,
none of the cheeses, which produced from those pasteurized
milk have contamination more than maximum tolerated level.
We concluded that as aﬂatoxins are soluble in polar compounds,
most of them will be gone out with whey and little of them will
remained in cheeses.
R1953
Evaluation of awareness of healthcare workers
about standard health precaution and isolation
M. Jamshidi, A. Jamshidi (Bandar Abbas, IR)
Objective: To evaluate knowledge of health care workers about
health precaution and its association.
Methods: This descriptive study is done on 191 health care
workers, working in teaching hospitals of Hormozgan university
of medical sciences in southern Iran. Data is collected by giving a
question are including questions about knowledge of healthcare
workers (HCW) about standard preventing health precaution
and demographic data. The results from questionnaires is
analysed by EPI INFO2000 program. For ﬁnding association we
used Fisher test and chi-square. We classiﬁed HCW according to
scores that they take into four groups; a (good), b (moderate), c
(weak), d (very weak).
Results: One hundred and ninety-one health care workers
participate in this program. 85.5% was female with average
age of 31.8 ± 5.6 .average work experience was 8.4 ± 6 years.
4.2% of health care workers was in group a, 57.6% in group b,
35.1%in group c and 3.1% in group d. There was no
statistically signiﬁcant correlation between scores and age,
sex or work experience but there was signiﬁcant correlation
between different hospitals and different wards. High scores
was seen in paediatric hospital and in ICU, CCU and
emergency ward.
Conclusion: Results of this study showed that awareness of
healthcare workers about preventing precaution is not enough




haemorrhagic fever in local and imported sheep
in Isfahan province, Iran in 2002
M. Darvishi, B. Ataee, S. Chinikar, N. Jalali, M. Mardani,
M. Mirkhani (Isfahan, Tehran, IR; Manchester, UK)
Crimean- Congo Haemorrhagic Fever is an Arboviral Zoonotic
infection which several cases of that have been reported in
Iran. Measurement of antibody level of Crimean-Congo
Haemorrhagic Fever among local and imported sheep’s in
Isfahan province and presence of tick on their body are the
main purposes of this study. This cross sectional study has
been performed among 372 local and the same amount of
imported sheep’s, regarding to the presence of IgG antibody
of Crimean-Congo Haemorrhagic Fever and tick on their
body. The study was made with the special helps of
Arbovirus laboratory of Iranian Pasteur Institute on 2002.
286 (76.9%) of local and 223 (57.8%) of imported sheep’s have
had seropositive results but these data were statistically
meaningless (P = 0.094). Ticks have been found on the body
surface of 115 (31%) of local sheep’s but among imported
one’s were totally absent. The results of this study revealed
the endemic spreading of CCHF in the sheep’s in Isfahan
province and it needs special attention to prevent the infection
in the communities and occupational exposure.
Fig. 1. Relative prevalence of CCHF serology in local and
imported sheep is in Isfahan province.
Fig. 2. Relative prevalence of the presence of tick on imported
and local sheep in Isfahan province.
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R1955
Epidemiology of Helicobacter pylori infection in
Kashan
H. Shariﬁ, R. Moniri, V. Mehrzad, G.A. Mousavi, H. Ehteram,
H. Ahmadi (Kashan, IR)
Objectives: Role of Helicobacter pylori (HP) in many gastrointes-
tinal disorders such aspeptic ulcer , gastritis, intestinalmetaplasia
and stomach cancer is established. In order to determine risk
factors of its infection this study was done.
Methods: Two hundred and thirty-two patients with gastroin-
testinal signs were studied. Endoscopy was done by internist
and 2–3 biopsies from antrum was taken. Specimens were
processed by Shandon tissue Processor (Citadel). Prepared
slides were stained by Hematoxycillin and Eosin & also giemsa.
Two pathologists and one microbiologist studied the slides.
Patients, blood groups were determined. Patients, data includ-
ing age, sex, smoking, residential status, clinical signs, patho-
logic diagnosis, blood group were recorded and then analysed.
Results: Of 232 patients 130 (56%) were females and 102 (44%)
were males. 222 patients (124 women and 96 men) showed HP
infection . Frequency of infection in females was 95.4% and in
males 94%. 88 patients (38%) were in age group £30 and 144
(62%) in age group 31–80 years. HP was detected in 84 (95.4%)
in ﬁrst group and 136 (94.4% ) in second, group. 95.7% rural
and 41.8% urban showed HP infection. The most frequent
blood group was B (78%). All smoked patients and patients
with history of smoking showed infection. HP infection in
active gastritis was 98.3% and inactive gastritis with intestinal
metaplasia was 64.2%. The most common symptom was
epigastric pain and the least common was hiccup and
vomiting.
Conclusions: Frequency of HP infection is high (95.7%). No
relation is between age , sex, clinical signs and HP infection.
Persons with blood group B are more predipose to HP and
smokers are high risk for HP infection. No difference is between
urban and rural.
R1956
The study of prevalence of aetiology and outcome
of septic shock patients admitted at obstetric and
gynecologic department
Z. Shahshahan, S. Boroomand (Isfahan, IR)
Objectives: The incidence of sepsis, the precursor of septic
shock, has continued to increase over past decades. The aim of
this study was to evaluate the outcome and aetiology of septic
shock in Iranian patients.
Methods: During the years 1992–2002 , we examined the blood,
urine, uterus discharge culture of patients who were known
cases of septic shock and the outcome and aetiology of the
patients were recorded.
Results: Four hundred patients with a mean age of 30 and a
range of 25–35 were included. The prevalence of aetiology
was 299 (74%) septic abortion, 55 (14%) endometritis, 27 (7%)
pyelonephritis, and 10 (2.5%) chorioamnionitis, and 172 (43%)
died. The results of culture were: E. coli (50%) klebsiella (20%),
enterobacter SP (15%) streptococcus SP (10.5%) and others
(4.5%).
Conclusion: According to this study illegal abortion was the
most common cause of septic shock, therefore education
effective methods of contraception are recommended to
women.
R1957
Co-infection of Salmonella typhi, Salmonella
paratyphi, and Giardia lamblis after travelling
abroad
J.-S. Eom, H.-S. Kim, J.-S. Kim (Seoul, KOR)
Introduction: We experienced a case of co-infection of Sal-
monella typhi, Salmonella paratyphi, and Giardia lamblis after
traveling abroad. Case: A Korean male who was 23 year old
had traveled India and Thailand for two weeks on January,
2004. He had a ﬁrst febrile sense on 10 days later after
traveling and started watery diarrhoea over 10 times in a day
for a week. Just after he returned to Republic of Korea, he
visited outpatient clinic of Division of Infectious Diseases in
our hospital. He had been drinking water in bottles which
were not completely corked and foods which were sold on
the side of the streets in India and Thailand. He was acute ill
looking and patient’s body temperature was 40C, pulse rate
78/min, respiration rate 24/min, and blood pressure 120/
70 mmHg. Physical examinations were shown that very
dehydrated tongue and decreased skin turgor but no other
remarkable ﬁndings. Laboratory ﬁndings were; in CBC, WBC
3,450/lL (neutrophil 67.8%, lymphocyte 18.2%, monocyte
13.8%), hemoglobin 10.9 g/dl, platelet 143,400/lL; in chem-
istry, AST 106 IU/L, ALT 71 IU/L, albumin 3.0 g/dl, total
cholesterol 66 mg/dl; peripheral blood smear for malaria was
negative; stool occult blood positive. We examined stool wet
smear by microcopy and discover the trophozoites of Giardia
lamblis. We prescribed metronidazole 500 mg tid po but
patient’s fever was not decreased after three days later. At
forth hospital day, Salmonella typhi was isolated from blood
culture. So, we added ciproﬂoxacin 500 mg bid po and then
patient’s body temperature normalized after four days later.
Each antibiotic administered for 10 days and then he dis-
charged hospital after results of follow-up stool culture were
negative. But, three days later, he had high fever and was
hospitalized again. Salmonella paratyphi were isolated from his
blood cultures. It was a question why Salmonella paratyphi
had not been isolated from previous blood and stool cultures
and had not eradicated despite administer of ciproﬂoxacin.
There were no outbreaks of Salmonella paratyphi in our
hospital and his community. He had not eaten out during
admission and after discharge. We prescribed ciproﬂoxacin
500 mg bid po again. After 10 days later, he was cured and
had no recurred.
Conclusion: Although we do not know the correct cause for late
onset of Salmonella paratyphi bacteraemia, we suggest strongly
that the co-infection of three pathogens was caused by food-





In vitro activity of ceftobiprole against recent
clinical isolates of Pseudomonas aeruginosa from
hospitalised patients in Europe and USA
M. Heep, M.E. Jones, D.F. Sahm, D.C. Draghi (Basel, CH;
Herndon, USA)
Objectives: Ceftobiprole (BPR), formerly BAL9141, is the ﬁrst of
a new class of cephalosporins and has broad-spectrum activity
towards a wide range of Gram-negative and Gram-positive
hospital-acquired pathogens includingMRSA. Pseudomonas aeru-
ginosa (PA) is a common nosocomial pathogen, which has
developed high resistance rates to various antibiotics. In this
study we investigated the in vitro activity of BPR and other
commonly used anti-pseudomonal antibiotics against a collection
of clinical P. aeruginosa isolates.
Methods: A total of 407 organisms originating from hospitals in
Europe (Belgium, France, Germany, Italy, and Spain) (n = 204)
and throughout the USA (n = 203), were studied. All isolates
were non-repeat isolates from hospitalized patients during
2001–4. MICs of BPR, ceftazidime, ciproﬂoxacin, imipenem,
piperacillin/tazobactam, and tobramycin were determined by
broth microdilution according to NCCLS guidelines. BPR
breakpoints used were 4 mg/L susceptible, 8 mg/L intermedi-
ate, and 16 mg/L resistant.
Results: Similar other recent reports, 14.2 and 9.4% of isolates
were imipenem resistant in EU and USA, respectively. At 8 mg/
L, 71.6/78.3% EU and US, respectively PA isolates were
inhibited by BPR, compared to 76.5/79.8% for ceftazidime. The
two drugs exhibited a high degree of cross-resistance.
Conclusion: In addition to its anti-MRSA activity, the spectrum
of activity of BPR towards P. aeruginosa resembles that of
ceftazidime.
Pharmacokinetics, pharmacodynamics, drug interactions,
tolerability
R1959
Importance of the infecting organism in
antibiotic penetration into the middle ear in
experimental otitis media
F. Soriano, A. Parra, C. Martinez-Marin, L. Huelves, M. Gracia,
G. del Prado, C. Ponte, C. Cenjor (Madrid, E)
Objective: To determine the rate of antibiotic penetration into
the ME in experimental acute otitis media caused by Streptococ-
cus pneumoniae (Sp), Haemophilus inﬂuenzae (Hi), or a combina-
tion of both (Sp + Hi).
Methods: A gerbil model of otitis media caused by either Sp, Hi,
and Sp plus Hi was induced. Animals were sbc treated with
amoxicillin (AMX), cefuroxime (CXM) or erythromycin (ERY) 2, 10,
and 18 h after bacterial challenge and antibiotic efﬁcacy was
evaluated clinically and bacteriologically. Antibiotic concentrations
were determined in the serum of healthy animals as well as in the
middle ear 90 min after drug administration in infected animals.
Results: The percentage of drug penetration into the middle ear
in animals with otitis media in relation to the inoculated
organism was as follows:
Conclusions: 1) The rate of penetration into the middle ear for
betalactam antibiotics ranged approximately from 20 to 30%
when animals were infected with Sp (alone or combined with
Hi) but such a rate was approximately 8 to 10% when the
organism involved was Hi. 2) The erythromycin rate penetration
ranged approximately from 40 to 50% whatever it was the
microorganism involved.
R1960
Penetration of telithromycin into nasal mucosa
and ethmoid bone of patients
T.S. Kuehnel, C. Schurr, K. Lotter, F. Kees (Regensburg, D)
Objectives: The ketolide telithromycin has a focused spectrum
of activity against respiratory tract pathogens, including peni-
cillin- and erythromycin-resistant pneumococci, as well as
intracellular and atypical bacteria. The aim of the present study
was to investigate the penetration of telithromycin into nasal
mucosa and ethmoid bone of patients to provide kinetic data.
Methods: The study was designed as an exploratory population
kinetics trial. A total of 29 patients undergoing rhinosurgery for
chronic sinusitis were evaluated. The patients received a single
oral dose of telithromycin 800 mg. Samples of blood, nasal
mucus, nasal mucosa and ethmoid bone were collected during
surgery 3, 6, 9, 15 and 24 h post-drug administration. Drug
concentrations were determined by HPLC with ﬂuorimetric
detection.
Results: The telithromycin mean (SD) concentrations 3–24 h
after administration are listed in the Table. The achieved
concentrations were generally above the MIC90 of common
pathogens in upper respiratory tract infections (S. pneumoniae
0.12 mg/L, S. aureus [MSSA] 0.06 mg/L,M. catarrhalis 0.12 mg/
L; data from the PROTEKT surveillance study). The relative
Region Agent
MIC (mg/L)
Range MIC50 MIC90 %S %I %R
Europe n = 204 Ceftobiprole 1–>32 4 32 50.0 21.6 28.4
Ceftazidime 0.5–>32 2 >32 76.5 2.5 21.1
Ciproﬂoxacin £0.06–>4 0.25 >4 62.7 6.9 30.4
Imipenem £0.25–>16 1 16 78.4 7.4 14.2
Piperacillin/Tazob. 0.5–>128 8 >128 82.4 – 17.6
Tobramycin £4–>32 £4 >32 75.0 0.5 24.5
US n = 203 Ceftobiprole 0.25–>32 4 16 64.5 13.8 21.7
Ceftazidime £0.25–>32 2 32 79.8 5.4 14.8
Ciproﬂoxacin £0.06–>4 0.25 >4 66.0 6.4 27.6
Imipenem £0.25–>16 1 8 86.2 4.4 9.4
Piperacillin/Tazob. £0.25–>128 8 >128 80.8 – 19.2
Tobramycin £4–>32 £4 8 89.2 2.0 8.9
Table 1
Drug (mg ⁄ kg) Sp Hi Sp + Hi
AMX (2.5) 29.8 – –
AMX (5) 19.7 9.4 23.8
AMX (10) – 7.8 –
AMX (20) – 9.8 –
CXM (5) – 7.7 21.8
CXM (20) – 9.4 –
ERY (2.5) 54.3 – –
ERY (50) – 43.6 40.6
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systemic exposure, expressed by the ratio of the area under the
concentration-time curve in tissue vs plasma, was 1.0 for nasal
mucus, 5.9 for nasal mucosa and 1.6 for ethmoid bone,
respectively.
R1961
The chinolones signiﬁcantly increased the release
of verotoxin2 from clinical VTEC O26 in vitro
A. Liptakova, O. Hikri, V. Takacova, M. Molokacova,
L. Siegfried, D. Kotulova (Kosice, Bratislava, SVK)
Objectives: Verotoxin-producing Escherichia coli (VTEC) cause
hemolytic-uremic syndrome (HUS) mostly in children. Children
hospitalised at Intensive Care Units are given antibiotics
prophylaxis. However, it has been recognized that certain
antimicrobial drugs have capacity to enhance the release of
verotoxin. We have investigated the inﬂuence of antimicrobial
drugs used against gram-negative bacteria to verotoxin2-posit-
ive clinical VTEC O26 in vitro.
Methods: The clinical VTEC strain isolated from 4-year-old
child suffering from HUS was incubated with ampicillin/
sulbactam, meropenem, cefepime, piperaciline, piperacilline/
tazobactam, cefotaxime, ceftazidime, gentamicine, amikacin,
ciproﬂoxacine and trimethoprime/sulfamethoxazole using dilu-
tion method. After 2 h and 4 h incubation, the verotoxin was
separated and the presence of verotoxin was conﬁrmed by
ELISA with monoclonal antibodies against verotoxin2. We used
t-test for statistical analysis.
Results: Based on ELISA tests, we have not found any signi-
ﬁcant increase or decrease of verotoxin release after 2 h
incubation. However, after 4 h incubation we have found that
ciproﬂoxacin (p < 0.05) signiﬁcantly induced the production of
verotoxin 2 and verotoxin release from clinical VTEC strain was
signiﬁcantly decreased by meropenem and amikacine (p < 0.05)
compared with clinical VTEC strain incubated without anti-
biotics.
Conclusions: Antimicrobial drugs play role not only as
inhibitors of the bacterial growth but some of them can
activate the production of important virulence factors. There-
fore, it is important not only isolation of VTEC from HUS
patients but also detection of the inﬂuence of antibiotics used
for prophylaxis in hospitals to verotoxin production of
isolated strain.
R1962
Continuous versus intermittent intravenous
administration of antibiotics: a meta-analysis of
randomised controlled trials
S. Kasiakou, G. Sermaides, A. Michalopoulos, E. Soteriades,
M. Falagas (Athens, GR; Boston, USA)
Background: Intermittent intravenous administration of antibi-
otics is the ﬁrst line approach in the management of severe
infections worldwide. However, the potential beneﬁts of alter-
native modes of administration of antibiotics, including the
continuous intravenous infusion, deserve further evaluation. We
performed a meta-analysis of randomized controlled trials
(RCTs) to compare the effectiveness and toxicity of the continu-
ous versus the intermittent mode of intravenous administration
of various antibiotics.
Methods: Data for this meta-analysis were identiﬁed from
PubMed (01/1950 to 09/2004), Current Contents, Cochrane
central register of controlled trials, and references from
relevant articles. RCTs comparing the continuous with the
intermittent intravenous administration of the same antibiotic
regimen, and examining effectiveness, mortality and/or
toxicity were included in the analysis. Experimental trials,
studies focusing on pharmacokinetic and/or pharmacodynam-
ic parameters, trials concerning antifungal, antiviral, or anti-
parasitic agents, and surgical prophylaxis trials were
excluded. We used data conforming to standard outcome
deﬁnitions of clinical failure and nephrotoxicity.
Results: A total of 20 comparisons from 9 randomized
controlled trials (RCTs) studying a-lactams (6), aminoglyco-
sides (2), and vancomycin (1) were included in the meta-ana-
lysis. Publication bias and statistically signiﬁcant heterogeneity
was not observed among the analysed studies. A better
outcome was observed with the continuous intravenous
administration of antibiotics; the pooled odds ratio for clinical
failure (10 comparisons from 7 RCTs) was 0.73 (95% CI, 0.53–
1.01) for the continuous compared to the intermittent intra-
venous administration. Regarding mortality (5 comparisons
from 5 RCTs) and nephrotoxicity (5 comparisons from 4 RCTs),
no differences were found; the pooled odds ratio and 95% CI
for mortality and nephrotoxicity was 0.89 (95% CI, 0.48–1.64)
and 0.91 (95% CI, 0.56–1.47), respectively, comparing the
continuous with the intermittent intravenous administration
of antibiotics.
Conclusion: Compared with the intermittent, the continuous
intravenous administration of antibiotics is more efﬁcient
regarding clinical effectiveness. In an era of gradually increas-
ing resistance rates among most pathogens, the potential
advantages of the continuous intravenous administration of
antibiotics on several clinical outcomes should be further
investigated.
R1963
Penetration of moxiﬂoxacin into rat mandibular
bone and soft tissue
G. Cachovan, O¨. Dogan Onur, U. Thuss, H.-M. Siefert, O. Oral,
I. Nergiz, U. Platzer (Hamburg, D; Istanbul, TR; Wuppertal, D)
Objectives: Odontogenic infections result in submucosal inﬁl-
trates and abscesses. They are able to penetrate into facial soft-
tissues and bone. These mixed infections are mainly caused by
both facultative and obligate anaerobes. Based on in vitro
activity, the new 8-methoxyquinolone antibiotic moxiﬂoxacin
(MXF) seems to be suited for the antibiotic therapy of these
odontogenic infections. The aim of this experimental study was
to determine the levels of MXF in plasma, soft tissue
(M. masseter) and the mandible.
Methods: Forty-nine male fasted albino Wistar rats (aged
6 weeks) weighing 190–300 g were used throughout the study.
A dose of 10 mg/kg MFX dissolved in water was administered
orally per gavage. Blood samples of 7 animals (6 MFX, 1 control)
were obtained 0.5 h, 1 h, 1.5 h, 2 h, 4 h, 8 h and 24 h, respect-
ively, after administration. The rats were killed with Ketalar
(10 mg/kg i.m.) and tissue samples were collected. After
homogenization (tissue samples) and protein precipitation all
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samples were analysed by HPLC/ﬂuorescence detection assay.
The pharmacokinetic evaluation was conducted based on non-
compartmental analysis.
Results: MFX concentrations above lower limit of quantitation
were measured from 0.5 h up to 8 h after administration. The
exposure in terms of AUC (0 – 1) amounted to 1821 lg h/L
(plasma), 2463 lg h/kg (mandibles) and 5192 lg h/kg
(M. masseter). The concentration–time curves of tissues were
more plateau-shaped compared to plasma. Calculated AUC
ratios tissue:plasma were M. masseter:plasma = 2.85 and man-
dibles:plasma = 1.35.
Conclusion: Administration of antibiotics is considered as an
important part of therapy during and/or after surgical proce-
dures in the maxillofacial area. Because of its good penetration
into bone and muscle tissues demonstrated in Wistar rats, MXF
might be an option for clinical application. Based on the
experimental data, controlled studies have to evaluate the
clinical efﬁcacy of MXF, also compared to other antibiotics.
R1964
Pharmacokinetic and pharmacodynamic aspects
of high dose oral levoﬂoxacin therapy for bone
infections
P. Viale, F. Pea, L. Scudeller, F. Pavan, M. Crapis, A. Londero,
F. Cristini, M. Furlanut (Udine, I)
Objectives: To assess pharmacokinetic and pharmacodynamic
aspects of high dose oral levoﬂoxacin in the therapy of bone
infection due to fully susceptible organisms.
Methods: All patients with microbiologically documented
bone infection, treated at our Institution from 01/04 to 10/04
with oral levoﬂoxacin, were included in the present analysis.
Two regimens were routinely used according to age, body
weight and renal function: 500 mg bid or 750 mg qd. Accord-
ing to different isolates other active antibiotics were adminis-
tered. Patients underwent weekly clinical, biochemical and
plasma therapeutic drug monitoring (TDM). Dosage adjust-
ments were made according to plasma levels to maintain
optimal exposure. Outcome was assessed at 8 weeks of
treatment (16 weeks for discitis) and at least 1 month after the
end of treatment.
Results: Fifteen patients were included. Mean age was 60 years
(SD 17). 10 were males. Mean weight was 77 kg (SD 13). Median
creatinine clearance was 91 ml/min (range 41–155). 7 pts had a
prosthetic joint infection, 5 a post-traumatic ostheomyelitis
(PTOM), 2 spondilodisicitis and 1 septic arthritis. Infections
were monomicrobial in 13 cases (4 MSSA, 6 CoNS, 1 each
E. faecalis, E. coli, K. ozaenae); polymicrobial in 2 (CoNS and
P.aeruginosa, MSSA and MRSA). All but one isolates (MRSA)
were levoﬂoxacin-susceptible (available MIC for 9 isolates
ranged 0.04–0.5 mcg/ml). Mean administered dosage was
8.9 mg/kg/daily (SD 2.2). Average Cmin and Cmax during the
overall treatment were 1.4 and 7.7 mcg/ml, respectively. Aver-
age Cmax/MIC ratio in the ﬁve patients with a punctual MIC
was 133.21. Median treatment duration was 62 days, (range 17–
135). At 1 month follow up after the end of treatment, 12 pts
were deemed cured (clinically and by C Reactive Protein
normalization). The 3 patients in whom levoﬂoxacin failed 2
were prosthetic joint infections in which infected prosthesis was
not removed, and 1 PTOM. No drug withdrawal was necessary
due to adverse events, but 3/15 pts experienced mild arthral-
gies.
Conclusion: In our experience,TDM tailored high daily dose
oral levoﬂoxacin enabled adequate plasma levels and high cure
rates, with no signiﬁcant adverse events throughout long-term
treatment. Plasma drug level monitoring is an exceedingly
useful tool in the management of bone infections, suggesting
dose reduction in pts at risk of adverse events and dose increase
in pts suboptimally exposed.
R1965
Penetration of levoﬂoxacin in sinusal mucosa of
patients with chronic sinusitis following oral
administration of a single 500 mg dose
F. Pea, G. Marioni, F. Pavan, R. Bottin, A. Stafﬁeri,
M. Furlanut (Udine, Padua, I)
Objectives: To assess levoﬂoxacin penetration in sinusal
mucosa of patients with chronic sinusitis undergoing functional
endoscopic sinusal surgery (FESS).
Methods: Seven patients (mean ± SD; age, 45 ± 18 yrs; weight,
77 ± 13 kg; sex, 5/2 M/F; CLCr, 1.28 ± 0.32 mL/min/kg) were
administered a standard 500 mg single oral dose of levoﬂoxacin
at 1 h (n = 4), 2 h (n = 1) or 3 h (n = 2) before surgical
intervention. Intraoperative mucosal tissue and blood samples
were collected simultaneously in each patient during FESS with
the intent of assessing and comparing plasma and tissular
concentration of levoﬂoxacin. Levoﬂoxacin concentrations in
plasma and tissue homogenate were analysed by means of a
validated HPLC method.
Results: Levoﬂoxacin concentrations in plasma (mcg/mL) and
tissue homogenate(mcg/g), respectively, after 1 h ranged 0.43–
8.52 mcg/mL, and 0.78–9.87 mcg/g; after 2 h were 7.27 mcg/
mL and 8.91 mcg/g; and after 3 h ranged between 3.59 to
5.14 mcg/mL, and 6.46 to 9.34 mcg/g. Tissue-to-plasma ratio of
levoﬂoxacin at different sampling times ranged between 1.16
and 1.82.
Conclusion: These preliminary ﬁndings suggest that single
500 mg oral dose of levoﬂoxacin may ensure therapeutically
effective concentrations in the sinusal mucosa of patients with
chronic sinusitis.Ofnote, considering thatﬂuoroquinolones exhibit
concentration-dependent bactericidal activity and that optimal
exposure may be achieved when peak-to-MIC ratio > 8–10
has been achieved, these data enable to conclude that a single
500 mg oral dose of levoﬂoxacin may ensure effective exposure
in sinusal mucosa against bacterial pathogens with an
MIC < 0.8–1 mcg/ml, that is a value lower than the MIC90 of
most pathogens usually responsible for bacterial sinusitis.
Accordingly, these pharmacokinetic data are consistent with
levoﬂoxacin 500 mg once daily to be an effective antibiotic in the
treatment of bacterial sinusitis.
R1966
A situation that mimics viral hepatitis: statin
induced rhabdomyolysis
F. Cokca, S. O¨zkan, G. Nergisoglu, O.K. Memikoglu,
A. Azap (Ankara, TR)
A 44-year-old woman was admitted to the emergency room
with the complaints of abdominal pain, generalized muscle
pain, cramps, and dark urine lasting for the last ﬁve days. She
was well orientated with a body temperature of 37.3C, blood
pressure of 110/80 mmHg, and pulse rate of 84/min. Systemic
examination did not reveal any pathological ﬁnding. The
biochemical tests showed elevated levels of ALT (1196 U/L),
AST (1200 U/L), LDH (1768 U/L), creatinine (2.1 mg/dL), and
BUN (62 mg/dL). Viral hepatitis, leptospirosis and hepatorenal
syndrome were considered in the differential diagnosis and the
patient was transferred to the Infectious Diseases Department.
She was diabetic and hypertensive for a year and was taking
gliclazide 60 mg/day, lisinopril 20 mg/day. She was also taking
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ﬂuvastatin 80 mg/day for hypercholesterolemia for a year
which was changed to simvastatin 40 mg/day for the last two
months by her doctor. The biochemical tests revealed that serum
CPK was 119.300 U/L in 1/40 diluted serum sample, myoglobin
was 4.000 ng/ml, viral hepatitis panel and Leptospira microag-
glutination test was negative. Her renal functions rapidly
deteriorated. She was diagnosed as statin rhabdomyolysis and
underwent to hemodialysis. The patient slowly improved and
recovered with hemodialysis and discontinuation of statin drug.
The incidence of rhabdomyolysis with statin monotherapy was
reported as 0.04–0.2%. Our patient was taking high dose statin
and was unaware of side effects. All patients taking statins
should be informed about the side effects of these drugs.
R1967
The rationale for higher dose levoﬂoxacin for the
treatment of serious infections
J. Kahn, N. Davis (Raritan, USA)
Background/Objective: Advances in medical care continue to
be associated with improved survival rates and better patient
quality of life. A consequence of these developments is an
increased vulnerability to serious infection due to traditional
pathogens (or commensals and relatively avirulent organisms)
that may be resistant to multiple antimicrobial agents. There
are few new antibacterial agents on the horizon. One strategy
for dealing with this threat is to maximize the utility of each of
our antibacterial drugs by dosing them more rationally. The
purpose of this paper is to summarize the rationale for
utilizing higher doses of levoﬂoxacin in the management of
serious infections.
Methods: We have reviewed and will report on all available
data from subjects exposed to daily levoﬂoxacin doses of 750 mg
or more.
Results: After more than seven years of use in the US,
levoﬂoxacin has maintained its excellent susceptibility proﬁle.
Drug levels seen in infected patients are signiﬁcantly higher
than those achieved in healthy volunteers and enable coverage
of organisms with higher MICs. Because of its concentration-
dependent bactericidal activity, higher doses of levoﬂoxacin
increase the speed and thoroughness of bacterial eradication
in vitro and can inhibit the emergence of ﬂuoroquinolone
resistance in studied organisms. Clinical trials with the 750 mg
dose have been undertaken in complicated skin and skin
structure infections, nosocomial pneumonia, and febrile neu-
tropenia; results were at least equivalent to comparator agents.
Use of this dose in community-acquired pneumonia and acute
bacterial exacerbations of chronic bronchitis has allowed for
more rapid resolution of symptoms and a shortening of the
course of therapy. Dosing in healthy volunteers at does up to
1500 mg per day resulted in no signiﬁcant alteration of the
adverse event proﬁle. Clinical trial data show that the safety of
750 mg daily is similar to the 250 and 500 mg forms.
Conclusion: Levoﬂoxacin has documented efﬁcacy and safety
credentials at clinical doses of at least 750 mg once daily. At
these higher doses, it is an attractive candidate for monotherapy
of some serious infections or for combination therapy with such
other agents as the carbapenems or 4th generation cephalospo-
rins. Additional clinical trials using these approaches seem
warranted.
In vitro activity of antimicrobial agents
R1968
Sensitivity to meropenem and imipenem
pseudomonas strains isolated from various
patients’ material
M. Dedic, S. Tomanovic, L. Nikolic (Belgrade, CS)
Introduction: Pseudomonas stem consists of resistible, aerobian,
Gram-negative, non fermentation bacilli. They might cause
various human infections and they are most frequent agents of
intrahospital infections.
Purpose: Investigation of Pseudomonas strains sensitivity to
meropenem and imipenem.
Material and methods: At the IGO CCS in Belgrade, from
January 1st, 2004, till September 16th, 2004, a total of 131 strains
of Pseudomonas from various patients’ material were isolated. In
98 isolated strains, sensitivity to meropenem and imipenem was
investigated by Gel Diffusion Technique, using commercial
antimicrobial susceptibility test discs – Oxoid.
Results: Sensitivity to meropenem and imipenem was regis-
tered in 52/98 (53.06%), while 32/98 (32.65%) showed sensitivity
to meropenem and resistance to imipenem. Another 10/98
(10.2%) of isolated strains were resistant to both antibiotics
subject of this study. In 4 cases (4.08%), sensitivity to merope-
nem (S) was investigated, while sensitivity to imipenem was not
tested. Out of 131 isolated strains, 79 were Pseudomonas
aeroginosa, and in 61 strains, sensitivity to both meropenem and
imipenem was tested. 36/61 (59.01%) showed sensitivity to both
antibiotics. 16/61 (26.22%) were sensitive to meropenem and
resistant either intermediary resistant to imipenem. 7/71
(11.47%) were resistant to both investigated antibiotics. 52/131
were Pseudomonas species, and in 37, sensitivity to meropenem
and imipenem was investigated. 16/37 (43.24%) were sensitive
to both antibiotics. 16/37 (43.24%) showed sensitivity to
meropenem and resistance to imipenem. 3/37 (8.1%) isolated
strains showed resistance to both investigated antibiotics.
Conclusion: Isolated Pseudomonas strains demonstrate a high
resistance to imipenem. In the investigation period, Pseudomonas
strains resistant to meropenem were isolated for the ﬁrst time
ever. Considering that karbapenems are drugs of choice for the
treatment of multiresistant strains, appearance of high resistance
points to the necessity of their rational use.
R1969
The bacterial causes of nosocomial infections
associated with short and long term-catheter
R. Sadeq, H. Mowafy, M. El-Hosiny, M. Abdel-Motleb (Zagazig,
EGY)
The urinary tract infection is the most frequent site of nosoco-
mial infections, accounting for approximately 40% of all NCIs.
Catheterization is the most risk factor that predispose for such
UTI. Two hundred sixty-six strains (76%) out of 348 catheterized
patients were isolated. Out of these 266 strains, 212 cases were
identiﬁed as NCIs, 54 cases (20%) were identiﬁed as community
acquired infection. The isolated strains were found to be 202
(76%) Gram-negative bacilli, 32 (12%) S. aureus and 32 (12%)
Candida isolates. The organisms were more common in NCIs
than in community-acquired infections. Nosocomial infections
were higher in the urology ward than in other ward involved in
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the study. The most effective antibiotic against S.aureus was
vancomycin (100%). For Gram-negative bacilli, the most effect-
ive antibiotics were amikacin (for E. coli), tobramycin (for
P. mirabilis), cefotaxime (for K. pneumoniae) and ceftazidime (for
P. vulgaris and E. cloacae). High level of antimicrobial resistance
was noticed among P. aeruginosa, the most active antibiotic was
amikacin. ESBL production was nearly the same in both NCL
and community acquired infection, and it was highly prevalent
among isolates of P. mirabilis (26%), followed by E. coli (8%).
Other isolates showed no ESBL activity. Rough comparison of
susceptibility results of E- test (ceftazidime strip) with that of
disc diffusion and agar dilution methods in detection of the
susceptibility test of the organisms to the antibiotic used. As
regard the plasmid proﬁle, it seemed that there is no particular
association between the plasmid content and ESBL activity of
the isolated nosocomial strains of both E. coli and P. mirabilis to
explain interspecies relationship.
———————
NCI = nosocomial infection
UTI = urinary tract infection
ESBL = extended spectrum B-lactamase
R1970
Bacteraemia – prevalence and antibiotic
resistance among clinical isolates from Slovakia
J. Blahova, K. Kralikova, M. Babalova, V. Krcmery
Sr. (Bratislava, SVK)
Objectives: Bacteraemia represents a serious complication in
hospitalized patients. Problems of therapy of bacteraemia
increase with the emergence of antibiotic resistance. The aim
of this study was to monitor the prevalence of pathogens and
trends of resistance in bacteria isolated from blood.
Methods: Six University Clinics and/or Regional Hospitals
have participated in the study and a total of 1795 isolates were
collected during 2002–2004. Microbiological diagnosis was
performed according to standardized methods in participating
laboratory. Antimicrobial resistance was estimated by the disc
diffusion method by NCCLS.
Results: The most prevalent organisms were coagulase negative
staphylococci (CONS) (28.7%), Staphylococcus aureus (14%),
among Gram-negative bacteria Escherichia coli (13.4%), Klebsiella
pneumoniae (9.3%) and Pseudomonas aeruginosa (6.4%) followed
by enterococci, Enterobacter spp. and Acinetobacter spp. All
CONS and S. aureus were susceptible to vancomycin, resistance
to oxacillin was observed for 55–74% of CONS and only for 2–
19% of S. aureus isolates. Enterococcus spp. isolates were fully
susceptible to vancomycin and teicoplanin. Resistance to amox-
icillin-clavulante increased from 9 to 35% among E. coli.
Ciproﬂoxacin-resistance of K. pneumoniae isolates increased from
19 to 41%, despite this, ciproﬂoxacin together with carbapenems
(100% susceptibility) was the most effective drug against
K. pneumoniae. The most effective antibiotics against P. aeruginosa
were meropenem, amikacin, piperacillin/tazobactam. Resist-
ance to ceftazidime increased from 13 to 40% among
P. aeruginosa. Imipenem retained 100% activity against Enterob-
acter spp. isolates, considerable was increasing of resistance to
ciproﬂoxacin (from 15 to 58%). Resistance to meropenem,
amikacin, ampicillin/sulbactam and cefoperazon/sulbactam in
Acinetobacter spp. was relatively low.
Conclusions: Staphylococci, i.e. CONS and S. aureus have been
identiﬁed as the most frequent causal agents of bacteraemia
during all study period. The most signiﬁcant rise in resistance
was observed in ciproﬂoxacin against Enterobacter spp., E. coli
and K. pneumoniae. Considerable is still good activity of
carbapenems in Gram-negative and 100% efﬁciency of vanco-
mycin and teicoplanin in Gram-positive bacteria. Surveillance of
antibiotic resistance provides data about efﬁciency of antimicro-
bials in given locality and is important part of measures
maintaining good antibiotic activity.
R1971
Comparative in vitro activity of ertapenem
against ESBL-producing E. coli and
K. pneumoniae isolated in Spain
J. R. Hernandez, L. Romero, C. Velasco, L. Martinez-Martinez,
A. Pascual (Seville, E)
Objectives: To study the in vitro activity of ertapenem against
ESBL-producing E. coli and K. pneumoniae isolated in Spain.
Methods: E. coli (289) and K. pneumoniae (174) isolates from a
Spanish multicentre study performed in 2000 (40 hospitals) and
from the University Hospital Virgen Macarena in Seville
(1995–2002) were included. ESBL production and antimicrobial
susceptibility (betalactams, betalactams + betalactamase inhibi-
tors, ciproﬂoxacin, aminoglycosides and co-trimoxazole) was
determined by microdilution (NCCLS guidelines). Ertapenem
activity was analysed according to clonal relationship (REP-PCR),
ESBL-type (PCR and ESBL-gene sequencing) and acquisition of
infection (community or nosocomial).
Results: The in vitro activity of ertapenem was as follows:
(Graphic 1)
All the isolates were susceptible to carbapenems. Resistance
(resistant + intermediate isolates) of ESBL-producing E. coli and
K. pneumoniae were: piperacillin-tazobactam 22% and 53%,
ciproﬂoxacin 71% and 34%, co-trimoxazole 65% and 60%, amika-
cin 8%and7%,gentamicin36%and48%, and tobramycin44%and
63%, respectively. No signiﬁcant differences were detected
among the clones found. Ertapenem was equally active against
all ESBL families (SHV, TEMandCTX-M) evaluated. Only four E.
coli and one K. pneumoniae isolates had a MIC of ertapenem
>0.5 lg/ml but still in the susceptibility range. Excluding these
isolates, all coming from hospitalised patients, no difference in
activity was observed according to the origin of infection.
Conclusions: Ertapenem showed an excellent in-vitro activity
against ESBL-producing E. coli and K. pneumoniae. Ertapenem
activity was similar to that of imipenem and meropenem but
higher than that of other antimicrobials tested. No differences in
activity were observed according to geographical origin, clonal
relationship and type of ESBL.
R1972
Effect of beta-lactamase-inhibitor concentrations
on in vitro test results with piperacillin/
tazobactam and piperacillin/sulbactam
H.Grimm, J.Wagner,A.C. Rodloff (Weingarten, Berlin, Leipzig,D)
Objectives: Recently, DIN 58940 was altered, now recommend-
ing to test the beta-lactamase inhibiting effect of Sulbactam in
presence of a constant concentration of 4 mg/L instead of
E. coli (n = 289) Ertapenem Imipenem Meropenem
RANGE <0.03–4 <0.03–1 <0.03–0.5
MIC50 <0.03 0.125 <0.03
MIC90 0.125 0.25 <0.03
K. pneumoniae (n = 174)
RANGE <0.03–4 <0.03–1 <0.03–0.25
MIC50 <0.03 0.125 <0.03
MIC90 0.25 0.25 0.06
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previously 8 mg/L. The present study was performed to assess
the effect of this change on the MIC distributions of E. coli for
Piperacillin/Sulbactam (P/S) as compared to Piperacillin/
Tazobactam (P/T) with Tazobactam tested at a concentration
of 4 mg/L.
Methods: The in-vitro activity of Piperacillin without and with
Tazobactam or Sulbactam, respectively, against E. coli (n = 2856
in Leipzig, n = 420 in Berlin) was tested by means of microdi-
lution MIC determinations as recommended by DIN 58940
using a ﬁxed concentration of 4 mg/L of Tazobactam and 4 as
well as 8 mg/L of Sulbactam.
Results: On the basis of MIC breakpoints according to DIN, the
superiority of P/T over P/S is maximal in Piperacillin-resistant
E. coli and minimal in Piperacillin-intermediate E. coli. The
recently recommended reduction of the ﬁxed Sulbactam con-
centration (from 8 to 4 mg/L) in susceptibility tests leads to
reduced susceptibility in Piperacillin-intermediate E. coli, too.
The results are as follows: (table)
Conclusion: The recently recommended 4 mg/L ﬁxed concen-
tration of Sulbactam in testing procedures shows that the
in-vitro activity of P/T exceed those of P/S not only in
Piperacillin-resistant but also in Piperacillin-intermediate E. coli.
These results are credible because of the stronger inhibition of
TEM-1 lactamases by Tazobactam in comparison to Sulbactam.
R1973
The inhibition of microbial adhesion in the
presence of immune compounds on the human
cell culture model
A.G. Aﬁnogenova, G.E. Aﬁnogenov (St. Petersburg, RUS)
Objectives: To comparatively evaluate the inﬂuence of the
commercial preparations of normal human immunoglobulin
(Russia), Intraglobin and Pentaglobin (Biotest, Germany) on the
clinical strain S. aureus adhesion to the human embryonic skin
ﬁbroblasts in culture.
Methods: The clinical isolate of S. aureus with the highest
adhesive capacity was selected in the model of it’s co-incubation
with the target cells in culture. The inoculums was prepared at a
baseline concentration of 108 cfu/ml after 24 h grown on meat-
peptone agar. The antiadhesive activity of the normal human
immunoglobulin (NHI), Intraglobin and Pentaglobin at a base-
line concentration of 20 lg/ml was assessed. The estimation of
the inﬂuence of the agents under investigation on the bacterial
adhesion process was performed on the above mentioned model
of co-incubation of microorganism and the target-cells in culture
as well as using 1 h pre-incubation with agents to be tested. Also
the experiments were held in the presence Protein A from the
staphylococcus cell wall as well as clostridial collagenasum and
animal hyaluronidasum. The intensity of bacterial adhesion and
antiadhesive properties of used compounds were expressed as
following indices: Index of adhesion (IA) calculated as mean
number of attached microbes per one eukaryotic cell; Percent of
affected cells of the monolayer (AC%); Microbial contamination
of the monolayer (MC) obtained as a product of IA•AC%;
Percent of inhibition of bacterial adhesion (II%) calculated from
the ﬁgures of IA with respect to the control.
Results: All preparations revealedmore or less signiﬁcant inherent
antiadhesive activity in vitro, which became apparent in the
reduction of all indices characterizing colonization of target-cells.
Most effective proved to be the preparations with 1 hour pre-
incubation with clinical isolate of S. aureus which protected ﬁbro-
blasts against the bacterial adhesion in more than 92% in this case.
Conclusion: The protective effect of NHI and Intraglobin disap-
peared with addition of Protein A, collagenasum or hyaluronida-
sum to nutrient medium but remained the same for Pentaglobin.
According to its speciﬁc polymeric structure and prospective
form as well as content of IgM Pentaglobin possesses much more
antiadhesive activity in the presence of Protein A, collagenasum
or hyaluronidasum. In the presence of Protein A and enzymes
IgM makes the antiadhesive activity of Pentaglobin irreversible.
R1974
EDTA (ethylenediamine tetraacetic acid)
enhances the activity of tetracycline in
P. aeruginosa by increasing drug accumulation
A. Sudano Roccaro, A.R. Blanco (Catania, I)
Objectives: In this work we investigated the potentiating effect
of EDTA on tetracycline, versus resistant P. aeruginosa strains.
Methods: We ﬁrst assessed, through MIC determination, the
effect of EDTA/tetracycline association on two tetracycline
resistant P. aeruginosa strains. Next, through ﬂuorescence micr-
oscopy, we evaluate the accumulation of tetracycline inside
bacterial cells in presence or not of EDTA; moreover, pre-
exposing cells to EDTA and successively (after washing them) to
tetracycline, we evaluate if differences in tetracycline accumu-
lation in presence of EDTA could be due only to its effect on the
bacterial cell wall.
Results: Data show as EDTA, at sub-MIC concentrations is able
to reduce the MIC for tetracycline. Fluorescence microscopy
shows as cells, in presence of EDTA, accumulate much more
tetracycline inside them respect cell directly exposed to tetra-
cycline alone and also respect cells pre treated with EDTA and
successively exposed to the drug.
Conclusion: Thus we argue that EDTA is able to improve
tetracycline MICs of resistant P. aeruginosa strains, not only
permeabilizing the external cell wall, but increasing in other
ways the bacterial tetracycline accumulation, perhaps interfer-
ing with the drug extrusion machinery.
R1975
Repeated in vitro exposure of Clostridium difﬁcile
to metronidazole, vancomycin and linezolid does
not result in resistance
C. Schmidt, G. Ackermann, A.C. Rodloff (Leipzig, D)
Objective: Clostridium difﬁcile remains the major cause of
nosocomial diarrhoea. First line therapeutics for the treatment
of C. difﬁcile associated diarrhoea are metronidazole and
vancomycin. Meanwhile impaired susceptibility was observed
for both substances, however not directly linked to treatment
failures. On the other hand, as many as 20% of patients had at
least one recurrence of CDAD after the initial therapy was
Cumulative % of strains inhibited at MIC (The intermediate
range is in bold)
Cumulative % of strains inhibited at MIC (The intermediate
range is in bold)
Piperacillin Origin n Antibiotic 0.5 1 2 4 8 16 32 64
resistant Leipzig 650 PIT (4) 1.1 4.5 42.0 64.6 72.5 78.0 81.2 86.2
Berlin 74 PIT (4) 0.0 6.8 48.6 67.6 70.3 77.0 82.4 83.8
Leipzig 650 PIS (8) 0.8 1.5 10.8 22.0 31.5 45.2 56.9 70.2
Berlin 74 PIS (8) 0.0 1.4 17.6 28.4 39.2 55.4 70.3 82.4
Berlin 74 PIS (4) 0.0 0.0 0.0 10.8 17.6 39.2 55.4 74.3
intermediate Leipzig 631 PIT (4) 3.3 15.4 72.1 90.8 96.5 99.5 100 100
Berlin 107 PIT (4) 0.0 21.5 77.6 90.7 99.1 100 100 100
Leipzig 631 PIS (8) 10.1 24.7 63.5 84.0 93.3 97.8 99.4 100
Berlin 107 PIS (8) 7.5 31.8 78.5 91.6 99.1 100 100 100
Berlin 107 PIS (4) 0.0 1.9 23.4 78.5 90.7 100 100 100
susceptible Leipzig 1575 PIT (4) 5.5 23.0 87.0 99.6 99.9 100 100 100
Berlin 239 PIT (4) 2.9 36.0 90.4 100 100 100 100 100
Leipzig 1575 PIS (8) 57.4 87.7 98.0 99.8 99.9 99.9 99.9 99.9
Berlin 239 PIS (8) 64.4 94.1 100 100 100 100 100 100
Berlin 239 PIS (4) 15.5 67.4 98.3 100 100 100 100 100
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discontinued. Routine susceptibility testing is performed in few
and specialized laboratories only. Therefore data on activity of
both substances are limited. The potency of resistance develop-
ment against vancomycin and metronidazole is not known.
Linezolid is a new antimicrobal agent active against gram-
positive bacteria.
Methods: Selection of resistant mutants of the ATCC strain
43255 (MIC in mg/l for metronidazole, vancomycin, linezolid:
0.064, 0.5, 0.75) was performed on supplemented agar plates
containing increasing amounts of the antimicrobials. Bacteria
collected from ﬁve agar plates (after 48 h growth) were collected
and centrifuged. The pellet was re-suspended and exposed to
the next higher antimicrobial concentration on agar plates.
Results: Repeating this procedure several times 7, 2 and 3
generations of bacteria for metronidazole, vancomycin and
linezolid were generated, respectively. The bacteria were ﬁnally
exposed to 5 mg/l metronidazole 2.0 mg/l vancomycin and
5 mg/l linezolid. Using Etest MHC values of 1.5 (23 · MHC), 2
(4 · MHC) and 2 (2.7 · MHC) mg/l could be conﬁrmed.
Conclusion: Higher MHC values but not resistance could be
selected in vitro in C. difﬁcile against metronidazole, vancomycin
and linezolid. This conﬁrms the clinical observation that
C. difﬁcile bacteria resistant to metronidazole or vancomycin do
not attribute to therapeutic failures in the treatment of CDAD.
R1976
Susceptibility rates of pathogens isolated from
ICU and haematology patients against different
antibiotics recommended for empiric treatment
B. Grabein (Munich, D)
Objectives: Infections in the ICU and haematology unit are a
main risk factor for mortality due to inadequate antibiotic
treatment. In this study we evaluated the in vitro activity of
different broad spectrum antibiotics. Cefepime, imipenem,
meropenem and piperacillin/tazobactam are recommended
treatment options in international and German guidelines for
treatment of severe infections in ICU or haematology patients.
Local data regarding epidemiology and resistance rates should
be considered in treatment decisions.
Methods: Over a period of three month in 2000, 2001, 2002
and 2003 pathogens isolated from patients in the ICU or
haematology unit have been collected. In vitro activity was
investigated by broth microdilution according to NCCLS
standards. Reference test strains were E. coli ATCC 25922,
S. aureus ATCC 29213, P. aeruginosa ATCC 27853 and E. faecalis
ATCC 29212.
Results: The strains were mainly isolated from lower respirat-
ory tract (tracheal aspirate, sputum) followed by blood and
urine. In total 160 isolates of enterobacteriaceae, nonfermentive
bacteria (P. aeruginosa and Acinetobacter spp.) and staphylococci
(MSSA, MSSE) have been isolated in the year 2003 and in vitro
activity of piperacillin/tazobactam (P/T), ceftazidime (CAZ),
cefepime (CEP), imipenem (IMI) and meropenem (MERO) has
been determined by MIC-testing. Differences in susceptibility
rates regarding enterobacteriaceae (n = 71) were seen in Ente-
robacter spp. (CEP 100%, IMI 100%, MERO 100%, P/T 72% and
CAZ 67%) and Klebsiella spp. (CEP/IMI/MERO 100%, CAZ
95%, P/T 86%). In nonfermentive bacteria (n = 38) P. aeruginosa
and Acinetobacter spp. susceptibility rates were highest for
MERO (86%, 100%) followed by CEP (86%, 94%) IMI (76,%,
100%), CAZ (81%, 94%) and P/T (71%, 94%). Susceptibility of
P. aeruginosa against IMI decreased from 100% in the year 2000
to 76% in the year 2003. Susceptibility rates in other bacteria
remained mainly stable over the years regarding all antibiotics.
In methicillin susceptible staphylococci (n = 51) IMI, MERO,
CEP and P/T showed excellent activity (MIC90?1 mg/l),
whereas CAZ activity was signiﬁcantly lower (MIC90 8 mg/l).
Conclusion: In our investigation regarding enterobacteriaceae,
nonfermentive bacteria (P. aeruginosa, Acinetobacter spp.) and
staphylococci (MSSA, MSSE) isolated from ICU and haematol-
ogy patients susceptibility rates where highest for MERO and
CEP followed by IMI, CAZ and P/T.
R1977
Carbapenem comparisons in P. aeruginosa
isolated from Brazilian hospitals: MYSTIC
Program Brazil 2004
C.M. Mendes, C.R. Kiffer, A.C. Arruda, P.J. Turner, P.C. Koga,
C. Oplustil, J.L. Sampaio on behalf of the MYSTIC Group Brazil
Objective: To compare the susceptibility patterns of P. aerugi-
nosa clinical isolates for imipenem and meropenem in the
MYSTIC Program Brazil 2004.
Methods: Four hundred and thirty-three P. aeruginosa clinical
isolates were collected by 18 centres participating in the 2004
MYSTIC Program edition in Brazil. Minimum inhibitory con-
centrations (MICs) were determined to imipenem, meropenem
and another seven antimicrobials at a central laboratory by
E-test methodology according to manufacturer’s instructions.
Interpretations followed the NCCLS document M100-S14. Sus-
ceptibility and cross-resistance rates to both carbapenems were
calculated.
Results: P. aeruginosa clinical isolates (n = 433) showed 45%
susceptibility (S), 3.2% intermediate (I), and 51.8% resistance
(R) to meropenem (MIC50 = 16 mg/L). As for imipenem
(MIC5 = 32 mg/L), there were 39.3% S, 2.5% I, and 58.2%
R. Of the 252 imipenem-resistant isolates, 23 (9.1%) were
susceptible and 10 (4%) were intermediate to meropenem. Of
the 224 meropenem-resistant isolates, 3 (1.3%) were susceptible
and 2 (0.9%) were intermediate to imipenem.
Conclusions: Although decreased susceptibility rates were
observed for both carbapenems, meropenem resistance rate was
lower than the detected for imipenem. Furthermore, some
imipenem-resistant isolates were still susceptible to meropenem,
while the opposite was less frequent. However, biased sample
cannot be ruled out, since centres are carbapenems users by
study design requirements and isolates could have been
overvalued due to their resistance patterns.
R1978
Activity of meropenem against Gram-negative
isolates from the intensive care unit – Part of the
MYSTIC (Meropenem Yearly Susceptibility Test
Information Collection) Programme, 1997–2004
J.A. Patzer, D. Dzierzanowska, A. Pawinska,
P.J. Turner (Warsaw, PL; Macclesﬁeld, UK)
Objective: The antimicrobial resistance of nosocomial isolates,
especially from intensive care units (ICUs), is increasing world-
wide. The aim of this analysis was to assess the in vitro activity
of meropenem (MEM) and eight other antibiotics against Gram-
negative isolates from a paediatric ICU.
Methods: Eight hundred and eighty Gram-negative isolates
were obtained from clinical specimens of children hospitalized
in ICU during 1997–2004. The isolates were identiﬁed using
conventional methods. The Minimum Inhibitory Concentrations
(MICs) of MEM, imipenem (IMP), piperacillin + tazobactam
(TAZ), cefotaxime (CTX), ceftazidime (CAZ), cefepime (CPE),
gentamicin (GM), tobramycin (TM) and ciproﬂoxacin (CIP) were
determined using the NCCLS agar dilution method.
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Results: The collection of Gram-negative isolates included
Escherichia coli (n = 127), Enterobacter cloacae (n = 173), Klebsiella
oxytoca (n = 71),Klebsiella pneumoniae (n = 151),Serratiamarcescens
(n = 37), Acinetobacter baumanii (n = 79), Pseudomonas aeruginosa
(n = 178) and other species (n = 64). MEM, IMP and CIP were
most active (>90% susceptibility) against the tested isolates. The
overall order of activity of beta-lactamantibioticswasMEM>IPM
> CPE > TAZ > CAZ > CTX. The MIC90 (mg/L) of MEM was
nearly identical in 1997 and 2004. It was equal to 0.06 for
Enterobacteriaceae, 1.0 for A. baumanii and 8.0 for P. aeruginosa.
The MIC90 (mg/L) of IMP was equal to 0.25 for Enterobacteri-
aceae, 1.0 for A. baumanii and 16 for P. aeruginosa. During 1997–
2004, among Enterobacteriaceae were only found three isolates
(two E. cloacae and one E. amnigenus) resistant to carbapenems.
Among IPM-resistant P. aeruginosa isolates no metallo-
beta-lactamase producing strains were found. Susceptibility
to GM and TM characterized 63.7% and 61.8% of the tested
isolates, respectively. The incidence of extended-spectrum
beta-lactamases and AmpC beta-lactamases producing isolates
among Enterobacteriaceae decreased from 68.5% in 1997 to 35.4%
in 2004.
Conclusions: MEM, IMP and CIP were the most active antibi-
otics (>90% susceptibility) against the tested strains, with no
observed reduction in activity over 8 years. A greater proportion
of P. aeruginosa isolates were susceptible to MEM compared to
IPM.
R1979
Comparison of in vitro activity of cefepime alone
or in combination with sulbactam against clinical
strains of multi-drug resistant Acinetobacter spp.
K.L. Leuthner, M.J. Rybak, H.S. Sader, R.N. Jones (Detroit, North
Liberty, USA)
Objectives: With the increase in multi-drug resistant Acinetob-
acter spp. (MDR-A) there is an urgency for unique and effective
antimicrobial regimens. The objective of this study was to
determine the effect of cefepime (C) alone and in combination
with sulbactam (S) against MDR-A isolates in an in vitro
pharmacodynamic model.
Methods: Three clinical strains of MDR-A: 15-11270A; 86-3473
and 15-2016 were used. A previously described in vitro PD
model was used to evaluate a variety of antibiotic regimens
using a starting inoculum of 1 · 106 CFU/ml over 72 h. C
dosing was simulated at 2 g per dose, where S was given as a 2:1
or 1:1 ratio concentration. Regimens evaluated included dosing
every 8 or 12 h, along with continuous infusion (CI) individually
or combined. When combined, the activity was evaluated for
drug ratios oft both 2:1 and 1:1 of C to S.
Results: MIC testing against C and S for 15-11270A, 86-3473
and 15-2013 were 32, 32 and 4 lg/ml and 2, 8, and 2 lg/ml,
respectively. Simulations utilizing single agents resulted in an
initial drop in inoculum, however, regrowth up to the original
organism density was demonstrated irregardless of dosing
regimen. Combination regimens of C+S resulted in a greater
kill at 72 h compared to individual agents. The phar-
macodynamics in combination appeared to increase as a
function of the dosing interval. When compared to the most
effective single regimen, CI(1:1) against 15-11270A showed
additivity (>1.5 log kill), whereas C+S every 8 h against 86-
3473 resulted in synergistic killing (>2.5 log kill). Resistance at
either 2 or 4 · MIC was demonstrated throughout these
models irregardless of regimen or drug, however with few
exceptions, individual MICs did not vary at 72 h compared to
baseline.
Conclusion: Combination of C and S demonstrated additivity
or synergy against MDR-A. Improved activity appeared to be a
function of the dosing interval, for instance the shorter intervals
such as every 8 h or CI were more effective. Further inves-
tigation of C + S combination treatment for MDR-A is
warranted.
R1980
Comparative in vitro activity of tigecycline and 14
other antimicrobial agents against 205 clinical
isolates from a university general hospital in
Athens, Greece
E. Koratzanis, M. Souli, F. Kontopidou, S. Athanasia,
Z. Chryssouli, I. Galani, G. Poulakou, A. Antoniadou, R. Vorou,
H. Giamarellou (Chaidari, GR)
Background: Continuous rise of resistance rates among nosoco-
mial isolates create an urgent need for new antimicrobial agents
potent against multiresistant pathogens. Tigecycline (TIG) is a
novel glycylcycline with an expanded spectrum of activity
against both Gram-negative and Gram-positive bacteria resist-
ant to many other compounds. We compared the activity of TIG
to that of 14 other broad-spectrum agents against a variety of
pathogens isolated in the Infectious Diseases Research Laborat-
ory in University General Hospital ’’Attikon’’ in Athens, Greece.
Methods: A total of 144 consecutive clinical isolates collected
between January and October 2004 were included in the
study. Only one isolate per species per patient was permitted.
Isolates derived from various clinical sources such as blood,
pus, sputum or bronchial secretions, bone and urine. MIC’s
were determined by the microdilution method according to
NCCLS. Microtiter plates were provided by Wyeth Pharma-
ceuticals and were inoculated using a RENOK system, as
instructed by the manufacturer. Methicillin resistance was
determined by the cefoxitin disk diameter, as recommended
by the NCCLS. For another collection of 61 multiresistant
Gram-negative strains isolated the past 6 months from ICU
patients, susceptibility to TIG was determined by the disk
diffusion method and interpreted according to the manufac-
turer’s recommendations.
Results: MIC90 (mcg/ml) of some of the tested compounds
were as follows: Of 61 ICU isolates 26 (42.6%) were resistant to
all currently available agents except colimycin. Eighteen of
these strains (69.3%) were susceptible to TIG. TIG was active
against isolates resistant to all other available agents.
TIG; Tigecycline, A/C; Amoxycillin/Clavulanic acid, PTZ; Piperacillin/
Tazobactam, LEVO; Levofloxacin, CAZ; Ceftazidime, FEP; Cefepime,
IMI; Imipenem, VA; Vancomycin, NA; Not applicable. 
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Conclusions: TIG is a potent compound with a wide spectrum
of activity against Gram-positive and Gram-negative problem-
atic bacteria, with the exception of P. aeruginosa. It could be an
alternative to colimycin against multiresistant isolates causing
infections in ICU patients.
Mechanisms of action and of resistance of antimicrobial drugs
R1981
The antibiotic resistance and metallo-b-lactamase
production of carbapenem-resistant
pseudomonas and acinetobacter
F. Yildirim, G. Sengoz, K.K. Yasar, S. Karabela, D. Berzeg,
S.B. Kutlu, Y.B. Durdu, O. Nazlican (Istanbul, TR)
Objectives: The betalactamase resistance mechanism are, outer
membrane protein mutation, efﬂux pumbs and metallo-betalac-
tamases (MBL). MBL enzymes which uses Zinc ion can
hydrolyse betalactamase antibiotics and are usually found in
Enterobactericeae ve and especially in Pseudomonas aeruginosa
like nonfermentative bacteria. The genes encoding MBL are
named as IMP, VIM, SPM and GIM, usually transmitted via
plasmids. Their importance are that they hydrolyse all betalac-
tam and betalactam inhibitor combinations except aztreonam.
Especially the abundance of strains producing MBL in hospitals
must be evaluated with care.
Methods: In our study carbapenem resistant 13 Pseudomonas
aeruginosa and 10 Acinetobacter spp. strains isolated from various
clinical samples sent to our clinical microbiology laboratory
were tested for MBL production by MBL E test and for their
susceptibilities for ciproﬂoxacin (CIP), gentamicin, amicasin,
aztreonam, piperacillin-tazobactam (TZP), ve cephaperazon-
sulbactam by disk diffusion test.
Results: Out of Carbapenem resistant 23 strains 21 were found
MBL positive with E Test method. 23 strains were sensitive 29%
for TZP, 28% for CIP, 17% for gentamicin, 19% for amikacin and
18% for cephaperazon sulbactam. Carbapenem resistant strains
were mostly resistant also for the other antibiotics.
Conclusion: As a result carbapenem resistance in Gram negat-
ive aerob and anaerobe bacteria due to MBL is a popular but
difﬁcult problem to solve.
R1982
Emerging resistance of bacterial strains causing
complicated and uncomplicated urinary tract
infections to current antimicrobials
M. Diab, A. El-Baz (Giza, EGY)
Objective: The aim of the current study was to highlight some
of the susceptibility patterns of bacterial pathogens responsible
for complicated and uncomplicated urinary tract infection (UTI)
and to assess the prevalence of antimicrobial resistance among
such uropathogens.
Methods: Ninty-nine patients were divided into two groups: 58
with complicated and 41 with uncomplicated UTI. All urine
specimens revealed signiﬁcant bacteruria. Gram negative and
positive isolates were identiﬁed to the species level. Antimicro-
bial susceptibility testing was performed by Kirby-Bauer disc
diffusion for all isolates. Detection of extending spectrum beta-
lactamases (ESBLs) producing organisms was performed by
screening test and oxoid combination test (CDO2). Also detec-
tion of methicillin (oxacillin) resistant (MR) Staphylococci was
performed by oxacillin disc diffusion assay. Resistance was
conﬁrmed by measuring minimal inhibitory concentrations
(MIC)by E test.
Results: Escherichia coli (E. coli) recordeda signiﬁcant higher rate of
isolation among uncomplicated UTI group (53.7%) than that of
complicatedgroup(24.1%).Gramnegative isolatesother thanE. coli
was 41.3% of the complicated UTI. Gram positive isolates were
32.3% with higher percentage among complicated UTI (34.4%).
E. coli, Enterobacter and Citrobacter spp. isolates of uncomplicated
UTI group were susceptible to commonly used drugs as amoxa-
cillin/clavulanate, nitrofurantoin, aminoglycosides, cepholospo-
rins and quinolones. While Klebsiella and Enterobacter spp. of
complicated group were absolutely resistant to trimethoprim/
sulfamethazole (MIC 16–32 lg/ml) and recorded low rate of
sensitivity to amoxacillin/clavulanate and ampicillin/sulbactam
(MIC > 256 lg/ml). ESBLs-producing organismswere 23.8%, 75%
of which belong to complicated UTI. All S. aureus of both groups
were susceptible to ampicillin, beta-lactamase inhibitors, amino-
glycosides and cephalosporins (75%). Among Staphylococcus
isolates 36.4% were MR S. aureus (MRSA) and MR S. epidermidis.
Imipenem and meropenem remained the most potent antibiotic
(100%) to Gram negative and positive isolates.
Conclusion: Antibiotics commonly used in UTI are still effect-
ive particularly in community acquired uncomplicated UTI.
Antimicrobial resistance is more common when complicated
factors are present. So, it is crucial to have regular monitoring of
such resistance to make reliable information available for
optimal empirical therapy for patients with UTI.
R1983
High frequency of mutator strains in
multiresistant Pseudomonas aeruginosa in cystic
ﬁbrosis patients from Germany
B. Henrichfreise, I. Wiegand, B. Wiedemann (Bonn, D)
Objectives: Pseudomonas aeruginosa infectionsare themajor cause
ofmorbidity andmortality in cystic ﬁbrosis (CF) patients. Rates of
multiresistance among Pseudomonas aeruginosa strains isolated
fromCFpatients are substantiallyhigher than amongPseudomonas
aeruginosa strains from other settings. Mutator strains are charac-
terized by increasedmutation ratesmainly due to defects in genes
involved in theDNAmismatch repair system. In a previous study
a link between high resistance rates in CF patients and the
presence of a high portion of mutator Pseudomonas aeruginosa
strainswas found.Theobjectiveof our studywas to investigate the
proportion of mutators among multiresistant Pseudomonas aeru-
ginosa from CF patients in Germany.
Methods: Multiresistant Pseudomonas aeruginosa strains from CF
patients were collected in a German hospital in 2004. Only one
isolate per patient was permitted. Multiresistance was deﬁned
as reduced susceptibility (intermediate or resistant according to
DIN guidelines) to at least four of the following class represent-
atives: imipenem, ceftazidime, piperacillin, ciproﬂoxacin and
gentamicin. The detection of mutators was performed by disk
diffusion. Mutation frequencies were determined in triplicate on
selective rifampicin agar plates. As previously deﬁned, strains
were designated hypermutable when the mutation frequency
was at least 20-fold higher than that of the wildtype strain PA01.
Results: A total of 26 multiresistant Pseudomonas aeruginosa
strains was collected. Of those 12 (46%) had increased mutation
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rates ranging from 5.85 · 10)7 to 1.43 · 10)5. Eight mutator
strains showed reduced susceptibility to all ﬁve and four
mutator strains to four class representatives.
Conclusions: Comparable to a previous study, in Germany the
rate of mutator strains is also extremely high among multire-
sistant Pseudomonas aeruginosa isolates from CF patients. Our
data underlines the link between hypermutation and the
evolution of antibiotic resistance in CF patients.
R1984
Mechanisms involved in carbapenems resistance
among isolates of Pseudomonas aeruginosa
strains
B. Kowalska-Krochmal, R. Franiczek, I Dolna, B. Krzyzanowska,
E. Litwinek, I. Choroszy-Kro´l, J. Ruczkowska (Wroclaw, PL)
Objectives: The aim of the study was to determine the role of
the permeability as well as metalloenzyme production in
carbapenems resistant P. aeruginosa strains.
Method: Thirty strains of P. aeruginosa determined as resistant
to one or two carbapenems (imipenem, meropenem) by disc
diffusion (NCCLS) and E-test (AB Biodisk) methods were
enrolled in this study. MICs of imipenem (IPM), meropenem
(MEM), erythromycin (E), gentamicin (GM), cefoperazone
(CFP), norﬂoxacin (NOR), piperacillin (PIP), tetracycline (T),
chloramphenicol (C), EDTA, sodium hexametaphosphate (NaH-
MP) were determined by agar dilution method according to
NCCLS. To estimate the role of the permeability MIC values
were also determined in the presence of different concentrations
of outer membrane (OM ) permeabilizers: EDTA (0.1 mM,
1 mM, 2.5 mM) and NaHMP (100 mM, 200 mM, 300 mM).
Detection of metallo-b-lactamases was performed by disc
diffusion method using 2-mercaptopropionic acid and EDTA
(as metalloenzyme inhibitors) as well as PCR using speciﬁc
primers bla IMP1-A 5¢- ACC GCA GCA GAG TCT TTG CC -3¢
and bla IMP1-B 5¢- ACA ACC AGT TTT GCC TTA CC-3¢.
Results: Among 30 P. aeruginosa studied strains 22were resistant
to two carbapenems while 8 were resistant only one of them.
Twenty-seven strains were resistant to GM, 26 to T, 18 to NOR, 17
to CFP. EDTA andNaHMPdecreasedMIC of E from 2- to 32-fold
and from 2- to 8-fold, respectively, MIC of GM from 2- to 16-fold
and from 2- to 4-fold, MIC CFP from 2- to 64-fold and from 2- to
64-fold, NOR only 2- to 8-fold and 2- and 2-fold, MIC of PIP from
2- to 4-fold and from 2- to 4-fold, MIC of T from 2- to 8-fold and
from 2- to 8-fold,MIC of C from 2- to 8-fold and from 2- to 16-fold.
Only 1 strain of P. aeruginosa resistant to CFP, 2 strains resistant to
PIP and 1 resistant to T became susceptible after treating with
EDTAand/orNaHMP.Fourof the30studiedstrainsweredetected
to produce metallo-b-lactamases by disc diffusion method. PCR
revealed that none of them was carring the bla IMP gene.
Conclusions: 1. Our results suggest that other metalloenzyme
(VIM) are involved in carbapenem-resistance in studied strains.
2. Inﬂuence of EDTA and NaHMP on MIC decreased may
indicate the role of permeability and efﬂux mechanisms in
carbapenem resistance.
R1985
Incidence of inducible clindamycin resistance in
staphylococci: ﬁrst results from Turkey
O¨. Kurt Azap, F Timurkaynak, G. Yapar, E. Kuru Inci, U¨. C¸agir,
H. Arslan (Ankara, TR)
Objective: To determine the incidence of constitutive and
inducible clindamycin resistance in a university hospital.
Methods: One hundred and ﬁve methicillin-resistant Staphylo-
coccus aureus (MRSA), 111 methicillin-sensitive S. aureus (MSSA),
192 coagulase-negative staphylococci (CoNS) (94 methicillin-
resistant) collected from consecutive clinical isolates were
studied. Isolates that were clindamycin-sensitive (CL-S) but
erythromycin-resistant (E-R) were tested for inducible resistance
by the D-test. CL and E disks were placed 15 mm apart from
centre to centre on Mueller–Hinton agar plates and the
D-shaped inhibition zones seen on the plates were interpreted
as D-test positive.
Results: Inducible clindamycin resistance was detected in 6
(5.7%) of 105 MRSA isolates, 4 (3.6%) of 111 MSSA isolates, 29
(30.8%) of 94 MR-CoNS isolates and 11 (11.2%) of 98 MS-CoNS
isolates. All MRSA strains that have ER-R CL-S phenotype were
D-test positive. The same results were obtained by using
azithromycin instead of erythromycin. All 408 staphylococcal
isolates tested were found to be susceptible to quinupristin–
dalfopristin.















ER-S CL-S 32 (30.4) 98 (88.2) 10 (10.6) 58 (59.1)
ER-R CL-R 67 (63.8) 5 (4.6) 43 (45.8) 14 (14.3)
ER-R CL-SD+ 6 (5.7) 4 (3.6) 29 (30.8) 11 (11.2)
ER-R CL-SD) 0 (0) 4 (3.6) 12 (12.7) 15 (15.3)
Total 105 111 94 98
Conclusion: Macrolides, lincosamides and streptogramins are
commonly used in the treatment of staphylococcal infections.
Increasing frequency of MRSA infections and the changes in the
antimicrobial susceptibility patterns have led to renewed inter-
est in the use of clindamycin in the treatment of such infections.
Clinical microbiology should report in vitro inducible clinda-
mycin resistance (MLSBi type) in staphylococci to alert phyisi-
cians about the potential treatment failures due to this resistance
pattern.
R1986
Detection of gyr A gene mutations in quinolone-
resistant clinical isolates of Pseudomonas
aeruginosa
M. El Gharbawy, M. El Mofty, H. Abd El Hady, M. El Shenity,
A. Moursi (Alexandria, EGY)
Objectives: To investigate the frequency of resistance of
P. aeruginosa to ﬂuoroquinolones and to detect gyrA gene
mutations in quinolone-resistant P. aeruginosa isolates obtained
from discharge of sinuses, middle or external ears of patients.
Methods: The 126 isolated strains were tested for susceptibility
to various antibiotics and those resistant to oﬂoxacin were tested
for point mutations in the gyr A gene using single strand
conformational polymorphism analysis ( SSCP, and by sequen-
cing in 2 selected strains.
Results: Twenty-eight (22.2%) out of the 126 isolates were
resistant to oﬂoxacin. Point mutation in gyrA gene was not
detected in any of the 28 quinolone resistant strains by SSCP.
However, by direct sequencing of the PCR- ampliﬁed gyrA
fragment from two clinical isolates, single mutation in which,
threonine at position 83 was substituted by an isoleucine, was
detected in both cases.
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Conclusion: SSCP was not a perfect method in the detection of
gyrA gene mutation (s) in clinical isolates of P. aeruginosa.
Conﬁrmation of SSCP by direct sequencing, or modiﬁcation of
the usual SSCP analysis ought to be considered in future studies.
R1987
Effects of a mixture of antibiotics on a resistant
bacterial strain during sewage treatment
R. Alexy, J. Unger, A. Brunswik-Tietze, J. Wiethan,
K. Ku¨mmerer (Freiburg, D)
Introduction: Recent research has shown that antibiotics are
present in the inﬂuent of municipal sewage treatment plants
(STP). Few data are available on elimination rates and effects of
antibiotics on bacteria present in the aeration tanks of sewage
treatment plants.
Methods: We investigated the fate and effects of antibiotics
during biological sewage treatment under standardized condi-
tions in laboratory scale sewage treatment plants (LSSTPs). The
plants were fed with a mixture of antibiotics whose composition
reﬂected the annual average input of antibiotics into German
municipal STPs. Two different concentration levels were
applied. In order to study its fate under antibiotic pressure, a
multi-resistant strain of Acinetobaer baumanniiwas added in high
concentration to some of the plants. The fate of the antibiotics
and of the multi-resistant strain were monitored by chemical
and microbiological means.
Results: The antibiotics were not fully eliminated in the LSSTPs.
After 2 weeks, the multi-resistant strain of Acinetobacter was no
longer detectable by classical microbiological, chemotaxonomi-
cal and PCR-based methods.
R1988
Evaluation of various conventional methods for
detection of methicillin resistance in
Staphylococcus aureus
E. Gu¨ndu¨z Kaya, S. Yagci, M. Yu¨cel, E. Karakoc¸ (Ankara, TR)
Methicillin resistant Staphylococcus aureus (MRSA), is a major
cause of nosocomial and community-acquired infections
throughout the world. Early detection of MRSA, is important
for both the treatment of the infected patients and the institution
of appropriate infection control measures. However, determin-
ation of methicillin resistance is often difﬁcult because of the
heterogenity of the resistance expression. In this study, various
conventional methods were compared with polymerase chain
reaction (PCR) for determination of oxacillin resistance. A total
of 160 clinical isolates of S. aureus were tested for oxacillin
resistance by disc diffusion, MRSA screen latex agglutination
test (Denka Seiken Co., Ltd., Tokyo, Japan), and the ATB Staph
System (bioMerieux, Marcy-lEtoile/France). The MIC value of
oxacillin was also determined with broth microdilution method
in 115 isolates. MecA gene was detected in 87 (54.4%) of 160
strains and 73 (45.6%) isolates were mecA negative with PCR.
Disc diffusion method failed to detect 1 mecA positive strain
and identiﬁed 2 mecA negative strains as oxacillin resistant.
MRSA screen test and the ATB Staph System detected 85 and 86
of the 87 mecA positive strains; respectively. They also identiﬁed
4 and 8 of mecA negative strains as oxacillin resistant; respect-
ively. The oxacillin MIC values were ‡ 4 lg/ml in 57 of 58 mecA
positive S. aureus isolates; and £ 2 lg/ml in 56 of 57 mecA
negative isolates with broth microdilution method. The sensi-
tivities of disc diffusion method, MRSA screen test, Staph ATB
System and broth microdilution method were 98.8%, 97.7%,
98.8%, and 98.2%; and the spesiciﬁcities were 97.2%, 94.5%, 89%,
and 98.2%; respectively against PCR as gold standard. The
differences in sensitivities or speciﬁcities were not statistically
signiﬁcant (p > 0.05).
R1989
Development of antibiotic resistance and the role
of differentiation in microbial bioﬁlms
J.A.J. Haagensen, M. Klausen, T. Tolker-Nielsen,
S. Molin (Lyngby, DK)
Cells attached to surfaces in bioﬁlms can be more tolerant to
various anti-microbial agents than their planktonic counterparts.
In bioﬁlm environments the cells have the ability to differentiate
and change phenotype leading to severe treatment problems in
many cases of persistent or chronic infections. An approach
addressing this issue identiﬁed speciﬁc resistant subpopulations
in Pseudomonas aeruginosa bioﬁlms and indicated that differen-
tiation plays an important role in this context. Bioﬁlms were
established in ﬂow-chambers, and their development and
responses to addition of colistin (a polymyxin) were monitored
by confocal scanning laser microscopy and time-lapse recording
together with use of live/dead staining. Initial results indicate
that modiﬁcation of LPS is an important factor in relation to
colistin tolerance development and may be the initiator of cell
differentiation as pmr mutant bioﬁlms of PAO1 result in
sensitivity to colistin.Results indicated furthermore a regulatory
connection between the composition of the cell envelope and cell
motility (twitching, swarming) and in that way a correlation
between motility and tolerance to anti-microbial agents. Tube
bioﬁlm experiments were set up for isolation of colistin treated
and non treated bioﬁlm material and further analysis of changes
happening in the differentiating population by use of micro
Array and LPS analysis.
Epidemiology of resistance, antibiotic usage
R1990
The evaluation of metallo-b-lactamase presence
with E-test in ﬁve imipenem resistant ﬁve
klebsiella strains
G. Sengoz, K.K. Yasar, F. Yildirim, D. Berzeg, S.B. Kutlu,
Y.B. Durdu, G. Altay, O. Nazlican (Istanbul, TR)
Objectives: Metallo-b-lactamases (MBL), are responsible enzy-
mes in resistance mechanisms of Enterobactericeae family and
nonfermentative Gram negatives. This resistance phenotype
spreading via plasmids, can be shown with E-test strips in
which on end is Imipenem and the other end is EDTA+
Imipenem. If the MIC values for Imipenem are 8-fold more then
the MIC values for EDTA+ Imipenem, it can be said that this
strain is producing MBL.
Methods: The isolated Imipenem resistant strains obtained
from various clinical materials are tested for MBL production
via E-test method. The strains were isolated in four patients in
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the Intensive Care Unit (ICU) and in one in the Internal
Medicine Ward. The resistant strains were isolated one from
blood in the patient in Internal Medicine Ward, two from
tracheal aspirates and two from blood in the patients in ICU.
Results: All of these strains were ESBL positive with double
disk synergy method. The resistant 1st, 3rd, 4th and 5th strains
were also resistant or intermediate susceptible for piperacillin
tazobactam and cefopearazone sulbactam. Only the 2nd strain
which was metallo-b-lactamase negative was susceptible for
piperacillin tazobactam and cefoperazone sulbactam. While four
strains among ﬁve were positive for Metallo-b-lactamase pres-
ence.
Conclusion: In our country the presence of ESBL is an import-
ant problem. The use of carbapenems to solve this problem
leaded to new problem, increase of carbapenem resistant
Klebsiella strains. Due to of antibiotic usage politics, the
carbapenem resistance due to MBL is now a popular problem
which is yet not solved.
R1991
Point-in-time prevalence survey of utilisation of
antibiotics in departments of surgical infection in
Russia: HIT-04 study results
L. Stratchounski, D. Galkin, A. Golub, E. Samuilo, A. Frolova,
A. Nikulin (Smolensk, RUS)
Objectives: To assess trends of utilization of antibiotics in
surgical infections departments of multidisciplinary hospitals
for evaluation of safety and efﬁciency of combinations.
Methods: Case histories of inpatients were evaluated from 23
August to 1 September 2004 in seven large Russian cities. Each
department of surgical infection was screened within one day
and all hospitalized patients were enrolled.
Results: Overall 300 case histories of hospitalized patients
were analysed. Of them, 179 (59.7%) were males and 121
(40.3%) were females with age 51.8 + 17.2 years. Length of
hospitalization at the moment of the study was 14.8 +
14.6 days. Of all patients 214 (71.3%) had undergone surgery.
Surgical infection was marked in 228 (76%) of patients.
Following infections were documented: skin and soft tissue
181 (79.4%), bone and joint 24 (10.5%) and intra-abdominal 23
(10.1%). Antibiotics were administered to 211 (70.3%) of
patients. Monotherapy and combination therapy received 129
(61.1%) patients and 82 (38.9%), respectively. There were 309
cases of administration of antibiotics and 305 (98.7%) were
given for the therapy and only 4 (1.3%) for the prophylaxis.
Three most often prescribed classes of drugs for monotherapy
were b-lactams 97 (75.6%), predominantly ampicillin 34 (26.4%)
and oxacillin 26 (20.2%); followed by lincosamides (lincomycin)
17 (13.2%), aminoglycosides 8 (6.3%). To notice, aminoglyco-
sides were prescribed to 51 (17.0%) of all patients who received
antibiotics. Body weight was determined in 6 (11.8%) and
serum creatinine was measured in 37 (72.5%) of patients
receiving aminoglycosides. Among prevailing combinations
were gentamicin plus oxacillin 12 (14.6%), lincomycin and
oxacillin 11 (13.4%), metronidazole and ciproﬂoxacin 5 (6.1%),
and ampicillin plus gentamicin 5 (6.1%) of cases. In total,
aminoglycosides for a combination therapy were administered
in 43 (52.4%) of patients.
Conclusion: Penicillins remain most often prescribed antibiot-
ics for monotherapy and in combination with aminoglycosides.
However surgeons often omit safety recommendations of
administration of aminoglycosides. Further strategies to
improve safety issues of antimicrobial therapy in surgery should
be implemented.
R1992
Prolonged regional arterial antibiotics infusion in
the management of severe acute pancreatitis
I. Bihalskyy, S. Chooklin, A. Perejaslov, T. Ivankiv, O. Granat
(Lviv, UKR)
Objectives: Development of the purulent-septic complications
is the main cause of the death of patients with severe acute
pancreatitis (SAP) after ﬁrst week of the disease onset. The
adequate antibiotics prophylactic is necessary part of the
management of these patients. However, the disorders of
microcirculation, which are typical for necrotizing pancreatitis,
do not permit achieve the therapeutical concentration of anti-
biotics in inﬂamed pancreas. Due to that the continuous regional
arterial infusion may have beneﬁts in the management of
patients with necrotizing pancreatitis.
Methods: Ninety-four patients with SAP were treated. In 25
patients the antibiotics (ceftriaxone, gatiﬂoxacin and imipinem)
administrated arterially. These patients compiled the ﬁrst group
and the rest patients – the control group.
Results: The Balthazar, Ranson (more than 3) score was not
different in both groups at admission. The rate of contamination
of the necrotic foci was compared. During the ﬁrst week the
contamination of the necrosis was noted in 5 (7.2%) patients of
the control group. During the second week the purulent
complications of SAP were noted in 15 (21.7%) of the control
group and one patients (4.0%) of the ﬁrst group, which received
ceftriaxone.
Conclusion: The continuous intraarterial infusion obviously
decreases the risk of contamination of the necrotic foci. Apply-
ing gatiﬂoxacin in the complex management of SAP has a
beneﬁt in prevention of purulent complications.
R1993
Drug-resistance and drug-sensitiveness of
bacterias causing urinary tract infections in
women under general practice care in Silesian
Province
I. Szymczyk, W. Lukas, J. Jo´zwiak, M. Kidziolka,
E. Mizgala (Zabrze, PL)
Objective: Estimation of etiological factors cousing UTI in
women. Antibiogram analysis considering drugs used most
frequently by GP. Optimalization of  in vitro bacterial disc
choice, considering their usefulness in general practice.
Materials and methods: Two hundred and eighty six positive
urine cultures in women > 18 years-old were analysed, in
January–October 2004 period. Morning urine from central
stream was sampled on Uromedium and was transported to
own laboratory. Antibiograms with use of Becton-Dicinson discs
for 23 antibiotics were performed.
Results: Most frequent pathogen of UTI was: E. coli-58%,
Staphylococcus aureus-10%, Proteus mirrabilis-10%, Pseudomonas
aeruginosa-3%. Remaining micro-organisms (Serratia, Morganel-
la, Enterococcus, Pseudomonas cepacia, Citrobacter, Klebsiella,
Staphylococcus epidermidis and saprophyticus) in 19% of cases were
observed. The highest E. coli sensitivity for Ceftazidim-90%,
Ciproﬂoxacin-88%, Amikacin-87%. Norﬂoxacin-85% and simul-
taneously highest resistance for Ampicilin-55%, Co-timoxazole-
29%, Tobramicin-26% was observed. Highest Staphylococcus
aureus sensitivity and resistance were observed for Neomicin-
100%, Amoxicilin/clavulonic acid-84%, Nitrofurantoin-83% and
Pipemidic acid-70%, Oxacilin-59%, Gentamicin-37%, Co-trim-
oxazole-37% respectively. Proteus mirabilis sensitivity for:
Abstracts
662
Amoxicilin/clavulonic acid-86%, Gentamicin-86%, Cefalotine-
83% and resistance for: Azlocilin-64%, Nitrofurantoin-54%,
Neomicin-52% were found. Taking under consideration all
micro-organisms drug-sensitivity we observed that most useful
in general practice was Ciproﬂoxacin-78% of sensitivity, Norﬂ-
oxacin –78% and Amoxicilin/clavulonic acid-68%.
Conclusions: In more than 50% of women under GP care the
UTI etiological factor was E. coli. Fluoroquinolones and amox-
icilin/clavulonic acid should be preferable drugs to use in GP,
considering their wide-spectum activity. Considering costs,
drug-sensitivity examination should be limited to antibiotics
most frequently used in GP.
R1994
Extended spectrum b-lactamase producing
Escherichia coli in a Kuwait hospital
A. Dashti, P. West, M. Johny, F. Habeeb, J. Kawaf (Suleibikhat,
Sharq, KWT)
Objectives: Although initially found in Klebsiella spp. extended
spectrum b-lactamases (ESBLs) are now far more frequently
encountered in Escherichia coli in the Amiri Hospital, Kuwait. In
this poster we present the results of our initial study of ESBL
producing E. coli, including origin, antimicrobial susceptibility,
PCR data for the detection of TEM and SHV b-lactamases and
pulsed ﬁeld gel electrophoresis (PFGE)results.
Methods: Clinical isolates were initially identiﬁed and tested
for antimicrobial susceptibility using the Vitek 2. Isolates
suggested by the expert system to harbour ESBLs were further
tested by the disc approximation test and E-test using cefotax-
ime/clavulanate and ceftazidime/clavulanate. PCR was per-
formed to detect the presence of TEM and/or SHV enzymes.
Xba1 was used to restrict the chromosomal DNA.
Results: A total of seventy two isolates were tested. Sixty two
strains were from 59 patients from the Amiri Hospital isolated
between November 2003 and May 2004. Nine were from a
neonatal ICU outbreak in another hospital in 1994, and one was
a control strain. The 2003–2004 isolates originated from many
different departments including casualty, outpatient, male,
female and paediatric wards and the ICU, and 27/59 were
patients ‡60 years. No outbreak was apparent during the
collection period. Cefotaxime/clavulanate detected ESBLs in
71/72 (98.6%) of the isolates and ceﬁpime performed best in the
disc approximation test, detecting ESBLs in (46/72) 64%. Strains
from 54/59 patients from 2003–2004 were resistant to ciproﬂ-
oxacin, 41/59 to cotrimoxazole and 40/59 to gentamicin. All the
1994 isolates were ciproﬂoxacin and cotrimoxazole susceptible,
but resistant to gentamicin. TEM enzymes were detected in 62/
72 (86%) isolates, SHV in 36 (50%) and TEM and SHV in 25
(34.7%). PFGE of DNA fragments showed the presence of
multiple genotype groups.
Conclusions: The epidemiology of ESBL producing E. coli in
Kuwait is complex, with many apparently unrelated cases
yielding different ESBL producing strains. The majority of ESBL
producing strains are now resistant to ciproﬂoxacin. Sequencing
studies will be required to determine the TEM and SHV types.
R1995
Emergence of ﬂuoroquionolone-resistant clones
of Streptococcus pneumoniae in far eastern Russia
A. Martynova, V. Turkutyukov, Y. Scurichina, A. Scheparyov,
E. Slabenko (Vladivostok, RUS)
To assess the ﬂoroquimolones resistace in S. pneumoniae strains,
further deﬁne molecular mechanisms of ﬂuoroquinolones resist-
ance in pneumococci strains at the territory of the Far East of
Russia.
Methods: We identiﬁed and genetically characterized a library
of clinical isolates (about 150 strains) of S. pneumoniae gained
from 1999 to 2003 in Primorye. MICs of ciproﬂoxacin, moxiﬂ-
oxacin, gatiﬂoxacin and levoﬂoxacin were determined by the
agar dilution method. PCRs were performed with appropriate
primers.
Results: The overall per cent of ﬂuoroquinolone resistant
strains is approximately 6.0% (9 strains).The overall rank order
of activity of the four ﬂuoroquinolones examined in this study
was moxiﬂoxacin > gatiﬂoxacin > levoﬂoxacin = ciproﬂoxacin,
in which moxiﬂoxacin (MIC at which 90% of isolates are
inhibited [MIC(90)], 0.25 lg/ml; modal MIC, 0.12 lg/ml) was
twofold more active than gatiﬂoxacin (MIC(90), 0.5 lg/ml;
modal MIC, 0.25 lg/ml), which in turn was fourfold more
active than either levoﬂoxacin (MIC(90), 1 lg/ml; modal MIC,
1 lg/ml) or ciproﬂoxacin (MIC(90), 2 lg/ml; modal MIC,
1 lg/ml). The isolates were evaluated for reserpine-sensitive
efﬂux of all tested ﬂuoroquinolones. The isolates were typed
using pulsed ﬁeld gel electrophoresis. The majority of the
isolates were genetically unrelated. Lower level ﬂuoroquino-
lone resistance (ciproﬂoxacin MIC 2 lg/ml) was associated
with amino acid substitutions in ParC, while higher level
resistance (ciproﬂoxacin MIC > or = 16 lg/ml) was associated
with amino acid substitutions in both ParC and GyrA. ParE
substitutions were not associated with clinical resistance. Three
of nine (30.0%) isolates demonstrated reserpine-sensitive efﬂux
of ciproﬂoxacin. Efﬂux alone conferred low level ciproﬂoxacin
resistance in 2 isolates.
Conclusions: The in vitro results suggest that recently devel-
oped ﬂuoroquinolones are very effective against clinical isolates
of S. pneumoniae isolates in Primorye. Nevertheless, emerging
ﬂuoroquinolone resistance should be acknowledged and clini-
cians alerted. Surveillance should be carried out to monitor any
changes in antibiotic resistance of S. pneumoniae.
R1996
Italian survey of urinary tract infections: in vitro
activity of pruliﬂoxacin
G. Bonﬁglio, M. Caccamo, G. Nicoletti, G. Tempera (Catania, I)
Objectives: During 2004 we performed a multicentric study in
order to evaluate: a) the incidence of different uropathogens
responsible of nosocomial, complicated and uncomplicate urin-
ary tract infections (UTIs); b) the trend of antibiotic resistance of
these uropathogens and c) the potency of a new ﬂuoroquino-
lone, pruliﬂoxacin, in comparison to ciproﬂoxacin and levoﬂ-
oxacin.
Methods: From February to May 2004, 9 microbiological
laboratories thoroughly distributed in Italy collected up to
200 microorganisms from hospitalised patients (nosocomial
UTIs), from patients in urology unit (complicated UTIs) and
up to 40 microorganisms (20%) from ambulatory patients
(uncomplicated UTIs). All the uropathogens collected were
sent to Department of Microbiological Sciences of Catania
(5 centres of south Italy) and Genoa (4 centres of north Italy).
These reference laboratories determined the identity of the
isolates and perform the antibiotic susceptibility tests by the
agar dilution method, as described by NCCLS. ATCC
references microorganisms were tested as quality control
strains.
Results: A total of 1835 uropathogens were isolated. E. coli
(37.0%) was the most isolated uropathogen from 1066 nosoco-
mial UTIs, followed by E. faecalis (17.3%) and P. aeruginosa
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(12.2%). E. coli (39.7%, 62.5%) was also the most isolated
microorganisms from 358 complicated UTIs and 411 uncompli-
cated UTIs, respectively, followed by E. faecalis (20.1% and
8.0%). Against Enterobacteriaceae and Pseudomonadaceae, pru-
liﬂoxacin showed an in vitro activity similar to that of ciproﬂ-
oxacin and levoﬂoxacin. However, pruliﬂoxacin showed a better
intrinsic activity (lower MIC values than other two ﬂuoroqui-
nolones). Whereas, the in vitro activity of pruliﬂoxacin was
equal to the other quinolones against Gram-positive uropatho-
gens.
Conclusion: E. coli remain the principal uropathogen in all
urinary pathologies and on the basis of in vitro activity,
pruliﬂoxacin could be an useful antibiotic in the treatment of
any kind of UTIs.
R1997
Patterns of antimicrobial resistance in Escherichia
coli, Klebsiella spp. and Proteus mirabilis isolates
from urinary tract infection: one-year study
M. Chondrogianni, L. Zachariadou, M. Nikolaou, J. Iakovou,
A. Chrysaki, A. Pangalis (Athens, GR)
Objectives: To suggest empirical antibiotic treatment of urinary
tract infections in children.
Methods: The sensitivity to antibiotics in 790 E. coli, 82 Klebsiella
spp and 72 P. mirabilis strains isolated from urine cultures of
hospitalized and non hospitalized children from August 2003 to
July 2004 was evaluated. All strains were tested for sensitivity to
ampicillin, amoxycillin/clavulanic acid 1st, 2nd and 3rd
generation cephalosporins, imipenem, nitrofurantoin, co-trim-
oxazole and aminoglycosides by Kirby–Bauer methodology
according to the NCCLS recommendations. The MICs of
resistant strains were also tested with VITEK II automated
system (Biomerieux).
Results: 362 (45.8%) E. coli isolates were found sensitive to all
antibiotics tested, with the same prevalence in hospitalized
and non hospitalized patients. 108 (13.7%) strains were found
resistant only to ampicillin, 50 (6.3%) only to co-trimoxazole
whereas 96 (12.2%) to ampicilline and co-trimoxazole together.
36 (4.6%) strains were resistant to amox/clavulanic acid.
Cefalosporins of 2nd and/or 1st generation revealed a
resistance rate of 19%. As for aminoglycosides, they were
active in 97.7% and nitrofurantoin in 98.9%. 30 (3.8%) E. coli
strains revealed extended spectrum b-lactamase (ESBL) resist-
ance. 24/30 (80%) of these strains, were isolated from
hospitalized children in neonate, intensive care and oncology
units or from children under antimicrobial prophylaxis suf-
fering from urinary tract abnormalities. Multiresistant strains
in more than three antibiotics were found to be 48 (2.3%).
Among ESBL resistant strains, 9 (30%) were multiresistant.
Klebsiella spp isolates were resistant to co-trimoxazole in 11/82
(13.4%), to amox/clavulanic acid in 6 (7.3%) and to cephalo-
sporins of 2nd and/or 1st generation in 28 (34.1%). ESBL
resistance was found to 16 (19.5%) strains derived mainly
from hospitalized patients. 28 (34.1%) of Klebsiella spp strains
were multiresistant. P. mirabilis isolates were resistant to
ampicillin in 30/72 (41.7%), to co-trimoxazole in 9 (12.5%), to
amox/clavulanic acid in 2 (2.8%) and to cephalosporins of
2nd and/or 1st generation in 7 (9.7%). Only 2 (2.8%) strains
were multiresistant. No E. coli, Klebsiella spp and P. mirabilis
strain was found resistant to imipenem.
Conclusions: Simple uncomplicated urinary tract infections
may be empirically treated with amoxicillin/clavulanic acid
(4.7% resistance) or co-trimoxazole (7.4% resistance). Aminogly-
cosides (2.7% resistance) may be added for complicated, serious
cases.
R1998
Klebsiella pneumoniae harbouring CTX-M-15
extended-spectrum b-lactamase in Hungary
A´. To´th, I. Damjanova, M. Gacs, J. Pa´szti, M. Fu¨zi (Budapest,
HUN)
Objectives: Since the 1990s the CTX-M type b-lactamases have
constituted one of themost rapidly spreading extended-spectrum
b-lactamase (ESBL) families. They have been detected in many
countries of the world. The aim of this study was to genetically
characterise the phenotypically ceftazidime susceptible and cefo-
taxime resistant ESBL-producing Klebsiella pneumoniae isolates.
Methods: Species identiﬁcation was performed with BBL Crys-
tal E/NF, and ESBL expression was conﬁrmed with E test ESBL.
CTX-M genes were ampliﬁed with PCR using consensus CTX-M
primers. The conjugation experiments were performed using
Escherichia coli J53-2 (rifampin resistant). The CTX-M genes in
the transconjugants was detected with PCR. The ampliﬁeld
products were analysed with RFLP, assigned to distinct groups
on the basis of RFLP proﬁles and further analysed using speciﬁc
primers. The ampliﬁed products were sequenced. The isolates
were also investigated by phagetyping, genomic ﬁngerprinting
by ERIC-PCR and PFGE and plasmid proﬁle analysis.
Results: Among 158 ESBL-producing K. pneumoniae strains
submitted to National Center for Epidemiology over one-year
period twenty strains were selected for further analysis on the
basis of phenotypic results. They were isolated in nine geo-
graphically distinct hospitals across Hungary. By PCR ampliﬁ-
cation the CTX-M encoding genes were detected in all strains
and they had identical RFLP pattern. Sequencing of the
corresponding genes conﬁrmed CTX-M-15 in selected isolates.
Of 20 strains, 15 and 5 belonged to XIA and IA26 phage type,
respectively. ERIC-PCR and PFGE analysis revealed clonal
relatedness among all CTX-M-producers. A plasmid of about
130 kb was obtained from all transconjugants by plasmid
extraction and CTX-M harbouring was conﬁrmed by PCR.
Conclusions: This is the ﬁrst description of K. pneumoniae
harbouring CTX-M-15 b-lactamase in Hungary. Epidemiological
typing suggested inter- and intrahospital clonal dissemination of
these Hungarian CTX-M-producing K. pneumoniae strains.
R1999
Antimicrobial susceptibility among invasive
Gram-positive bacteria in the UK and Ireland:
The BSAC Bacteraemia Resistance Surveillance
Programme 2003
R. Reynolds, M. Colman on behalf of the BSAC Working Party on
Bacteraemia Resistance Surveillance
Objective: To monitor prevalence of established forms of
resistance, detect emerging forms, and assess the activity of
newer antimicrobial agents.
Methods: Bacteraemia isolates were collected from 25 laborat-
ories in the UK and Ireland in 2003, excluding duplicates
isolated within one week. MICs were determined centrally using
the BSAC agar dilution method and interpreted by BSAC
criteria. Results were compared with those from similar sur-
veillance in 2001 and 2002.
Results: Among 235 S. aureus, 40% were methicillin-resistant
(MRSA), similar to previous years. Of these MRSA, 98% were
resistant to ciproﬂoxacin and 90% resistant to erythromycin. Of
212 coagulase-negative staphylococci, 58% were methicillin-
resistant (MRCoNS), a signiﬁcant reduction from 80% in 2001
and 72% in 2002. MRCoNS were also commonly resistant to
ciproﬂoxacin (62%), erythromycin (98%) and trimethoprim
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(77%). Overall, 10% of 245 enterococci were vancomycin-
resistant (VAN-R), comprising 4% of 156 E. faecalis and 24% of
74 E. faecium, like earlier years. VAN-R E. faecium were often
highly resistant to gentamicin (67%) and had high ciproﬂoxacin
and erythromycin MICs. Penicillin non-susceptibility (PEN-NS)
occurred in 8% of 239 S. pneumoniae, but, as in previous years, no
MICs > 1 mg/L were seen. PEN-NS isolates were more com-
monly resistant to erythromycin (37%) and tetracycline (32%).
Two were of serotype 35B, a serogroup not covered in current
vaccines, making its ﬁrst reported appearance in the UK.
Prevalence of tetracycline (and minocycline) resistance in 68
group B. streptococci remained very high at 82%, but these
isolates were highly susceptible to b-lactams, and tigecycline
MICs were not raised. Activity of new agents against resistant
isolates is shown in the table by mode and maximum MIC; all
these distributions were unimodal.
Conclusion: Major ’headline’ resistance rates have changed
little since 2001, apart from a reduction in MR-CONS. The tested
new agents had good activity against multi-resistant isolates.
The arrival of PEN-NS S. pneumoniae of a non-vaccine serogroup
(35B) could herald troublesome serotype replacement.
R2000
Setting up a surveillance system of antimicrobial
resistance and use in a low-resource setting: West
Delhi, India
C. Wattal, A. Kotwani, A. Sharma, R. Raveendran,
S.K. Bhandari, S. Khanna, R.R. Chaudhury, K. Holloway,
T. Sorensen (New Delhi, IND; Geneva, CH)
Objectives: To set up a surveillance system for antimicrobial
resistance and use of antimicrobials in the community in a low
resource setting using E. coli as an indictor organism.
Methods: The study area was Blocks in a 10 Km. radius of Sir
Ganga Ram Hospital, New Delhi, India. Microbiology Surveil-
lance: MSU’s were collected from all cases not taking antimicro-
bials and without suspected complicated UTI attending the OPD
from designated region. Once E. coli (pathogenic as well as
contaminants) were isolated and identiﬁed using conventional
biochemical reactions its susceptibility was determined using
Kirby Baur disc diffusion method on Muller Hinton agar.
Antimicrobial use surveillance: Monthly purchase of all antimi-
crobial drugs from 30 private retail pharmacies was collected
and converted to DDD. The denominator for the drug use was
the population of the administrative areas in which these
pharmacies are based. In addition, exit interviews (prescription
auditing) were done at each pharmacy to have information on
15–25 consecutive prescriptions per month having any antimi-
crobial agent. Data on use is presented as DDD’s per total
number of patients/prescriptions.
Results: During the study period (11/03–9/04) 3590 MSU
samples were collected and 377 E. coli were isolated. 85% of
the strains were resistant to ampicillin, and more than 50% were
resistant to quinolones (60%), tetracycline, third generation
cephalosporins, cotrimoxazole and ampicillin + sulbactam. Pur-
chase data and exit interview data was analysed for 9 months
and the results showed that ﬂuoroquinolones are the most
frequently sold antimicrobials. Exit interview data revealed that
DDD/1000 prescriptions/patients/month for ﬂuoroquinolones;
penicillins, cephalosporins and macrolides are 2972,1296,
1034,884 respectively.
Conclusions: The extensive usage of quinolones and penicillins
are reﬂected in the antimicrobial resistance. A decrease in
resistance to cephalexin from 85% to 41% could be noticed
during the study period. The data collected on antimicrobial
drug use and antimicrobial resistance in E. coli isolated from
antenatal cases seems suitable for collection of information on
the resistance and use in the community, valuable for planning
targeted interventions. This is an on going project for one year.
Funding agency: WHO, Geneva.
R2001
Resistance to telithromycin in Streptococcus
pneumoniae is rare and associated with reductions
in bacterial ﬁtness
D.J. Farrell, J.G. Hurdle, I. Chopra (London, Leeds, UK)
Objectives: PROTEKT - a global, longitudinal study of the
antibiotic susceptibility of bacterial respiratory tract pathogens -
has now completed its fourth year. The objectives of this study
were to determine the global rates of bacterial resistance to
telithromycin, the ﬁrst ketolide antibiotic, and to evaluate the
ﬁtness of two telithromycin-resistant Streptococcus pneumoniae
isolates relative to their putative isogenic telithromycin-suscept-
ible counterparts.
Methods: Minimum inhibitory concentrations (MICs) for telith-
romycin were determined by the NCCLS broth microdilution
method and interpreted using NCCLS breakpoints. The isogenic
relationships between telithromycin-susceptible and -resistant
isolates (two independent sets) were determined by serotyping
andmulti-locus sequence typing. The relative competitive ﬁtness
(W) of telithromycin-resistant strains was evaluated by estab-
lished procedures involving mixed culture competition between
isogenic pairs of telithromycin-resistant and -susceptible strains.
Results: Of the 20 750 S. pneumoniae isolates collected between
1999 and 2003 in the PROTEKT study, 0.1% exhibited low-level
resistance to telithromycin (MIC ‡ 4 mg/L),with thehighestMIC
being 8 mg/L. This low rate of telithromycin resistance is
observed across the globe, ranging from 0% in Australasia, the
Middle East and North America to 0.22% in Central Europe. The
development of resistance to telithromycin was accompanied by
moderate reductions inW- 32% in one strain and 25% in the other.
Conclusions: Clinical resistance to telithromycin among
S. pneumoniae is rare and low level, with a global prevalence of
around 0.1%. In the two sets of isogenic strains examined,
resistance to telithromycin was associated with moderate ﬁtness
cost (25–32%). These data suggest that the potential for
S. pneumoniae to develop clinically relevant resistance to telith-
romycin may be limited. However, further studies are needed to
examine the mechanisms of telithromycin resistance and the
potential for genetic adaptation, which might reinstate bacterial
ﬁtness in telithromycin-resistant strains.
R2002
Administration of gentamicin in a Dublin
teaching hospital
E. O’Neill, H. Humphreys, E. Smyth (Dublin, IRL)
Objectives: Appropriate use of antimicrobial therapy improves
patient outcome and prevents the spread of antimicrobial
resistance. It has been established that gentamicin should be
administered at a dose of 5mg/kg in patients with normal renal
MIC summaries, mg/L
Resistant species Ceftobiprole Daptomycin Linezolid Tigecycline
Mode Max Mode Max Mode Max Mode Max
MRSA, n = 95 2 4 0.5 1 2 4 0.25 2
MRCoNS, n = 122 1 4 0.5 1 1 2 0.25 2
PEN-NS S.pneumoniae, n = 19 not tested 0.25 0.25 1 2 0.06 0.25
VAN-R E. faecium. n = 18 not tested 1 2 2 2 0.12 0.25
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function and for a shorter duration of therapy to improve
bactericidal killing and post-antibiotic effect whilst reducing the
risk of toxicity associated with prolonged treatment. We per-
formed a prospective audit of gentamicin usage in our institu-
tion over a one month period.
Methods: Patients with normal renal function receiving gen-
tamicin were identiﬁed from Clinical Microbiology team ward
rounds, review of drug prescription charts, consultation with
staff nurses and gentamicin assays done in the microbiology
department. A member of the Clinical Microbiology team
reviewed patients on a daily basis. Details including patient
demographics, indications for treatment, dose administered and
duration of treatment were obtained.
Results: A total of 86 patients in our institution were on
gentamicin therapy over the four week period with hospital
acquired pneumonia (24.4%), intra-abdominal infection (23.2%)
and neutropaenic sepsis (16.3%) accounting for the most
common indications for therapy. 75% of patients were admin-
istered an inappropriate dose of gentamicin, of which 95% were
being underdosed. One third of patients received a prolonged
course of gentamicin therapy (i.e. longer than one week) in the
absence of clinical or microbiological requirements.
Conclusions: This audit highlighted the high number of
patients in our centre on inappropriate gentamicin therapy. In
conjunction with the Microbiology and Pharmacy departments
education sessions have been arranged for health care profes-
sionals to optimise gentamicin therapy and allow feedback on
the ﬁndings of this audit.
R2003
Antibiotics susceptibility patterns of commonly
isolated pathogens in a Greek university hospital
A. Tatsiopoulos, E. Tsiakiri, F. Tsiapara, M. Giannousis,
O. Basilaki, X. Karanasou, S. Alexiou-Daniel (Thessaloniki, GR)
Objective: Our aim was to assess the sensitivity to antibiotics of
the most commonly isolated pathogens in blood cultures from
patients admitted in a tertiary care hospital.
Materials and methods: We analysed the results of 858 positive
blood cultures, during last year from patients admitted in Ahepa
University hospital, focusing on their susceptibility to antibiot-
ics. Identiﬁcation of bacterial isolates and their antibiotic
susceptibilities were performed by Vitek 2 analyzer of Bio-
Merieux.
Results: The most frequent isolate was coagulase-negative sta-
phylococci (CNS) (29%) followedbyStaphylococcus aureus (16,9%),
Acinetobacter calcoaceticus (12,8%), Pseudomonas aeruginosa (9,6%),
E. coli (9,4%), Klebsiella pneumoniae (5,9%), and Proteus spp (3,5%).
Klebsiella spp and Proteus spp. isolates were not signiﬁcantly
resistant to the antibiotics used. E. coli isolates were resistant as
followed: 64% to ampicilline, 36 % to trimethoprime /sulfameth-
oxazole, 28% to amoxicillin/clavulanic acid (A/CA), 7% to
cefuroxime, 19% to nitrofurantoin and 6% to ciproﬂoxacin (CIP).
Therewasno resistance to ceftazidime (CFZ)and imipenem(IMI).
Among Pseudomonas aeruginosa isolates 26% were resistant to
CFZ, 28% to CIP, 22 % to IMI, 24% to tobramucin (TO) and there
was no resistance to piperacillin/tazobactam (P/T). In terms of
sites of isolation Acinetobacter spp were mainly isolated from
surgical wards while Staphylococcus epidermidis spp from other
clinics. 36% of Acinetobacter spp isolates examined showed
resistance to ampicillin/sulbactame, 77% to IMI , 79 % to
meropenem, 72% to P/T and 97% to CIP. 89% of CONS strains
and 67% of S. aureus isolates were resistant to oxacillin. As far as
glycopeptide resistance is concerned 88% of CONS isolates and
100% of S. aureuswere sensitive to teicoplanin, while no VRSA or
VRSE strains were isolated.
Conclusions: One third of the S. aureus isolated in our hospital
were methicillin resistant (33% MRSA). Compared with previ-
ous results there has been observed a signiﬁcant increase in
resistance rates of pseudomonas aeruginosa to all antibiotics except
ceftazidime, as well as in Acinetobacter spp to piperacillin/
tazobactam.
R2004
Resistance to antibiotics and heavy metal in
different species of Aeromonas collected from the
Loa River in Chile
J. Silva, R. Del Campo, H. Espinoza, C. Lizama, I. Ku¨hn,
P. Colque-Navarro, F. Baquero, R. Mo¨llby (Antofagasta, CHL;
Madrid, E; Stockholm, S)
Objectives: The Loa river, are the longest in Chile, and has been
dramatically contaminated with heavy metals several times in
recent years. The objective of this study was to determine the
possible resistance to heavy metals as effect of these contami-
nations, as well as, the antibiotic resistance levels in Aeromonas
spp. present in the Loa River.
Methods: Samples of waters and sediments were collected by
duplicated from 22 stations through the river. The samples were
analysed by the membrane ﬁltration technique and the ﬁlters
were incubated on ampicillin-dextrine agar (ADA), a selective
medium for Aeromonas, at 30C for 24 hours. Yellows colonies
from the ADA and oxidase positive were presumed to be
Aeromonas colonies. Eight of these colonies were typed by the
PhP-AE rapid screening plate for Aeromonas. Selected PhP types
were identiﬁed by biochemical test and typed for PFGE. The
MIC for several antibiotics and heavy metals was done by a
dilution agar technique.
Results: A total of 186 Aeromonas isolates belonging to 7
different species were recovered from the Loa River, including
A. hydrophila (29.5%), A. veronii (22.4%), A. caviae (12.2%),
A. media (11.5%), A. sobria (10.9%). The incidence of antimicrobial
resistance in this Aeromonas isolates was relatively low,
showing less than 10% of the isolates resistance to nalidixic
acid, ciproﬂoxacino, cloranfenicol or tetracilina. However, all
isolates were resistant to ampicillin. A high percentage of
resistance to the heavy metals was observed. The MIC90 values
for Lead and Arsenic were 3200 mcg/ml (ranges from 800 to
3200 mcg/ml). For Copper, the complete range observed was
200–1600 mcg/ml, and the MIC90 value was 1600 mcg/ml. In
the case of Cadmium the population was distributed from 25 to
>400 mcg/m, being the MIC90 400 mcg/ml. Genetic typing by
PFGE-XbaI show high heterogeneity in the isolates. No differ-
ences were detected among the isolates recovered from the
beginning and through the all way of the river.
Conclusions: The high metallic contamination could been
contributed to the resistance to heavy metal of Aeromonas





What factor will inﬂuence fever in community-
acquired pneumonia?
D. Genne´, R. Sommer, R. Rakotoarimanana, D. Lew (La Chaux-
de-Fonds, CH)
Objectives: Although fever (> 38 C) accounts for one of the
major clinical signs of community-acquired pneumonia (CAP), it
is not well studied in that disease.
Methods: We conducted a prospective observational study
involving 228 adults patients hospitalized for CAP (diagnosed
on IDSA guidelines) and measured their axillary body tempera-
ture 3 times a day until discharge. The causal pathogen, the
empirical antibiotic choice and other factors that could inﬂuence
the follow-up of fever were investigated.
Results: 162 (71%) patients requiring a hospitalisation for a
CAP presented with fever. Although the level of fever
decreased with age, it was not statistically signiﬁcant. The
mean duration of fever was 3 days (1–28). Except the presence,
in one instance, of inﬂuenza virus which shortened the
duration of fever, there were no differences related to the
causal agent. A multivariate analysis showed that the presence
of empyema and the empirical use of the quinolone trovaﬂ-
oxacin prolonged the duration of fever of 3 days (CI 95% 1.5–
4.7, p < 0.001) and 0.7 days (CI 95% 0.09–1.30, p = 0.024)
respectively.
Conclusions: Fever was absent in a signiﬁcant proportion of
patients (29%) hospitalised for a CAP. It should last for about
3 days for appropriately treated patients. For those with a febrile
period exceeding 5 days, the presence of empyema should
actively be searched.
R2006
Peripheral T-cell lymphoma masquerading as
cellulitis
I. Bliziotis, G. Peppas, P. Rafailidis, P. Vergidis, A. Kapaskelis,
P. Papastamataki, M. Falagas (Athens, GR)
Objectives: Primary cutaneous non-Hodgkin lymphomas
(NHLs) encompass many subtypes of lymphoma, namely
mycosis fungoides, lymphoblastic lymphoma, follicular lym-
phoma, diffuse large B-cell lymphoma, marginal zone lym-
phoma, anaplastic large cell lymphoma and peripheral T cell
lymphoma not otherwise speciﬁed. However, there are no
reports of cellulitis due to lymphoma.
Methods: Description of our experience with a patient with
peripheral T-cell lymphoma masquerading as cellulitis.
Results: A 28-year-old Greek-American male presented with
extensive cellulitis of the left sub-axillary area. The patient had
been evaluated in two hospitals abroad where he was advised to
receive antibiotics, which did not lead to any appreciable
improvement. A supraclavicular mass, thought clinically to be
an enlarged lymph node, was removed at the second hospital.
The biopsy showed inﬂammatory changes without any evidence
for malignancy. Biopsy of a mass from the left axillary fossa,
removed at our hospital, showed conclusive evidence for
peripheral T-cell lymphoma.
Conclusion: A signiﬁcant delay in the correct diagnosis was the
result of a rare manifestation of lymphoma and limitations of the
diagnostic work up, including biopsy of removed tissue.
Clinicians should be aware that lymphoma may present with
typical cellulitis-like lesions.
R2007
Regression of skin lesions of Kyrle’s disease with
clindamycin: implications for an infectious
component in the aetiology of the disease
S. Kasiakou, E. Rosmarakis, G. Peppas, A. Kapaskelis,
A. Sergounioti, M. Falagas (Athens, GR)
Background: Kyrle’s disease was ﬁrst described in a 22-year-
old woman with diabetes mellitus by J. Kyrle in 1916, under the
name of hyperkeratosis follicularis et parafollicularis in cutem
penetrans. It refers to a disorder of keratinization, which usually
appears as scattered or grouped keratotic papules on the
extremities and the trunk. Kyrle’s disease belongs to a group
of skin disorders called perforating skin dermatoses. This
group consists of four skin diseases: (a) elastosis perforans
serpignosa (b) reactive perforating collagenosis (c) perforating
folliculitis and (d) Kyrle’s disease.
Methods: We describe a patient with Kyrle’s disease who was
successfully treated with clindamycin.
Results: We report our experience with the management of a
44-year-old man with manifestations of Kyrle’s disease. The
patient presented with skin lesions of two different types on his
face and upper and lower extremities. The old lesions were large
hyperkeratotic plaques with burrows without signs of inﬂamma-
tion. The newer lesionswere also hyperkeratotic plaques but they
clearly had signs of inﬂammation. The patient was successfully
managed with combined surgical and medical management. The
hyperkeratotic old and large skin lesions, which did not have
manifestations of ongoing inﬂammation, were surgically
removed. In addition, antimicrobial therapy with oral clindamy-
cin was administered for one month, which led to disappearance
of the small newer lesions, which had ﬁndings of ongoing
inﬂammation and were clearly part of Kyrle’s disease. No
recurrence was observed during 8 months of follow up.
Conclusion: Although clindamycin may have some anti-inﬂam-
matory effects unrelated to its antimicrobial action, the observed
control of the inﬂammation and the gradual regression of the
newer lesions with clindamycin, suggest that microorganisms
(probably anaerobic bacteria) play a role in the pathogenesis of
the progression of Kyrle’s disease at least in the initial stages of
the skin lesions.
R2008
A prospective study of neck mass excluding
thyroid nodules in one hospital
M. Zangeneh (Tehran, IR)
Introduction: A mass in the neck is a common clinical ﬁnding
that presents in patients of all age groups. The differential
diagnosis may be extremely broad, and although most masses
are due to benign processes, malignant disease must not be
overlooked. Therefore, it is important for physicians to develop
a systemic approach for developing a working diagnosis and
management plan for the patient.
Objective: The aim of this study is to evaluate neck masses and
their etiology except thyroid nodules.
Materials and Methods: This is a Cross-Sectional Prospective
study on 155 patients who has been referred to adult infectious
diseases clinic with neck mass from 1999/March/20 to 2003/
March/19. In this study correlation between neck mass and age,
sex, initial time, size, number, position, sign, symptom, and
etiology has been evaluated.
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Results: Thirty-two patients did not accept more evaluation,
the ﬁndings of 123 patient left include: 47/3% men, 52/7%
women, 43/6% single, 56/4% married; 8% less than 10-years-
old, 28% 10–19-years-old, 22% 20–29-years-old, 7/4% 30–
39-years-old, 10/2% 40–49-years-old, 10/2% 50–59-years-old,
6/6% more than 60-years-old; time of neck mass in 24/1%
less than one month, 29/9% 2–3 months, 21/8% 4–6 months,
10/3% 7–12 months, 13/8% more than 12 months; mass
position 42/8% on left side of neck, 29/7% on right side of
neck, 24/1% on both sides, 2/8% on midline, 0/7% on
occiput; number of mass 59/4% one mass, 6/3% 2 masses,
34/3% 3 or more than 3 masses; also size of masses was
evaluated. 30% have signs and symptom, the more common
signs are lymphadenopathy on the axilar and hepatomegaly,
13/6% have past history. Etiology: 35% toxoplasmosis, 14/6%
tuberculosis, 13% cancer, 8/5% bacterial lymphadenitis, 6/3%
viral infections, 4/8% lymph node hyperplasia with unknown
ethiology, 4/8% salivary glands infections, 1/6% thyroiditis
and ectopic thyroid, 1/6% infected cyst, 1/6% brucellosis,
0/8% lypoma.
Conclusion: According to the results that TB and cancer are
more common in the adult, it is important that in any patient
with neck mass physician to develop a systemic approach for
developing a working diagnosis and management plan for the
patient.Supported by Azad Islamic University
R2009
Hormone replacement therapy and prevalence of
bacterial vaginosis
A. Giakoumatou, E. Zagotzidou, V. Charalambidis,
D. Apostolou, A. Iliadou, I. Chatzipapas,
M.-E. Alexandrou (Athens, GR)
Objectives: The purpose of this study was to evaluate the effect
of oral estroprogestinic hormone replacement therapy (HRT) on
the bacterial vaginosis (BV) prevalence in postmenopausal
women.
Methods: One hundred thirty eight women, aged 45–69 years
were enrolled in this study. All of them had a natural termination
of menstruation in at least 12 months prior the study. Fifty eight
(group A) were currently received oral HRT (tibolone), whereas
the other 80 (group B) had not received HRT, orally or
transdermally at least in the past six months. All vaginal
speciments were collected from the posterior fornix or lateral
vaginal wall. Diagnosis of BV mainstayed on the Nugent score
method (a score of 7–10 was considered indicative of BV) as well
as the presence of clue cells on Gram stained vaginal smears.
Results: The mean age ± SD of women in group A and the
average number of postmenopausal years was 56.4 ± 3.9 years
(range, 51–63 years) and 6.8 ± 3.1 (range, 4–13 years). While in
group B was 55 ± 5.2 (range, 45–69 years) and 6 ± 3.2 (range,
1–18 years) respectively. Prevalence of BV in group A was
slightly lower (12.5 %) than among women in group B (13.3 %),
but the difference was not statistically signiﬁcant (P > 0.05).
Absence of lactobacilli from vaginal smears without any
symptoms of vulvovaginitis was found in 36.6% of women in
group B and 11% of women in group A. High number of
lactobacillus colonization was observed in only 10% of women
who did not received HRT.
Conclusions: Treatment of postmenopausal women with
tibolone has no statistically signiﬁcant effect on full BV
prevalence. However, it did seem to affect lactobacillus
colonization of the vagina, altering the ﬂora to premenopau-
sal proﬁle.
R2010
Bacterial pathogens associated with acute
diarrhoea on the island of Crete, Greece, and their
resistance to antibiotics
S. Maraki, E. Stylianoudaki, E. Nioti, A. Georgiladakis,
G. Samonis, Y. Tselentis (Heraklion, Crete, GR)
Objective: The aim of the present study was to determine the
prevalence of bacterial pathogens associated with diarrhoea on
the island of Crete, Greece, and their resistance to commonly
used antimicrobial agents.
Methods: From January 1999 to December 2003, stool samples
from 6.814 diarrhoeal patients were examined for bacterial
pathogens. Cultures and identiﬁcation of the isolates were done
using standard microbiological methods. Susceptibility testing
to antibiotics was performed by using the disc diffusion method
following the recommendations of the NCCLS.
Results: Bacterial pathogens were identiﬁed in 681 (10%)
patients. Salmonella enterica were the most commonly isolated
bacteria (58.7%), followed by Campylobacter spp. (29.7%),
enteropathogenic Escherichia coli (EPEC) (4.4%) and Yersinia
enterocolitica (4.1%). Aeromonas spp. (1.6%) and Shigella spp.
(1.5%), were less frequently isolated. Resistance to ampicillin
was observed in 10.7% of the Salmonella, 50% of the Shigella,
and 33.3% of the EPEC isolates. Resistance to cotrimoxazole
was observed in 4% of the Salmonella, 50% of the Shigella, and
16.7% of the EPEC isolates. High percentages of resistance to
ﬂuoroquinolones (37%), were detected among Campylobacter
isolates, while resistance to erythromycin was observed in
14.4% of them.
Conclusion: The knowledge of the bacterial agents of diar-
rhoea and their local patterns of antimicrobial resistance are of
utmost importance for the selection of the appropriate treat-
ment.
R2011
Eosinophilic cellulitis (Wells syndrome) due to
tick bite
D. Balaban, M. Aslan-Kayiran, K. Koc, G. Sengoz,
A. Karaoglu (Istanbul, TR)
Objective: To present a case of Wells Syndrome due to tick
bite.
Case report: A case of Wells syndrome possibly due to tick
bite is presented. Eosinophilic cellulitis (Wells Syndrome) is
characterized by skin eruptions with edema, ﬂame ﬁgures and
marked inﬁltrate of eosinophils in the dermis. Hypersensitivity
to arthropod bites, cutaneous viral infections (HSV-2), cutane-
ous parasitic infestations (toxocariasis), ascariasis and drug
hypersensitivity has been reported as etiologic factors. Sixty-
year-old woman was referred to our clinic with the suspect of
erythema chronicum migrans and erythema annulare centrif-
ugium. The patient complained from widespread reddish
elevations since 5 months after tick bite. Lesions had ﬁrst
appeared in scalp and face, then had spread to the body. She
was hospitalized in the local hospital; skin biopsy was
consistent with nonspeciﬁc chronic dermatitis and anti-Borrelia
IgM and IgG were positive. Terbinaﬁne (systemic and local),
systemic tetracycline, amoxicilline clavulanate was adminis-
tered but no response was observed. The patient was hospit-
alized in our clinic with the initial diagnosis of eosinophilic
cellulitis, erythema chronicum migrans and erythema annulare
centrifugium. Dermatologic examination revealed widespread
elevated erythematous papules and plaques of 1–10 cm diam-
eter formed by coalescing papules, with central sparing.
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Histopathological examination of punch skin biopsies showed
eosinophilic inﬁltration in the dermis, but no ﬂame ﬁgures
were observed. Borrelia burgdorferi IgG was positive but IgM
was negative. Marked eosinophilia (11%) was noted in the
peripheral blood sample, total IgE was elevated (275 mg/dl)
other biochemical parameters were normal. No other signs of
systemic Borreliosis was found. The patient was treated with
dapsone (150 mg/day) and methylprednisolone (80 mg/day)
with the diagnosis of eosinophilic cellulitis. Lesions had
tended to resolve by the 2nd month of the therapy and
complete resolution without sequele was observed on the 6th
month.
Conclusions: Tick bite has been reported as a causal factor for
Wells’ syndrome. Moreover, arthropod born infectious agents
like Borrelia burgdorferi may also be a triggering factor. Dapsone
combined with corticosteroids may be an effective treatment in
this situation. The role of antibiotherapy in the acute phase of
the infection is controversial.
R2012
Rabdomyolysis complicating Shigella ﬂexneri
acute gastroenteritis
C. Papaefstathiou, A. Diakakis, K. Mitsouras, M. Marioli,
G. Kouppari (Athens, GR)
Objectives: To report a case of acute rabdomyolysis associated
with Shigella ﬂexneri acute gastroenteritis.
Methods: Stool specimens cultured on the appropriate media
for isolation of the enteropathogenic bacteria and direct smears
were examined. The enteropathogenic bacterium was identiﬁed
by standard methods, API 32E system (bioMerieux) and
serotyping with antiserum reagents. Myoglobin was detected
by biochemical method. Susceptibility testing was carried out by
disc diffusion method.
Case report: A male patient aged 71 years was admitted to the
hospital because of acute gastroenteritis with watery, bloody
stools associated with abdominal pain and myalgias. He was
suffering from coronary artery disease and diabetes. The patient
was pyrexial (380C), dehydrated, hypotensive (blood pressure:
90/70 mmHg) and had generalized weakness. Abundant leu-
kocytes and erythrocytes were seen on direct smears of stools.
Admission laboratory data included WBC count 18.250/ll
(neutrophils 84.6%), Ht 45.1%, Hb 15.9 g/dl, urea 64 mg/dl,
creatinine 1.5 mg/dl, glucose 192 mg/dl, Eˆ 3.6 mEq/l, Na
134 mEq/l, CPK 11840 IU/L (normal value < 170 IU/L), CK-
MB 124 IU/L (normal value < 6%), LDH 543 IU/L, SGOT
265 IU/L, SGPT 81 IU/L, a˜-GT 21 IU/L, albumin 3.2 g/dl and
myoglobinuria. From the clinical and laboratory ﬁndings
rabdomyolysis was diagnosed. The patient was treated with
parenteral hydration and ciproﬂoxacin 400 mg tid iv. From the
stool culture S. ﬂexneri isolated. The strain was resistant to
trimethoprime/sulphamethoxazole, ampicillin, amoxycillin/
clavulanic acid, tetracycline, chloramphenicol and susceptible
to ciproﬂoxacin, cefotaxime, piperacillin. His condition showed
gradual improvement. At the next days he was presented
gradual improvement. CPK on the 2nd and 3rd hospital day was
4700 IU/L 900 IU/L respectively and had returned to within
normal by the sixth hospital day. The patient was discharged on
day 7.
Conclusions: Rabdomyolysis complicating S. ﬂexneri gastroen-
teritis is very rare. The present case is only the second found in
the English literature. The possibility of rabdomyolysis must be
considered in all cases of severe gastroenteritis so that
prevention and timely treatment of complications are made
possible.
R2013
Corynebacterium urealyticum encrusted cystitis:
a new case and review of literature
E. Lecuyer, L. Petit, S. Malinowski, M. Boutemy, B. Vidal,
M. Albertini, F. Duchemin, J. Turblin, J.L. Schmit, C. Dayen,
Y. Douadi (Saint Quentin, Amiens, Abbeville, F)
Encrusted alkaline cystitis (EC) is an unusual process, almost
forgotten by urologists. It tends to appear complicating an
underlying cystopathy. EC consists of a vesical mucosal inﬂam-
mation with encrustation of amonium magnesium phosphates
in the urothelium. Their genesis requires pre-existing mucosal
damage, urinary infection by urolithic microorganisms and
alkaline urine. A 50-years-old man was victim of a trafﬁc
accident with multiple injuries. He was admitted in our ICU
hospital and urinary catheterisation was perfomed for 20 days.
Because of hematuriae and abdominal pain urine samples were
collected. Corynebacterium urealyticum grown in the urine, and
some foci of malakoplakia were found in the area of encrusta-
tion and endoscopically excised. Antibiotic treatment with
teicoplanin and ciproﬂoxacin was fulﬁlled during 60 days. After
30 days of treatment, endoscopical resection of bladder wall was
achieved for bacteriological data. Few cases of encrusted cystitis
were reported this past years. We propose literature review and
therapeutic options in this communication.
R2014
Differences in aetiology according to Fine score
in adult patients with hospital admitted CAP in
Spain
M. De-la-Rosa, F. Baquero, A.M. Martı´n-Sa´nchez, J. Ruiz,
C. Garcı´a-Rey on behalf of the NACER Group
Objectives: Despite the overlapping aetiology of CAP regard-
less of severity, there exists a trend towards a higher implication
of S. pneumoniae as severity increases. Here we present the
relative involvement of different pathogens in a large series of
adults with CAP admitted to hospital in Spain.
Methods: Retrospective review of the microbiological requests
and results of patients admitted to hospital with the diagnosis of
CAP over a 1-year-period (1Nov2001 to 31Oct2002) in 10
geographically scattered hospitals in Spain. Data were available
from 3233 patients. Of those patients only 1722 had recorded the
necessary information to calculate the Fine score, and this was
our target population.
Results: The prevalence (%) of the main respiratory pathogens
by Fine score is shown in the Table 1.The composite prevalence
of S. pneumoniae in patients with low risk Fine score (groups 1–3)
was 58.5% vs. 69.0% in those with high risk Fine score (groups
IV–V), p = 0.025.
Conclusions: (1) Mean etiologic diagnosis was established in
around 25% of patients. (2) S. pneumoniae remained as the most
important responsible in any of the Fine groups. (3) Contrary to













1 25.3 52.9 11.8 3.9 2.0 29.4
2 24.7 65.1 7.9 4.7 7.9 14.3
3 26.9 57.3 9.4 8.3 6.3 18.8
4 23.4 66.4 8.2 2.7 4.0 18.6
5 22.4 76.7 4.7 3.1 0.0 15.6
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risk than in high risk Fine groups. (4) However, S. pneumoniae
was signiﬁcantly more common as severity increased. (5)
H. inﬂuenzae did not show clustering in any group. (6) M. pneu-
moniae was more common in less severe cases.
R2015
Inﬂuence of inﬂuenza cases on the number of
hospital admissions of CAP in Spain
J.M. Nogueira, J. Torres, F. Baquero, J.E. Martı´n-Herrero,
R. Dal-Re´ on behalf of the NACER Group
Objectives: The processing of microbiological samples is
known to yield different results depending on many external
factors many of them are of logistic nature. We wanted to
assess whether this statement stands in the microbiology of
samples from patients with CAP admitted to 10 Spanish
hospitals.
Methods: Retrospective review of the charts of patients admit-
ted to the hospital with the diagnosis of CAP over a 1-year
period (from 1 Nov 2001 to 31 Oct 02) in 10 geographically
scattered hospitals in Spain. Data were available from 3233
patients. Concomitantly, we represent the number of declared
cases of inﬂuenza as provided by the Spanish Institute for
Health Carlos III from the same time period.
Results: Number of CAP admissions and inﬂuenza cases
declared are shown in Figures.
Conclusions: (1) The number of CAP admitted to hospital
increased from the beginning of the study period peaking
abruptly in January and decreasing at a steady pace after-
wards to increase again from September onwards. (2) Like-
wise, the number of inﬂuenza cases had a mirroring increase
during the last two months of 2001 with a parallel, although
much larger magnitude, bursting increase in the ﬁrst weeks of
2002. (3) However, the decrease in the notiﬁcation of inﬂuenza
cases was faster than the decrease in hospital admission due to
CAP.
R2016
Prevalence of complicated urinary tract infections
in Italy among patients attending the urologist’s
ofﬁce
F. Marchetti, C. Ferri (Verona, Bologna, I)
Background: Few data are available on the prevalence of
complicated urinary tract infections (cUTIs) in Italy. We report
here the major results of a large prospectively planned survey
carried out on the prevalence and disease management of cUTIs.
Methods: Some 111 urologists throughout Italy recorded all
outpatient visits. Each case of cUTIs, according to stated clinical
deﬁnitions was comprehensively evaluated. All the urologists
were speciﬁcally trained on the protocol and case report-form
compilation.
Results: A total of 13,030 patients were observed in the study
timeframe. Approximately 20% of visits were audited. Overall,
the prevalence of cUTIs was 10.8% (n = 1405). The mean age of
the patients population was 60.9 years (sd 15.7). cUTIs diagno-
ses were mainly associated with prostatic hypertrophy (40.7%),
presence of stones in bladder or urinary tract (19.7%) and recent
urologic surgery (12.8%). Diabetes was the more frequently
observed co-morbidity (17.5%). The cUTIs clinical picture
included: prostatic hypertrophy (42.9%) suprapubic pain
(40.6%), ﬂank pain (13.4%), etc. The ﬁrst cUTIs episode was
observed in 51% of the patients, while 34% and 10.3% presented
a re-infection or a recurrent episode, respectively. The more
frequently encountered pathogens were E. coli (39.2%), Proteus
(8%), Klebsiella (4%), Enterococcus (3.9%), and Pseudomonas (3%).
Nearly 20% of patients declared absence from work for the
current episode (mean of 6.6 days ds 5.2; range 1–35). No
signiﬁcant geograﬁcal variations among all the major items were
detected.
Conclusion: cUTIs are a signiﬁcant clinical entity among Italian
outpatients in terms of morbidity, quality of life and social costs.
R2017
Group B streptococcal arthritis in an
immunocompetent adult
M. Tsironi, M. Kalkani, Sp. Fokas, P. Andriopoulos, M. Perdiki,
M. Dionysopoulou, G. Assimakopoulos (Sparta, GR)
Objectives: Group B streptococci (GBS) are causes of lifethreat-
ening infections in neonates, infants and pregnants ,but they are
possible causes of invasive infections especially in immunocom-
promised adults. GBS arthritis has been rarely described in
immunocompetent adults, usually associated with other risk
factors as neoplasms, cirrhosis, diabetes. We present a GBS
arthritis in an immunocompetent male patient.
Case report: A 65-year-old white man, presented with a 2-day
history of fever and chills, abdominal pain and a 1-day history
of torticollis and pain of the right hip. Remarkable physical
ﬁndings included toxic appearance, temperature of 38.5 C,
neck stiffness. His past medical history was unremarkable,
except arterial hypertension under treatment. Admission
laboratory tests revealed WBCs 17000 cells/mm3 (87% neu-
trophils), hematocrit 47.7%, normal platelets. Coagulation tests
were normal. ESR was 125 mm/1st hour and CRP qualitive
measurement was positive. Transaminase levels were normal.
Three sets of blood culture and a urine one were obtained.
Blood cultures were carried out by mini Vital system (Bio-
Merieux). The patient began receiving ciproﬂoxacin and
dicloxacillin, thought to be a septic arthritis. At 72 hours,
three bottles of blood culture grew group B streptococcus.
Species identiﬁcation was performed by classic methods.
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Susceptibility test was performed by disc diffusion method
(according to NCCLS).The strain was resistant to aminoglyco-
sides. Antibiotic therapy was changed to intravenous penicil-
lin. Whole body bone scan, with Tc99m-MDP revealed arthritis
of the right acetabulum. 8 days later, the patient presented
increased mobility of the right hip and he ﬁnally recovered
without sequelae.
Conclusions: This case report tries to increase the awareness of
clinicians to GBS as a potential cause of septic arthritis.
Although GBS disease is frequent in adults with asplenia-
organic or functional-, chronic liver disease, diabetes and
congestive heart failure, and although urinary tract infection,
pneumonia and soft tissue infections are the commonest
presentations, GBS has not to be underestimated in the differ-
ential diagnosis of septic arthritis even in patients without
predisposing factors.
R2018
Severe complications in patients with Brucella
melitensis infection
A. Karakolios, T. Kallinikidis, A. Poulou, A. Garefas,
G. Lazaridis, V. Kontos, G. Vasilikos (Serres, GR)
Brucellosis can present with a variety of symptoms and can
affect virtually every organ and tissue of the body. We report
here complications in 15(17%) out of 88 patients with Brucellosis
that were diagnosed and treated at our Hospital in a period of
7 years. These complications were of clinical signiﬁcance
because they lead to diagnostic and therapeutic dilemmas.
Complications that lead to diagnostic dilemmas because of the
broad list of differential diagnosis included skin rash in 3
patients, orchitis/epipidymitis in 3 patients, severe pancytope-
nia in 2 patients and single lineage cytpenias in another 3, and
ﬁnally stiff neck with CSF pleocytosis in one patient.Therapeutic
dilemmas emerged in 3 patients who developed arthritis
(spondylitis, sacro-ileiitis and spondylitis, and right ankle
arthritis, respectively) while they were receiving treatment for
Brucellosis. Finally, it was only after a detailed diagnostic work
up that a patient who presented with recurrent fever and
arthritis while on treatment for Brucellosis for 8 weeks was
diagnosed with endocarditis of an artiﬁcial aortic valve. Suc-
cessful management required prolonged treatment with a
combination of antibiotics.
Conclusion: The diagnosis and treatment of Brucellosis are
usually simple. However, the successful management of its
complications that can be severe, may require detailed diagnos-
tic work up and prolonged treatment.
R2019
Therapeutical problems and effective
antimicrobial therapy in post-traumatic patients
with Streptococcal cellulitis and Streptococcal
toxic shock syndrome
M. Stasiak, J. Lasek, J. Komarnicka, A. Samet,
Z. Witkowski (Gdansk, PL)
Objective: We observe an increasing number of invasive soft
tissue infections caused by Streptococcus pyogenes in recent years
among patients following trauma hospitalized in The Dpt. of
Trauma Surgery of the Medical University of Gdan˜sk. GAS may
cause cellulitis, necrotizing fasciitis, myositis and myonecrosis.
The highest rate of mortality (30–70%) occurs in cases with
Streptococcal Toxic Shock Syndrome (STSS) related with soft
tissue infections in 40–50% cases.
Methods and materials: We analysed records of patients
clinical materials from recent 2 years. We present 4 posttrau-
matic patients with severe GAS infections of soft tissues with
cellulitis and STSS. All patients developed infectious complica-
tions following injuries. All cases required quick and aggressive
surgical procedures- large incisions and removal of necrotic
tissues; one of the patients needed multiple surgical interven-
tions. Three patients improved in spite of severe course of
infection; one patient died. Two patients suffered from head
injury, two patients had injuries to the extremities complicated
by extended tissue necrosis. Amputations of the limbs were not
necessary. The course of infections was rapidly progressive with
fever, extensive soft tissue necrosis and marked systemic
toxicity. All cases required broad spectrum antimicrobial ther-
apy- patients were treated with lincosamids, mainly with
clindamycin given intravenously in large doses from 1800 to
3600 mg/day. In all patients microbiological procedures were
performed: cultures of the wound and blood were obtained and
sent for routine and anareobic cultures and for direct micro-
scopic examination. Suitable diagnostic materials were: exsudate
from the wound and fragments of necrotic tissues.
Conclusion: GAS infections are severe and life threatening.
According to our ﬁndings clindamycin in high doses improves
the prognosis and should be the drug of choice in Streptococcal
cellulitis and STSS.
R2020
Demographic and microbiologic features of
urinary tract infections in young and adult
patients
M. Bonadio, T. Tartaglia, S. Mori, G. Morelli, P. Tanzilli (Pisa, I)
Background: Urinary tract infection (UTI) is one of the most
common bacterial infections. Since antibiotics are often admin-
istered empirically, it is necessary to evaluate the spectrum and
susceptibility of the etiological agents in the various clinical
settings.
Objectives: To evaluate some demographic and microbiologic
features ofpatientswithUTI and some risk factors associatedwith
the resistance of E. coli to the most common oral antimicrobials.
Methods: All consecutive young and adult patients
(16–50 years of age) attending the Urinary Tract Infection Clinic
at the Pisa General Hospital from January 1997 to October 2004
were evaluated.Results: During the study period, 460 ( 375
females and 85 males) pts with UTI were enrolled. E. coli was
isolated in 62.1% of the women and in the 45.0% of the males;
the difference however was not statistically signiﬁcant. Pseudo-
monas spp was more frequently isolated in males than in females
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(10% vs 0.8%, p < 0.001 ). E. coli showed similar resistance rate
in males and females to ampicillin, cotrimoxazole, nitrofurant-
oin and ciproﬂoxacin. The isolation rate of E. coli was lower
(54.4% vs 64.2% , p < NS ). in women treated with antimicro-
bials during the 2 months prior their enrolment than in those
with no previous treatment. The resistance rate of E. coli to the
antimicrobials in previously treated and non treated women
was the following respectively : cotrimoxazole 22.6% vs 8.3%,
p = 0.07; ampicillin 41.9% vs 22.6%, p NS; ciproﬂoxacin 9.7% vs
0.4%, p NS ; nitrofurantoin 9.7% vs 8.8%, p NS).
Conclusions: In young and adult pts (16–50 years of age), E. coli
is the causative agent of UTI more frequently in females than in
males. In men, other microorganisms (expecially Pseudomonas )
play a signiﬁcant role. In females, a previous antimicrobial
treatment increases the risk of E. coli resistance to ampicillin and
cotrimozazole.
R2021
Complications of acute brucellosis among adults
in Diyarbakir, Turkey
M.K. Celen, S. Hosoglu, M.F. Geyik, C. Ayaz,
M. Ulug (Diyarbakir, TR)
Objective: Brucella infection is endemic in our region Diyarba-
kir in particular. We describe here the clinical results and the
complication of the infection in the hospitalized patients.
Methods: This retrospective study was conducted on patients
with acute brucellosis in department of infectious diseases in
Diyarbakir from 2003 to 2004. The complications and laboratory
test results were noted.
Results: The study included 34 patients (20 females, 14 males)
and their mean age was 34.8 ± 14.9 (range, 16–74) years old.
Fever (91%) and sweating (91%) were the most common
clinical ﬁndings which were determined in all patients.
Arthralgy (85%) and headache (35%) were the other ﬁndings
in patients. The diagnosis was established according to the
clinical ﬁndings and serologic markers in all patients. Rose-
bengals test was positive in 29 patients. Brucella spp. was
grown from blood cultures in 12 patients (35.3%). Osteoartic-
ular involvement in 16 patients (47%), epididimoorchid in ﬁve
patients (14.7%), Central nervous system (CNS) involvement in
two patients (5.9%), spinal abscess and liver involvement in a
patient (2.9%) were developed. Combination antibiotherapies
of duo or trio (rifampicin, doxocycline/streptomycin and/or
cotrimoxazole/streptomycin/ceftriaxone) were given to
patients for 2–6 months period.
Conclusion: Osteoarticular involvement is by far the most
common focal complication of Brucella infection. Osteoarticular
involvement (47%) was the most complication in this study
too. Because of this reason patients which were came with
Osteoarticular complains, were researched about Brucella infec-
tion.
R2022
Microbiology facts in cystic ﬁbrosis patients
in Greece
S. Kanavaki, S. Karabela, M. Tzeti, M. Makarona, H. Moraitou,
S. Triantafyllou, J. Kamatsos, E. Pouliou (Athens, GR)
Objectives: Serious respiratory infections, due to P. aeruginosa
and B. cepacia consist a major problem in the life of Cystic
Fibrosis (CF) patients. In Greece, the B. cepacia isolation in CF is
considered rather rare. The aim of our study was to investigate
the presence of B. cepacia in respiratory infections of CF patients
of Sotiria Chest Diseases Hospital of Athens.
Methods: The selective medium B. cepacia agar (Oxoid) was
used, in addition to conventional media, for quantitatively
culturing sputum samples of CF patients, admitted to our
Hospital, for the period 2003–2004. Identiﬁcation methods
included API 20E, API NE, and Vitek 2 (Biomerieux). All Gram
(-), oxidase (+) isolates were also molecularly identiﬁed initially
by multiplex PCR, in order to identify two bacterial species
P. aeruginosa and P. cepacia. The multiplex PCR included primers
speciﬁc for the 520 bp fragment of the ribosomal 16S gene,
identifying the ﬁve main gemovars of B. cepacia. Included in the
multiplex PCR was a universal bacterial primer pair targeting
the 16S rRNA to act as internal control (233 bp). Samples giving
results for the 520 and/or 463 bp fragments were further tested
for the identiﬁcation of the bacterial strain with speciﬁc PCR.
The recA gene PCR is a useful assay, which discriminates
between the B. cepacia complex and B. cepacia like microorgan-
isms.
Results: None of the isolates was identiﬁed as belonging to
B. cepacia complex, either by selective medium or PCR. A
high level of correspondence was noted between selective
B. cepacia medium and molecular identiﬁcation of isolates.
Conclusions: There is evidence that B. cepacia participation in
CF respiratory infections is rather unusual in Greece.
R2023
Inﬂuence of proper antimicrobial prescribing on
outcome of acute sinusitis
S. Ratchina, S. Kozlov, L. Stratchounski,
V. Kretchikov (Smolensk, RUS)
Objective: The aim of the study was to evaluate correlation
between antimicrobial (AM) prescribing for outpatient adults
with acute sinusitis (AS) and outcome of the disease.
Methods: Case histories of outpatients with the diagnosis of
AS were consecutively selected in outpatients’ departments in
8 regions of Russia for retrospective analysis. AM were
classiﬁed using ATC-codes. All collected data were analysed
with specially designed software Pharmatherapeutical Data
Analysis (IAC, Smolensk, Russia). Outcomes were classiﬁed
as success (cure or improvement) and failure (hospitaliza-
tion or prescription of an additional AM). Patient’s age and
frequency of sinus puncture (SP) as factors potentially
inﬂuencing outcome of AS were also analysed. Ages were
compared with Wilkokson–Mann–Whitney test. Outcomes and
frequency of SP for the treatment with different AM were
compared using weighted pairwise Fisher criterion.
Results: A total of 1529 case histories of outpatients aged
from 16 to 81 (539 males, 990 females, average age
37.1 ± 13.2 years) were analysed. 10 most popular AM
(82.7% from all AM) used for initial monotherapy including
ampicillin (AMP), amoxicillin (AMX), amoxicillin/clavulanate
(AMC), erythromycin (ERY), midecamycin (MID), gentamicin
(GEN), lincomycin (LIN), doxycycline (DOX), ciproﬂoxacin
(CIP), co-trimoxazole (CTX), were prescribed to 1029 (67.3%)
patients. All groups were similar according to age. AMX
group was associated with signiﬁcant less frequency of SP
than LIN, CIP, GEN (p < 0.001) and MID, AMC (p < 0.05)
groups. Initial prescription of CIP or LIN was found to have
higher rates of SP compared to AMP, ERY and DOX
(p < 0.05). Rates of treatment success and failure are presented
in the table. Treatment with AMX was statistically more
successful than with other AM (p < 0.05) except AMC and
MID. There was no signiﬁcant difference in outcomes between
other groups except MID, which had better outcome than CIP
and DOX (p < 0.05).
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Conclusion: proper AM prescribing (AMX) for initial treatment
of AS led to better outcome. AMX start-up therapy was
associated with less frequent SP.
R2024
Antimicrobials prescription patterns in
outpatient adults with community-acquired
pneumonia in Russia: 2003 vs 1998
L. Stratchounski, S. Ratchina, E. Bodyaeva, T. Kornilova,
I. Leshenko, L. Ziganshina, N. Shevtchenko, N. Tumanova,
V. Kuzin, L. Sidorova, N. Zubareva, I. Sirotko, E. Ortenberg,
S. Djachenko, L. Gabbasova, D. Bochkarev (Smolensk, Barnaul,
Ekaterinburg, Kazan, Krasnodar, Moscow, Nizhnij Novgorod,
Novosibirsk, Perm, Samara, Tyumen, Khabarovsk, Chelyabinsk,
Volgograd, RUS)
Objective: A number of guidelines for CAP management in
adults have been published since 2000. The present survey
evaluates the patterns of antimicrobial (AM) prescribing to
adults with CAP in Russian outpatient departments in 2003, as
compared to 1998.
Methods: Case histories of outpatients with CAP who had not
required hospitalization were randomly selected in ﬁfteen
regions of Russia for retrospective analysis and were compared
with the data obtained in 1998. The system of distance double
data entry was used for data collection.Results: Altogether, 2174
case histories of patients from 16 to 91-years-old (1140 males,
1034 females, average age 47.0 + 16.4) were included in the
study in 2003 vs. 778 case histories of patients from 16 to
88-years-old (383 males, 395 females, average age 47.1 + 15.2) in
1998. A total of 35 AM were prescribed in 2003 compared to 36
in 1998. The most common drugs for initial monotherapy in 2003
were amoxicillin (24.0%), ciproﬂoxacin (14.6%), midecamycin
(10.9%), cefazolin (10.1%), amoxicillin/clavulanic acid (6.5%) vs.
gentamicin (15.6%), ampicillin (12.1%), ciproﬂoxacin (10.5%), co-
trimoxazole (8.0%) in 1998. About 8% of patients in 2003 vs. 16%
in 1998 received combinations of 2–3 AM as initial therapy.
Amoxicillin + gentamicin (14.7%), ampicillin + gentamicin
(9.2%), ciproﬂoxacin + gentamicin (5.5%) were the most fre-
quently prescribed combinations in 2003 vs. ampicillin +
co-trimoxazole (26.1%), gentamicin + co-trimoxazole (9.2%),
ampicillin + gentamicin (6.7%) in 1998. In 72.5% of cases AM
were administered orally (vs. 71.6% in 1998), in 24.7% –
intramuscularly (vs. 28% in 1998), 0.5% – intravenously, 2.3%
– route was not indicated.
Conclusion: Numerous AM were used for CAP treatment in
2003 as well as in 1998, but prescribing habits have improved.
An increased rate of amoxicillin and amoxicillin/clavulanic acid
and a decreased gentamicin and co-trimoxazole usage were
observed. The very low rate of new macrolide usage and an
unacceptably large number of ciproﬂoxacin and cefazolin
prescriptions should be noted.
R2025
Isolation of Haemophilus inﬂuenzae and
Haemophilus parainﬂuenzae in non-gonococcal
urethritis
A. Amor, M. Sanchez Conde, N. Portocarrero, M. Baquero,
A. Enriquez (Madrid, E)
Objectives: Haemophilus spp. have been suggested as a poten-
tial pathogen in urethritis. We report four cases in which
Haemophilus spp. were isolated in men with urethritis as only
pathogen present.
Methods: Samples from 97 males with sexual risk behaviors
(homosexuality), were processed for bacterial and fungi culture.
Chlamydia trachomatis and Mycoplasma urealyticum were per-
formed by speciﬁc request and microscopic examination for
Trichomonas vaginalis 21.64% of patients had symptoms of
urethritis and 79.36% were asymtomatic
Results: Haemophilus spp. was isolated in 24 patients (24.7 %):
H. inﬂuenzae en 2 cases (8.3%) and H. parainﬂuenzae in 22 cases
(91.7%) Haemophilus spp. was isolated as only pathogen in four
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Conclusions: Haemophilus spp. was isolated at a hight fre-
quency in our studied group.The pathogenic role of Haemophilus
spp. was suggested when it was isolated as an only pathogen.
Nosocomial infections, infection control
R2026
Cure of multidrug-resistant (MDR) Acinetobacter
baumannii bacteraemia with continuous
intravenous infusion of colistin
S. Kasiakou, A. Michalopoulos, E. Rosmarakis, P. Vergidis,
M. Falagas (Athens, GR)
Background: Although intermittent intravenous bolus dosing
of antimicrobial agents is the standard way of administration of
antibiotics in clinical practice, the last few years, there is
renewed interest among clinicians and researchers in examining
the beneﬁts of continuous mode of treatment. Methods: Des-
cription of a patient with multidrug-resistant Acinetobacter
baumannii bacteraemia who was successfully managed with
continuous intravenous infusion of colistin.
Results: A 41-year-old white man was admitted to the ICU of
our hospital because of sudden cervico-occipital headache
accompanied by vomiting. A CT of the brain revealed extensive
intraventricular haemorrhage originating from the basal ganglia.
During his long-standing hospitalization to our hospital several
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events of clinical signiﬁcance occurred. On day 84 of his
hospitalization, the patient developed pneumonia due to
Staphylococcus aureus and Pseudomonas aeruginosa strains. He
was managed with intravenous antimicrobial agents including
vancomycin, gentamicin, and piperacillin/tazobactam, which
led to clinical improvement. However, on day 96, the above-
mentioned isolates grew again from cultures of bronchial
secretions specimens. Gentamicin was discontinued, and intra-
venous ciproﬂoxacin and rifampin were started. On day 117, the
patient developed an extensive maculopapular rash on the trunk
and the extremities. In addition, ocular and perioral swelling
was observed. All antimicrobial agents were discontinued. On
day 119, he developed bacteraemia due to Klebsiella pneumoniae
strain. Intravenous gentamicin was started but it was discon-
tinued one day later due to the ﬂare up of the rash. Finally, on
day 127, a blood specimen culture grew a MDR Acinetobacter
baumannii strain, sensitive only to colistin. A continuous intra-
venous infusion regimen with colistin 2,000,000 units per
24 hours was initiated. The clinical condition of the patient
gradually improved, and the rash gradually diminished.
Conclusion: Continuous intravenous administration of colistin
may be associated with fewer hypersensitivity (adverse) reac-
tions and may be as effective as the traditional intermittent way
of infusion.
R2027
Colonisation and antimicrobial resistance
in tracheal aspirates of hospitalised patients
in intensive care units of a tertiary medical care
centre in Kosova
L. Raka, G. Mulliqi, L. Berisha, L. Begolli, A. Kurti, A. Jaka,
X. Jakupi, D. Zoutman (Pristina, CS; Kingston, CAN)
Objective: To determine colonization rate of the nosocomial
pathogens in tracheal aspirates of patients hospitalized in
intensive care units of University Clinical Center of Kosova
and to investigate their in vitro antimicrobial susceptibility
pattern.
Methods: A total of 324 isolates from ICU patients received
between November 2003 to November 2004, were processed in
the Department of Microbiology within the National Institute of
Public Health of Kosova. Standard microbiologic methods were
used for microorganisms identiﬁcation. The antimicrobial resist-
ance was determined with disk diffusion methods according to
NCCLS guidelines.
Results: Of 324 tracheal aspirates 259 (79.9%) specimen
yielded growth of microorganisms. 75.3% of isolates were
recovered from adult intensive care units. Of all positive
isolates, 6.8% were polymicrobic. Gram negative bacilli accoun-
ted for 75.3% of all microorganisms. Pseudomonas aeruginosa
was the most common aetiologic agent isolated (29.5%),
followed by Acinetobacter baumanni (16.9%), Klebsiella pneumo-
niae (9.9%) and Citrobacter freundii (5.4%). Staphylococcus aureus
predominate among gram positive bacteria with overall pres-
ence of 9.8% accompanied by Staphylococcus epidermidis (5.35%).
Ampicillin, gentamycine, ceftriaxone and imipenem global
resistance rates were 93.8%, 87.6%, 78.1% and 25.9%, respect-
ively. 75.4% of Staphylococcus aureus isolates were resistant to
oxacillin Resistance rate of Pseudomonas aeruginosa to third
generation cephalosporins was 85.7%. All isolates of Acinetob-
acter were multidrug resistant.
Conlcusion: High frequency colonization of multidrug resistant
nosocomial pathogens in tracheal tube of ICU hospitalized
patients suggest that infection control measures should be
implemented with prudent use of antimicrobial agents.
R2028
Changing pattern of neonatal bacteraemia:
microbiology and antibiotics resistance
S. Ellabib, S. Haﬁda, R. Amal, B.N. Turia (Tripoli, LYB)
Objective: The work presented here sought to determine the
most important causative agents of bacteraemia in a neonatal
intensive care unit (NICU), their changing distribution and their
antibiotic susceptibility patterns over a ﬁve years period from
1997 to 2001 in the Tripoli Medical Center (TMC).
Methods: This study was performed between January 1997 and
January 2001 at the Microbiology section in Tripoli Medical
Center. During this period 1431 Oxoid Signal Blood Cultures
sets were obtained from 1092 Neonatal Intensive Care Unit
(NICU) with suspected bacteraemia. Conventional methods,
API 20E and API 20NE (bioMerieux) were used to identify the
isolated bacteria. The Kirby-Bauer disk diffusion method was
performed to assess their antibiotic susceptibilities in accordance
with NCCLS standard.
Results: Over the period of the study 801 sets out of the total
1431 blood cultures were positive for microbial growth, which
represented 648 cases of neonatal bacteraemia from a total of
1092 cases. From the total number of isolates the members of
enterobacteriaceae Serratia, Klesiella and Enterobacter spp were the
most common cause of bacteraemia. The coagulase negative and
positive Staphylococci were also frequently isolated. A changing
pattern of causative pathogen was observed during this study
between members of the three leading genera of Enterobacte-
riaceae. Antibiotic susceptibility testing showed a high level of
resistance among the most common pathogens. Resistace to
Aztreonam, Imipenem, Ciproﬂoxacin and piperacillin/tazobac-
tam was less frequently encountered. Staphylococcus resistance
to anti-staphylococcal antibiotic and due to hyperproduction of
penicillinase enzyme was also high and all isolates were
remained sensitive to vancomycin.
Conclusion: Gram-negative bacteria especially members of the
enterobacteriaceae are important causes of bacteraemia in
neonatal intensive care units. Although most isolates remain
sensitive to the new antibiotics, emergence of resistant strains
can not be excluded in the future. For that reason new strategies
and continuous surveillance are required to monitor the chan-
ging epidemiology of pathogens, antibiotic susceptibilities and
antibiotic use needed to overcome the increasing incidence of
resistance to conventional drugs.
R2029
Phagocytic activity of human peripheral blood
polymorphnuclear leucocytes to methicillin-
sensitive and resistant coagulase-negative
Staphylococci
A. Zilevica, R. Treimane, R. Paberza (Riga, LV)
Objectives: Two types of white blood cells, the polymorphnu-
clears (PMN) and monocytes are important in resistance to
infections. Phagocytes play a signiﬁcant part as the ﬁrst line of
defence against bacteria, viruses and fungi in the human host.
Methicillin-resistant Staphylococci have emerged as signiﬁcant
nosocomial pathogens and express certain virulence factors. The
aim of the present study was to evaluate the host defence
against methicillin-resistant Staphylococci in comparison with
methicillin-sensitive strains.
Methods: The study was conducted during 2002–2003 in the
Hospital of Traumatology and Orthopedics, Riga, Latvia.
During this period, 31 strains of coagulase-negative Staphylo-
cocci were studied. From them – 10 strains isolated from
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healthy persons (control strains, additionally ATCC 12208
were used as the control), 15 methicillin-resistant strains
(MRCoNS) and 5 methicillin-sensitive (MSCoNS) isolated from
clinical specimens were studied. The phagocytic capacities of
human peripheral blood polymorphnuclears of 11 volunteers
(against the above-mentioned strains) were evaluated. The
percentage of active cells and the phagocytic index were
measured, as well as the percentage of digested cells in
3 hours.
Results: Using the control strains of Staphylococci, 80% of active
phagocytes with the phagocytic index 7.8 was observed. In
3 hours, 100% of Staphylococciwas digested. In experiments with
MSCoNS, the following results were registered: 77% of active
cells with the phagocytic index 4.36 and 78.2% of digested cells.
In experiments with MRCoNS, there was 67.75% of active
phagocytes with the phagocytic index 3.71 and 68.4% of
digested cells in 3 hours.
Conclusions: Methicillin-resistant strains of CoNS are more
virulent than MSCoNS and are not destroyed by phagocytes as
actively as MSCoNS.
R2030
Colonisation of nasopharynx by Gram-negative
rods in patients with resectable lung cancer
during short-term hospitalisation
R. Los, A. Malm, P. Rybojad, F. Furmanik (Lublin, PL)
Objectives: The aim of this study was to assess the frequency of
colonization of nasopharynx by Gram-negative rods in patients
with lung cancer undergoing thoracic surgery, who routinely
receive antimicrobial prophylaxis (piperacillin, cefuroxime
alone or in combination with amikacin). Antimicrobial agent
susceptibility of isolated strains was also deﬁned.
Methods: Sixty-three patients with resectable lung cancer
were included in the study. Throat and nasal specimens were
taken two times: on the day of hospital admission (examina-
tion I) and on the fourth day after surgery (examination II).
Samples were routinely cultured under aerobic conditions.
The strains were identiﬁed by using API 20E or API 20NE.
Susceptibility to selected antimicrobial agents was detected by
the disc diffusion method according to NCCLS recommenda-
tions.
Results: 24 strains of Gram-negative rods, 17 belonging to
Enterobacteriaceae family and 7 – to non-fermenting rods, were
found in 28 samples: in 8 patients in examination I (12.7%)
and in 16 patients in examination II (25.4%). Double increase
of frequency of these bacteria on mucous membranes of
nasopharynx in examination II was observed (v2 test, p =
0.0695). The strains of Enterobacteriaceae were highly suscept-
ible to antimicrobial agents, whereas the most of non-fer-
menting rods were classiﬁed as multidrug resistant organisms.
Among the antibiotics used in this study, cefepime and
ticarcillin/clavulonic acid were the most active in vitro against
the isolated Gram-negative rods. We found that 1 strain
produced extended-spectrum b-lactamases and 4 strains –
inducible b-lactamases.
Conclusion: During hospitalization, in patients with lung can-
cer undergoing thoracic surgery and preoperative prophylaxis,
qualitative and quantitative changes in Gram-negative rods
colonizing nasopharynx were observed. In the samples taken on
the 4th day after surgery increased prevalence of non-ferment-
ing rods (mostly multidrug resistant) was found. Obtained
results conﬁrm the need to conduct analyses of microﬂora
of upper respiratory tract in patients with lung cancer to
monitor potential etiologic factors in nosocomial respiratory
tract infections.
R2031
Outbreaks of Serratia marcescens bacteriuria in a
neurosurgical intensive care unit of a tertiary care
teaching hospital: a clinical, epidemiologic, and
laboratory perspective
H.J. Yoon, J.Y. Choi, J.M. Kim, D. Yong, K.W. Lee,
Y.G. Song (Seoul, KOR)
Objectives: The aims of this study were (1) to identify the risk
factors associated with the development of Serratia marcescens
bacteriuria in neurosurgical intensive care units (NSICU) (2) to
genotype the pathogens in order to determine a source of
infection (3) to compare these results with the antibiogram and
(4) to implement the appropriate control measures.
Methods: A retrospective case-control study of the epidemio-
logical data, the surveillance of environmental cultures and the
genotyping of strains using arbitrarily primed polymerase chain
reaction (AP-PCR) were performed in a 750-bed, tertiary care
teaching hospital. Seventy-four bacteriuria patients were com-
pared with 74-age-gender-matched control-patients in the
NSICU between March 2002 and March 2004. The factors
assessed included the patients’ demographics, the duration of
the hospital stay and the indwelling catheter before and during
admission to the NSICU, a chronic underlying illness (diabetes
mellitus, cardiovascular disease, malignancy), other sites of
infection, a history of trauma, exposure to a nasogastric tube,
mechanical ventilation, urinary catheterization, central venous
catheterization, surgical drainage, tracheostomy, or brain or
spine surgery, and thereceipt of total parenteral nutrition (TPN),
antimicrobials (b-lactams, aminoglycosides, quinolones, carbap-
enems, vancomycins) or steroids.
Results: Patients with S. marcescens bacteriuria were more likely
to have a longer NSICU stay and other sites of infection.
Environmental surveillance showed the handling of urine jugs
to be a point source of contamination. Genotyping and an
antibiogram of 14 patients were the same except for two
patients.
Conclusions: The patient-related risk factors were identiﬁed,
and a rapid identiﬁcation of the organism was made. Altering
the method for handling urine jugs provided a focus for the
heightened surveillance, infection control measures, and empir-
ical therapy, terminating outbreaks.
R2032
Spondylodiscitis after facet joint steroid injection
M. Falagas, I. Bliziotis, A. Mavrogenis, D. Antoniou,
P. Papagelopoulos (Athens, GR)
Background: Reported infections following facet joint injections
are rare and include paraspinal and epidural abscess formation
and septic facet joint arthritis.
Methods: We describe a case of Pseudomonas aeruginosa spond-
ylodiscitis after facet joint steroid injection.
Results: A 78-year-old male was presented to his local ortho-
pedic surgeon for low back pain. The patient had no neurologic
deﬁcits, and with the presumptive diagnosis of degenerative
spondylosis, he has been treated with non-steroidal anti-inﬂam-
matory agents and physiotherapy for 3 months. Three months
later, the patient had worsening of his back pain. Plain
radiographs, computed tomography (CT) and magnetic reson-
ance imaging (MRI) of the lumbar spine showed osteoarthritis of
the lower lumbar facet joints. Facet joints injection was done
using methyl-prednisolone acetate and bupivacaine hydrochlo-
ride 0.5%. The patient had temporary relief of his symptoms for
2 days followed by deterioration of his low back pain and acute
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onset of low-grade fever. Laboratory investigation revealed
increased white blood cell count (16.010/ı`l), erythrocyte sedi-
mentation rate (83 mm/1st hour), and C-reactive protein
(185 mg/l). Spine infection was suspected and ciproﬂoxacin
was administered (500 mg p.o. q12h) for four weeks. However,
this treatment led to minimal improvement of the clinical
symptoms. At the time of his admission to our institution, his
main signs and symptoms included low back pain and tender-
ness, and increased body temperature. MRI, ﬁne needle aspir-
ation and cultures of the affected area conﬁrmed the diagnosis
of Pseudomonas aeruginosa spondylodiscitis at the L2-L3 and
L3-L4 levels. The patient was treated with intravenous admin-
istration of amikacin (500 mg q12h) and imipenem plus cilastatin
(500 + 500 mg q8h), for four weeks, followed by oral adminis-
tration of ciproﬂoxacin for 24 weeks. At the latest follow-up,
6 months after the completion of the antimicrobial therapy, MRI
of the lumbar spine showed signiﬁcant narrowing of the L2–L3
and L3–L4 intervertebral spaces with no signs of active infection.
Conclusion: The association of the facet injection with the
deterioration of the patient’s clinical condition, in addition to the
absence of any obvious hematogenous mechanism of infection,
suggests an iatrogenic cause of spondylodiscitis. This iatrogenic
complication should be included in the risk-beneﬁt analysis of
clinicians. Sterile preparation prior to the procedure should be
stressed.
R2033
Selected virulence factors and resistance to
antimicrobials of nosocomial and carrier S. aureus
strains
A. Longauerova, D. Kotulova, L. Slobodnikova (Bratislava, SVK)
Objectives: To detect the production of selected virulence
factors and the resistance to antistaphylococcal therapeutics of
S. aureus strains causing sepsis, wound and joint implants
infections and to compare them with the carrier strains.
Methods: S. aureus strains were isolated from haemocultures
(31 strains), surgery wounds (40 strains), prosthetic hip and knee
joints infections (42 strains) of patients of Faculty Hospital,
Bratislava, and from nasal swabs of carriers (31 strains).
Production of hyaluronidase, alpha, beta, and delta-haemo-
lysisns, adherence to glass surface, polysaccharidic extracellular
adhesin (PIA) production (on Congo-red plates), and the
dynamics of plasmacoagulase production were tested. Resist-
ance to oxacillin, erythromycin, clindamycin, gentamicin,
ciproﬂoxacin, trimethoprim/sulfamethoxazol, quinupristin/
dalfopristin (Q-D), linezolid (LNZ) and vancomycin (VAN) was
estimated by disk diffusion test according to NCCLS. Suscep-
tibility to VAN was conﬁrmed by E-test and PBP2a in methi-
cillin-resistant strains (MRSA) was detected by latex
agglutination test.
Results: The comparison of investigated groups of S. aureus
strains showed, that all, except 2 patient strains, produced
alpha-haemolysin – some of them in combination with beta and
delta haemolysins. Plasmacoagulase production till the 1st hour
of incubation was detected in the majority of patient strains (45
to 70%), while among the carrier strains only in 30%. The most
active were strains isolated from joints prostheses infections - JPI
(70%). Adherence to glass surface was detected in 93% of all
tested strains. The most intensive production of PIA (+++) was
detected in 25% strains from haemocultures and 20% from JPI,
but only in 12.5 % strains from wounds and 6.5 % of carrier
strains. Only 6 strains were found to be MRSA (2 from
haemocultures and 4 from wound infections), and all 6 pro-
duced only alpha-toxin and PIA. 7 % of strains (from patient
samples only) were resistant to gentamicin. All tested strains
were susceptible to VAN, LNZ, and Q-D.
Conclusions: Patient S. aureus strains differ from the carrier
strains by a more rapid production of plasmacoagulase. Strains
from haemocultures and prosthetic joint infections are charac-
teristic by a more intensive production of PIA, which differen-
tiates them from wound and carrier strain groups. MRSA were
found only in the group of haemoculture and wound infection
strains. All strains were susceptible to VAN, LNZ, and Q-D.
R2034
Investigation of a possible nosocomial urinary
tract infection outbreak due to ESBLS producing
E. coli
M. Kanellopoulou, P. Giakkoupi, N. Skarmoutsou,
S. Karakatsani, D. Adamou, G. Koratzanis, A.C. Vatopoulos,
E. Papafrangas (Athens, GR)
Aim: Multiresistant E. coli are very rare in our hospital. Thus
the isolation of four E. coli isolates showing the same multire-
sistant resistance phenotype from the urine of four patients
hospitalized in the same ward during a week period (14/06/
2004–21/06/2004) urged us to investigate the possible epidemi-
ological signiﬁcance of this ﬁnding.
Material and Patients: The E. coli strains were isolated from
equal number of inpatients, two men and two women, mean
aged 75 years old who were hospitalized for infections other
than UTI (n : 3) and immunosuppression (n : 1). All but one had
pyuria (>50 leucocytes p. f), fever (>38C) and were receiving
extended spectrum antibiotics. Indwelling catheters were pre-
sent in all four patients.
Methods: The resistance phenotype was performed by Kirby
Bauer and microdilution methods according to NCCLS guide-
lines. ESBLS production was conﬁrmed by Double Disk Test
(DDT) and E-test : cefepime/cefepime–clavulanic (AB BIODISK,
Solna, Sweden). Biotyping was based on Wider II (Francisco
SORIA Melguizo, SA) automated system results. The ERIC II
PCR was used for the molecular typing of the isolates.
Results: Although epidemiological data (time and space clus-
tering) as well as phenotypic data (all strains showed the same
resistant phenotype and the same biotype) were consistent with
possible clonal spread of the same isolate in all patients,
molecular typing revealed that only two out of the four E. coli
ESBLS producing strains (isolated from patients who shared the
same room) were similar and thus could be associated as part of
the same outbreak. The remaining two strains had different
molecular patterns.
Conclusion: This study supports the clue that classic microbio-
logical studies (colonial morphology, biotype and resistance
phenotype) as well as molecular typing methods are both
necessary and must be performed to investigate and reveal an
outbreak of infection in a hospital setting.
R2035
A prospectic nosocomial infection – survey
in a medical department in Italy
A. Tosti, M. Fiorio, S. Marmotta, M. Bellini, N. Miele (Spoleto,
Perugia, I)
Objectives: Measuring the incidence of nosocomial infections
and microbial isolates in an Internal Medicine 23 bed-Unit in a
100-bed hospital.
Methods: Data were collected according to the NNIS protocol
using a dedicated software from Epinfo program.
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Results: From October 2002 to December 2003 (for a 14-month
term), 1920 patients were enrolled (55% male and 45% female,
median age: 76) for a total of 8530 patient-days; 78% of the
patients had one or more comorbidities. The infections were 36
in 33 patients (1.71% of the total cases): 20 Urinary tract
infections (UTI), 18 of which were catheter-related, 10 pneu-
monia, 5 blood stream infections (BSI), 1 of which Central Line
Catheter-associated, 1 case of Pseudomembranous colitis. The
device-utilization ratios were: 1.2% for CVC with an average
catheterization of 7 days (103 central line-days); 19.9% for
urinary catheter with an average catheterization of 5 days (1702
urinary catheter-days). A Central Line Catheter-associated BSI
developed in 8% of patients exposed to CVC with a central line-
associated BSI rate of 9.7 &. An UTI developed in 6.1% of
patients exposed to a urinary catheter with an urinary catheter-
associated UTI rate of 10.5 &. One patient died because of
nosocomial pneumonia (0.9% attributable mortality), 7 patients
died having been diagnosed a nosocomial infection. The
microbial etiologies of UTIs were: Gram negative in 11 cases,
Gram positive in 10 cases, Candida albicans in 3 cases (4 patients
showed two contemporary pathogens isolated); BSIs Staphilo-
cocci in 3 cases, Gram negative in 1 case, 1 case of Clinical Sepsis.
Conclusions: Our study, comparing NNIS data, shows that
nosocomial infections may be a problem also in Hospital Units
not usually considered at high risk, probably due to advanced
age and multiple comorbidities of the patients admitted. Despite
a urinary catheter-utilization ratio within the norm, we observed
a high incidence of UTI, which however showed an approximate
10% decrease during the period of our research.
R2036
Epidemiological aspects of hospital-acquired
pneumonia in intensive care units in the far east
of Russia
E. Slabenko, V. Turkutyukov, A. Martynova (Vladivostok, RUS)
Objectives: Surveillance of nosocomial infection in the inten-
sive care unit (ICU) received a high level of attention and
outcome indicators are now used in benchmarking the quality of
patient care.
Methods: Continuous prospective data collection was conduc-
ted on 4602 patients admitted to at the intensive care unit of the
Second State Vladivostok Hospital in 2000–2003.
Results: The most numerous group consists from 1377 (29.9%)
patients with neurological diseases, 40.8% of them were after 50
years and 7.7% (106) were children. The 73.1% of patients among
adult ones were males and 68% of patients among children were
boys. Children and age patients with chronic infections, severe
conditions were the main groups of risk. There were 580 patients
(42.1%) including 19 children with lethal outcome. The main
reason of lethal outcome in adults were severe combined and
skull-brain traumas (75.9%), acute disturbance of brain blood
circulation, and infectious disease (5.5%). The severe combined
and skull-brain traumas also have taken the leading positions
among children. During last 3 years 15 children (79%) have died
of this reason, 10.5% of children have died of the infectious
disease, and the others have died of the acute disturbance of
brain blood circulation and tumors. The 25% of adults and 47.4%
of children died of the traumas during the ﬁrst hours. About
53% of adults and 86.7% of children spent in the ICU more than
5 days. The main causative pathogens of hospital-acquired
pneumonias were E. gergovia, S. aureus, P. aeruginosa. The most
strains of E. gergovia was resistant to amikacin, ampicillin,
amoxicillin, gentmycin, tobramycin, carbenicillin, cefalotin,
cefalexin.The most frequent causative pathogen in children was
S. aureus which was resistant to penicillin, ceftazidim. But also it
was sensitive to cefobite, oxacillin, amoxicillin, gentomycin,
lincomycin, chloramphenicol, erythromycin, doxicyclin. P. aeru-
ginosa takes the second place in the ethiological structure of the
causative pathogens of hospital-acquired infections which was
resistant to cefalexin, cefalotin, carbenicillin, tetracycline, tobra-
mycin, levoﬂaxacin.
Conclusions: There are some problems in registration of labor-
atory results of anaerobic infections which are connected with
absence of specialists. Also it leads that there is the large group
of undiagnosed infections which complicates treatment and




S. Kanavaki, M. Makarona, H. Moraitou, S. Pentea, M. Stagas,
A. Panagiotakis, S. Triantafyllou, S. Karabela (Athens, GR)
During the period 1992–2004, Microbiology Dept of Sotiria
Chest Diseases Hospital of Athens had an interesting experience
of several not widely known bacteraemia-associated isolates.
These were as following:
• Achromobacter xylosoxidans, following an interventive cardio-
logic examination. Outcome: death
• Pasteurella multocida, in one patient with COPD and in one
patient with myelosclerosis. Outcome of both cases: death
• Burkholderia pseudomallei, in a patient traveling from S. Asia, on
the grounds of pneumonia caused by the same pathogen.
Outcome: favorable
• Cardiobacterium hominis, in a patient with endocarditis. Out-
come: favorable
• Yersinia enterocolitica, in a multi-transfused patient. Outcome:
favorable
• Beta-haemolytic streptococcus group B, in one patient with
endocarditis, in a second patient with lung cancer and in a
third patient with diabetes mellitus. Outcome: favorable for
the ﬁrst two cases, death for the third
• Beta-haemolytic streptococcus group A, in an intravenous
drug-abusing patient. The patient left hospital latently. Out-
come: unknown
• Serpulina pilosicoli, in a critically ill patient with gastroenteritis.
Outcome: death
• Cryptococcus neoformans, in a chronic lymphocyte leukaemia
patient, and in a second patient with sarcoidosis. Outcome:
death for the ﬁrst, and favorable for the second patient
• Radiobacter rhizobium, in a patient with myelosclerosis. Out-
come: death
• Pseudomonas testosteroni, in one patient with cardiac valve
insufﬁciency and in a second patient with acute abdomen.
Outcome: favorable in the ﬁrst case, death in the second Given
the fact that new pathogens emerge as causative factors of
bacteraemia, the microbiology laboratory should be alert and
able to detect, isolate and identify them.
R2038
Pseudomonas aeruginosa colonisation in adult
patients with cystic ﬁbrosis: antimicrobial
susceptibility pattern
D. Monclus Arroyo, B. Buendı´a, R.M. Giro´n, A. Pe´rez de Ayala,
E. Garcı´a-Pen˜uela, M. Lo´pez-Brea (Madrid, E)
Objectives: To evaluate the prevalence of infection and/or air
way colonization by Pseudomonas aeruginosa from September
2003 to September 2004, in cystic ﬁbrosis (CF) diagnosed patients,
and to determine the susceptibility in respiratory isolates.
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Methods: Forty-two patients with cystic ﬁbrosis, 21 male and 21
female, with an average age of 26.60 years. 78.6%with pancreatic
insufﬁciency. The patients came from the monographic unit of
adults with C.F. The sputum samples were cultured following
standard microbiological procedures. Colonies quantiﬁcation in
OFPBL agar, saboureaud chloramphenicol agar, blood agar,
chocolate agar, chocolate agar with bacitracin, MacConkey agar,
mannitol salt agar and Gram stain was performed. Isolates were
identiﬁed by conventional test and an automated system (Micro-
scan, Dade-Behring) The antimicrobial susceptibility was deter-
mined by an automatic system (Micro-scan) and disk diffusion
method according to NCCLS recommendations.
Results: The prevalence of infection by Pseudomonas aeruginosa
was 47.6%. It was isolated in 20 patients, 10 females and 10
males, with an average age of 23.75 yrs. The number of
Pseudomonas aeruginosa isolated in the 20 patients during the
study period was 81. 35% of patients were also colonizated by
Aspergillus fumigatus, 30% by S. aureus methicillin sensitive, 15%
by S. aureus methicillin resistant and 15% by Haemophillus sp.
The antimicrobial susceptibility obtained is shown in the table.
Conclusions: A high frequency of Pseudomonas aeruginosa col-
onization was found in patients with cystic ﬁbrosis. The 100% of
Pseudomonas aeruginosa strains were susceptible to colistin in
vitro. The highest resistance rate was shown by gentamicin.
R2039
Adhesion to catheters and slime production of
Staphylococcus haemolyticus isolated from
hospitalised patient occurrence of antibiotic
susceptibility
M.B. Bartoszewicz, J. Nowicka, A.P.M. Przondo-Mordarska
(Wroclaw, PL)
Objectives: Last ten years studies showed participation of
Coagulase Negative Staphylococci (CNS) in pathogenicity of
many diseases. The reason of growing interest about CNS as the
ethiological infectious factors can be seen in increasing number
of patients from high risk group and use of the invasing
diagnostic and clinical methods. The most exposed to the CNS
infections except patients with artiﬁcial implants. The best
characterized CNS pathogenic factors are ability to tissue
colonization, adhesion to the synthetic surfaces and evasion.
There is a fundamental stage in the pathogenicity of CNS
infections. These properties are caused by the cell wall ingredi-
ents (teichoic acid), and also by integral substances associated
with bacterial cell such as extracellular polysaccharide (slime).
The study have been done on S. haemolyticus strains isolated from
patient hospitalized on Surgical Unit. Aim of the study was to
determine pathogenic traits of S. haemolyticus: slime producing,
adhesion to biomaterials, antibiotics susceptibility.
Methods: Slime production has been examinated by means of
two methods according Christiansen. Adhesion of S. haemolyt-
icus strains was analysed according to Richards method asses-
sing the value of substrate TTC reduced to isolube red formazan.
Susceptibility to antibiotics was determined using the disc-
diffusion method.
Results: Among 44 S. haemolyticus strains, in the test-tube
method, there have been 38% labeled as slime producing and
62% as non-producing. In the plate method at 48% slime
production was noticed, while 52% strains did not produce
slime. 7% of analysed strains were found to have TTC reduction
of 3+, 77% of 2+ and 14% of 1+. Among these 2% of the assessed
strains did not reduce TTC.
Conclusions: It is quite signiﬁcant that all strains which have an
ability to slime produce, that was proved by means of two
methods (test-tube and plate), show a high level of TTC’s
reduction to formazan. The analysis of resistance to antibiotics in
relation to slime production demonstrated more frequent
antibiotic resistance of the slime-producing strains. A detailed
study into the mechanism and adhesion factors of CNS
staphylococci can help prevent infections caused by these
microorganism.
Acknowledgments: This study was supported by the Polish
Committee of Scientiﬁc Studies (KBN Grant No 2 P05D 134 26).
R2040
Follow up of MRSA (methicillin-resistant
Staphylococcus aureus) after discharge from the
hospital
A.E. Bakker, G. Tooten-Verkaar, E.R. van der Vorm (Amsterdam,
NL)
Objective: In 2004 the VU medical centre started active follow-
up of patients known with MRSA contamination in the past. The
MRSA status was determined and if necessary treatment was
offered. MRSA carriership in the past is a reason for strict
isolation measures. With this programme we hope to reduce the
impact of MRSA on the environment and future hospital
admissions.
Method: Of each patient a ﬁle was made with following items:
general data, case history, risk factors, results of culture, results
of molecular typing, agreements made with the treating doctor
or general practitioner. For each patient was decided which
approach was best to be followed: contacting the patient at
policlinic visit, an approach via the general practitioner or via
other hospitals. Signalling of MRSA positive patients was
started by a hospital monitoring system. Entering the system
with the patient’s identiﬁcation results in a warning concerning
the MRSA status.
Results: Of 66 MRSA patients admitted since 1998 the current
MRSA status was unknown in 2004. From March 2004 a total of
12 patients have been declared MRSA-free. For 12 patients the
follow up is still in progress. 3 patients were known to be
deceased. 27 could not be traced; reasons could be that they
lived abroad and were admitted in our hospital only once or
changed general practitioner or were possibly deceased. The
general practitioners of 15 patients were asked to contact the
patients. Nine of them agreed to do so. Three patients have
cooperated and could be declared MRSA-free. They are inclu-
ded in the 12 mentioned above. The other patients refused to
participate in the programme.
Conclusions: An active follow-up system is time consuming,
but will eventually reduce isolation measures and thereby costs.
Furthermore, It will be less aggravating for the patients. A
monitoring system can simplify the tracking down of patients.
The approach by means of the general practitioner takes a lot of
Antimicrobial agent
Sensitive Intermediate Resistant
Number % Number % Number %
Gentamicin 34 42 10 12 37 46
Tobramycin 58 72 14 17 9 11
Amikacin 48 59 2 2 31 38
Piperacillin 64 79 3 4 14 17
Piperacillin/tazobactam 65 80 7 9 9 11
Ciproﬂoxacin 47 58 11 14 23 28
Oﬂoxacin 39 48 9 11 33 41
Ceftazidime 63 78 1 1 17 21
Cefepime 51 63 13 16 17 21
Aztreonam 54 67 8 10 19 23
Imipenem 59 73 5 8 17 21
Colistin 100 100 – 0 – 0
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effort and is relatively unsuccessful. Hence, it is important that
at the time of detecting MRSA, a clear route of follow up is
agreed with the patient and the treating doctor. The general
practitioner should also be involved. Moreover, it is important
to give the patient enough information in order to be certain of
good cooperation.
R2041
Molecular characterisation of MRSA outbreaks
in a children’s clinical university hospital
L. Cupane, N. Pugacova, L. Bagrade, L. Drukalska, A. Balode,
U. Dumpis, A. Martinsons, E. Miklasevics (Riga, LV)
Objectives: To characterize MRSA isolates by PCR- based
methods.
Methods: Antimicrobial susceptibility of the MRSA isolates was
determined according to NCCLS standards by disc-diffusion
method. Presence of the mecA, clfA and lukS-lukF genes as well
as the type of SCCmec were determined by PCR. MRSA strains
were typed by restriction fragment length polymorphism (RFLP).
Results: MRSA isolates (n = 20) from 17 patients were collected
at Children’s Clinical University Hospital from November 2003
to September 2004. Eight isolates originated from intensive care
unit and 4 from neonatal unit. All but one MRSA isolates carried
type III SCCmec. The 11861-122 clone possessed type IV SCCmec.
None of them, including 11861-122, was PVL positive. RFLP
typing revealed two evident groups of 11 isolates from 9 patients
in one and 5 isolates from 4 patients in the other, respectively.
Conclusions: Molecular data strongly suggest that two separate
outbreaks could have occurred over the study period.
R2042
Outcome of coagulase-negative staphylococci
bacteraemia in an intensive care unit
A. Artero, R. Zaragoza, J. Camarena, J. Tamarit, R. Gonza´lez,
C. Tormo, J.M. Nogueira (Valencia, E)
Objectives: The aims of this study were to determine the
prevalence of coagulase- negative staphylococci bacteraemia
(CNSB), their clinical characteristics and prognosis in critically
ill patients in an intensive care unit.
Material and methods: From 1996 to 2004, 226 patients with
nosocomial bacteraemia admitted in an intensive care unit were
prospectively evaluated. Clinical characteristics and global and
related mortality of cases produced by CNE are presented.
A multivariate analysis was performed to determine the
inﬂuence of CNE on related mortality.
Results: Thirty-eight (16.8%) of 226 nosocomial bacteraemias
were due to CNB. The mean age of patients with CNSB was
67.4 ± 9.8 years and the relation between men/women was 1.9.
Thirty-six (94.7%) of CNSB were considered primary bacterae-
mias (11 cases related to catheter infections and 25 of unknown
origin); the origins of the other 2 cases were: 1 abdominal and 1
cutaneous. The mean APACHE II score at the onset of
bacteraemia was 15.4 ± 6.8. Severe sepsis or septic shock was
present in 57.8%. The incidence of inadequate empirical antibi-
otic treatment was 42.1%, and the related mortality rate for
CNSB was 15.7% (not signiﬁcantly different from the mean of
mortality by other signiﬁcant microorganisms, 23.4%). By
multivariate analysis the factors related to mortality were septic
shock, inadequate empirical antimicrobial treatment, Staphylo-
coccus aureus bacteraemia and Apache II, but not CNSB.
Conclusions: CNSB is a signiﬁcant cause of mortality in
critically ill patients with nosocomial bacteraemia. Almost all
cases were considered primary bacteraemias, probably related
to intravascular invasive procedures. Frequently, patients with
CNSB are given inadequate empirical antimicrobial treatment.
R2043
Susceptibilities of isolates of Enterobacter cloacae
and Citrobacter freundii to seven broad-spectrum
antibacterial agents: results of the Antimicrobial
Resistance Surveillance Study of the Paul-
Ehrlich-Society for Chemotherapy, 2001
M. Kresken, D. Hafner, F.-J. Schmitz, T.A. Wichelhaus on behalf
of the Working Group for Antimicrobial Resistance of the Paul-
Ehrlich-Society for Chemotherapy
Objectives: Enterobacter cloacae and Citrobacter freundii fre-
quently cause nosocomial infections. Both species produce
chromosomal AmpC beta-lactamases. In addition, strains may
become resistant to other antimicrobial drug classes. The
objective of this study was to evaluate the in vitro susceptibil-
ities of clinical isolates of E. cloacae and C. freundii to various
frequently used broad-spectrum antibacterial agents.
Methods: In November 2001, a total of 234 isolates of E. cloacae
and 73 isolates of C. freundii were prospectively collected from
26 microbiology laboratories distributed throughout three Cen-
tral European countries (Austria, Germany, and Switzerland).
Minimal inhibitory concentrations of ceftazidime, cefepime,
imipenem, meropenem, piperacillin-tazobactam, ciproﬂoxacin,
and tobramycin were determined by the broth microdilution
method according to the standard of the German DIN.
Results: Ninety-three and 187 isolates were collected from
patients in intensive care units (ICUs) and non-ICU inpatient
areas, respectively. The remainderwere either fromoutpatients or
data were not available. Susceptibility patterns of E. cloacae
isolates showed the highest susceptibility to meropenem (99.6%)
followedby imipenem (98.7%), cefepime (95.3%), and tobramycin
(94.4%). The susceptibility to ciproﬂoxacin was 89.7%, whereas
susceptibilities to ceftazidime and piperacillin-tazobactam were
each below 70%. Meropenem (100%), imipenem (98.6%), and
cefepim (93.2%) were also the most active compounds against
C. freundii. The susceptibilities to ciproﬂoxacin and tobramycin
were 91.8% and 89.0%, respectively, and again susceptibilities to
ceftazidime and piperacillin-tazobactam were each below 70%.
Rates of resistance (%) were as follows: E. cloacae - ceftazidime
20.9, cefepime 2.6, imipenem 0.4, meropenem 0.4, piperacillin-
tazobactam12.0, ciproﬂoxacin 7.7, and tobramycin 3.0; C. freundii
- ceftazidime 31.5, cefepime 2.7, imipenem 0, meropenem 0,
piperacillin-tazobactam 17.8, ciproﬂoxacin 5.5, and tobramycin
5.5. For the two species combined, susceptibilities to ceftazidime
and piperacillin-tazobactam were signiﬁcantly lower (p < 0.05)
among isolates from ICU patients (59.1% and 55.9%) than among
isolates from non-ICU inpatients (71.1% and 70.1%).
Conclusion: Carbapenems and cefepime seem to be the most
active antimicrobial agents against isolates of E. cloacae and
C. freundii recovered from patients in hospitals located in
Germany, Austria, and Switzerland.
R2044
blaVIM-2 Pseudomonas aeruginosa isolates in a
newly established intensive care unit
M. Horianopoulou, A. Tsakris, M. Kanellopoulou,
E. Papafrangas, G.L. Daikos, S. Labropoulos,
N. Legakis (Athens, GR)
Metallo-b-lactamases are emerging worldwide as acquired
resistance determinants in nosocomial strains of Gram(–)
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bacteria. The results of the present study suggest the risk factors
for VIM appearance in an Intensive Care Unit.
Material and methods: We identiﬁed the ﬁrst 35 patients (20
male, 15 female), who were admitted in a newly established
ICU during 3 month period. Tracheobronchial aspirates and
urine cultures, were obtained every day during the ﬁrst three
days, and then, every second day after their admission to the
ICU. Identiﬁcation was performed with the PASCO system
used according to the manufacturer’s instructions. MICs of
antipseudomonal drugs, except carbapenems, were deter-
mined with the PASCO microdilutionsystem and applying
the criteria prescribed by the NCCLS. Susceptibility to
imipenem and meropenem was determined by agar disk
diffusion in accordance with NCCLS recommendations. A
blaIMP, blaVIM speciﬁc product was ampliﬁed by PCR with
crude DNA extracts using published primers and conditions.
Qualitative data were expressed as percentages and compared
by chi-square test. We considered p < 0.05 to be statistical
signiﬁcant. The p values are based on 2-tailed test results.
Statistic analyses were performed using logistic regression
(SPSS).
Results: We isolated totally 43 multiresistant strains. 33 of those
was P. aeruginosa strains,5 was K. pneumoniae and 5 A. Bauman-
nii. All the P. aeruginosa strains were imipenem resistant, and
among those only nine (27%), were blaVIM-2 positive. All the
strains of K. pneumoniae and A. Baumannii, were blaVIM-2
negative by PCR. Among the total of 9 blaVIM-2 positive P.
aeruginosa isolates collected, 22% were from urines and 78%
were from bronchial secretions.
Discussion: Risk factors for VIM appearance include: (A)
Carbapenems administration (n = 0.002), fact that may be due
to the augmentation in selections of the above genes under the
press of the speciﬁc drug. (B) Administration of several b-lactam
derivatives (n = 0.005), aminoglycosides (n = 0.039), and com-
binations between carbapenems-aminoglycosides (n = 0.026).
The statistical signiﬁcant results of aminoglycoside’s adminis-
tration, may be due, to the augmentation of selection press (the
same integron contain the blaVIM gene and three different
aminoglycoside resistance determinants, which carried on
mobile gene cassettes (aphA15 aacA29A, aacA29). (C) Long
length of ICU stay, is a risk factor for blaVIM-2 positive strains,
appearance (n = 0.015).
R2045
Urinary tract infections in patients with spinal
cord injury
A. Betra´n, C. Marne, M.L. Aisa, M.J. Revillo (Zaragoza, E)
Objectives: Urinary tract infections in patients with spı`nal cord
injury (SCI) is the most frequent complication due to vesical
neurogenic alteration. It is enhanced by the use of permanent
urethral catheters with deﬁcient vesical voiding and frequent
hospitalization. The objective of this study is the update of
ethiology and antimicrobial susceptibility in urinary tract
infections in this group of patients.
Methods: Over a six year-period (1998–2003) a total of 176 866
urine specimens were cultured. About 8013 corresponded to
patients of the SCI unit. Antimicrobial susceptibility was
performed by authomatized microdilution and in special strains
by disk diffusion method.
Results: In the SCI patients 56.5% urine specimens were
positive and 43.5% negative or contaminated. Bacterial species
most frequent were E. coli (35.0%), P. aeruginosa (12.6%),
Enterococcus spp. (9.8%), P. mirabilis (9.8%), Klebsiella spp.
(7.9%), P. stuartii (5.7%) and A. baumanii (5.4%). Isolation of
Enterobacteriaceae with extended spectrum beta-lactamase
(EEBL) in SCI patients has increased considerably (47 patients
in the last three years), being the hospital unit with the highest
number.
Conclusions: 1. Positive results were considerably higher in
SCI patients (56.5%) compared with the rest of patients
(21.3%). 2. Percentage of E. coli isolates is lower than in other
patients (35.0% vs. 57.2%), due to the increment of urinary
infections by nosocomial species. 3. The elevated percentage
of P. aeruginosa can be due to the use of urethral catheters.
4. P. stuartii is an important urinary pathogen in SCI patiens,
with a degree of isolation 20 fold higher than in the rest of
patients and with antimicrobial multiresistence. It is the
second species with EEBL, after E. coli. 5. Persistence of
EEBL strains in these patients is a reservoir difﬁcult to
erradicate. 6. SCI patients present a high degree of coloniza-
tion by A. baumanii and S. aureus meticillin resistant. 7. Risky
sport activities and trafﬁc accidents are increasing the number
of SCI patients, affecting mostly young people. Patients
cooperation is essential in the prevention of urinary tract
infections.
R2046
Serum amyloid A and brucellosis
M. Tsironi, P. Andriopoulos, E. Hantzi, M. Kalkani,
G. Assimakopoulos, I. Papassotiriou (Sparta, Athens, GR)
Objectives: Brucellosis remains an illness with a wide clinical
spectrum and universal distribution; Greece, in particular, is one
of the most endemic regions worldwide. Diagnostic procedure
and laboratory evaluation is a challenge. Inﬂammation markers
can be used to evaluate the clinical state and the outcome of the
disease.
Methods: The study included patients admitted with suspec-
ted infection in the Emergency Department. Serological eval-
uation was performed using Brucella agglutination test (Wright
test). A titre of 1:160 or higher was considered signiﬁcant and
titres of 1:40 to 1:80 suspicious despite the endemic character-
istics of our area. Blood cultures were obtained independently
of STA titres. Clinical manifestations were recorded and
evaluated. Any organ involvement was referred as localized
disease. Serum Amyloid A (SAA) measurements were per-
formed using nephelometric assays (Dade-Behring) and values
higher than 6.0 mg/L were considered indicative of high
inﬂammatory state.
Results: SAA was measured in 26 patients with culture-proven
brucellosis. 23 patients (88%) had values >6.0 mg/L. Average
positive value 232.59 mg/L (SD 299.51 mg/L Conﬁdence inter-
val 95%). Patients with anemia presented with values
>294.59 mg/L and patients with osteoarticular involvement
>258 mg/L. Any localized disease was associated with higher
levels of Serum Amyloid A while febrile illness alone did not
present with such values.
Conclusions: Although our sample represents a pilot study
measurement, SAA seems to be an interesting inﬂammatory
marker in brucellosis and can be associated with localized
infection and hematopoiesis disorders in terms of anemia. Such
ﬁndings may explain anemia of brucellosis, involving other
cytokine production and modulating bone marrow hematopo-
etic progenitor cells. Further study is required in order to




Accessing quality in infection control
surveillance
A.C. Pasqualotto, D.S. Branco, L.R. Martins, A.P. Amaral,
S.M. Colares, I.G. Rocha, D. Wiltgen, T.C.T.
Sukiennik (Porto Alegre, BR)
Objectives: To evaluate adequacy in activities executed by
health care professionals in a 1,200-bed teaching Brazilian
hospital.
Methods: Study performed during the period of June 2003 to
October 2003 designed to evaluate the level of adequacy related
to four main procedures: urinary catheter care, intravenous
catheter care, and dressings and health care facilities care.
Adherence to barrier precautions was also evaluated. This study
was composed of two parts. The ﬁrst part was an observational
study. In this phase, performed by the infection control nurses,
the observations were registered in a standardized case report
form. The second component of the study was an intervention:
the results were presented to assistant professionals, who were
also trained. After that, new observations were taken.
Results: The proportion of non-conformity was 59.0%, 75.6%,
68.4%, and 71.4% for procedures involving urinary catheters,
intravenous catheters, catheter dressings and material cleaning,
respectively. After training, the global level of adequacy
increased to 66.6%. At this moment, trained health care
professionals are evaluating the quality of assistance and
making new observations, and their work is being audited by
infection control nurses.
Conclusions: As infection control professionals do not provide
direct care to patients, the value of their practice must be
demonstrated in other ways, such as stressing quality and
economy. These professionals can not be seen as a merely data-
gatherers. Demonstrating value in infection control pro-
grammes has become a very important issue; according to this
statement, the acquisition of new skills should be one of the
priorities. It is important to consider how to help optimize costs,
serve the customer better, improve productivity, and innovate,
mainly in areas of limited resources.
R2048
Five-year surveillance of nosocomial infections
in a training and research hospital in Ankara
F.S. Erdinc, M.A. Yetkin, C.A. Hatipoglu, M. Yucel,
A.E. Karakoc, M.A. Cevik, N. Tulek (Ankara, TR)
Objective: To assess the rate of nosocomial infections, fre-
quency of nosocomial pathogens and antimicrobial susceptibil-
ity changes in our hospital in a 5-year period.
Methods: Laboratory based nosocomial infection surveillance
was performed in 530-bed hospital between 1999 and 2003.
Results of the cultures taken from hospitalized patients evalu-
ated daily by bed-side visits. Nosocomial infections were
deﬁned according to the CDC deﬁnitions for nosocomial
infections and nosocomial surgical site infections. Nosocomial
infection rate was calculated by number of nosocomial infec-
tions per number of hospitalized patients for every year.
Antimicrobial susceptibility tests were performed according to
NCCLS.
Results: Nosocomial infection rates were between 1.4 and 2.4%.
High nosocomial infection rates were observed in neurology,
neurosurgery, pediatry and dermathology clinics in changing
orders. The most common infections were urinary tract
infections, surgical site infections and primary bacteraemia in
every year of surveillance.The most frequent pathogens were
Escherichia coli, Klebsiella pneumoniae, Enterococcus spp, and
Staphylococcus aureus. Carbapenems were the most effective
antimicrobials against Enterobacteriaceae isolates and more than
609% of E. coli and K. pneumoniae isolates were susceptible to
aminoglycosides, quinolones and cephalosporins with some
slight decline in years. Methicillin resistance of S. aureus isolates
were less than 50% and all S. aureus and Enterococcus spp.
isolates were susceptible to glycopeptides except one glycopep-
tide resistant E. faecium isolate identiﬁed in 2003. Chloramphen-
icol was the second most effective agent after glycopeptides
against S. aureus isolates.
Conclusion: Nosocomial infection surveillance provides tracing
the hospital speciﬁc health care for hospitalized patients and
supplies data regarding which precautions should be taken. Our
low percentage of nosocomial infection rates was due to our
method of surveillance. However, following the data by the
same method provided both comparisons between years and the
changes occurred recently. Nosocomial pathogen isolation and
antimicrobial susceptibility tests provided guidance to empirical
antimicrobial therapy of nosocomial infections and determining
outbreaks.
R2049
Outbreak of glycopeptides Enterococcus faecium
infection in a university teaching hospital
in Clermont-Ferrand, France, 2004
H. Laurichesse, J.-P. Romaszko, O. Baud, L. Mihaila,
J.-M. Constantin, B. Villemagne, F. Robin, B. Souweine,
R. Bonnet, J. Beytout, O. Traore´, O. Lesens (Clermont-Ferrand, F)
Objectives: To report the ﬁrst outbreak of glycopeptides-resist-
ant Enterococcus faecium (GR-E. faecium) infection in a university
tertiary-care hospital, Clermont-Ferrand, France, and to identify
risk factors for GR-E. faecium infection/colonization.
Methods: Patients were identiﬁed through the hospital surveil-
lance system focused on nosocomial and/or multi-resistant
bacterial infections. Resistance to glycopeptides was deﬁned by
the laboratory of Bacteriology (MIC vancomycin > 256 mg/l
and MIC teı¨coplanin at 32–64 mg/l). A nested case–control
study was restricted to 16 patients hospitalised at the St Vincent
ward including the infectious diseases and haematology unit
and who were diagnosed with GR-E. faecium colonization or
infection from the 1st of January to the 31 of July 2004. The
control group was derived from a randomized sample of
patients who were hospitalized in the ward during the same
period. All strains were sent to the National Laboratory Centre
for Streptococci to identify the PFGE patterns.
Results: 30 patients were identiﬁed in 14 different wards
between the ﬁrst of January 2004 and the 31st of October 2004:
the epidemic curve peaked in April and in September. GR-E.
faecium was isolated from blood in 6 patients (2 pts died), from
urines in 16 pts (11 with a urinary catheter, 5 without catheter),
from peritoneal ﬂuid (2 pts), from IV catheter (1 pt), from
wounds (2 pts), from drainage tubes (3 pts). All GR-E. faecium
infections were hospital-acquired. Multivariate analysis, con-
trolling for time at risk and the Charlson Index of Co morbidity,
identiﬁed prior exposure to IV 3rdG cephalosporin (OR = 10;
95%CI: 1.5–64; p = 0.02), antimicrobial regimen with a beta-
lactamase inhibitor (OR = 5; 95%CI: 0.9–28; p = 0.07) and urin-
ary catheter (OR =20; 95%CI: 1.3–291; p = 0.03) to be independ-
ently predictive for GR-E. faecium infection or carriage. Clinical
isolates were also resistant to amoxicillin, macrolides and
clindamycin, but susceptible to linezolid, vibramycine and
intermediate to aminoglycosides, quinupristin-dalfopristin. All
PFGE patterns, but one, were clonally related.
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Conclusion: Clonal emergence and diffusion of GR-E. faecium is
likely to be a result of antibiotic pressure and cross-transmission.
As a result, strict recommendations regarding isolation of the
patients with multi-resistant bacterial infections and restrictions
in the prescription of broad-spectrum antibiotics have been
implemented in our hospital.
R2050
Genotypic analysis and occurrence of extended
spectrum beta-lactamases (ESBL+) producing
Klebsiella spp. strains in a neonatology unit –
1 year study
J. Jursa, K. Kopron, A. Jurczak, S. Giedrys-Kalemba (Szczecin,
PL)
Objectives: To determine the occurrence of ESBL+ Klebsiella
pneumoniae and Klebsiella oxytoca isolated from newborns and the
genetic relatedness between strains.
Material and methods: A total of 28 Klebsiella pneumoniae
(K.pn.) and 28 Klebsiella oxytoca (K.ox.) was isolated from
various material (blood, urine, swabs from nose, throat, anus)
from newborns hospitalized in Intensive Care Unit and
Neonatology Unit between April 2003 and March 2004 were
tested for detection of ESBL – double disc test. Strains of
Klebsiella sp. were submitted to a molecular characterisation by
pulsed-ﬁeld gel electophoresis (PFGE) with using the enzyme
Xba I.
Results: 50% of K.pn. and 60% of K.ox. strains produced
ESBL. For K.pn. three clonal epidemic strains were found:
type A included 9 strains (recovered from 7 newborns), type
B – 6 strains (5 newborns), type C – 4 strains (3 newborns),
type D – 2 strains (2 newborns) and 8 unique unrelated
strains. For K.ox. described three types: type A included 21
strains (15 newborns), type B – 2 strains (2 newborns), type
C – 2 strains (2 newborns) and 3 strains unrelated.Type A of
K.pn. was isolated between July 2003 and March 2004, type
B was isolated between June 2003 and February 2004, type C
was recovered from newborns between November 2003 and
January 2004, type D was isolated once in August and once
in September 2003. Type A of K.ox. was isolated between
July 2003 and March 2004, type B was isolated in September
2003 and type C was isolated in July 2003 and in November
2003. All clonal epidemic strains of K.pn. and K.ox. produced
ESBL opposite to unrelated strains. Clonal strains were
isolated from both Intensive Care Unit and Neonatology
Unit. Some of them were responsible for infection and
colonization also.
Conclusion: Isolation of the same genetic types from different
newborns and units during 1 year proves spreading and
remaining of the Klebsiella clones in Neonatology Unit. This
epidemiological situation should be under full control of
hospital infection committee.
R2051
Mechanisms of nosocomial S. aureus resistance to
beta-lactam antibiotics
Tsipoura, G. Nanou, T. Daskalou, M. Pagalou, N. Karampatakis,
T. Karampatakis, A. Ammari (Didimoticho, GR)
Introduction: Of the various mechanisms of acquired S. aureus
resistance to (b-lactams, resistance due to (b-lactamases is the
most prevalent. Alterations in the preexisting penicillin-binding
proteins (PBPs), acquisition of a novel PBP insensitive to (b-
lactams can also confer resistance to methicillin and (b-lactams.
These changes in the outer membrane of proteins include
production of supplement PBP (PBP2a or PBP 2) that are
encoded by a chromosomal mec gene (mecA, mecB).
Objective: The study of both resistance mechanisms to a-lac-
tams of nosocomial strains of S. aureus.
Methods: Over a period of 3 years 340 strains have been tested.
All the tests have been performed with the following methods:
(1) oxascreen agar (Bio-Merieux), a Muller–Hinton agar with
NaCl 4% and oxacillin 6 mg/ml, for detection of the resistance
to oxacillin. (2) MRSA test (Bio-Merieux), an agglutination test
for detection of PBP 2. (3) Ceﬁnase discs (Bio-Merieux), for
detection of (b-lactamase production. (4) Etest (Solna-Sweden),
for detection of penicillin and oxacillin MICs.
Results: Out of 340 strains of S. aureus, 248 (72.09%) were
resistant to (b-lactam antibiotics.Out of the latter, 85 strains
(34.27%) have shown resistance, which was due to the produc-
tion of (b-lactamase. Furthermore,134 strains (54.03%) have
shown resistance which was due of the alterations in penicillin-
binding proteins. Finally, 29 strains (11.69%) have shown
resistance which was due to both mechanisms.
Conclusions: (1) High percentage of nosocomial S. aureus
strains was resistant to (b-lactams.
(2) In this study, the resistance mechanism of change of the
PBPs proteins to PBP2 was the most frequent.
R2052
Computerised surveillance of nosocomial
infections at a university hospital
C. Herr, J. Steinmann, A. Moussa, J. Mu¨ller, J. Joch, D. Walmrath,
T. Eikmann (Giessen, D)
Objectives: Computerized surveillance of ventilator associated
pneumonia (VAP), catheter related bloodstream infections (BSIs)
and surgical site infections (SSIs) by treating physicians at a
German university hospital: implementation, quality assurance
and time as well as cost related aspects.
Methods: Two computer-based surveillance input masks were
developed with the Department for Clinical and Administra-
tive Data Processing of the Giessen University Hospital
(AKAD), one for VAP and BSIs and one for SSIs. The VAP
and nosocomial BSIs were protocoled and identiﬁed by the
ward physicians and surgical sites were assessed upon
dismissal under surveillance of the infection control unit.
This was accomplished for six intensive care units and seven
surgical departments. Indicator operations were chosen
according to the operations given by the National Reference
Center for surveillance of nosocomial infections (NRZ). The
input masks were based on the criteria of the Centers for
Disease Control and Prevention (CDC) and the OP-KISS
(Krankehaus Infection Surveillance System) module of the
NRZ. For both input masks, several data components could
automatically be taken out of other computer programs. The
infection control staff examined the documentation via intra-
net. The results were discussed with the departments during
surveillance ward rounds. Work time was evaluated using
log-tables and an external quality control was performed
during a routine phase for 15 weeks.
Results: Nearly complete documentation was achieved by the
physicians and/or the medical documentation ofﬁcers. Type
and infections rates of VAP, BSIs and SSIs concerning indicator
operations will be given and compared to NRZ data. Also data
on work time and personnel costs as well as quality assurance
will be presented.
Conclusion: Due to the simple and computerized data assess-
ment, personnel time concerning surveillance is very low
compared to the non computer assisted surveillance and




Prevalence of extended-spectrum beta-lactamases
in a university hospital
M.K. Celen, C. Ayaz, M.F. Geyik, S. Hosoglu,
M. Ulug (Diyarbakir, TR)
Objective: Nowadays resistance against the drug is growing
problem in all over the world. In this study we aimed to
determine the prevalence of extended spectrum beta-lactamases
(ESBL) which responsible of nosocomial infections at the Dicle
University Hospital which is the main hospital based in South
Eastern of Turkey.
Methods: A total of 182 g negative bacterial which were isolated
from clinical specimens to 2 years according to Center for
Disease Control (CDC) criteria were included the study for to
determine prevalence of ESBL as nosocomial infection at the
Dicle University Hospital. ESBL were determined in hospital
based gram negative bactericea (GNB) which resistant at least
against on of ceftriaxone, ceftazidime and cefotaxime, by E-test.
Results: A total of 182 GNB were studied by E-test and 62 (34%)
were found to be ESBL producers. ESBL was detected in 24 of
Klebsiella spp., 14 of Escherichia coli, 13 of Pseudomonans spp., 4 of
Enterobacter cloaca, 4 of Acinetobacter spp., 2 of Proteus mirabilis
and 1 of Serratia marcescens.
Conclusion: This is the second study on ESBL production at the
Dicle University Hospital and 34% GNB were conﬁrmed to be
ESBL producers. In the ﬁrst study this ratio were reported to be
31%. Infections with ESBL producing organisms can pose a
therapeutic challenge; leading to treatment failure in wrong
class of antibiotics is used. As a result it is very important that
each hospital should create their rational antibiotic management
strategies.
R2054
P. aeruginosa susceptibility differences among
specialised hospital units: MYSTIC Program
Brazil 2004
C.R. Kiffer, A.C. Arruda, P.C. Koga, P.J. Turner, C. Oplustil, J.L.
Sampaio, C.M. Mendes on behalf of the MYSTIC Group Brazil
Objective: To compare the susceptibility patterns of P. aerugi-
nosa clinical isolates for meropenem, cefepime, amikacin, and
ciproﬂoxacin in different specialized hospital units in the
MYSTIC Program Brazil 2004.
Methods: Nineteen specialized hospital units in Brazil partici-
pated in the 2004 programme edition. Centres were intensive
care (ICUs) (12), neutropenic patients (2) and general ward (5)
units. Minimum inhibitory concentrations (MICs) were deter-
mined in 471 P. aeruginosa clinical isolates to meropenem,
cefepime, amikacin, and ciproﬂoxacin, by Etest methodology
according to manufacturer’s instructions. Interpretive criteria
used were described by NCCLS document M100-S14. Suscep-
tibility patterns of all isolates from ICUs (309), neutropenic
patients (37) and general ward units (125) were determined and
described. A chi-square test (Altman, 1999) was applied to
identify differences in the susceptibility rates among the three
unit types studied. p values below 0.05 were considered
signiﬁcant.
Results: Unit differences among the 471 P. aeruginosa clinical
isolates are described. Overall resistance rates (%R) were 50.1%
to meropenem, 50.7% to amikacin, 56.9% to ciproﬂoxacin, and
60.7% to cefepime. Higher resistance rates were observed in
ICUs for all antimicrobials, except for amikacin. However,
differences among resistance rates in specialized units were only
signiﬁcant for meropenem (p = 0.03).
Conclusions: Elevated resistance rates were observed to all
antimicrobials, with higher overall susceptibility to meropenem.
Meropenem resistance rates were higher among ICU isolates.
This could be due to higher antimicrobial use or biased sample,
since clonal spread or overvalued resistant clinical isolates could
not be ruled out so far.
R2055
Predictors of outcome in patients with
blood-stream infections
C. Ayaz, M.K. Celen, M.F. Geyik, S. Hosoglu,
M. Ulug (Diyarbakir, TR)
Objective: To evaluate the epidemiology and risk factors of
bloodstream infections (BSI), to determine the mortality associ-
ated BSIs and identify independent predictors of mortality.
Methods: This study was performed retrospectively, at the
hospital from April 2002 to November 2002.
Results: 324 patients with BSI were enrolled to the study. Mean
age was 41.7 ± 23.1 years old, and 196 (60.5%) were male.
During study period 407 episodes occurred, of which 47.4%
were nosocomial bacteraemia, 25.8% were community acquired
bacteraemia, 22.2% represented contamination and 4.6% repre-
sented transient bacteraemia. Gram positive microorganisms
were the most commonly isolated microorganisms (66.5%).
Nosocomial BSI occurred in 134 (41.3%) patients. The most
common pathogens nosocomial BSI group were coagulase
negative Staphylococcus (29.2%), S. aureus (23.5%), E. coli
(11.9%), Acinetobacter spp. (6.4%), P. aeruginosa (5.6%) and
Klebsiella spp. (5.1%). Methicillin resistance was detected in
58% of staphylococcus isolates in nosocomial BSI group. 18.7%
of the patients died. Mortality rate associated with bacteraemia
obtained as 14.8%. Mortality rate in nosocomial BSI group
obtained as 33.4%. Multivariate analysis revealed nosocomial
acquisition, age > 60 years, hospital stay more then 7 days, stay
in intensive care unit as factors associated with mortality rate.
Conclusion: These results indicate that eliminate factors inﬂu-
encing the outcome of bacteraemia especially in nosocomial
bacteraemia. The prevention of nosocomial infections and appro-
priate antibiotic treatment can improve the prognosis of patients.
R2056
Antibiotic susceptibility patterns and serotypes
of Streptococcus pneumoniae isolated from
invasive and other infections at a university
hospital in Turkey
A. Yaman, F. Kibar, N. Gu¨rler, O¨. Bu¨yu¨kc¸elik, I.H. Du¨ndar
(Adana, Istanbul, TR)
Objectives: To determine the antibiotic susceptibility and ser-
otype prevalence of clinically signiﬁcant S. pneumoniae isolated
from a teaching hospital in Turkey.
Unit differences among resistance rates (%R) of 471 P. aeruginosa







(n = 125) P value
Beta-lactems
Meropenem 168 (54.5) 16 (43.2) 52 (41.6) 0.03
Cefepime 199 (64.4) 20 (54.1) 67 (53.6) 0.08
Aminoglycoside
Amikacin 156 (50.5) 18 (48.6) 65 (52) 0.9
Fluoroquinolone
Ciproﬂoxacin 179 (57.9) 18 (48.6) 71 (56.8) 0.6
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Methods: The antimicrobial susceptibilities to nine antimicro-
bial agents of 61 clinical isolates of Streptococcus pneumoniae
recovered from patients with invasive and other clinically
signiﬁcant pneumococcal infections from 2002 to 2004 were
studied using E-test and disk diffusion methods following the
NCCLS guidelines. Of the 61 isolates, 25% (n = 15) were from
blood, 20% (n = 12) from bronchoalveolar-lavage, 16% (n = 10)
from tracheal aspirate, 10% (n = 6) from cerebrospinal ﬂuid, 8%
(n = 5) from pleural ﬂuid, 7% (n = 4) from endophthalmitis,
5% (n = 3) from peritoneal ﬂuid, 3% (n = 2) from sinus aspirate,
3% (n = 2) from middle ear ﬂuid, 2% (n = 1) from catheter, 2%
(n = 1) from ﬁstula specimen. Serogrouping of the pneumococcal
isolates was performed using the Quellung technique (Statens
Serum institute, Copenhagen, Denmark).
Results: Antibiotic susceptibilities and serotypes were shown in
Table. Capsular types of 46 pneumococcal isolates belonged to
types 23 (24%), 19(15%), 9(15%), 6(13%), 18(11%), 7(11%), 1(7%)
and 3(4%).
Conclusions: Antibiotic resistance was common in pneumo-
coccal isolates in our region. Vaccine formulations can prevent
the majority of pneumococcal infections.
R2057
Clostridium difﬁcile infection in hospital: active
surveillance
E. Sala, S. Butti, M. Spinelli, A. Gangemi, S. Cimetti, R. Signori,
G. Giana, D. Santoro (Como, I)
Objectives: Clostridium difﬁcile is a Gram positive anaerobic
spore-forming rod. It is present in intestinal ﬂora, in soil and it
circulates in hospitals. C. difﬁcile produces different potential
virulence factors: a 308 kDa enterotoxin (toxin A) and a 270 kDa
cytotoxin (toxin B). Toxin A is the major cause of enteric disease.
Colitis can be determined by endogenous or exogenous causes
and antibiotic treatment is the most important endogenous
cause. The exogenous origin of the infection is referred to oro-
faecal contamination due to colonised patients. In 1997 an
epidemic took place in a surgery division and this fact led to the
formulation of an operative protocol for C. difﬁcile associated
infection. The operative protocol starts from CDC guidelines
and is based on the enteric isolation of C. difﬁcile. The protocol
deﬁnes the hygienic procedures to be adopted in case of
C. difﬁcile associated infection. The target of the protocol is the
prompt identiﬁcation of the symptomatic patient and the
subsequent application of procedures to avoid the pathogen’s
transmission.
Methods: Since May 1997, a surveillance programme is active
for C. difﬁcile associated infection and in 2004 the protocol’s
review was planned. Case deﬁnition: C. difﬁcile associated
infection is suspected in a patient with diarrhoea. In this case,
the patients is investigated for presence of C. difﬁcile and toxin A
in stool: if one or both analyses are positive, the division is
alerted to implement the protocol’s directions and the epidemi-
ological nurse is alerted too.
Results: We analysed the positive results for C. difﬁcile infection
related analysis from 2000 to October 2004.The study of the
time-infection in the different divisions of the hospital showed
that no new epidemic occurred and the positive cases are
referred to isolated infections. Only in 2004 a small cluster in
Geriatrics Division was reported, in occasion of the moving of
the division.
Conclusions: Clostridium difﬁcile monitoring infections per-
formed in hospital during last years and after the introduction
of a dedicated protocol, conﬁrmed the surveillance’s effective-
ness in infection’s control. We believe that management of
antibiotic related C. difﬁcile infections based on a dedicated
protocol, can avoid further epidemics.
R2058
G-control Charts. A novel method for monitoring
contamination rates of blood cultures
S. Lunding, T. Slotsbjerg, H. Westh (Hvidovre, DK)
Objectives: Blood culture (BC) is the criterion standard for
identifying patients with bacteraemia. However, elevated false-
positive rates are common and are associated with substantial
health care costs. We had monitored numbers of BC without
Coagulase-negative Staphylococci (CNS) between blood cultures
with CNS in a g-type control chart. Periods with deviation from
the protocols for skin disinfection and for specimen’s collection
were compared with periods without deviations.
Methods: Results of blood cultures from tree hospitals had been
exported from the laboratory system. The protocols for skin
disinfections and for specimen’s collection and inoculation are
standardized for all hospitals. Periods with deviation from the
protocols:
Amager Hospital (AH): From June 2000 to November 2001
alcohol swabs in separate packing were replaced with alcohol
swabs in an open container, from witch alcohol evaporated.
Hvidovre Hospital (HH): From February to September 2004
alcohol swabs were replaced with iodine and gloves were
recommended at blood culture sampling.
Bispebjerg Hospital (BBH): Needle holders were thermal
disinfected between every blood sampling.
g-Control chart: The centre line CL illustrate the central
tendency of number of BC without CNS between BC with CNS.
The upper control limit (UCL) is CL + 3 x standard deviation
(the lower control limit is zero). The most important criteria for
lack of statistical control are control values outside the UCL,
eight consecutive values on the same side of CL and any 12 of 14
consecutive control values on the same side of CL.
Results: When alcohol swaps from an open container were used
for skin disinfection at AH, CNS were isolated from 9% of BC
versus 2.8% of BC when separate packing alcohol swabs were
used. The rate of CNS in BC was not reduced with use of iodine
andglows (HH)or thermaldisinfectionofneedleholdersbetween
BC sampling (BBH). In the container swabs period the AH












Levoﬂoxacin Disk 51 (98) 1 (2)
Meropenem E-test 58 (95) 1 (2) 2 (3) 0.004 0.125
Cefotaxime E-test 56 (92) 2 (3) 3 (5) 0.023 0.75
Chloramphenicol Disk 51 (88) 7 (12)
Clindamycin Disk 46 (79) 12 (21)
Tetracycline Disk 45 (78) 13 (22)
Erithromycin E-test 44 (72) 2 (3) 15 (25) 0.032 3
Penicillin-G E-test 35 (57) 22 (36) 4 (7) 0.047 0.75
Trimeth-sulph Disk 26 (45) 32 (55)
*In the disk diffusion method, intermediate-susceptible isolates were interpreted as
resistant.








g-control chart showed lack of statistical control with up to 100
control values below the centre line through months. G-contol
charts from HH and BBH had several out of control periods.
Conclusion: A g-control chart was found to be a valuable
statistical tools allowing quick identiﬁcation of an increasing
CNS contaminations rate of blood culture. Sufﬁcient skin
disinfection think to bee the most important factor for minim-
izing blood culture contaminants.
R2059
Gastric ﬂuid cultures of neonates
E. Ikonomopoulou, P. Grammenou, A. Nikolopoulou,
K. Papadopoulos, E. Stavrianou, D. Petropoulou,
A. Regli (Patras, GR)
Objectives: To estimate the type of microorganisms that are
usually isolated from gastric ﬂuid cultures of neonates, as soon
as possible after their birth in order to determine the potentially
pathogenic microorganisms that colonize the neonate during its
passage from genital channel.
Methods: We analysed retrospectively the neonates gastric
ﬂuid cultures that turned to positive during the 2003 and ﬁrst
half-year period of 2004. The reception of gastric ﬂuid usually
followed immediately birth. The identiﬁcation and sensitivity
test against antimicrobial agents was performed by the Vitek
system (Biomerieux).
Results: 230 neonates gastric ﬂuid cultures turned to positive
during the 2003 and ﬁrst half-year period of 2004. Microorgan-
isms that isolated were: 95 Coag negative Staphylococci (41%), 72
E. coli (31%), 16 Klebsiella pneumoniae (7%), 14 Enterococcus faecalis
(6%), 8 S.aureus (3.5%), 6 Streptococcus bovis (2.5%), 6 Streptococ-
cus agalactiae (2.5%), 4 Serratia marcescens , 4 Pseudomonas
aeruginosa and 5 Candida spp. All Coag negative Staphylococci
strains were sensitive to Vancomycin but only 62.1% were
sensitive to Oxacillin. E. coli strains were 66.7% sensitive to
Ampicillin and there were not ESBL positive strains.
Conclusions: Gastric ﬂuid culture of neonates is a useful
method to determine the microorganisms that colonized the
neonate during birth.
R2060
Culture negative infective endocarditis: two
decades experience at tertiary care hospital
A. Almohaizeie, F. Alrabiah, S. Al Saif (Riyadh, SA)
Objectives: 1. To review all culture negative Infective Endo-
carditis (IE), presentation and outcome. 2. To compare medical
VS surgical culture negative IE.
Methods: Retrospective study of all Echocardiography (echo)
positive vegetations and all intraoperative ﬁndings suggestion
of endocarditis. Patients conﬁned at King Faisal Specialist
Hospital and Research Center from 1985 to 2003
Results: Thirty-one patients satisﬁed the inclusion criteria. Of
the 31 cases, 17 cases were identiﬁed to be native valve IE while
14 cases were prosthetic valve IE. Fifty per cent of the studied
patients were male patients. Fifty-nine per cent of the cases were
having rheumatic valvular diseases. The most common affected
valves were mitral (71.9%), aortic (50%), and tricuspid (9.4%).
Prior valvular diseases (37.5%), Prosthetic valve, (9.4%), and
dental procedure (9.4%) were highly attributed risk factors to IE.
Sign and symptoms available at presentation were fever (71%),
new murmur (50%), Clubbing (46.9%), microscopic hematuria
(18.8%), heart failure (59.4%), joint pain (25%), and splenomeg-
aly (15.6%). Of all cases, the ECG ﬁndings were remarkable for
heart block (34.4%). Echo, as TTE, was done in (90%) of the
cases, in which vegetation was present in (37.5%) of the
identiﬁed cases, while, valve lesion and abscess were identiﬁed
in (50%) and (12.5%) of the cases, respectively. Eighty-one per
cent of all patients were managed medically and surgically,
while only (15%) were managed medically. Of the identiﬁed
patients, (87.5%) survived IE, while (9.4%) of them died. Of
interest, there was no recurrence of IE after surgery.
Conclusion: This study shows that mitral valve was the most
affected valve in culture negative IE patients. One third of
patients showed heart block. Most of the patients were managed
both medically and surgically. Interestingly, of the 31 IE
patients, mortality rate was shown in almost 10% of all patients.
Infection in the immunocompromised host (except HIV)
R2061
Cefepime combined with a short (four days) or
long course of isepamicin for empirical therapy of
high-risk febrile neutropenic haematologic
cancer patients: a prospective, randomised,
multicentre study
H. Akin, V. Korten, H. Akan, I. Aydogdu, E. Senol, S. Dinc¸er,
A. Keskin, R. O¨ztu¨rk, L. U¨ndar, F. Buyukkececi, M.
Akova for the Febrile Neutropenia Study Group of Turkey
Objectives: To compare the efﬁcacy and safety of cefepime plus
either a short course (SC) (four days) or a long course (LC) of
once daily isepamicin in the empirical treatment of febrile
neutropenia.
Methods: Between Feb 2002 and Feb 2003, a total of 134 adult
neutropenic patients with fever and hematologic malignancies
were randomized to receive cefepime (2 g tid) in combination
with isepamicin (15 mg/kg/o.d.) either four days or longer
from 10 different centres all over Turkey. Classiﬁcation of febrile
episodes and evaluation of response were designed in accord-
ance with the guidelines published by Immunocompromised
Host Society. Duration of the SC arm was selected as 4 days to
avoid early unnecessary modiﬁcations of empirical treatment.
Results: A total of 119 patients were assessable for efﬁcacy (58
SC, 61 LC). Underlying diseases were AML (86), ALL (22), BMT
(2), lymphoma (7), other hematological malignancies (2). The
median duration of isepamicin therapy was 10 (4–21) days in the
LC arm. Infection was microbiologically and clinically docu-
mented in 33 episodes (28%) and in 7 episodes (6%), respect-
ively. The overall success rate without modiﬁcation was 50% in
SC arm, 49% in the LC arm. The mean time to defervescence was
3.8 + 2.5 days in the SC arm and 4.1 + 3.1 days in the LC arm
(p > 0.05). Modiﬁcation of the initial regimen with antivirals
and/or antifungals raised the success rate to 60% in the SC arm,
57% in the LC arm. Without a change in antibiotics, the response
rates were 5/7 in the SC arm and 5/6 in the LC arm in patients
with single-organism gram-negative bacteraemia. Overall side-
effects were observed in 19 patients (29%) in SC arm, 22 (32%) in
the LC arm in the intent to treat analysis. The nephrotoxicity
were rare and similar in both arms (4 SC, 2 LC, p = 0.31).
Mortality due to infection with or without hemorrhage occurred
in a total of 9 patients (4 SC, 5 LC).
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Conclusion: Cefepime combined with a short (four days)course
of isepamicin seems to be as effective and safe as a longer
duration of isepamicin in febrile high-risk neutropenic
patients.
R2062
Clinical-evolutive aspects of varicella in
immunocompromised patients
I. Marincu, L. Negrutiu, L. Marincu, M. Popa (Timisoara, RO)
Immunocompromised patients represent a high risk group for a
large number of viral and bacterial infections, requiring a strict
clinical and therapeutic surveillance.
Objectives: The study of clinical-evolutive aspects of varicella
in adult immunocompromised patients.
Methods: The authors have studied a group of 24 patients from
the Clinic of Infectious Diseases in Timisoara suffering from
varicella occurring on known chronic affections, evolving on
immunocompromised ﬁeld. Five of the patients were known to
have insulin-dependent diabetes mellitus, 4 patients with
chronic renal insufﬁciency (hemodialysis) 3 patients with
chronic lymphatic leukaemia, 2 patients with chronic myelo-
genous leukaemia, 8 patients with tuberculosis, one patient with
breast cancer and one patient with Hodkin disease. The
diagnosis of varicella was based on the clinical-evolutive
symptoms (fever, general itching rash consisting of maculas,
papulas and vesicles, affecting both the skin and the mouth,
anal–genital, and conjunctiva mucosa occurring in 3–4 waves)
and epidemiological elements (contact with patients suffering
from varicella or herpes zoster). All patients followed treatment
with acyclovir, 2 g/day for 8–10 days, C vitamin, calcium,
antihistamines, sedatives, adequate diet and the treatment of the
basic disease.
Results: The duration of the skin rash was of 4 weeks in 18
patients and of 5 weeks in 6 patients; the rash was intensively
expressed in 4 waves in 20 patients; the following complications
were observed: interstitial pneumonias in 15 patients, acute
congestive anginas in 5 patients, mouth Candida in 8 patients,
cerebellum ataxia in 3 patients, viral meningitis in 2 patients,
bacterial skin over-infections in 10 patients, 1 patient with
erysipelas, 4 patients with bacterial conjunctivitis; antibiotic
treatment with claritromicine in 5 cases, amoxicillin + clavulanic
acid in 4 cases and cotrimoxazol in 6 cases was performed. No
decease was recorded.
Conclusions: Adult immunocompromised patients develop
prolonged clinical forms of varicella with the possibility of
complications that impose a clinical and therapeutically strict
surveillance.
R2063
Microbial ﬂora of the peritoneal catheter exit site
in patients on continuous ambulatory peritoneal
dialysis
C. Papaefstathiou, A. Karaitianou, P. Metaxaki, M. Zoumberi,
D. Vlasopoulos, G. Kouppari (Athens, GR)
Objectives: The study of the microbial ﬂora of the peritoneal
catheters exit site in continuous ambulatory peritoneal dialysis
(CAPD) patients and its relation to exit site infection and
peritonitis episodes.
Patients and methods: During 24 months (2002–2003) perito-
neal catheter exit site cultures were examined independently of
the presence exit site infection in 18/28 (64.3%) CAPD patients.
The specimens were cultured on the appropriate media. The
identiﬁcation of the microorganisms was performed by standard
methods and API systems (bioMerieux). Susceptibility testing
was carried out by disc diffusion method.
Results: During these 2 years exit site infection was noticed in
11/18 patients (61.1%). No peritoneal catheter tunnel infection
was noticed. From the exit site infection episodes Gram (+)
microbes were isolated in 57.9% of the strains (CNS in 42.1% and
Staphylococcus aureus 15.8%), Gram ()) bacteria in 36.8%, and
Candida crusei 5.3%. Resistant colonization by the same strain,
was noticed in 45.5% of the patients with exit site infection
(colonization time 3–14 months). Production of extended spec-
trum (-lactamase (ESBL) was observed in 14.3% of isolated Gram
()) bacteria. CNS strains were 100% resistant to oxacillin. 54.5%
of the patients were treated by systemic antimicrobials, 18.2% by
local antimicrobials and 18.2% by local antiseptic (povidone
iodine). In 26 specimens from 11 patients without exit site
infection, CNS were isolated in 75% of the strains, Gram ())
bacteria in 17.6% and Candida spp. in 7.1%. CNS strains were
90.4% resistant to oxacillin, 57.1% to erythromycin, 66.7% to
gentamicin, 52.4% to ciproﬂoxacin, 66.7% to trimethoprime/
sulphamethoxazole and 61.1% to fucidic acid. Production of
ESBL was observed in 40% of isolated Gram ()) bacteria.
Peritonitis episodes from microbes which have been isolated
from the exit site (colonization or inﬂammation) were noticed in
4/18 (22.2%) patients.
Conclusions: Multiresistant CNS were isolated from the exit
site in the majority of CAPD patients. 50% of the Gram (-)
bacteria were unfermented, and 25% were producing ESBL.
Cultures from normal exit site are useful for prevention in
CAPD patients. Clinical evaluation of exit site appearance is
essential for the administration of treatment dependent of
isolated microorganisms.
R2064
Infections in patients with malignancies
E. Kouskouni, S. Demeridou, E. Logothetis, G. Kaparos, S. Baka
(Athens, GR)
Objectives: This study was conducted in order to assess the
prevalence of infections and pathogens in critically ill patients
with underlying malignancy in our hospital.
Methods: We studied 164 cancer patients presenting to our
hospital with signs and symptoms of infections. Cultures were
performed adequately in accord with the infection site. Identi-
ﬁcation of strains and antibiotic susceptibility testing were
performed with the VITEK System, ATB Expression (Bio-
Merieux, France).
Results: Out of the 164 patients there were 88 (53.7%) men
(mean age 60.8 ± 11.5 years) and 76 (46.3%) women (mean age
62.5 ± 13.2 years). Overall mortality was 17.9%. The sites of
primary malignancy were: lung 25.0%, digestive tract 17.1%,
breast 12.2%, urinary tract 11.6%, gynecologic 10.9%, prostate
9.7%, head–neck 5.5%, haematologic 4.3% and others 3.7%.
Ninety-four (57.3%) patients were diagnosed with metastatic
cancer. In particular, the sites were: bone 50.0%, liver 22.3%,
lung 9.6% and others 18.1%. There were 186 concomitant
infection sites, of which the most common were urinary tract
(33.4%), bacteraemia (24.7%), pulmonary (21.5%), skin or soft
tissue (14.5%) and abdominal infections (5.9%). We observed a
high prevalence of multiresistant strains among the pathogens
isolated. In particular, the most commonly isolated pathogens
and their multiresistance rate were as follows: in the urinary
tract, Escherichia coli (27%), Pseudomonas aeruginosa (60%) and
Enterococcus faecalis (58%), in bacteraemia, Staphylococcus epider-
midis (58%), E. faecalis (43%) and P. aeruginosa (61%), in
pulmonary infections, Klebsiella pneumoniae (67%) and P, aerugi-
nosa (68%), in skin and soft tissue infections, P. aeruginosa (75%),
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S. epidermidis (60%) and Candida albicans, while in abdominal
infections E. faecalis (52%) and S. epidermidis (54%).
Conclusions: The most commonly encountered infections in
patients with underlying malignancy were urinary tract infec-
tions, bacteraemias and respiratory tract infections. In our study
there was a high percentage of multiresistant isolates. Gram-
positive cocci were the leading cause of bacteraemia and
abdominal infections. Of all Gram-negative rods P. aeruginosa
was the most resistant.
R2065
Isolation of Neisseria meningitidis from sputum/
bronchial secretions from immunocompromised
patients
G. Tzanakaki, M. Kanellopoulou, N. Skarmoutsou,
M. Martsoukou, K. Kesanopoulos, A. Charalampopoulou,
D. Adamou, G. Floropoulou, J. Kremastinou, E. Papafrangas
(Athens, GR)
Objectives: Two cases of immunocompromised patients in
which Neisseria meningitidis strains were isolated from spu-
tum/bronchial secretions are presented in this study.
Methods: Both sputum and bronchial secretions were cultured
in blood/chocolate agar. Isolation and identiﬁcation of
N. meningitidis strains, were performed according to conven-
tional microbiological procedures. To the isolated N. meningitidis
strains, serogroup was performed by the slide agglutination test
and serosubtyping by the use of monoclonal antibodies with
Whole-cell ELISA. Simultaneous diagnostic approach was car-
ried out by the use of PCR in whole blood samples of the two
patients. The ampliﬁed gene was crgA speciﬁc for N. meningit-
idis and siaD speciﬁc for serogroups A, B, C and Y. The
ampliﬁcation products were 230 bp for N. meningitidis and
450 bp, 250 bp, 400 bp, and 120 bp for the serogroups B, C, A,
and Y, respectively.
Results: In the ﬁrst case although the blood cultures were
negative, PCR in the whole blood was positive for N. meningit-
idis serogroup W-135, indicating meningococcal septicemia and
the same strain was isolated from the sputum. In the second
case, N. meningitidis serogroup C:4:P1.14 strain was isolated
from the bronchial secretions although blood cultures and PCR
was negative.
Conclusions: N. meningitidis in sputum or bronchial may cause
severe bacteraemia or meningococcal disease especially in
immunocompromised patients. PCR detecting genetic material
of N. meningitidis in whole blood, play important role in
laboratory diagnosis of the infection. In cases in which
N. meningitidis is isolated from respiratory tract infections, this
should be notiﬁed and chemoprophylaxis must be given to
avoid complications of meningitis or septicaemia.
R2066
Bacteraemia in patients with hematological
malignancies
N. Bagirova, N. Dmitrieva (Moscow, RUS)
Objectives: To determine of predominant pathogens isolated
from blood of patients with hematological malignancies.
Methods: A total of 309 strains were isolated from 1535 blood
cultures taken from 239 patients with hematological malignan-
cies between 1997 and 2003. BACTEC 9050 (Becton Dickinson
Diagnostic instrument Systems) and Bact/ALERT 3D (Bio-
Merieux) automated blood culture systems were used in our
study. The clinical signiﬁcance of isolates was assessed at the
time of the positive culture by consultation with the patients
physician. Decisions were also made in accordance with the
deﬁnitions published by the Centers for Disease Control and
Prevention.
Results: 126 from 309 strains were determinated as contami-
nants (40.8%). Thus clinically signiﬁcant strains accounted for
183 ones. Gram-positive cocci presented 49.2% (90), gram-
negative bacilli – 31.1% (57/183), fungi – 14.8% (27/183).
S. aureus was the leading pathogen (19.1%, 35/183), followed
by coagulase-negative staphylococci (15.8%, 29/183), Enterococ-
cus spp. (9.8%, 18/183), Candida spp. (9.8%, 18/183), E. coli
(8.7%, 16/183), Streptococcus spp. (4.4%, 8/183), Enterobacter spp.
(4.4%, 8/183), Klebsiella spp. (3.3%, 6/183), other gram-negative
enteric bacilli (3.3%, 6/183), P.aeruginosa (4.4%, 8/183), other
non-fermenting gram-negative bacilli (7.1%, 13/183), other
yeasts (1.6%, 3/183), moulds (3.3%, 6/183), anaerobes (2.2 %,
4/183), Corynebacterium spp. (1.1%, 2/183), Bacillus spp. (0.5%,
1/183), Listeria ivanovii (0.5%, 1/183), Stomatococcus mucilagino-
sus (0.5%, 1/183).
Conclusion: Gram-positive cocci (mainly S. aureus) were pre-
dominant pathogens between 2000 and 2003. It is necessary to
notice the changing landscape: Listeria ivanovii, Stomatococcus
mucilaginosus, Rhodotorula rubra, Nectria mauritiicola – unusual
pathogens for our hospital.
R2067
Blood stream infections in children with acute
myeloid leukaemia: contribution of
microbiological gum and gut monitoring
C. Ploton, A.S. Brunet, A.M. Freydiere, C. Galambrun,
C. Pondarre, M.P. Pages, N. Bleyzac, G. Barbe,
Y. Bertrand (Lyon, F)
Objectives: Blood stream infections (BSI) have an important
impact on the clinical course and the outcome of patients with
acute myeloid leukaemia (AML). Viridans group streptococci
(VGS) are considered the main cause of severe sepsis in these
patients (20–30%). The aim of this study was to evaluate (i) the
frequency of BSI, (ii) the incidence of VGS sepsis and (iii) the
contribution of microbiological monitoring of gum decontamina-
tion by vancomycin mouth-washing in the prevention of VGS
sepsis, in ourpaediatric patientswithAMLbetween 1993 and 2003.
Methods: Medical records of 78 children, treated according to
the EORTC 58921 clinical trial including 264 chemotherapy
courses, were retrospectively analysed. For prevention of infec-
tion, patients were isolated in laminar air ﬂow rooms, had gum
decontamination (vancomycin mouth-wash), gut decontamina-
tion (per os aminoglycoside and amphotericin B), and received
trimethoprim–sulfamethoxazole. Weekly quantitative microbio-
logical analyses of gum and gut were performed to check the
effectiveness of decontamination and the absence of emergence
of resistant bacteria. In case of febrile episodes, empirical
antibiotic treatment consisted of piperacillin, amikacin and
vancomycin. Vancomycin was stopped 72 hours later if Gram-
positive sepsis was absent.
Results: Overall, 58 BSIs occurred corresponding to a total of 59
microorganisms(49 Gram-positive, 8 Gram-negative and 2
yeasts). Only 4 VGS sepsis occurred in 3 patients. No patients
died from BSIs and no patients with VGS sepsis required
intensive care unit management. The weekly microbiological
gum monitoring found a very low incidence of VGS. In those
cases where VGS were detected, this enabled the mouthwash
regime to be modulated accordingly, which no doubt further
contributed to our very low rate of VGS sepsis (6.7% in our
population versus 20–30% in other studies). Weekly microbio-
logical gut monitoring found no vancomycin-resistant entero-
cocci in spite of use of local antibiotics.
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Conclusion: Weekly microbiological analyses enabled the
effectiveness of vancomycin-mouth washing to be monitored
and adjusted. Our procedures contributed to signiﬁcantly
decreasing the frequency of VGS sepsis in children with AML,
without emergence of vancomycin-resistant enterococci.
R2068
Efﬁcacy of meropenem versus imipenem-
cilastatin for the treatment of diabetic patients
with complicated skin and skin structure
infections
J. Embil, N. Soto (Winnipeg, CAN; Wilmington, USA)
Objectives: A previous study has shown the broad spectrum
carbapenem, meropenem (MEM), to be as effective as imipe-
nem–cilastatin (IPM) in patients with complicated skin and skin
structure infections (cSSSI). Skin infections in patients with
diabetes may be more severe, more complicated and associated
with Gram-negative and anaerobic pathogens. This study
reports the results from a large subgroup of patients with and
without diabetes mellitus.
Methods: This was a multicentre, double-blind, randomized
trial comparing MEM with IPM (both 500 mg IV every 8 hours).
Results from patients were analysed according to the presence
or absence of diabetes mellitus. The primary efﬁcacy endpoint
was clinical outcome at follow-up, as determined by the
investigator, in the clinically evaluable (CE) population (all
patients meeting eligibility criteria receiving at least 1 dose of
study drug, who received adequate therapy, did not receive
concomitant antibiotics and who had an appropriate follow-up).
Results: Of the 1037 patients enrolled and treated in the study,
398 (38%) had a history of diabetes mellitus. Overall, pathogens
were identiﬁed in 79% of the patients. There were a larger
proportion of Gram-negative and anaerobic pathogens in
patients with diabetes (42% of isolates) than in patients without
diabetes (34%). Similarly, polymicrobial infections were seen in
44% of patients with diabetes and 34% of patients without the
diagnosis. The most common pathogens were Staphylococcus
aureus and Enterobacteriaceae. Clinical cure rates in the CE
population were similar between patient and treatment groups:
85.6% (83/97) MEM and 72.4% (76/105) IPM for patients with
diabetes, and 86.6% (142/164) MEM and 89.0% (162/182) IPM
for patients without diabetes. In patients with infected diabetic
ulcers, the clinical cure rates were 71.4% (10/14) for MEM and
55.6% (10/18) for IPM.
Conclusion: Patients with diabetes mellitus had a higher
proportion of Gram-negative, anaerobic and polymicrobial
infections than those without diabetes. MEM 500 mg IV every
8 hours was as effective as IPM irrespective of a diagnosis of
diabetes. MEM was also at least as effective as IPM in patients
with diabetic foot ulcers.
R2069
Does the granulocyte transfusion therapy have
the potential to adversely affect the clinical
outcome of subsequent haematopoietic stem cell
transplantation?
S.M. Choi, S.H. Park, D.G. Lee, J.H. Choi, Y.R. Kim, J.H. Yoo,
W.S. Shin, M.W. Kang (Seoul, KOR)
Objectives: Granulocyte transfusion therapy (GTx) has been
done increasingly for the treatment of severe bacterial and
fungal infections in patients with prolonged neutropenia.
However, the effect of GTx on clinical outcome after subsequent
hematopoietic stem cell transplantation (HSCT) have not been
precisely deﬁned to date. The aims of this study were to
determine the effect of GTx on the point of engraftment, graft-
versus-host disease (GVHD), neutropenic fever and CMV
infection after subsequent HSCT.
Methods: Out of patients who received allogeneic HSCT at the
Catholic HSCT Center from January 2001 to December 2002,
patients who had previous history of GTx enrolled into the case
group. Patients who had no history of GTx and matched at the
aspect of age, sex, underlying disease, HSCT type, stem cell
source, and GVHD prophylaxis regimen, enrolled into the
control group.
Results: Fourty-one patients enrolled into the case group and
1:2 matched 82 patients enrolled into the control group. Mean
age of the two groups were 34.2 and 34.8 years, respectively.
Acute leukaemia (75.6%) was the most common underlying
disease. Matched related transplantation was 75.6%. Median
follow-up duration were 570 and 651 days after transplantation
(P = 0.15). Engraftment failure was more frequent in the case
group than in the control group (14.6% vs 1.2%, P = 0.006).
However, duration of neutropenia was not different between the
two groups. Neutropenic fever and invasive fungal infection
developed more frequently in the case group (P < 0.05).
Duration of neutropenic fever and use of intravenous antibiotics
were longer in the case group (P < 0.05). Although the incidence
of acute and chronic GVHD was not different, more extensive
type of GVHD tended to occur in the case group (P = 0.05).
CMV infection occurred more frequently in the case group, but
there was no statistical signiﬁcance. Whereas CMV disease
developed more frequently in the case group (8.6% vs 1.2%,
P = 0.049). Crude mortality during post-engraftment period had
no signiﬁcant difference between the two groups (45.7% vs
38.3%).
Conclusion: GTx has the potential to adversely affect the course
and outcome of subsequent HSCT. So, GTx should not be
considered for routine management of infectious complications
and should be reserved for the treatment of severe, potentially
life-threatening infections refractory to conventional antimicro-
bial therapy in prolonged neutropenic patients.
R2070
Severe pulmonary Nocardia otitidiscaviarum
infection in a patient with underlying chronic
lung disease and long-term corticosteroid
therapy, conﬁrmed by 16S rRNA gene sequencing
D.H. Forster, A. Becker, E. Kniehl (Karlsruhe, D)
Objective: Nocardiosis is a rare opportunistic infection and
presents most commonly as pulmonary disease. The species
commonly associated with disease are N. asteroides sensu stricto
type VI,N. brasiliensis, N. farcinica andN. nova. N. otitidiscaviarum
represents only between 1.3 and 4.8% of clinical Nocardia isolates
in larger studies from Europe, Japan and the USA. Just a few
cases of N. otitidiscaviarum infections of the lower respiratory
tract were published. We describe the case of a severe pulmon-
ary N. otitidiscaviarum infection in an immunocompromised
patient with underlying lung disease and review published
cases.
Case report: A 75-year-old man, under long-term corticosteroid
therapy because of chronic organizing pneumonia since
12 months, was admitted to a regional hospital (day 0) with
left-sided pneumonia and empirically treated with ampicillin/
sulbactam and ciproﬂoxacin. A complicating cerebral infarction
led to the transfer to the stroke unit/neurological ICU of our
tertiary care hospital (day 2). There he needed mechanical
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ventilation (day 6) due to respiratory insufﬁciency. On two
occasions, 8 days, respectively 11 days after incubation, gram-
positive branching rods were cultured from tracheal aspirate.
The strain was identiﬁed as N. otitidiscaviarum by partial 16S
rRNA gene sequencing showing 100% sequence homology with
the N. otitidiscaviarum type strain DSM 43242. Subsequently,
treatment was changed to meropenem (day 25) plus cotrim-
oxazole (day 27). The patient was further treated on a medical
ICU of our institution. Cerebral and pulmonary abscesses were
excluded radiologically. Corticosteroids were stopped. Weaning
from mechanical ventilation was protracted and complicated by
pleural effusion requiring chest tube drainage and reincubation
due to CO2-narcosis (day 61). Meropenem was stopped after
4 weeks but cotrimoxazole continued for long-term treatment.
The patient was eventually extubated 73 days after incubation
(day 79) and, after altogether 89 ICU days (day 95), was
discharged distinctly improved to a rehabilitation facility.
Conclusion: Our patient with severe pulmonary N. otitidiscavi-
arum infection had typical predisposing factors for nocardiosis
with underlying lung disease in association with long-term
corticosteroid therapy. To our knowledge, so far only six cases
with lung infection (1 pyothorax) due to this species were
published including two cases in patients without apparent
immunosuppression.
R2071
C.R.P. and P.C.T. in septic patients
C. Petrochilou, V. Karabassi, M. Pouyouka, K. Kotoula,
N. Alexandropoulos, C. Kontou-Castellanou (Athens, GR)
Purpose: The purpose of this study was to determine and
associate PCT and CRP levels in serum of septic patients that
were hospitalized in the intensive care unit for the last
10 months in Hippocration General Hospital.
Methods: During a 10-month interval, 450 serum specimens
were examined which corresponded to 92 I.C.U. patients. The
PCT value in serum was determined using the immunolumino-
metric assaymethod (LIAISON–BRAHMSPCT) taking as normal
values 0.10–0.50 ng/ml. TheCRP value in serumwas determined
using the nephelometric method with high sensitivity reagents
(Dade–Behring) taking as normal values 0–5 mg/l.
Results: From the 450 samples of 92 patients, 143 (32%) had
pathological PCT levels that ranged from 1 to 131 ng/ml and
87% of these septic patients had positive blood cultures. In all
450 serum samples (100%) were found high CRP levels that
ranged from 3.0 to over 20.0 mg/l 35 (38%) out of 92 patients
with sepsis died.
Conclusions: Our study shows that: (1) The CRP levels
remained high in serum measurements of the patients. (2) The
PCT values showed some ﬂuctuation (low and high). (3) The
patients with high PCT serum levels also had positive blood
cultures. (4) There was no connection between PCT and CRP
serum levels. (5) High PCT levels remaining in the serum for a
long time consist a bad prognostic factor for disease outcome.
R2072
Bacteraemia as a result of bacterial translocation
from gastrointestinal tract in patients in the
haematological department of a university
hospital in Gdansk, Poland
A. Sledzinska, A. Samet, E. Arlukowicz, M. Bronk,
A. Hellmann (Gdansk, PL)
Objectives: The aim of the study was to estimate the frequency
of bacteraemia as a result of bacterial translocation of the
microorganisms from gastrointestinal tract.
Materials and methods: We analysed 583 positive blood cul-
tures between 01-01-2004 and 30-09-2004 from 125 patients
treated in Haematological Department in Gdansk. The blood
samples were incubated in BacT/Alert system (bioMerieux).
Strains were identiﬁed by classical methods and GNI+ VITEK
cards (bioMerieux). Sensitivity was determined by the agar
dilution method according to NCCLS guidelines.
Results: We analysed positive blood cultures from the group
of 59 pts (36 male, 23 female) where bacteraemia was caused
by aerobe intestinal microﬂora (Gram negative rods, entero-
cocci, candida). Gram negative bacteraemia appeared in 49
cases (38 pts), enterococcal bacteraemia in 38 cases and
candidemia in 10 cases (9 pts). In 17 pts, we observed mixed
bacteraemia caused by Gram negative rods, enterococci and/or
candida. In 16 cases, there were two or more microorganisms
cultures from one blood sample. The most often isolated
pathogen was Enterococcus faecium (79 isolates, 17 pts) and
Gram negative rods – Escherichia coli (29 isolates, 15 pts) and
Pseudomonas aeruginosa (20 isolates, 7 pts). The most often
isolated yeast was Candida albicans (20 isolates, 8 pts). The
correlation between microorganisms isolated from blood and
stool samples was conﬁrmed in 25 cases caused by Gram
negative rods and the lack of correlation was in 23 cases. In all
patients with enterococcal bacteraemia we conﬁrmed the
correlation between blood and stool samples. The correlation
in cases of candidemia was in 8 cases. The homology of
microorganisms isolated from blood and stool samples was
determinated by resistant phenotype of resistance and bio-
chemical tests GNI+ (VITEK, bioMerieux).
Conclusions: 1. The correlation between the colonization of
gastrointestinal tract and microorganisms cultured from blood
samples is conﬁrmed in patients of Haematological Department
in Gdansk. 2. The most closest correlation was observed in
enterococcal bacteraemia and fungaemia. 3. The existence of
correlation between bacteraemia and microbial ﬂora of the
intestine requires conﬁrmation by other methods (PCR ﬁnger-
printing).
R2073
Listeria monocytogenes infection. A clinical and
epidemiological report from a Spanish general
community-based hospital
S.M. Quevedo, M.D. Martin, G. Sesen˜a, A. Sa´nchez-Valladares,
R. Jime´nez, R.B. Mohedano, M. Pa´ez (Leganes, E)
Objective: To describe the frequency, clinical presentation,
underlying conditions, and clinical outcome of a series of
patients suffering from invasive listeriosis.
Methods: Retrospective review of clinical charts from patients
with a positive culture in usually sterile ﬂuids for Listeria
monocytogenes occurring along a 10-year period (1994–2004) at a
hospital that provides specialized care to approximately 390,000
inhabitants.
Results: Sixteen out of seventeen cases occurring along the
study period are reported (50% females, 50% males). Mean age:
52.3 years (ranging from 19 to 87); no neonatal cases were
found. Underlying conditions: Age over 65 years 6 (37.5%),
malignant hematological disease 3 (18.75%), chronic liver
disease 2 (12.5%), malignant solid tumor 1, chronic kidney
disease 1, and pregnancy 1 (6.25% each one). No patients
suffered from HIV-1 infection. Six patients (37.5%) had
received prolonged immunosuppressive therapy. Three
patients had no known underlying condition, all of them
presenting as meningitis. Clinical presentation: Nine patients
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presented with bacteraemia or sepsis, one of them as preg-
nancy listeriosis; ﬁve patients presented as meningitis or
meningoencephalitis, and two patients as spontaneous bacterial
peritonitis. Six cases had in-hospital onset of symptoms.
Antimicrobial treatment included either ampicillin or trimeth-
oprim–sulfamethoxazole in all patients. Clinical outcome: Four
out of 16 patients died (25%), all of them displaying at least
one predisposing condition and three of them older than
70 years.
Comments: Invasive Listeria monocytogenes infection is a disease
very rarely detected in our hospital. As mortality remains quite
high despite correct antimicrobial treatment, clinicians should
be alert to rule it out, specially in older patients with predis-
posing factors.
R2074
Usefulness of procalcitonin and neopterin
measurement in the management of
exacerbations in chronic obstructive pulmonary
diseases
J.A. Domı´nguez, C. Prat, F. Andreo, S. Blanco, C. Vilaplana,
R. Rivelo, I. Latorre, L. Matas, M. Gime´nez, C. Ramil,
J. Ruiz-Manzano, V. Ausina (Barcelona, E)
Objectives: To determine the usefulness of procalcitonin (PCT)
and neopterin measurement as inﬂammatory markers in
patients diagnosed of chronic obstructive pulmonary disease
(COPD). To establish if differences are observed in PCT and
neopterin levels during a clinically stable period, during an
acute exacerbation, and during the process until resolution, as
well as in COPD patients with pneumonia. The results will be
analysed taking into consideration the severity and etiology of
the COPD exacerbation.
Methodology: A total of eighty-nine patients diagnosed of
COPD were included in the study. Patients were grouped as
follows: Group 1: COPD patients in stable period (4); Group 2:
COPD patients undergoing an acute exacerbation, and Group 3:
COPD patients with clinical, radiographic and microbiological
diagnosis of pneumonia (16). In addition, a control group of 10
healthy individuals was included. Comparison between the
different groups of patients was conducted by the Mann–
Whitney test in order to evaluate the usefulness of the deter-
mination of PCT and neopterin. PCT was measured by
immunoluminometric assay (Lumitest PCT, Brahms Diagnosti-
ca) and neopterin was measured by enzyme immunoassay
(Neopterin ELISA, IBL) in serum samples.
Results: The PCT basal levels in the control group patients were
lower than 1 ng/ml (median 0.35, 5–95 percentiles 0.258-2-223).
The higher values were obtained in COPD patients undergoing
pneumonia (median 3.11, 5–95 percentiles 0.158-72-44). The
neopterin basal levels in the control group patients were lower
than 30 ng/ml (median 0.195, percentiles 0.014–5.334). The
higher values of neopterin were also obtained in COPD patients
affected of pneumonia. In addition, the PCT levels were higher
in COPD exacerbated patients than in stable COPD patients.
However, signiﬁcant differences were only observed when
comparing the exacerbated severe COPD patients (p = 0.018) to
the stable COPD patients.
Conclusion: We can conclude that PCT and neopterin show
higher levels in COPD patients presenting pneumonia than in
those presenting clinical exacerbation without pneumonia and
those in a stable period of the disease. Furthermore, a
correlation between PCT and the severity of the COPD is
observed.
R2075
Pneumocystis jiroveci (carinii) pneumonia in the
era of PCP prophylaxis
Z. Racil, D. Minarikova, P. Volfova, M. Lengerova,
D. Dvorakova, J. Mayer (Brno, CZ)
Methods: From 6/1999 to 7/2004 192 BAL have been per-
formed in hematooncological pts. for the reason of pulmonary
pathology on chest X-ray or HRCT. 34 pts. had positivity for
P. jiroveci (carinii) by nested PCR. 4 pts. had false positivity
(speciﬁcity 91%). 30 cases of PCP (P. carinii pneumonia) have
been diagnosed. Data from these patients have been reviewed.
Results: Underlaing diseases of these 30 pts. are: NHL – 6
(20%), myeloma – 6 (20%), Hodgkin’s lymphoma – 4 (13%), CLL
– 4 (13%), acute leukaemia – 2 (7%), aplastic anemia – 1 (3%),
CML – 1 (3%), HCL – 1 (3%), MDS – 1 (1%), myeloﬁbrosis – 1
(1%), other – 3 (10%). PCP occured in 5 pts. (17%) in the time of
diagnosis, in 12 (40%) during treatment, in 3 (10%) in remission
and in 10 pts. (33%) during progression of underlaing disease.
29 pts. (97%) were without PCP prophylaxis and 21 (70%) had
steroid treatment. 27 pts. (90%) have been treated with HD
co-trimoxazole (3 pts died before start) with 67% treatment
response. 15 pts. (50%) needed mechanical ventilation. Overall
mortality of these 30 pts with PCP was 50%. The need for
mechanical ventilation were higher in pts. with steroids in
anamnesis (52% vs. 44%), with >20 mg of steroids/day (67% vs.
20%), with CD4 count £0.2 · 109/l or £20% (50% vs. 33%) and
with underlaing disease in the stage of new diagnosis or during
treatment (60%, 58% vs. 33%, 40%).Mortality was higher in pts.
with steroids in anamnesis (57% vs. 33%), with >20 mg of
steroids/day (53% vs. 40%), with CD4 £0.2 · 109/l or £20% (56%
vs. 33%), with neutrophile count £1 · 109/l (60% vs. 45%), pts.
on mechanical ventilation (67% vs. 33%) and pts. with under-
laing disease in the stage of new diagnosis or progression (80%,
70% vs. 33%, 0%). We did not ﬁnd higher mortality and higher
need for mechanical ventilation in the group of pts. with CD4/
CD8 count £1. (43% vs. 50%, 14% vs. 55%).
Conclusion: Our retrospective analysis demonstrates very low
incidence of PCP in the groups of pts with hematological
malignancies where PCP prophylaxis is commonly used (e.g.
acute leukaemia). By contrast most of pts. with PCP in our
institution were pts. with underlaing disease and treatment
where PCP prophylaxis isn’t routinely used (NHL, Myeloma,
Hodgkin’s lymphoma, CLL), but steroids were part of treatment
protocols (especially >20 mg/day), CD4 count was £0.2 · 109/l
or £20% and underlaing disease was in the stage of new
diagnosis or progression. These are pts. who need PCP prophy-
laxis.
Need for mechanical ventilation and mortality
Condition n (%)
Mechanical
ventilation-n (%) Death-n (%)
Underlaing disease stage new diagnosis 5 (17) 3 (60) 4 (80)
During Treatment 12 (40) 7 (58) 4 (33)
Remission 3 (1 0) 1 (33) 0 (0)
Progression 10 (33) 4 (40) 7 (70)
Steroids Yes 21 (70) 11 (52) 12 (57)
No 9 (30) 4 (44) 3 (33)
Steroids > 20 mg/day Yes 15 (75) 10 (67) 8 (53)
No 5 (25) 1 (20) 2 (40)
CD 4 </= 0.25 ·
10e9/l or </= 20%
Yes 18 (67) 9 (50) 10 (56)
No 9 (30) 3 (33) 3 (33)
CD 4/8 </= 1 Yes 7 (26) 1 (14) 3 (43)
No 20 (74) 11 (55) 10 (50)
Neu</=1 · 10e9/l Yes 10 (33) 4 (40) 6 (60)
No 20 (67) 11 (55) 9 (45)
Mechanical ventilation Yes 15 (50) N.A. 10 (67)




Peritoneal tuberculosis as a possible complication
of imatinib therapy for chronic myelogenous
leukaemia
L. Senn, A. Telenti, T. Kovacsovics, P. Meylan (Lausanne, CH)
Background: Imatinib mesylate (STI571 – Glivec) is a selective
inhibitor of the Bcr–abl tyrosine kinase, which deregulated
expression is involved in the pathogenesis of chronic myeloid
leukaemia (CML). We report a case of peritoneal tuberculosis in
a patient with global lymphopenia following a four-month
treatment with imatinib for a newly diagnosed CML.
Case report: A 37-year-old Swiss male, who was diagnosed
with BCR–ABL positive CML in chronic phase, complained after
four months of imatinib therapy of abdominal pain, lack of
appetite, lost of weight, nausea. Abdominal CT-scan revealed
homogenous hepato-splenomegalia, diffuse inﬁltration of mes-
enteric fat and ascitis. Ascitis was inﬂammatory with predom-
inance of lymphocytes and remained sterile on culture. The
symptomatology was attributed to an adverse effect of imatinib
and the treatment was then interrupted. One month later, he
was admitted because of worsening symptoms. An explorative
laparoscopy displayed extensive chronic granulomatous perito-
nitis, and peritoneal tuberculosis was diagnosed by positive
Mycobacterium tuberculosis PCR of peritoneal biopsies. Chest
X-ray was strictly normal. At admission, he presented global
lymphopenia (CD4 155 cell/mm3 and CD8 39 cell/mm3).
Discussion: This case raises two points: an atypical presenta-
tion of tuberculosis in a non-exposed patient and a global
lymphopenia in an HIV-negative patient. To the best of our
knowledge, this is the ﬁrst report of an infection suggestive of
immune compromise after imatinib treatment. Imatinib is
known to induce cytopenia. Moreover, two recent studies have
shown that imatinib inhibits the activation and proliferation of
T-cells in vitro and delayed-type hypersensitivity in vivo
(Cwynarski et al. 2004, Dietz et al. 2004) suggesting that imatinib
might affect immunity and could lead to a higher than expected
incidence of opportunistic infections. No epidemiological data
are yet available to support this hypothesis. Of note, tuberculosis
itself induces transient lymphopenia in HIV-seronegative
patients and patients with CML are at risk for infection due to
a possible dysfunction of the immune response.
Conclusion: Further studies of imatinib effect on immunity and
on the incidence of opportunistic infections should be per-
formed. Checking CD4 and CD8 T cell counts in patients during
imatinib treatment could be considered.
R2077
Identiﬁcation of lactic acid bacteria isolated from
blood samples and their susceptibility to
antibiotics
A. Sevcikova, P. Svec, M. Vacanneyt, J. Swings, I. Sedlacek
(Brno, CZ; Ghent, B)
Objectives: Since the 1980s members of lactococci, pediococci,
leuconostocs and lactobacilli have rarely been indicated as
opportunistic pathogens in humans. Generally, these taxa are
part of the normal intestinal ﬂora and occur in fermented foods
and on plants. Due to their low virulence it is assumed that these
bacteria are pathogenic only in immunocompromised hosts.
Their sporadic occurrence in human clinical samples is often
overlooked and/or they are misidentiﬁed.
Methods: A total of 59.845 blood samples were isolated at the
Department of Clinical Microbiology (Teaching Hospital, Brno,
Czech Republic) during the 2000–2003. Biochemical identiﬁca-
tion was performed on selected lactic acid bacteria (LAB) by API
50 CH kit and by conventional tests. (GTG) 5-PCR ﬁngerprinting
and whole cell protein proﬁle analysis by SDS-PAGE were
performed to conﬁrm the biochemical identiﬁcation results. The
MICs for antimicrobial agents (benzylpenicillin, ampicilin,
cefotaxim, imipenem, erytromycin, clindamycin, gentamicin,
ciproﬂoxacin, cotrimoxazol, metronidazol, vancomycin and
teikoplanin) were determined by using the E-test MIC (Biodisk,
Solna, Sweden).
Results: A total of 59.845 investigated blood samples yielded
12.767 (21.3%) infected hemocultures of which 33 (0.25%)
contained LAB. They were identiﬁed based on phenotypical
testing as Lactobacillus plantarum (3 strains), Lactobacillus rhamno-
sus (7), Lactobacillus paracasei ssp. paracasei (2), Lactobacillus
salivarius ssp. salivarius (1), Lactobacillus fermentum (1), Leuconos-
toc mesenteroides (9), Leuconostoc lactis (5) and Pediococcus pen-
tosaceus (1). The (GTG)5-PCR ﬁngerprinting and whole cell
protein proﬁle analysis conﬁrmed above identiﬁcations and
furthermore identiﬁed four strains which were biochemically
classiﬁed at the genus level as Lactobacillus sakei ssp. Carnosus,
Lactobacillus curvatus, Leuconostoc pseudomesenteroides and Weis-
sella confusa. All investigated strains (19) were resistant to
vancomycin, teicoplanin and metronidazol and most of them to
cotrimoxazol. Susceptibility to cefotaxim, imipenem, gentamicin
and ciproﬂoxacin was variable.
Conclusion: Lactobacillus rhamnosus and Leuconostoc mesentero-
ides were the most common LAB species isolated from blood
samples. Although isolation of LAB from blood samples is rare,
it is of clinical signiﬁcance and it should be taken into account
during treatment decision – especially when they are isolated in
pure culture from sterile sites.
R2078
Risk factors for bacterial infections in multiple
myeloma treated with vincristine–adriamycin–
dexamethasone schedule
A. Zaharof, R. Koutri, G. Svoukas, K. Kanakis, N. Kostakos,
C. Flevaris, C. Petrogiannopoulos (Halandri, Athens, GR)
Objective: We evaluated bacterial infections (BIs) in patients
with multiple myeloma (MM) treated with vincristine–adria-
mycin–dexamethasone (VAD) schedule during the last 4 years
in our Department.
Design and methods: Sixty-ﬁve patients were studied during
290 VAD cycles. VAD was given by continuous intravenous
infusion (CII) to hospitalized patients. The characteristics of
patients and VAD schedules were retrospectively analysed to
detect correlations with the incidence of BI.
Results: By analyzing each VAD cycle, we found that profound
hypogammaglobulinemia (p = 0.05) and post-treatment neu-
tropenia (p = 0.09) were associated with a higher risk of
infection, while renal function impairment was signiﬁcantly
correlated with BI risk at multivariate (p < 0.001) analysis. We
evaluated only the ﬁrst 3 months of therapy, characterized by a
signiﬁcantly higher incidence of BI than the later period
(p < 0.0001).Continuous schedule (p = 0.07), and profound
hypogammaglobulinemia (p = 0.01) were associated with a
tendency to a higher risk of infection. The high probability of
CII-related infection was demonstrated to depend on the
frequent development of nosocomial infections.
Conclusion: Patients with profound hypogammaglobulinemia
who receive VAD as ﬁrst line treatment are at a major risk of BI
up to the completion of the third month of therapy. These
patients require antibacterial prophylaxis with intravenous
immunoglobulins which could be appropriate and effective.
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R2079
Catheter-related bacteraemia due to
Mycobacterium chelonae complex (M. Fuerth)
J. Wu¨llenweber, J. Schubert, M. Bregulla,
M. Herrmann (Homburg/Saar, D)
Objectives: M. Fuerth was described in 2002 as a member of the
rapid growing Mycobacterium chelonae complex. Its clinical signiﬁ-
canceandoptimal therapeutical regimenshavestill remainedunclear.
Methods: Here we report on a case of a 39 years old woman
with catheter related disseminated infection due to M. Fuerth
following bone marrow transplantation due to aplastic anemia.
Results: M. Fuerth could be cultivated in April 2004 from two
blood cultures and in high numbers from a central venous
catheter. Therapy was started using imipenem and clarithromy-
cin. During the following 4 months, no signs of infection could be
observed, but the patient developed disseminated purple col-
oured inﬁltrations of her the skin, which were initially regarded
as cutaneous GvHD. In September 2004, a skin biopsy revealed
large amounts of mycobacteria, which could also be subse-
quently identiﬁed as M. Fuerth. According to susceptibility
testing results, a therapy with linezolid (Zyvoxid) was started.
During the next three weeks, the lesions improved and were
sterile upon follow-up biopsy and culture. Ultimately, the patient
succumbed due to chronic transplant-associated complications.
Conclusion: As other members of the rapid growing mycobacte-
ria, M. Fuerth is able to cause catheter-related and disseminated
infections in severely immunocompromised patients. Linezolid,
whichhas in vitro activity againstmanymycobacteriawas effective
led to resulting in rapid improvement of the mycobacterial skin
inﬁltrations and sterilization of blood cultures and skin biopsies.
R2080
Massive pericardial effusion due to Salmonella
enteritidis in a patient with rheumatoid arthritis
A. Ceﬂe, S. Gundes, B. Erkol, N. Dagdelen (Kocaeli, TR)
Objectives: Although pericardial involvement is frequent in
patients with rheumatoid arthritis (RA), it is rarely symptomatic
and the course is mostly benign and self-limiting; also, septic
pericarditis is extremely uncommon. In this case report, we
describe a patient with RA who developed massive pericardial
effusion due to Salmonella.
Methods: The patient, a 48-year old man who suffered RA for
two years, was on low-dose corticosteroid and methotrexate
treatment for the last four months. He presented with palpita-
tions and retrosternal pain. On physical examination he was not
in cardiopulmonary distress. Erythrocyte sedimentation rate
was 80 mm/h and the leukocyte count was 11300/mm3. An
echocardigraphic examination revealed minimal pericardial
ﬂuid collection which was considered to be due to RA and the
dose of corticosteroid was increased. However, the amount of
ﬂuid increased and periods of fever (38 C) were observed. A
pericardiocentesis was performed and 600 mls of purulent ﬂuid
was drained. The pericardial ﬂuid cultivated to BACTEC system
were passaged to Endo and Blood agar plates. The identiﬁcation
and susceptibility tests were done with VITEK automated
systems (bioMerieux, VITEK, Inc. USA) and conventional
microbiological methods. The isolate was serotyped by using
Salmonella O Antiserum Group 04, Group 09 and Salmonella
antiserum poly a–z.
Results: The strain was identiﬁed as Salmonella enteritidis and
found susceptible to all 15 antimicrobials (ampicillin, ampicil-
lin/sulbactam, cefazoline, cefepime, cefotaxime, cefotetan, ci-
proﬂoxacin, oﬂoxacin, imipenem, meropenem, gentamycin,
tobramycin, amikacin and trimethoprim/sulfametaxazole) stud-
ied. The blood culture remained sterile. The patient was given
ciproﬂoxain p.o. 2 · 500 mg/day for two weeks. After the
completion of the treatment the pericardial ﬂuid had disap-
peared with remarkable clinical improvement.
Conclusion: Although pericardial involvement is frequent in
RA, these patients are predisposed to various infections
because of immunosuppressive drug treatment and infectious
etiology should be considered in the presence of atypical
features such as increasing ﬂuid during steroid treatment and
fever.
Immunology, host defenses, immunotherapy
R2081
Antibody titre to hepatitis B vaccine after 5 years
of vaccination in Iranian children
H. Salehi (Isfahan, IR)
Background: The ﬁrst dose of hepatitis B vaccine in ﬁrst
year of life induces immunity about 85–95% and level of
antibady(Ab) decreases subsequently. The need to assece the
boster dose of Hepatitis B vaccine is the main purpose of
this study.
Materials and methods: 4160 children aged 6 years from
three province of IRAN whom were vaccinated at birth, 1.5
and 9 months by recombinant hepatitis B vaccine were
selected randomly and a questionnaire were ﬁlled for weight
at birth, growth condition, chronic diseases and any medica-
tion and tested for antibody titre to Hepatitis B surface
antigen. The level of Ab under 10 MIU/ML were assumed
negative.
Result: 2609(65%) of subjects were boy and 1481(35%) girls.
From 4160 children, 1248(30%) were negative for hepatitis B Ab.
1017(39%) of boys and 473(32%) of girls were seronegative(non-
immune).
Conclusions: Our study suggests that high percentage (30%) of
vaccinated children are non-immune after 5 years and need the
revaccination.
R2082
Serotypes of Salmonella isolated strains in
northern Greece and antimicrobial resistance
rates
A. Poulou, F. Markou, P. Rozi (Serres, GR)
Objectives: Salmonella enterica is one of the main causes of
diarrhoea world wide. In this study, we present the serotypes of
Salmonella isolates from diarrheal patients over 2 years in our
hospital in Northern Greece and determine the antimicrobial
resistance rates.
Methods: Overa 2-yearperioda total of 648 stool specimens from
diarrheal patients were cultured. Identiﬁcation of the isolated
strainswasmade by conventionalmicrobiologicalmethodswhile
determination of their antibiotic susceptibility against ampicillin
(AMP), ampicillin/sulbactam (SAM), tetracycline (Te), chloram-
phenicol (Cl), ciproﬂoxacin (Cip), ceftriaxone (CRO) and trim-
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ethoprim–sulfamethoxazole (SXT) was performed using Auto
Scan 4 of Dade Boehring. The disc diffusion method of Kirby
Bauer was used when necessary according to the NCCLS
recommendations. Serotyping was performed with monospeciﬁc
antisera by the slide agglutination method.
Results: A total of 53 Salmonella strains were isolated, 11 of
them (20.8%) derived from adults and the majority 42(79.2%)
from children. There is also a seasonable distribution of
Salmonella cases with a peak in the summer months. The most
prevalent serotype was S. enteritidis 9:g,m (75.5%), followed by
S. typhimurium 4,5:i (18.8%), S. goldcoast 6.8:r:1,w(1.9%), S. blockley
6.8:k:1,s (1.9%) and S. thompson 6,7,14:k:1,s(1.9%). 49 strains
(92.4%) were susceptible to all antibiotics tested while three
strains (5.7%) 2 S. typhimurium and 1 S. goldcoast were resistant
to AMP, SAM, CL, Te and one strain of S. enteritidis (1.9%) was
resistant to Te. Medical case histories revealed two interesting
incidences of family infection. In one, S. enteritidis was isolated
from ﬁve members of the same family who had eaten infected
meat. In the second case, S. typhimurium was isolated from two
infants after close contact with their grandfather, who was
found to be a chtonic carrier of the same strain.
Conclusions: Salmonella enteritidis predominates over the other
serotypes. Children are more susceptible than adults to salmo-
nellosis. Although in our region the resistance rates are low in
comparison with other countries the rational use of antibiotics
and continuous surveillance are essential in order to prevent the
dissemination of resistant Salmonella strains.
R2083
Acute morphine treatment reduce innate
immunity against systematic infection of HSV-1
in mice
A. Jamali, M.H. Roostaie, T. Bamdad, H. Solimanjahi, F. Ghaderi
Pakdel (Tehran, IR)
Objective: The opioids including morphine are believed to be
responsible for many systemic effects in drug abusers. Involving
immune system the opioids increased susceptibility to infec-
tions. The effect of acute administration of morphine on
Systemic HSV-1 infection was evaluated in this study.
Method: HSV-1 was propagated and titered on BK cell line.
Three groups of BALB/c mice were received 50 mg/kg,
75 mg/kg or PBS (positive control) subcutaneously, 24 h after
ip injection of 2 · 107 TCID50 HSV-1. Under the same
conditions a group of mice just received 75 mg/kg morphine
as negative control. The survival rate was followed for 14 days.
The cytotoxic activity of NK cells using MTT assay.
Results: Survival analysis demonstrated that comparing to
control group administration of 75 mg morphine signiﬁcantly
reduces innate immunity to hsv-1 infection. The NK cell activity
has been reduced in morphine-treated group in comparison
with saline-treated one.
Conclusion: The results showed that adverse effects of Mor-
phine on innate immunity can be taken as a result in enhanced
rate of mortality in HSV-1 infected mice.
R2084
Effect of the function of polymorphonuclear
leukocytes and interleukin-1 beta on wound
healing in patients with diabetic foot infection
O. Oncul, S. Yildiz, U. Soyogul Gurel, E. Yeniiz, T. Qyrdedi,
C. Top, P. Gocen, B. Gunbuz, A. Cevikbas, S. Cavuslu (Istanbul,
TR)
Objectives: Disorders of polymorphonuclear leukocytes
(PMNL) phagocytoses and intracellular killing activities play
vital role in pathogenesis of diabetic foot infections. High blood
levels of interleukin-1 beta (IL-1 beta),which is a proinﬂammatary
cytokine, are detected at the initial phase of inﬂammations. In this
study, we aimed to investigate the changes in the phagocytic and
intracellular killing activities of PMNL and blood levels of IL-1
beta during the treatment of diabetic foot infections (DFI).
Methods: Thirty-eight patients with DFI [(24 male, 14 female,
mean age 66.15 ± 9.8(37–84)] were enrolled in this prospective
study betweenMarch 2003 and June 2004. Venous blood samples
(20 ml) were obtained in the pretreatment period and at 2nd and
4th weeks of the treatment period. Polymorphonuclear leuko-
cytes (1 · 107 cells/ml) were separated from venous blood with
EDTA by Ficoll–Hypaque gradient centrifugation. These PMNL
were incubatedwith Candida albicans blastospores and number of
ingested organisms per 100 PMNLwere calculated. Wound care,
rational antibacterial therapy and hiperbaric oxygen therapy
constituted the treatment protocol. The IL-1 beta levels were
detected in the three period by ELISA (Quantikine HS, R&D
Systems, Inc., US). Statistical analysis was performed by Mann–
Whitney U–test and p < 0.05 was admitted to be meaningful.
Results: Twenty-three cases responded to the therapy com-
pletely. Amputation was performed to eight of 15 cases who did
not respond to the therapy. A statistically signiﬁcant increase in
phagocytic activities of PMNL were detected only in responder
group, whereas no signiﬁcant change in intracellular killing
activities of PMNL due to treatment were detected in none of the
groups. A statistically signiﬁcant decrease in the blood levels of
IL-1 beta was detected in responder group at the 2nd week. In
non-responder group, IL-1 beta levels increased slightly but it
was not statistically signiﬁcant. At the 4th weeks of the
treatment, the IL-1 beta levels decreased slightly in both groups
but it was not statistically signiﬁcant. On the other hand, there
was signiﬁcantly change in IL-1 beta level between responder
and non-responder groups in 2nd weeks of the treatment
(1.97 ± 3.96 vs 4.91 ± 6.88, p = 0.025).
Conclusion: The present study conﬁrmed that increased phag-
ocytic activity of PMNL and decreased blood levels of IL-1 beta
correlatewellwith good clinical prognosis in the treatment of DFI.
R2085
Chlamydia pneumoniae and risk factors of acute
myocardial infarction
S. Suzuk, S. Aksaray, O. Gulel, E. Guvener, B. Urunal,
D. Tezeren, A. Toyran, V. Ulusoy, S. Aydogdu (Ankara, TR)
Objectives: Acute myocardial infarction (AMI) is still the most
important cause of death. Recently, it is believed that the
microorganisms that causes chronic or persistant infections may
play a role in the development of AMI (besides the classical risk
factors). In this study, seropositivity of Chlamydia pneumoniae in
patients suffering from acute myocardial infarction is searched
and correlation of its presence with other classical risk factors is
questioned.
Methods: Between March and May 2004 a hundred patients
(mean age 62.7) who were diagnosed as AMI considering typical
chest pain, Electrocardiography ﬁndings, serum cardiac enzyme
values and 50 healthy control (mean age 59.8) were included in
this study. Inquiry was made by asking classical risk factors to
both groups. C. pneumoniae IgG antibodies were searched in
serumsamplesbymicroimmunoﬂuorescence assay (Euroimmun,
Germany) and the titres over 1/100 were accepted signiﬁcant.
Results: C. pneumoniae IgG antibodies were positive in 67% of
patient and 40% in the control group (p < 0.05). The relation
between the positivity of C. pneumoniae IgG antibody and the
classical risk factors (sex, smoking, high total cholesterol level)
were found signiﬁcant (p < 0.05).
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Conclusions: We believe that C. pneumoniae’s property of
developing chronic infection triggers processing of other AMI
risk factors although it is not a direct risk factor for AMI.
R2086
Pre- and post-operative changes in complement
C3, complement C4 levels in acute appendicitis
D. Tezeren, B. Kulah, A. Ozmutlu, S. Aksaray, F. Coskun,
A. Toyran, E. Guvener (Ankara, TR)
Objectives: Intraabdominal infection activates alternate path-
way of complement system. Complement C3 is an important
component of alternative pathway whereas complement C4 is a
component of classical pathway of complement activation. C4
and C3 deﬁciencies are associated with pyogenic infections such
as acute appendicitis. Our study is aimed to evaluate the
preoperative and postoperative changes in C3 and C4 levels in
acute appendicitis.
Patients and Methods: Our study involved 33 patients who
underwent appendicectomy for acute appendicitis. Serum C3
and C4 levels were measured immediately before operation and
postoperatively in one hour. All serum samples were tested by
using nephelometric method (Dade-Behring, Germany). Results
were analysed statistically (SPSS 9.0 Package program for
Windows) with Chi-square test and p < 0.05 values were
accepted as signiﬁcant.
Results: C3 levels were found low in 22(67%) patients and
normal in 11(33%) patients preoperatively whereas low in
30(91%) patients and normal in 3(9%) patients postoperatively
(p = 0.016). C4 levels were found low in 9(27%) patients and
normal in 24(72%) patients preoperatively. However in 12(36%)
patients have low C4 levels and in 21(64%) patients have normal
C4 levels postoperatively.
Conclusion: Postoperative C3 levels were found signiﬁcantly
low compared with the preoperative C3 levels in the patients
underwent appendicectomy. C4 levels have no signiﬁcant
difference between preoperative and postoperative measure-
ments.
R2087
CD4 and CD8 levels in Crimean-Congo
haemorrhagic fever, and relation to the outcome
Z. Ozkurt, S. Erol, M. Ertek, K. Ozden, M. Parlak,
M.A. Tasyaran (Erzurum, TR)
Objective: Crimean–Congo haemorrhagic fever (CCHF) is a
tick-borne infectious disease with severe hemorrhagia. There is
not any study on immunology of the disease and T cell response
in acute stage of CCHF. This study was aimed to investigate
CD4, CD8 levels and CD4/CD8 ratio in CCHF.
Methods: Serum samples of 21 suspected and conﬁrmed
patients were collected at admission (early stage of disease),
during hospitalization (acute stage of disease) and at discharge
from hospital (recovery periods of disease). CD4–CD8 values
were determined by ﬂow cytometry.
Results: CD4 and CD8 values were normal in most of the
patients, CD4 values were slightly increased in only 2 patients,
and CD8 values increased in 1 patient and decreased in 1
patient. There is no signiﬁcant difference between CD4 and CD8
values and CD4/CD8 ratios of the patients at early stage of
disease, at acute stage of disease, at recovery periods of disease
and healthy control (p > 0.05). CD4/CD8 ratios were usually
normal, but reversed in 4 patients (19.0%) at early and acute
stage of disease, and spontaneously returned to normal levels at
recovery periods. To investigate effect of CD4/CD8 ratio on
clinical outcome of disease, features of patients with reversed
CD4/CD8 ratio and patients with normal CD4/CD8 ratio were
compared. There were no difference respect to bleeding,
ecchymosis, mortality, platelet and leukocyte counts, aspartate
amino transferase (AST), creatine phosphokinase (CK), lactate
dehydrogenase (LDH) and partial thromboplastine time (PTT).
Mean hospitalization time of patients with reversed CD4/CD8
ratio were longer than others (12.2 vs. 7.1 days, P = 0.01).
Conclusion: CD4–CD8 values and CD4/CD8 ratios in CCHF
were usually normal. The data demonstrate that during the
acute phase of CCHF CD4/CD8 ratio may reverse. To deter-
mined role of CD4 and CD8 in CCHF further studied are need.
R2088
Changes in serum cytokines proﬁle and nitric
oxide levels in cystic echinococcosis patients at
preoperative and postoperative period
M.R. Bayraktar, N. Mehmet, R. Durmaz, Y. Ersoy (Malatya, TR)
Objectives: Cytokines and nitric oxide play an important role in
the human immunological response. The aim of study to
determine their role in immune response in patients infected
with Echinococcus granulosus.
Methods: Thirty-two patients with cystic echinocosis (CE) were
studied and all underwent surgery. Serum levels of tumor
necrosis factor-alpha (TNF-alpha), interleukin IL-1beta, receptor
of soluble IL-2 (sIL-2R), IL-6, IL-8, nitrate/nitrate, and C-reactive
protein (CRP) were evaluated before surgery, on ﬁrst day, and
three months post operation. Data were compared with those
obtained from 30 healthy volunteers.
Results: IL-6 was elevated in vast majority of CE patients
(96.9%). IL-8 was increased in 12/32 (37.5%). Slight increases
of sIL-2R, and TNF-alpha levels were found in limited
number of them particularly those showing cysts in the
central area of the liver (5/32, 6/32). IL-1 beta level was not
elevated in any patient. CRP and nitrate /nitrate levels were
also increased. A positive correlation between CRP and IL-6
(r = 0.78, p < 0.001) was found conﬁrming the link between
inﬂammation due to CE and activation of monocytes. All
patients were completely recovered and studied parameters
levels were declined to normal levels except one patient in
whom recurrent disease occurred at interval of 2 years from
the ﬁrst operation.
Conclusion: These results suggest that there are different
immunoregulatory events and cytokines response during CE
and may be in part related to slight monocytosis in CE patients.
IL-6, NO and CRP were involved in the host immune response
against E. granulosus and may be useful markers in diagnosis,
monitoring CE management and evaluation surgical stress.
R2089
Detection of Fc receptors released by
streptococcal isolates of anginosus group
G. Bancescu, R. Matre, N. Skaug, A. Bancescu (Bucharest, RO;
Bergen, N)
Objectives: Oral streptococci, especially those belonging to the
anginosus group, are the main facultatively anaerobic microor-
ganisms involved in oral infections. The aim of the study was to
detect soluble Fc receptors (FcR) secreted by some streptococcal
strains of anginosus group isolated (either as single bacteria or
in association with other microorganisms) in pus samples




Methods: The strains were identiﬁed at species level using the
Rapid ID 32 STREP system (Bio-Merieux, France). Cell-free
supernatant samples obtained from the culture of each isolate
were blotted onto nitrocellulose membrane (Bio-Rad Laborator-
ies) using a multiﬁltration apparatus. Horseradish peroxidase –
rabbit anti-peroxidase complexes (PAP) (DAKO-Immunoglobu-
lins a/s, Dakopatts, Denmark) were used to react with the
bound FcR and afterwards, with the second antibody (goat anti-
rabbit antibodies conjugated with horseradish peroxidase). In
addition, 4-chloro-1-naphthol (Sigma Immuno Chemicals) was
used to detect horseradish peroxidase in order to visualize the
immune complexes.
Results: Forty isolates were identiﬁed as S. anginosus, while
only one and three isolates were found to belong to S.
intermedius and S. constellatus species, respectively. Positive FcR
reactions (grey-blue dots) were obtained in all test samples.
Conclusion: Streptococci of anginosus group involved in pyo-
genic infections secrete small amounts of FcR which can be
detected by this sensitive dot-immunobinding assay.
Pathogenesis, animal models including experimental treatment
R2090
Role of innate immunity in the pathogenesis of
meningitis
S. Vassilopoulou, M. Kyriakopoulou, P. Koutoukas,
D. Plachouras, T. Poukoulidou, H. Giamarellou,
E.J. Giamarellos-Bourboulis (Athens, GR)
Objective: Microglial cells behave as cells of innate immunity
in the brain. In order to study the pathogenesis of meningitis
blood monocytes were triggered by cerebrospinal ﬂuid (CSF)
and by sera from patients with bacterial and abacterial
meningitis
Methods: Cerebrospinal ﬂuid and blood serum were collected
upon admission from nine patients with bacterial meningitis
and twenty-four patients with abacterial meningitis. Mononu-
clear cells were isolated from healthy individuals after density
gradient centrifugation of heparinized whole blood over
Ficoll-Hypaque. They were then washed three times with
Phospate-Buffered Saline (pH: 7.2) and suspended in ﬂasks.
After incubation for one hour at 37C under 5% CO2, non-
adherent cells were removed and monocytes were re-suspen-
ded in 12-well plates in RPMI with 10% FBS and 2 mM
glutamine at a density of 1 · 105 cells/well. After 30 minutes
of incubation at 37C in 5% CO2 100 ll of sampled CSF and
100 ll of sampled serum of each patient were added into
different wells of each of the volunteers. Cells were subse-
quently incubated for 18 hours at 37C in 5% CO2. TNF-a,
interleukin-1b (IL-1b), IL-10, IL-12, IL-6 and interferon-c
(IFN-c) were measured in culture supernatants with an
enzyme immunoassay; procalcitonin (PCT) by an assay based
on immunochemoluminescence.
Results: Mean values of TNF-a and IL1b (pg/10000 cells)
produced after triggering with CSF and serum from patients
with bacterial meningitis were 126.35 and 51.55 pg/10000 cells,
respectively and 82.86 and 66.54 pg/10000 cells from patients
with abacterial meningitis, respectively. Respective mean values
of IL-1b were 44.63 and 9.68 pg/10000 cells and 18.59 and
19.48 pg/10000 cells; of IL-6 119.92 and 65.53 pg/10000 cells and
66.49 and 37.83 pg/10000 cells; of IL-10 43.53 and 34.07 pg/
10000 cells and 20.04 and 6.13 pg/10000cells; of IL12 84.36 and
31.76 pg/10000 cells and 24.31 and 22.51 pg/10000 cells; of
IFN-b 65.08 and 17.04 pg/10000 cells and 75.03 and 18.17 pg/
10000 cells; and of PCT 1.49 and 0.73 ng/10000 cells and 0.64
and 0.39 ng/10000 cells.
Conclusion: Triggering of innate immunity elicits cytokine
responses that are higher in bacterial than abacterial meningitis;
IL-1b, IL-6, IL-10 and PCT are important mediators in bacterial
meningitis and IL-6 and IFN-c in abacterial meningitis. Further
research is mandatory to fully elucidate the clinical relevance of
these ﬁndings.
R2091
Clarithromycin as an effective immunomodulator
when administered late in experimental sepsis by
pan-resistant Klebsiella pneumoniae
P. Koutoukas, V. Tziortzioti, L. Sabracos, T. Tsaganos,
F. Baziaka, H. Giamarellou, E.J. Giamarellos-Bourboulis (Athens,
GR)
Objectives: There is literal evidence that clarithromycin pos-
sesses an immunomodulatory role in experimental sepsis
(Giamarellos-Bourboulis et al. AAC 2004). The present study
was designed to evaluate its activity when administered
24 hours after bacterial challenge in experimental sepsis by
pan-resistant K. pnumoniae.
Methods: Sepsis was induced in 40 New Zealand rabbits after
ligation of the right pelvo–ureteral junction and inoculation of
the test isolate in the renal pelvis. Animals were then divided
into four groups: A, controls; B, clarithromycin; C, amikacin; and
D, both agents. Therapy in groups B, C and D was administered
24 hours after bacterial challenge; two consecutive intravenous
of 80 mg/kg of clarithromycin and one dose of 10 mg/kg of
amikacin. Three days after bacterial challenge, animals were
sacriﬁced and tissue samples were cut for quantitative culture
and pathology. A semiquantitative histology climax was applied
based on the addition of ﬁndings of acute and chronic
inﬂammation, each scored from 0 to 3 depending on their
severity.
Results: (In parenthesis comparisons with group A).
Mean ± SD of pathology scores of liver of groups A, B, C and
D were 2.57 ± 1.13, 1.55 ± 0.53 (p: 0.009), 2.22 ± 0.44 and
1.67 ± 0.70 (p: 0.018), respectively. Respective values of spleen
were 3.43 ± 0.53, 3.44 ± 0.53, 3.22 ± 0.44 and 3.33 ± 0.71.
Respective values of the right kidney were 5.43 ± 0.97,
3.78 ± 1.48 (p: 0.032), 3.78 ± 1.64 (p: 0.032) and 3.11 ± 2.36 (p:
0.004). Respective values of the right lung were 1.42 ± 0.53,
1.89 ± 0.33, 2.00 ± 0.50 and 1.55 ± 0.53. No differences were
recorded in tissue bacterial counts between groups of treatment.
Conclusions: Administration of clarithromycin attenuated
organ inﬂammation in experimental sepsis by pan-resistant
K. pneumoniae without affecting tissue bacterial load. Results are
favorable for a considerable immunomodulatory effect of
clarithromycin.
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R2092
Is there any association between fungal
colonisation of gastric mucosa and gastric ulcer
healing? A model of fungal colonisation in
healthy adult rats
M. Zwolinska-Wcislo, D. Trojanowska, A. Budak,
T. Brzozowski (Cracow, PL)
Objectives: The aim of the study was: 1/to evaluate the
inﬂuence of isolated from patients with gastric ulcers/GU/and
chronic gastropathy/CG/Candida strains, on gastric secretion
and gastric ulcer healing in rats in conditions of Aspirin/ASA/
oral administration. 2/to evaluate the inﬂuence of probiotics on
GU healing.
Methods: We investigated 60 Wistar rats equipped with gastric
ﬁstula, with GU induced by acetic acid/ulcer area 28 mm2/.
Animals were divided into 3 groups. I: rats inoculation for
25 days with C. albicans: 105 CFU/ml/i.g. was preceded by
5 days supply of proteinase 0.2 U/kg i.g., promoting fungal
colonization and aspirin/ASA/: 40 mg/kg/i.g. II: Rats received
Candida ASA and proteinase as group I, besides Lactobacillus
acidophilus 106 CFU/ml i.g. III: rats with GU-induced, given
vehicle/saline/and proteinase. Animals were sacriﬁced after 4,
15, 25 days upon induction. The ulcer area was measured with
planimetry, the gastric blood ﬂow/GBF/was determined H2 gas
clearance. Gastric biopsy was taken for quantitative and qual-
itative mycological investigation and for the histopathology.
Plasma levels of IL-1b, TNF-a, gastrin were measured. RT-PCR
expression of IL-b, TNF-a was evaluated in gastric tissue.
Results: In rats inoculated with fungi, given ASA, gastric
output was reduced in over 40% and GBF was decreased ,in
comparison with rats given vehicle/group III/. The rats from
group III showed progressive decrease in the area of GU by 13%,
45% and 95% at 4, 15 and 25 day, respectively. In contrast , the
ulcers were present till 25 day in all rats inoculated with Candida
. In rats given probiotic, decrease of GU area was observed more
rapidly, in comparison with group I. In Candida colonized rats,
upregulation of TNF-a, IL-b mRNA and the rise of plasmagas-
trin, TNF-a, IL-b, IF-c levels was recorded.
Conclusions: 1. Fungal colonization could be achieved in rats
by antisecretory or ASA treatment. 2. Fungal infection markedly
reduces gastric secretion, delays gastric ulcer healing, probably
due to fail of GBF at ulcer area and maintaining the mucosal
inﬂammation, involving expression and release of IL-b, TNF-a.
3. Administration of probiotic reduces the delay of GU healing
caused by Candida inoculation.
R2093
Serum antibody proﬁle against Helicobacter
pylori VACa and CAGa genes in Turkish patients
with duodenal ulcer
B. Kocazeybek, Y. Erzin, S. Altun, A. Dobrucali, M. Aslan,
S. Erdamar, A. Dirican (Istanbul, TR)
Objective: To evaluate the impact of major virulance factors of
Helicobacter pylori (Hp) on the development of duodenal ulcer
(DU) in Turkish, dyspeptic patients.
Methods: Prospective study from a tertiary referral hospital.
Patients who were referred to our endoscopy unit due to
dyspepsia between June 2003 and March 2004 and diagnosed to
have DU or normal endoscopic ﬁndings [non-ulcer dyspeptic
(NUD) control group] were included. Exclusion criteria were as
follows: previous eradication treatment for Hp, the use of non-
steroidal antiinﬂammatory drugs, the use of antisecretory drugs
and antibiotics in the previous two weeks and of bismuth
compounds in the previous one month. Four biopsies from the
antrum and three from the body were taken in order to assess
the current Hp status by histology, rapid urease test and culture.
Blood samples were taken and patients who were seropositive
for anti Hp IgG were further analysed by westernblotting
against cagA and vacA. Age and sex adjusted multiple logistic
regression analysis was used to determine the impact of cagA
and vacA genes.
Results: 62 seropositive patients with NUD (36.9 ± 12.3) (93%
Hp-positive) and 63 seropositive patients with DU (43.14 ±
16.27) (97% Hp-positive) were eligible for the ﬁnal analysis. All
patients sera were tested for antibodies of class G and A against
cagA and vacA genes. 9 of 62 (15%) NUD and 30 of 63 (48%) DU
patients were positive for anti-cagA IgA. Age and sex adjusted
multiple logistic regression analysis only disclosed the presence
of anti-cagA Ig A as a risk factor for the development of DU
pointing out to a recent infection with a highly virulant strain of
Hp.
Conclusion: Recent infection with HP strains having cagA
gene, seems to be a promoting factor for Hp development of DU
in Turkish population.
R2094
The anti-candidal activity of Pseudomonas
aeruginosa strains isolated from clinical
specimens
I. Kaleli, N. Cevahir, M. Demir, U. Yidirim, R. Sahin (Denizli,
TR)
Objective: To investigate in vivo and in vitro the anti-candidal
activity of Pseudomonas aeruginosa strains against Candida spe-
cies.
Methods: Forty-four P. aeruginosa strains isolated from various
specimens of intensive care patients in the study. Candida
albicans ATCC 10231, C. parapsilosis ATCC 22019, C krusei ATCC
6258 and a clinical isolate of C. tropicalis were used as Candida
strains and anti-candidal activity of the strains were examined
by using Kerr’s method.
Results: The total inhibition rates obtained by using blood
agar for C. albicans, C. parapsilosis, C. krusei and C. tropicalis
were 41%, 34%, 34% and 25%, respectively. These rates were
45%, 39%, 48% and 25%, respectively when Sabouroud
dextrose agar used. In mice model of concomitant subcuta-
neous infection with Candida species and P. aeruginosa, no
yeast was recovered from skin cultures despite 100% detection
of P. aeruginosa.
Conclusion: P. aeruginosa strains isolated from intensive care
patients showed anti-candidal activity against these Candida




Molecular bacteriology (incl. diagnostics)
R2095
Real-time PCR identiﬁcation of Bacillus anthracis
strains containing PAG and CAPR genes using
Real-time
L. Lukhnova, S. Zakaryan, M. Dempsey, L. Cooper, M. Dobson,
T. Hadﬁeld (Almaty, KAZ; Washington, USA)
Objectives: The M. Aikimbayev Kazakh Scientiﬁc Center for
Quarantine and Zoonotic Diseases monitors anthrax throughout
Kazakhstan. Recent opportunities allowed the initiation of
molecular biology testing for bacterial agents. Through spon-
sored collaboration between the Kazakhstan Institute and the
Armed Forces Institute of Pathology real time PCR assays were
developed and optimized. This collaborative effort introduced
Real-Time PCR as a new technology to the Kazakhstan Public
Health System for their potential implementation.
Methods: Primers sets selected and designed using Integrated
Diagnostics Inc. Web–based Primers Selection Program for protect-
ive antigen and capsule genes. These primer sets were optimized on
an Idaho Technologies Inc. Ruggedized Advanced Pathogen Iden-
tiﬁication Device (RAPID) using Syber Green as the reporter dye.
Results: Limit of Detection (LOD) studies showed a sensitivity to
the 1 fg level (approximately 2 copies of genomic DNA). Testing
multiple replicates of DNApreparation at the 10 fg concentration
conﬁrmed the reliability of the assay to consistently detectDNAat
this concentration. Speciﬁcity testing was done using a panel of
B. anthracis isolates and other Bacillus species including multiple
isolates of B. cereus and B. thruingiensis. Both the PAG and CAPR
primer sets were detected at the 10 fg concentration and melting
curves conﬁrmed their presence. Agarose gels also conﬁrmed the
presence of an amplicon of the correct size in reaction containing
B. anthracis DNA but not are near neighbor PCR reactions.
Speciﬁcity panel testing showed no cross-ampliﬁcation with non-
B. anthracisDNA; all wild type B. anthracisDNAwere positive for
pag and cap and expected results were observed from lab-
modiﬁed B. anthracis strains (pX01-) or (pX02-) DNA.
Conclusion: These results coupled with the high speed run-
time (<1 hour) and small foot-print of the RAPID thermal cycler
show strong potential for adaptation of this technology by the
Kazakhstan Public Health System. The research described in this
publication was made possible in part by support provided by
the U.S. Defense Threat Reduction Agency (DTRA) under the
project «KB0-1950-AL-03» and administered by U.S. Civilian
Research and Development Foundation for the Independent
States of the Former Soviet Union (CRDF).
R2096
Determination of Helicobacter pylori cagA gene
prevalence in Iranian GUD and PUD patients
M. Bojary Nasrabadi, A.H. Alvandi, M. Frouzandeh,
M. Hashemi, F. Masjedian, A. Nazify (Tehran, IR)
Introduction: Helicobacter pylori are commonly associated with
gastritis but only sometimes it causes clinically signiﬁcant
infectious diseases such as gastric and peptic ulcer diseases.
The development of disease depends on the virulence of the
infecting H. pylori strain, the susceptibility of the host, and
environmental co-factor. The cytotoxin associated protein enco-
ded by cagA gene is an important virulence factor that is
produced by some H. pylori strains, and has been used as
virulence marker in some populations. The aim of study was to
determine the prevalence of cagA gene as a virulence factor on
H. pylori strain types in Iranian GUD and PUD patients.
Material and Methods: In this study, biopsy specimens were
obtained from antrum of 180 patients, who were admitted to the
ward of internal medicine, Hazrat Rasoul Akram Hospital, Iran
University of Medical Sciences, Tehran, Iran. A positive H. pylori
strain was identiﬁed by cultured isolates, biochemical tests
standard methods, and the molecular typing was used by PCR
technique to detect cagA gene.
Result: Among 129 biopsy specimens who were taken during
the study period, 105 (81.33%) patients had GUD and 24 (18.6%)
patients had PUD, in which 63 (59%) and 19 (80%) patients were
infected by H. pylori infection, respectively. The cagA gene was
detected in 37 (59%) of GUD and 19 (100%) of PUD patients
whom were positive for H. pylori.
Conclusion: There was signiﬁcant difference in the prevalence
of the cagA gene between GUD and PUD patients (p < 0.001).
Moreover, the presence of the cagA gene in H. pylori may be
used as an indicator marker for increased risk of PUD.
R2097
Epidemiologic analysis and antibiotic resistance
of Shigella sonnei isolated from patients in Seoul
J.H. Lee, M.-S. Kim, S.-K. Park, Y.-A. Yu, M.-O. Song, S.-G. Park,
B.-H. Choi (Seoul, KOR)
Shigella sonnei is a major cause for diarrheal disease in developed
as well as in developing countries. Epidemiologic studies of this
organism have been limited by the lack of a simple and effective
method for comparing strains. The study of epidemiologic
markers is important in an attempt to trace the sources of
infection. We used PFGE, ERIC-PCR to study the genetic
relatedness of 78 isolates of S. sonnei collected in Seoul. For
quantitative illustration of the relationships within a large body
of isolates, computer generated dendrogram were used to
determine the number of isolates in pulsotypes at Dice coefﬁ-
cients of similarity of 80%. From 2000 to 2003, 78 isolates of
Shigella sonnei were isolated from patients in Seoul. By the PFGE
experiment, Over 80% band similarity has divided 6
Group(A ~ F) band patterns. XbaI digestion produced about
40 fragments and their sizes ranged from 32.4 to 582 kb. Isolated
from the same outbreak showed identical PFGE patterns, Most
of the different outbreak strains and sporadic strains showed
identical or different PFGE patterns. The ERIC-PCR technique
successfully typed all isolates examined and produced bands in
the 300 to 2,000 bp size range. The susceptible strains to
Chloramphenicol, Amikacin and Cefoxitin was the most pre-
valent 100%, respectively. In case of the multiple antibiotic
resistant pattern, the most prevalent pattern was NA-SM-SXT-
TE, followed by AM-NA-SM-SXT-TIC-TE. During an outbreak
of infection, the aim of bacterial typing is to provide laboratory
evidence that epidemiologically related isolates are also gen-
etically related. Isolated from the same outbreak showed
identical PFGE patterns, Most of the different outbreak strains
and sporadic strains showed identical or different PFGE
patterns. We found that PFGE and ERIC-PCR have the highest
discriminatory power for differentiation of strains of S. sonnei.
ERIC-PCR ﬁngerprinting is particularly useful because of its
simplicity and represents a less time consuming procedure. We
conclude that it is possible for a typical clinical laboratory to
analyze a large amount of PFGE information on Shigella isolates
obtained under controlled conditions. Such data analysis should
enhance surveillance capabilities and give indications of further
work to various aspects of bacterial pathogenicity of the species.
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R2098
Inactivation of mraZ and mraW genes of dcw
cluster in Salmonella enterica serovar
Typhimurium SL1344
J. Ayala Serrano, D. Vega Mendoza (Madrid, E)
The versatility and adaptability of bacterial pathogens as well as
complexity and variety of antimicrobial resistance mechanisms
even against last generation antibiotics actually in use, are
causing a serious health problem in developing countries with
re-emerging of infectious diseases considered totally eradicated.
Our working group is trying to discover a new antibacterial
target highly speciﬁcic, selective and essential for survival of our
pathogenic bacterial study model: Salmonella enterica serovar
Typhimuruium SL1344 (STM). It presents as an important
virulence factor its capacity to replicate intracellularly in
epithelial cells, been necessary to develop a very complex
molecular mechanism to improve penetration, intracellular
survival and replication in the host cell. Focusing bacterial
division process and speciﬁcally the mraZ and mraW genes,
located at the beginning of the division cell wall cluster, we are
trying to determine the potential character of this genes like a
useful target in design of therapeutic strategies that will allow to
limit infection and avoid the acquisition of antimicrobial
resistance mechanisms. Since the pathogenicity of STM is given
by its capacity to penetrate to non-phagocitic host cells, we have
designed a deletion mutant of STM for the mraZ and mraW
genes implied in the process of cellular division. This mraZW –
mutant was obtained by using a very simple PCR and homol-
ogous recombination technique. We ﬁrst used a set of 60
nt-primers to amplify the chloramphenicol resistant gene
ﬂanked by FRT regions (FLP Recognition Target) followed by
homologous regions of genes adjacent to mraZ and mraW genes.
We then used the PCR product to transform competent STM
cells containing the low number copies and temperature
sensitive pKD46 vector, which express the red recombinase of
phage lambda under the control of arabinose inducible promo-
ter. Afterwards, we selected the chloramphenicol resistant
mutant. Finally, this antibiotic resistance gene was eliminated
using the pCP20 plasmid that shows ampicillin and chloram-
phenicol resistance, temperature-sensitive replication and ther-
mal induction of a recombinase FLP synthesis. We have
subjected this mutant to several tests like the in vitro intracel-
lular infection test using non-phagocitics cell-lines: HeLa, NIH/
3T3 and NRK. In parallel, an in vivo test using a mouse model
in order to determine the kinetic value of intracellular prolifer-
ation has been carried out.
R2099
Identiﬁcation of the pathogens caused the
outbreak of Streptococcus suis toxic shock
syndrome and meningocephalitis of swine and
human
J.Q. Tang, C.J. Wang, H.B. Guo, X.Z. Pan (Nanjing, RC)
Objectives: To reveal the relationship between the pathogens of
toxic shock syndrome and meningocephalitis outbreak of pigs
and human in 1998 in East China.
Methods: Epidemiological survey, isolation and identiﬁcation
of pathogenic bacteria were performed.
Results: Characters of the disease were quick onset, serious
symptoms, short course and high mortality. The main clinical
manifestations of the disease were high fever, sometimes with
nausea, vomiting and diarrhoea, then might developed to
myositis, fascitis, DIC, multiple organ failure, shock, and usually
died in 2–3 days. Among 25 patients, 16 manifested clinically as
streptococcal toxic shock syndromes (STSS) and 9 streptococcal
meningocephalitis syndrome, with mortality 81.25% and
11.11%, respectively. 16 bacterium strains isolated from blood
and cerebrospinal ﬂuid specimens from the diseased pigs and
patients were identiﬁed as Streptococcus suis based on biochemi-
cal reactions and 16S rRNA gene sequence analysis. The isolates
from both pig and human also showed indistinguishable
antibiotic and pulse-ﬁeld gel electrophoresis patterns.
Conclusion: The pathogen isolated from the blood of patients
and pigs were identiﬁed as the swine streptococci. It suggests that
the outbreak of Streptococcus suis sepsis spreads from pigs to
humans.
R2100
Real-time PCR screening of women with term-
ruptured membranes for carriage of group
B streptococcus
K. Levi, K. Chan, L.H. Kean, M.M. Ramsay, V. Weston,
K.J. Towner (Nottingham, UK)
Objectives: To evaluate a Light Cycler PCR assay for the
detection of group B streptococcus (GBS) carriage in women with
term-ruptured membranes in comparison with conventional
culture.
Methods: Low vaginal swabs were obtained from 143 pregnant
women who presented with term rupture of membranes. After
incubation for 1 h in brain–heart infusion broth, DNA was
extracted with the InstaGene matrix (BioRad), and real-time
PCR for ampliﬁcation and detection of the cfb target was
performed with the LightCycler (Roche). Samples were proc-
essed in parallel by conventional culture on HSA and ISLAM
plates, with conﬁrmation of GBS isolates by latex agglutination.
Results: Twenty (14.0%) samples were positive for GBS by
conventional culture, whereas the PCR assay detected GBS
carriage in only 10(7.0%) cases, although two PCR-negative
samples were positive on repeat testing. The PCR false-negative
results did not always correlate with low numbers of target cells,
thereby indicating a problem with extraction and/or inhibition
rather than sensitivity per se. The negative and positive
predictive values of the PCR assay were 92.5% and 100%,
respectively, but the overall sensitivity of the assay was only
50%.
Conclusions: Although the real-time PCR assay generated a
result within 3 h of receipt of a sample, the current method
highlighted the need to further optimise DNA extraction and
puriﬁcation protocols for use in the clinical setting. Further
studies will continue to address the optimisation of the sample
processing and DNA extraction steps.
R2101
Use of PCR in the diagnosis of sexually
transmitted infections in Lithuania
R. Mikalauskas, D. Ambrasiene (Vilnius, Kaunas, LT)
Today’s medicine takes advantage of the latest achievements in
natural sciences and successfully employs new techniques to the
diagnostics and treatment of diseases. Recently molecular-
genetic science has been applied in the ﬁeld of diagnostics of
sexually transmitted diseases (STD) in addition to the conven-
tional culture-based and serological methods: the technology of
in vitro speciﬁc DNA-ampliﬁcation or Polymerase Chain Reac-
tion (PCR). The molecular methods have many advantages: high
sensitivity, high speciﬁcity, option for standardization and
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genotyping. The samples collected for molecular diagnostics
tolerate transportation, testing procedures are rapid and these
techniques can be performed in less than 24 hours. It is very
important for patient and physician. In the molecular diagnostic
laboratory Biomedical research centre (Lithuania) PCR tech-
nique has been applied for the direct detection and identiﬁcation
of sexually transmitted pathogens (C. trachomatis, U. urealiticum,
M. hominis, M. genitalium, N. gonorrhoea, HPV and 16/18
genotype, HSV-I/II, T. vaginalis, G. vaginalis, etc.) in different
clinical samples (cervical, urethral and vaginal swabs).
Objectives: To describe the epidemiology of prevalent sexually
transmitted pathogens in different clinical samples using
molecular genetic methods.
Materials and methods: In this analysis were included data
collected from 1 January 2003 to 1 January 2004. During this time
men and women with ailments or prophylactic referred to
Biomedical research centre and 11713 PCR tests for genital
pathogens were done in laboratory. Our PCR tests for detection
microbial pathogens consisted of the following stages: DNA
puriﬁcation from different clinical samples; DNA ampliﬁcation
with speciﬁc primers and PCR product visualisation by agarose
gel electrophoresis.
Results: We detected 15.3%(1797/11713) tests positive for sex-
ually transmitted pathogens. The prevalence of C. trachomatis
was 15.9%(416/2616), U. urealiticum – 29%(509/1758),
M. hominis – 9.8%(132/1349), M. genitalium – 6.5% (72/1117),
N. gonorrhoea – 2.4%(21/879), G. vaginalis – 27%(314/1164),
T. vaginalis – 5.3%(57/1075), HPV – 25.6%(228/892), HPV – 16/
18 – 33.8%(22/65), HSV – 3.3%(26/798).
Conclusions: It was detected that U. urealiticumi was the most
common pathogen in the country population (29%), while C.
trachomatis only 15.9%. The identiﬁcation of genital infections by
PCR is speciﬁc and rapid test in laboratory diagnostic.
Diagnostic methods (other than molecular)
R2102
Development of a new p24 antigenaemia enzyme
linked immunosorbent assay (ELISA) for
detection of human immunodeﬁciency virus
R. Mohebi, M. Ravanshad, F. Sabahi, F. Mahboudi (Tehran, IR)
Human immunodeﬁciency virus (HIV) is a member of the
Retroviridae family. The HIV genome resembles that of other
retroviruses with the typical gag, pol, and env gene organ-
ization. HIV establishes a permanent infection once the
proviral DNA integrates into the host cell genome. HIV has
been shown to infect a variety of cells, including peripheral
lymphocytes, macrophages and other CD4+ cells. HIV is
associated with immune system dysfunctions and, is respon-
sible for opportunistic infections involved in AIDS. Trans-
mission of HIV through blood transfusion and diagnosis of
infection in hospitals and public health settings continues to
be a worldwide concern. Polyclonal, mono-speciﬁc antibody
against HIV recombinant p24 antigen, the capsid protein
region, has been developed in rabbit and puriﬁed with gel
ﬁlteration and afﬁnity chromatography techniques. The puri-
ﬁed antibody has been conjugated with the horseradish
peroxidase enzyme and a capture enzyme linked immuno-
sorbent assay (ELISA) has been developed for detection of
p24 Antigenemia. HIV-negative human sera failed to react
with the developed assay, thereby showing the speciﬁcity of
the HIV antigenaemia assay. Seventy-ﬁve human positive
serum samples as well as human negative serum samples
were tested for the presence of p24 antigen by the developed
and a reference assay (Abbot Lab., USA). There was a 100%
concordance when the samples tested with both assays. The
results of this study showed that the developed p24
antigenaemia assay could be used for detection of HIV
infection in human early before appearance of any detectable
antibodies against the virus. This assay appears to be highly
sensitive and speciﬁc to HIV. The test also has several
advantages, including a relatively short test time and, most
importantly, an adequate and reproducible supply of anti-
body to be used. Further research is needed to better
evaluate the developed assay reactivity in a larger number
of HIV positive sera.
R2103
The comparison of Western blot test with FTA-
ABS test as conﬁrmatory tests in syphilis cases: a
cross-sectional study in Turkish population
S. Saribas, S. Temurhan, V. Oz, M. Aslan, R. Caliskan, H. Cakan,
B. Karatoka, H. Bahar, B. Kocazeybek (Istanbul, TR)
Objectives: We aimed to compare and detect the serological
conﬁrmatory performances of Western blot (WB) and FTA-ABS
tests as conﬁrmatory tests in early (ES) and latent syphilis (LS)
cases from different medical clinics of Istanbul with cases that
showing biological false positiveness and cases with infected
with other spirochetes (leptospirosis, borreliyosis) and healthy
blood donors (HBD).
Methods: Forty-nine cases with syphilis (29 ES, 20 LS), 60
control individuals (20 cases with biological false positiveness,
20 cases infected with spirochetes and 20 HBD) were included
cross-sectionally, in this study. The presence of reactive anti-
bodies against to the speciﬁc and natural antigens of T. pallidum
were detected with commercial Euroimmun Anti-treponema
pallidum Western blot (WB) and FTA-ABS test kits.
Results: 29 cases with ES and 20 cases with LS were found
positive in WB/IgM andWB/IgG tests, respectively but 26 cases
with ES and 19 cases with LS were found positive in FTA-ABS/
IgM and FTA-ABS/IgG tests, respectively. No WB positivity
was found in any of control cases. While the per cent agreement
of WB/IgM and FTA-ABS IgM tests in the diagnosis of ES cases
was 90%, the per cent agreement of WB/IgG and FTA-ABS/IgG
in the diagnosis of LS cases was 95%. The conﬁrmatory
performances (sensitivity, speciﬁcity, positive predictive value,
negative predictive value and accuracy value) for WB/IgM test
in the diagnosis of ES cases were detected 100% for all of them
and the same parameters for FTA-ABS/IgMnin were detected
90%, 100%, 100%, 90% and 94%, respectively. The same
parameters for WB/IgG test in the diagnosis of LS cases were
detected 100% for all of them and the same parameters for FTA-
ABS IgG were detected 95%, 100%, 100%, 95% and 97.5%,
respectively.
Conclusions: As conclusion, an ideal conﬁrmation test for every
periods of syphilis must be optimal, objective, fast, speciﬁc and
away from subjective results which show variation depending
Clinical Microbiology and Infection, Volume 11, Supplement 2, 2005
699
on the experience of microbiologist who check the samples on
ﬂorescence microscope like FTA-ABS test. Routinely used
treponemal and non-treponemal screening and diagnostic tests
can show diagnostic efﬁcacy insufﬁciency in different periods of
syphilis depending on the different reasons. We suggest that WB
test is useful than FTA-ABS test which is already and commonly
used as a conﬁrmatory test in the serological diagnosis of both
ES and LS.
R2104
Procalcitonin and the diagnosis of early syphilis
S. Saribas, V. Oz, S. Temurhan, G. Karhan, Y. Seyhun, S. Altun,
M. Aslan, B. Kocazeybek (Istanbul, TR)
Objectives: The aim of this study was to determine procalcito-
nin (PCT) and C-reactive protein (CRP) levels in early syphilis
(ES) cases and evaluate these indicators in diagnosis of syphilis.
Methods: Twenty-nine patients with ES, 30 patients with
bacteraemia and 30 healthy blood donors (control group) were
included in this study. PCT levels in blood samples were
measured by monoclonal immunoluminometric method.
Results: The mean PCT levels (minimum–maximum) were
found 0.80 (0.55–1.680) ng/ml in ES group, 7.5 (0.68–35.4)
ng/ml in bacteraemia group, and 39 (0.15–1.25) ng/ml in
control group, The PCT levels in the ES cases were statistically
higher than those observed in healthy blood donors (p < 0.01).
The area under the ROC (receiver operating characteristic) curve
using PCT to predict early syphilis was 0.920 (95% CI: 0.831–
1.008). The sensitivity, speciﬁcity, positive predictive value and
negative predictive value for PCT were 100%, 90%, 90%, and
100%, respectively at 0.5 ng/ml, which was an optimal concen-
tration. Consequently, PCT levels were found slightly higher
than the cut-off value (mean: 0.80 ng/ml) in ES.
Conclusions: In conclusion, this research is the ﬁrst preliminary
study for determination of PCT levels in ES cases in spite of few
number of case-control cases. Our results suggested that PCT is
a useful and additional marker at 0.5 ng/ml optimal serum
concentration according to the ROC curve when conventional
laboratory test results were false positive and false negative,
Nevertheless, we believe that new, extended serial case-control
studies are needed to further support our results.
R2105
The microagglutination test as a complement to
ELISA examination in serological diagnosis of
Legionella infections
K.W. Pancer, W. Gut, H. Stypulkowska-Misiurewicz (Warsaw,
PL)
In Poland, laboratory diagnosis of Legionella infections gener-
ally is based on serological investigation. Bacteria L. pneumophila
sg 1 are more frequent cause of severe pneumonia, less frequent
are L. pneumophila other serogroups or other Legionella species.
Examination of serum sample using ELISA IgA, IgM and IgG
assays is the method of choice in our laboratory for detection
L. pneumophila sg 1. For L. pneumophila non-1 or other Legionella
species infection the microagglutination test has been used.In
our study we determined the signiﬁcant titre of serum antibody
to some L. pneumophila non-1 serogroups and other Legionella
species on the base of results of examinations of serum samples
collected from blood donors. The titre of antibody was deter-
mined using 14 antigens prepared in-house from the reference
strains L. pneumophila and others Legionella. Statistical analysis
of obtained results allowed to determine cut-off titre for all used
antigens. The value of cut-off was 64 for L. pneumophila sg 1, 2, 4,
5, L. longbachae, cut-off = 128 for L. pneumophila sg 3, 7, 8,
L. micdadei, L. jordanis, and cut-off = 256 for L. pneumophila sg 6,
12, L. bozemanii, L. anisa. Using those cut-off points we are able to
eliminate not signiﬁcant titre due to some cross-reactivity of
L. pneumophila serogroups.Determination of speciﬁc serum IgA,
IgM and IgG antibody levels to L. pneumophila sg 1 by
commercial ELISA is more sensitive, standarised, informative
and faster than microagglutination test. However, from our
point of view the microagglutination test should be used as
complement test to ELISA, especially for diagnosis of infection
due to L. pneumophila non-1 serogroups or other Legionella
species. In 16% of all serum samples tested this year the
signiﬁcant titre of antibody speciﬁc to one of serogroup of
L. pneumophila non-1 was found using MAT. In those sera
increased but not signiﬁcant level of IgM antibodies to L. pneu-
mophila sg 1 (in range 0.32–0.75) or IgA antibodies (0.38–0.53)
was determined by ELISA. It is probably connected with cross-
reactivity of some antigenic structures of L. pneumophila strains.
Moreover, two cases of legionellosis due to L. micdadei were
diagnosed. In those cases the antibiotic had been changed and
the patients recovered. Because of unspeciﬁc symptoms and
rather high mortality rate in legionnaires disease the microbio-
logical diagnosis of Legionella infection should be done using as
many supplementary techniques as possible.
R2106
Comparison of different laboratory methods for
detection of methicillin-resistant Staphylococcus
aureus
M. Rahbar, M. Yaghoobi, A. Fatahi (Tehran, IR)
Objective: The aim of this study was to compare conventional
phenotypic methods for detection of methicillin resistant Sta-
phylococcus aureus in laboratory practice.
Methods: This study was conducted on a selection of 96 clinical
isolates of Staphylococcus aureus in Milad hospital of Tehran. In
our study four different laboratory methods including disk
diffusion, oxacillin screen agar, E-test and latex agglutination
compared for detection of MRSA. The disk diffusion method
performed with oxacillin disks (1 lg) and interpreted according
to National Committee for Clinical Standards (NCCLS) guide-
lines. Screening for MRSA also performed by using Muller–
Hinton agar plate containing 6 lg/ml oxacillin and supplemen-
ted with 4% NaCl as recommended by NCCLS.A commercial
latex agglutination test, the MaslatexTM, was assessed for the
detection of penicillin binding protein 2a (PBP2a), the mecA
gene product. Minimum inhibitory concentration (MIC) were
measured for all isolates by E-test (AB Biodisk, Solna, Sweden)
were according to the manufacture’s guidelines.
Results: Of 96 isolates of S. sureus by disk diffusion method 52
had inhibitory zone in the resistance range (10 mm), 9 in the
intermediate range (11–12 mm) and 36 in susceptible range
(13 mm). By E-test method of 96 isolates 51 isolates were MRSA
and 45 isolates susceptible to methicillin. Oxacillin screen agar
showed only two false positive MRSA. The sensitivity and
speciﬁcity oxacillin screen agar methods was 96% and 95%
respectively. The MRSA-screen latex agglutination showed 54
(three false positive) MRSA isolates and 42 isolate were
susceptible to methicillin. The sensitivity and speciﬁcity for this
method were 94% and 93% respectively.
Conclusion: The oxacillin screen agar test is reliable alternative
for detection of MRSA in clinical laboratory where molecular
method are not available and ﬁnally MRSA latex agglutination





Evaluation of external proﬁciency testing results
among 532 microbiology laboratories of Tehran
2004
M. Rahbar, S.H. Yazdi, R. Sabourian, M. Saremi (Tehran, IR)
Objective: The aim of this study was to evaluate external
proﬁciency testing in microbiology laboratories located in
Tehran and suburbs for identiﬁcation of three unknown bac-
teria.
Methods: The 14th survey of external programme for 2004
distributed to 532 laboratories in Tehran. The selected microor-
ganisms were: Shigella ﬂexneri, Sreptococcus agalactiae and Stenot-
rophomonas maltophilia. S. ﬂexneri were sent to all 532, S. agalactia
to 395, and S. maltophilia to 137 microbiology laboratories. We
asked all laboratories for identiﬁcation each unknown organism,
performance of susceptibility testing for S. ﬂexneri and return
their answer to reference laboratory within 2 weeks receipt of
samples. Scoring of results determined according to WHO
external surveys criteria.
Results: Of 532 laboratories we received answer from 428
(80.5%) laboratories. Of 428 laboratories 205 (38.5%) produced
correct answer for identiﬁcation of S. ﬂexneri and received 3
score of points. and 31(5.8%) laboratories produced incorrect
answer for identiﬁcation of this organism. The remaining 192
(36.1%) laboratories received 1–2 score of points (mean score 2.2,
SD ± 0.91). Of 137 labs only 11(8%) labs produced correct
answer for identiﬁcation of S. maltophilia and 66 (48.2%) labs
received zero score of points. The remaining labs 23 (16.8%)
received 1–2.5 score of points (mean score 81, SD ± 1.13). Of 395
labs 146 (37%) identiﬁed S. agalactiae correctly and obtained 3
score of points and 32 (8.15) were not able to identify this
organism and therefore received 0 score of points The reaming
laboratories 137( 36%) obtained 1–2.5 score of points (mean sore
2, SD ± 1.1). The results of susceptibility testing were satisﬁed
and the majority of laboratories produced correct answer for
susceptibility testing of S. ﬂexneri (mean score 4.52). It is
assumed that the result of external quality control in Tehran
microbiology laboratories was not acceptable.
Conclusion: Our study reveals that unfortunately proﬁciency
testing in microbiology laboratories of Tehran is poor .The poor
results were due to: defective reagents, l culture media inap-
propriate settlement of internal quality control programme and
of unqualiﬁed technologists.
R2108
Sensitivity and speciﬁcity of laboratory based
serological tests for detection of Helicobacter
pylori infection compared to histopathological
test
H. Shariﬁ, R. Moniri, V. Mehrzad, H. Ehteram, G.A. Mousavi,
H. Ahmadi (Kashan, IR)
Objectives: Helicobacter pylori (HP) role in duodenal ulcer,
gastric ulcer, gastritis, intestinal metaplasia, maltoma and
adenocarcinoma of stomach is established. Then detection of
HP by non-invasive methods such as serological test (ELISA) is
important. In order to determine of sensitivity and speciﬁcity of
ELISA in detection of HP infection comparing to histopathology
(Gold standard) this study was done.
Methods: In an analytic study 232 patients with gastrointestinal
signs were studied. Endocopy was done and 2–3 biopsies were
taken from antrum. Specimens were processed by shandon
tissue processor (citadel) and prepared sections were stained by
Hematoxylin–Eosin and Giemsa. Slides were studied by two
pathologist and one microbiologist. Also 5 cc blood was taken to
determine anti HP (IgG) by ELISA method. Patients data
including age, sex, clinical signs, histological diagnosis, exist-
ence of HP in biopsies and results of ELISA tests were recorded
and analysed by statistical tests.
Results: Of 232 patients 130 (56.1%) were females and 102
(43.9%) males. They were in age group 10–80 years. The most
common clinical sign of infected patients was epigastric pain
and the least were hiccup and vomiting. The most common
pathologic ﬁndings were chronic active gastritis with ulcer or
intestinal metaplasia and then chronic active gastritis alone. In
the base of histopathology 222 (95.7%) patients had HP infection,
by ELISA method 197 patients were IgG positive. ELISA
sensitivity was 85%. Of 10 patients who were negative in
histology in 2 patients IgG was negative. Speciﬁcity of ELISA
was 20%. ELISA method showed positive predictive value
95.9% and negative predictive value 5.7%.
Conclusions: This study showed that serologic test (ELISA
method) IgG is a good test for screening but no for diagnosis.
We recommend ELISA method be used for screening and then
diagnostic tests such as histology or microbiology be used for
deﬁnite diagnosis. There is no relation between H.P infection
age, sex and clinical signs.
R2109
Toxin A negative/toxin B positive Clostridium
difﬁcile strains isolated from patients with
diarrhoea in a tertiary hospital in Athens
H. Malamou-Lada, H. Kafkoula-Alevizou, P. Karampoyia-
Karaﬁllidis, A. Strouza (Athens, GR)
Objectives: During the last ﬁve years, toxin A negative/toxin B
positive (A–B+) Clostridium difﬁcile (Cd) strains were isolated in
Asia, Canada and Europe. No A–B+ Cd strains have been
isolated from patients in Greece so far. The aim of this study is to
present ﬁve cases of diarrhoea caused by A–B+ strains in our
hospital, over a two year period.
Methods: Over the last two years, we prospectively examined
913 stool samples obtained from patients with diarrhoea for the
presence of Cd and its toxins A&B. Culture for Cd was
performed on cycloserine–cefoxin blood agar and the strains
were identiﬁed by conventional methods. Toxin A was detected
from stools by an ELISA assay (Vidas, bioMe´rieux) and a
chromatographic assay (Color Pac, BD). Toxigenicity of the
isolated strains was examined using Color Pac test for toxin A
and Premier toxins A&B test (Meridian, USA) for toxins A&B.
Cd strains negative by Color Pac and positive by Premier test
were considered A–B+. The MIC’s of the A–B+ isolates to
antibiotics were determined using E-test (AB Biodisk, Sweden).
Results: Cd was isolated in 70/913 (8%) stool samples. Toxin A
was detected in 79/913 (8.6%) samples. Five of 70 (7%) Cd
strains were A–B+, two (3%) were A–B– and 63 (90%) were
A+B+. The A–B+ strains were isolated from ﬁve patients (age
range 50–85 years), hospitalized in different wards of the
hospital during 2003 (4 patients) and 2004 (1 patient). All
patients had more than one risk factors to develop Cd associated
diarrhoea such as antibiotic therapy (3), malignancies (2),
chemotherapy (2), advanced age (4). All ﬁve A–B+ strains were
resistant to clindamycin, three were resistant to penicillin, but all
were sensitive to vancomycin and metronidazole.
Conclusions: This is the ﬁrst report of isolation A–B+ Cd strains
from hospitalised Greek patients with diarrhoea. The strains
were resistant to clindamycin and all the patients had high risk
factors to develop Cd associated diarrhoea.Laboratories should
apply diagnostic assays to detect both toxins A&B, especially in
patients with risk factors to develop Cd intestinal infections.
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R2110
Accuracy of cefoxitin disk diffusion for the
detection of oxacillin resistance in Staphylococcus
lugdunensis and Staphylococcus saprophyticus
E. Cercenado, O. Cuevas, N. Garcia-Escribano, O. Perez-Olaso,
A. Vindel, E. Bouza (Madrid, E)
Objectives: The NCCLS interpretive criteria for oxacillin
against coagulase-negative staphylococci (resistant: MIC > 0.25
mg/l or <18 mm) may overcall resistance for Staphylococcus
lugdunensis and Staphylococcus saprophyticus. Recent reports
indicate that cefoxitin is better than oxacillin in detection of
oxacillin-resistance in staphylococci. In this study we compared
the cefoxitin disk with four other methods for the detection of
oxacillin resistance in S. lugdunensis and S. saprophyticus.
Methods: A total of 64 clinical isolates of S. lugdunensis and 78
of S. saprophyticus recovered from patients at our institution
were studied. The isolates were identiﬁed using the MicroScan
system (Dade Behring. Sacramento, CA) and conﬁrmed by
additional tests. All S. lugdunensis were mecA negative. Among
S. saprophyticus, 5 were mecA positive, and 73 mecA negative.
Following standardised NCCLS methods, oxacillin susceptibil-
ity was determined using: disk diffusion with oxacillin 1 mcg
and cefoxitin 30 mcg disks, oxacillin microdilution using the
MicroScan system, and detection of PBP2a by the latex agglu-
tination test (OXOID. Hampshire. UK). The detection of the
mecA gene by PCR was used as the gold standard assay.
Results: Sensitivity and speciﬁcity of cefoxitin disk for the
detection of oxacillin resistance in S. saprophyticus were 100%
and 81%, respectively. Speciﬁcity against S. lugdunensis was
96%. All mecA positive isolates were cefoxitin-resistant
(<25 mm), however 17 mecA negative S. saprophyticus (22%)
and 2 mecA negative S. lugdunensis were cefoxitin-resistant. The
speciﬁcities for oxacillin disk diffusion, oxacillin microdilution,
and PBP2a detection against S. lugdunensis were 61%, 23%, and
100%, respectively. Against S. saprophyticus, the sensitivities
and speciﬁcities for oxacillin disk, oxacillin microdilution, and
PBP2a were: 100% and 5%; 100% and 19%; 60% and 98%,
respectively.
Conclusion: Cefoxitin disk diffusion is more speciﬁc than
oxacillin disk and oxacillin microdilution for the detection of
oxacillin resistance in S. lugdunensis and S. saprophyticus. The
cefoxitin disk is an accurate surrogate test for S. lugdunensis, but
is less speciﬁc in the case of S. saprophyticus.
R2111
Identiﬁcation of genital mycoplasmas:
comparison of two methods
E. Kouskouni, J. Logginidis, P. Salomidou, V. Efstratiou,
E. Makrakis, D. Hassiakos, S. Baka (Athens, GR)
Objectives: Mycoplasmas represent a unique group of micro-
organisms. Mycoplasma hominis (Mh) and ureaplasma urealyt-
icum (Uu) are common genital inhabitants that have been
associated with a variety of clinical conditions in pregnancy,
infertility and pelvic inﬂammatory disease. The aim of the study
was to compare two methods for the isolation of the organisms
from the lower genital tract.
Methods: We studied 97 vaginal secretions from an equal
number of women attending our hospital. All samples were
cultured for aerobic and anaerobic bacteria. For the identiﬁca-
tion of both Mh and Uu two methods were used.One was the
commercial kit Mycoplasma IST 2 (BioMerieux, France) and the
other was an in house method which is used for years in our
laboratory. For the identiﬁcation of Mh we prepared DNA-
PPLO agar, while Uu was identiﬁed by its ability to metabolize
urea using T-broth, a preparation containing 10% urea broth.
Results: Out of the 97 samples, with the commercial kit we
isolated 26 positive samples (26.8%) for Uu and 6 positive (6.2%)
for Mh. On the other hand, our method resulted in 28 (28.9%)
positive samples for Uu and 4 (4.1%) positive for Mh. The
commercial kit offers the advantage of performing the antibiotic
susceptibility testing. The most sensitive antibiotics for mycopl-
asmas were tetracycline (96.2%) and deoxycycline (92.2%). To
our surprise, quinolones (Oﬂoxacin and Ciproﬂoxacin) showed
decreased susceptibility rates (26.9% and 3.8%, respectively),
while the intermediate sensitivity rates were very high (69.3%
and 73.1%, respectively). In 42.3% of the cases Uu was the only
pathogen isolated. Uu coexisted with bacterial vaginosis in
38.4% of cases, while with other pathogens like Gram-negative
rods, Gram-positive cocci and yeasts in 11.5%, 3.9% and 3.9%,
respectively. Concurrent infections by both Uu and Mh were in
all cases accompanied by bacterial vaginosis.
Conclusions: The two methods proved to be similar in sensi-
tivity and speciﬁcity. The commercial kit has the advantage of
the antibiotic susceptibility testing. Mycoplasmas were moder-
ately sensitive to quinolones probably because of the irrational
use over the last years. Both Uu and Mh correlated positively
with bacteria involved in the speciﬁc clinical entity bacterial
vaginosis.
R2112
Detection of cytolethal distending toxin for
diagnosis of Campylobacter jejuni gastroenteritis
N.P. Mortensen, P. Schiellerup, D.G. Newell,
K.A. Krogfelt (Copenhagen, DK; Addlestone, UK)
Objective: Campylobacter spp. are recognized as a major cause
of acute bacterial enteritis in the developed countries. Several
potential virulence factors have been proposed as important
factors in the pathogenesis of Campylobacter jejuni e.g. motility,
adherence, invasion and toxin production. The only toxin of
C. jejuni characterized at the molecular level is the cytolethal
distending toxin (CDT); cdt genes have also been found in
various other Gram negative bacteria. The aim of this study
was to examine whether the level of CDT expressed had
any impact on the clinical outcome in patients infected with
C jejuni.
Methods: The levels of CDT expressed by 30 clinical C. jejuni
isolates, from patients with campylobacteriosis, were deter-
mined using a HeLa cell assay. The presence of the three CDT
coding genes, cdtA, cdtB and cdtC was tested in these isolates
by PCR. The presence and titres of serum neutralizing antibod-
ies to CDT in the corresponding patient serum was also
measured. Clinical data were obtained from these patients
using a standardised questionnaire.
Results: PCR examination of the cdt genes revealed that 29 of
the strains had the wild type sequence; the remaining strain had
major deletions in the CDT genes. Three of the 30 C. jejuni strains
had undetectable levels of CDT, 20 strains had low CDT titres
while 7 had high titres. CDT neutralizing antibodies were found
in all patient sera. The levels of anti-CDT antibodies did not
correlate with the levels of IgG, IgM or IgA against whole cell
heat-stable C. jejuni antigens.
Conclusion: The results showed a trend in low CDT titre
increasing the risk for patients to become febrile. Neither CDT
expression nor the presence of CDT neutralizing antibodies in
patient serum correlated to clinical outcome. Thus, this study




Usefulness of chromogenic agar Candida ID2 for
differentiating Candida dubliniensis from
Candida albicans
E. Eraso, S. Ismail, M. Villar Vidal, C. Marcos, M.D. Moragues,
L. Madariaga, J. Ponto´n, G. Quindo´s (Bizkaia, E)
Objective: To test the hypothesis that Candida dubliniensis and
Candida albicans isolates can be differentiated on the basis of
colony color in the chromogenic media Candida ID2 (bio-
Me´rieux, France) and CHROMagar Candida (CHROMagar,
France).
Methods: One hundred C. dubliniensis and 100 C. albicans
isolates were tested on Candida ID2 and CHROMagar Candida
agar plates. Isolates had been previously identiﬁed by conven-
tional mycological methods, as the germ tube induction test in
serum, microscopical morphology and chlamydospore forma-
tion in corn meal agar with Tween 80, and carbon source
assimilation with the commercial kit API ID 32C (bioMe´rieux).
C. dubliniensis identiﬁcation was conﬁrmed by PCR with
speciﬁc primers. Prior to testing, each strain was subcultured
for 24–48 h at 36 ± 1C on Sabouraud glucose agar to ensure
viability. Plates were incubated at 36 ± 1C and read for visual
colony color independently by three investigators after 24 and
48 h of incubation.
Results: All yeast isolates grew well on both agars after 24 h of
incubation, although growth on CHROMagar Candida was
slower and colonies smaller. After 48h of incubation, all
C. dubliniensis isolates produced blue turquoise colonies on
Candida ID2, whereas 91 C. albicans isolates grew as blue cobalt
colonies and 9 as blue turquoise colonies (Chi square, p < 0.01).
However, on CHROMagar Candida 13 of C. albicans isolates
evaluated gave a lighter shade of green and 12 gave dark green
color. In contrast, 62 C. dubliniensis isolates gave dark green
color.Therefore, the sensitivity and the speciﬁcity for differen-
tiating between C. albicans and C. dubliniensis on Candida ID2
chromogenic medium were 100% and 91%, respectively.
Conclusion: Candida ID2 agar provides a simple laboratory
tool for the differentiation of C. dubliniensis from C. albicans in
clinical microbiology laboratories.This work was ﬁnanced in
part by the project IE019 ETORTEK-2002 (Diamolfun subproject)
from the Departamento de Industria, Comercio y Turismo del
Gobierno Vasco-Eusko Jaurlaritza.
R2114
Electroencephalographic ﬁndings in patients
with clinical features of meninges excitation
V. Turkulov, N. Madle-Samardzija, V. Ivetis, G. Lanak, J.
Vukadinov, R. Doder (Novi Sad, CS)
This study presents 80 patients who had been treated at Clinic
for Infectious diseases during the last two years, and who had
exhibited the signs of meninges excitation, with or without
neurological disorders, but with normal cytological and bio-
chemical ﬁndings in cerebrospinal ﬂuid.The most common
diagnoses were virosis, bronchopneumonia, pharyngitis, verti-
ginous syndrome, urinal infections, etc. The majority of the
patients were 10–25 years old. Among them, 5% reported
previous convulsions, end even 14% informed us of earlier
head trauma. Pathological electroencephalographic (EEG) ﬁnd-
ings were observed in 50% of the male and 63% of the female
patients. The EEG disorders occurred mostly between the 5th
and the 15th day of the disease. Among the patients with
pathological EEG ﬁndings, 94% were conscious, 3% somnolent,
and 3% soporal. According to the location of EEG changes, the
temporal region dominated – 27%, and the frontal region was
the rarest – 8%. Most of them had unspeciﬁc EEG disorders, a
few exhibited irritative changes, steeper waves or speciﬁc
changes. In our opinion, earlier convulsions and head traumas
in these patients explain way they reacted with meningeal or
neurological symptoms to other infection.
R2115
Analysis of consecutive blood cultures performed
in one year by an infectious team: were three
haemocultures still necessary?
A. Ben Ali, S. Males, M.D. Kitzis, J.C. Nguyen Van, R. Sanz,
J. Carlet, F.W. Goldstein (Paris, F)
Introduction: Blood cultures for the purpose of isolating blood-
borne pathogens have routinely included the use of media for
detection of both aerobic and anaerobic organisms. Although
methods for the detection of anaerobic bacteria from blood
cultures have improved, the per cent recovery of anaerobes
isolated from blood cultures has declined. This study analyses
all blood culture isolates in view of clinical condition for one
year.
Materials: During the year 2002 the infectious disease team
(IDT), who help for the diagnosis and treatment of all infected
patients in Saint-Joseph hospital, analysed all the positive
bottles. The IDT determined the clinical signiﬁcance of all blood
positive culture. Contamination was determined if one bottle
out of two or three sets (2 bottles) collected on the same day
grew with coagulase negative staphylococci, corynebacterium
species, bacillus species and if there is a habitual pathogen with
no clinical signiﬁcation and clinical improving without treat-
ment. A beginning of antibiotherapy in case of false positive
positive bacteraemia was reported.
Results: For the year 2002, 8094 sets were utilised. 931 were
positives. 377 (40 %) bottles were considered as contamination
with 207 (22 %) aerobic and 170 (18%) anaerobic, concerning 274
patients. 31 contaminations induced antibiotic therapy. 554
bottles were considered as a true bacteraemia for 487 patients. 48
(%) bacteriemic patients have positive anaerobic bottle only.
Bacteria present only in anaerobic bottle were anaerobes (16
cases), Staphylococcus aureus (5 cases), Escherichia coli (14 cases),
others enterobacteriacae (8 cases), 2 Streptococcus pneumoniae and
others streptococci (5 cases). Infections concerned in these cases
were intra-abdominal (27 cases), soft-tissue infections (3 cases),
pyelonephritis (11 cases) and others (7 cases).35 of 48 bacterie-
mic patients in only anaerobic bottle were positives since the
ﬁrst set, 12 since the second set with 8 patients treated with
active antibiotherapy and one patient in the fourth set.
Conclusion: In view of these results, we think that only 2 sets of
bottles are necessary for blood stream infection diagnostic.
R2116
The application of Avidity Index testing to
identify recent HIV infection
S. McDonnell, J. Connell (Dublin, IRL)
Valuable epidemiological data can be obtained by determining
the incidence if new HIV infection. Currently the only FDA
approved system to determine how recent a HIV-1 infection
occurred is STARHS – Serologic Test Algorithm for Recent HIV
Seroconversion. This presentation describes the application of
avidity index (AI) testing to determine how recent HIV-1
infection was acquired. The protocol involved the modiﬁcation
of Bioelisa HIV-1+2 (rec) (BIOKIT), by the introduction of a
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dissociation step, which resulted in the disruption of the binding
between antibody and antigen. The assay protocol was devel-
oped and evaluated using well characterised samples collected
from HIV infected individuals using a range of serological and
molecular assays. An AI of 60% was identiﬁed as a threshold
below which HIV infection probably occurred within the
previous 90 days. Avidity index has the advantage of determin-
ing the relative timing of HIV infection using only one sample,
which is often the case when performing unlinked epidemio-
logical investigation. Data will be presented showing the
application of the assay to the investigation of newly identiﬁed
HIV infection.
R2117
Comparison of 2 Chlamydia trachomatis IgG
ELISAs with the MIF test
D. Baetens, W.A. Verstrepen, I. Opdenbergh, P. Bruynseels,
A. Mertens (Antwerp, B)
Introduction: In the fertility work-up C. trachomatis antibody
testing is also used. It is a less invasive procedure than
laparascopy in the detection of tubal pathology as a result of a
C. thachomatis infection. This study was performed because
ELISA’s are less prone to subjectivity and are easier to automate
as compared to the microimmunoﬂuorescence test (MIF).
Objectives: To compare 2 ELISA kits (Chlamydia trachomatis-
IgG/IgA-pELISA medac, MEDAC and Vir-ELISA anti-Chlamy-
dia-IgG/IgM, Viro-immun) with the current gold standard MIF
technique (FOCUS) which is our routine technique.
Methods: 72 serum samples from individual patients were
analysed for IgG antibodies with the 3 methods described above.
All tests were performed according to the manufacturers
instructions. The Medac ELISA is coated with synthetic
C. trachomatis-speciﬁc peptide, whereas the Viro-immun ELISA
is coated with puriﬁed, homogeneous, inactive antigen.
Results: In the MIF test we have found 32 IgG positive and 40
IgG negative serum samples. In the Medac ELISA we have
found 28 positives and 44 negatives of which 4 were positive in
MIF (sensitivity 88.8%/speciﬁcity 100%). In the Viro-immun
ELISA there were 36 positives of which 5 were negative in MIF,
1 equivocal and 35 negatives of which 1 was positive in MIF
(sensitivity 96.9%/speciﬁcity 88.8%).
Conclusion: Both ELISA’s performed well as compared to the
MIF test and further prospective study to evaluate the diagnos-
tic accuracy of the ELISA test will be done.
R2118
Procalcitonin and fever as markers of bacteraemia
in patients with sepsis
M. Lupse, A. Slavcovici, L. Ursu, M. Flonta, C. Bondor,
D. Tatulescu (Cluj-Napoca, RO)
Objective: To assess the clinical informative value of Procalc-
itonin (PCT) plasma concentration and fever as markers of
bacteraemia in patients with sepsis.
Material and methods: All adult patients admitted between Jan
2002 and Aug 2004 who fulﬁlled the criteria for sepsis/severe
sepsis according to the American College of Chest Physicians/
Society of Critical Care Medicine. Fever and plasma PCT with a
semi-quantitative method were measured and two sets of blood
cultures were taken at admittance. Patients without proven
bacterial sepsis were excluded. We compared results in patients
with or without bacteraemia using t test, chi-square test and
descriptive statistics.
Results: 117 patients with bacterial sepsis/severe sepsis were
included, 73 (62%) with bacteraemia: 24 with Gram-positive
bacteraemia and 49 with Gram-negative bacteraemia. There
were no statistically signiﬁcant differences between either
bacteremic and nonbacteremic (p = 0.46) or between Gram-
negative and Gram-positive (p = 0.37) bacteremic patients,
regarding fever. At cut-off value of 2 ng/ml, PCT discriminate
between bacteremic and non-bacteremic septic patients
(p = 0.0002) with a positive predictive value of 80% and a
sensitivity of 78% for bacteraemia. There are no signiﬁcant
differences for PCT values between Gram positive and Gram-
negative bacteremic patients but at cut-off of 10 ng/ml for PCT
the positive predictive value was 73% for Gram-negative
bacteraemia.
Conclusion: Fever does not have a discriminatory power for
bacteraemia in septic patients and the use of PCT assessment
could help physicians limit the number of blood cultures to be
processed.
R2119
Urogenital mycoplasma diagnosis, identiﬁcation
and sensitivity testing to 7 antibiotics
I. Gulbinovic, D. Ambrasiene (Vilnius, Kaunas, LT)
U. urealyticum (U.u) and M. hominis (M.h) are species in the
family Mycoplasmataceae, which is the smallest bacteria
replicating in culture medium and they do not possess
peptidoglycan cell walls. These tiny microorganisms can be
found commensal in lower genitourinary tracts of sexually
active men and women. Moreover, they cause many disorder
such as non-gonococcal urithritis, postpartum fever, infertility,
and pelvic inﬂammatory disease. 15 human species have been
found to date all belonging to the mollicutae class. They differ
from other bacteria in their lack of a cell wall and hence a
natural resistance to a-lactams, as well as by the presence of a
membrane rich in sterol obtained through their adhesion to
eukaryotic cells.
Objective: The aim of present study was to evaluate the
occurrence of U.u and M.h in non-gonococcal urethritis and to
determine the bacterial resistance to seven antibiotics in order to
determine the most suitable treatment strategy.
Methods: A total of 83 patients were enrolled into the study.
Urethral samples were taken with a dacron swab placed into
urethra 2–3 cm in males, and vaginal samples were taken from
the endocervical region in women. Mycofast EvolutioN 3 detects
urogenital mycoplasma growth in a liquid milieu. During
growth, U.u and M.h metabolise urea and arginine respectively
resulting in a colour change of the medium, which contains
phenol red indicator, from yellow-orange to red. This colour
change is due to liberation of ammonia resulting in an alkaline
pH of the medium.
Results: Of the 83 patients in the study, 8 (9.6%) were men
and 75 (90.4%) were women with signs of urethral discharge
and/or urethral discomfort and lower urinary tracts symp-
toms. Mycoplasma Mycofast EvolutioN 3 (International Micro-
bio, France) was used for the isolation of U.u and M.h. U.u
was isolated from 40 (48.1%) patients. 30 (36.1%) of them had
only U.u, and the rest had mixed pathogen organisms 9
(10.8%) U.u and M.h. While 1 (1.2%) patient had M.h only. 7
antibiotics (doxycycline, pristinamycin, roxithromycin, azith-
romycin, josamycin, azithromycin, ciproﬂoxacin and oﬂoxacin)
were used in this system. In the evaluation of antibiotic
susceptibility, higher resistance was obtained against ciproﬂ-
oxacin and oﬂaxin in U.u.
Conclusion: Our results indicated that deoxycicline or pristi-
namycin should be the ﬁrst choice when empirical treatment is
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necessary. This commercial kit is good for the isolation of U.u
and M.h.
R2120
Comparison of the antimicrobial agents on the
MicroScan Synergies plus Neg Combo Type 2
Panel with an NCCLS reference panel
A. Chipman, R. Badal, R. Miller, J. O’Connor, L. Van Pelt,
B. Zimmer (Sacramento, USA)
Objectives: The MicroScan Synergies plus Neg Combo Type 2
Panel combines early MIC results with the capacity to hold and
read panels incrementally up to 18 h. The accuracy of this panel
in detecting antimicrobial resistance was evaluated by compar-
ing results from this panel format to results obtained with an
NCCLS Reference Panel.
Methods: Fresh and stock gram-negative isolates were tested.
The Synergies plus Neg Combo Type 2 panel contains the
antimicrobials ampicillin (Am), ceftazidime (Caz), and gentam-
icin (Gm) in MIC format (>3 dilutions), and amikacin (Ak),
ampicillin/sulbactam (A/S), ceftriaxone (Cax), cefuroxime
(Crm), ciproﬂoxacin (Cp), gatiﬂoxacin (Gat), imipenem (Imp),
levoﬂoxacin (Lvx), meropenem (Mer), piperacillin/tazobactam
(P/T), tobramycin (To), and trimethoprim/sulfamethoxazole
(T/S) in breakpoint (BP) format (less than or equal to 3
dilutions). The number of organisms evaluated for each antimi-
crobial ranged from 329 to 761, and varied depending on the
indications for use with that antimicrobial.
Results: The essential agreement between Am, Caz and Gm
and the reference method ranged from 98.0% for Am to 99.1%
for Gm. Absolute categorical agreement (CA) for these three
antimicrobials was 95.2% for Am, 96.0% for Caz and 96.3% for
Gm; major error (MJ) rates ranged from 0.6% for Am to 0% for
Gm. Very major (VMJ) error rates ranged from 0.8% for Am to
0% for Caz and Gm. For the BP format antimicrobials, CA
ranged from 88.1% for A/S to 99.1 for T/S. MJ rates for BP
ranged from 1.8% for Crm to 0% for Ak, Gat, Lvx, Mer and To.
VMJ error rates for BP ranged from 8.3% for P/T (4/48 resistant
organisms, 1-dilution errors) to 0% for A/S, Cax, Cp, Gat, Imp,
Mer and T/S.
Conclusion: This study showed that the antimicrobials on the
MicroScan Synergies plus Neg Combo Type 2 panel provide
appropriate performance in the detection of Gram-negative
bacterial resistance in comparison with an NCCLS broth
microdilution reference panel.
R2122
Evaluation of BACTEC LX blood culture system
P. Beaty (Sparks, USA)
Objective: Evaluate the performance of the new fully automa-
ted BACTECTM LX Blood Culture diagnostic system. This
system utilizes a ﬁnely resolved beam of infrared light through
the culture headspace to obtain an infrared absorption spec-
trum. This infrared absorption spectrum provides headspace
composition information. The growth of microorganisms is
determined algorithmically by either kinetic analysis of the
headspace or by net headspace composition. This evaluation
includes data on instrumentation and reagents that are currently
in clinical evaluation.
Methods: The study includes ATCC strains of Enteric bacteria,
Staphylococci, Streptococci, Enterococci, Obligately-oxidative
Gram negative bacteria. BACTEC Aerobic Plus and BACTEC
Anaerobic Plus media were both included in the study. Suspen-
sions of cells from a fresh culture on solid media were used as
inocula. The target inoculum per bottle was 10 CFU. The test
included banked human blood to determine the effect of blood
volume on the system. The BACTEC LX system incubates at
35 C, agitates the cultures and tests for CO2 accumulation on a
20-minute cycle. The systemwas compared to the BACTEC 9240.
Results: The average time to detection for the Aerobic Plus
medium for all bacteria was 18 (±8) h for the BACTEC 9240
system and 18 (±8) h for the BACTEC LX. The average time to
detection for the Anaerobic Plus medium for all bacteria was 25
(±14) h for the BACTEC 9240 system and 26 (±13) h for the
BACTEC LX.
Conclusions: The data demonstrates that under typical work-
ﬂow conditions in the laboratory the BACTECTM LX Blood
Culture system is equivalent to the BACTEC 9240 system. This
test was performed on the BACTECTM LX Blood Culture
system in the conﬁguration to be evaluated clinically at multiple
sites in a controlled comparison study. The BACTECTM LX
Blood Culture system utilizes technology that provides data
from the direct measurement of carbon dioxide. This type of
system allows quantiﬁcation of carbon dioxide (true delayed
vial entry detection). The system is less susceptible to secondary
noise effects since the system is a direct measure of carbon
dioxide and not a secondary measurement like sensor tech-
nology.
R2123
Evaluation of the ROBOBACT system for
automatic processing of vaginal cultures for
screening of Streptococcus agalactiae in pregnant
women
A. Delgado-Iribarren, S. Ocan˜a, J. Valverde, J. Ferna´ndez
(Madrid, E)
Context: Group B streptococcus (GBS) is the most common cause
of early-onset neonatal sepsis in developed countries, and
determination of the GBS colonization status in pregnant
patients near term is essential for the provision of prophylactic
measures to prevent early-onset disease.
Objectives: To determine if GBS recovery rates of a semiauto-
matic method, Robobact (RB, Rotec), is similar to selective SB
Broth (SBB, Biomedics).
Patients and methods: 294 pregnant women were evaluated for
GBS colonization by combined lower vaginal-anorectal swabs
(LVRS). Mean age was 30.3 years old (range 17–42; standard
deviation 1.56). Swabs were inoculated to both culture broths as
preenrichment media. Subculture in Blood Agar was done
manually in SBB culture 18 h later, and by an automatic system
with RB 6 h later. Investigation of GBS was done with agglu-
tination test (BioMerieux).
Results: LVRS were positive in 18.7% and 17.4% of pregnant
women with SBB and RB methods respectively (p = 0.75). With
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combination of both methods 19.7% were positive (3 cases only
detected with RB and seven only with SBB).
Conclusions: These results indicate that ROBOBACT system
(ROTEC) is a reliable method that can be used to screen for
maternal GBS colonization with similar results than SB Broth.
(Biomedics) in only 24 h.
R2124
Fever of unknown origin and ferritin level: three
cases of adult-onset Still’s disease
V. Avkan Oguz, N. Yapar, S. Alp Cavus, O. Eren, Z. Kuruuzum,
N. Cakir, A. Yuce (Izmir, TR)
Background: Fever of unknown origin (FUO) is a clinical
picture which has both infectious and noninfectious causes.
Neoplasm and connective tissue diseases are most common
noninfectious etiological categories. Among connective tissue
diseases, Adult-onset Still’s disease (ASD) accounts for approxi-
mately one quarter of cases. Clinical and laboratory ﬁndings are
nonspeciﬁc in ASD and serum ferritin levels were markedly
elevated.
Purpose: In this study, we presented three cases of FUO
diagnosed as ASD with different clinical and laboratory ﬁndings
whereas ferritin levels markedly elevated in all patients.
Cases: Cases presented here were 23, 25 and 20 years old male
patients. Clinical and laboratory ﬁndings were summarized in
the table.
Conclusion: As shown in the table clinical and laboratory
ﬁndings of all patients were different and nonspeciﬁc. Long
lasting fever, arthralgia with elevated levels of CRP, ESR, and
ferritin were common ﬁndings. Most published studies focused
on the potential usefulness of serum ferritin assay for diagno-
sing ASD. In FUO cases, after exclusion of infections and
malignancies, diagnosis of ASD was supported with the eleva-
tion of serum ferritin levels strongly.
Mycobacterial infections (incl. diagnostics)
R2125
Mycobacterial skin infections: pathologic section
results
I. Fedotova (Kharkov, UKR)
Objective: Detection of acid fast bacilli (AFB) in chronic
granulomatous inﬂammation is an important clue for mycobac-
terial infection.
Methods: We reviewed of 77 pathologic sections of mycobac-
terial skin infections to study histopathologic features and the
correlation with the presence of AFB in the section was
performed.
Results: All cases showed granulomatous inﬂammations that
can be categorized into 4 types: mixed cell, suppurative,
tuberculoid and palisading granuloma. AFB was found in 15
sections (19.5%). 44.15% compared to the AFB negative group.
Mixed cell granuloma was the most common histologic feature,
but suppurative granuloma was the most common histological
feature (47.12%) in which AFB could be found, which was
statistically signiﬁcantly different from other types of granuloma.
Tuberculoid granuloma was more common in the AFB negative
group (10.53%) compared to the AFB positive group (9.37%) but
the difference was not statistically signiﬁcant. In cases that AFB
could not be found, the inﬂammation tended to be located in the
upper half of the dermis.
Conclusion: AFB can be more frequently detected in suppura-




tuberculosis in a centre of Tunisia
A. Ferjeni, H. Benabdallah, N. Ben Saida, J. Boukadida (Sousse,
TN)
The multi-drug resistance (MDR) of Mycobacterium tuberculosis
represents currently the biggest problem concerning tuberculo-
sis on the individual and collective scale. Through 800 stumps of
Mycobacterium tuberculosis isolated in the laboratory of micro-
biology of Farhat Hached university hospital in Sousse – Tunisia
during a period from January 1990 to August 2004, we have
represented the main features of this problem. The 800 stumps
of Mycobacterium tuberculosis have been isolated for more then
90% from sputum. The study of the sensitivity to the anti-
tuberculosis drugs has been achieved by method of proportion.
The global resistance to isoniazid (INH) is 5%, to rifampin
(RMP) is 2.5%, to ethambutol (ETB) is 2.5%, to pyrazinamide
(PZN) is 2.8% and to streptomycin (STM) is 2.5%. The multi-
drug resistance interested 11 strains/patients.
• 5 patients present a secondary resistance causing by a bad
therapeutic observance.
• 2 patients present a secondary resistance due to a bad
digestive absorption.
• 5 patients present a primary resistance.
Therapeutic assays after bacteriological diagnosis were limited.
The prognosis was fatal for 5 patients whereas 6 continue to live
with a multi-drug resistance tuberculosis. In view of the gravity
Clinical and laboratory ﬁndings Case 1 Case 2 Case 3
Fever + + +
Rash ) + +
Arthritis + ) +
Arthralgia + + +
Sore throat + + +
Wasting + + +
Conjunctivitis + ) +
Lymphadenopathy + ) )
Hepatomegaly + + +
Splenomegaly + + )
WBC (mm3) 32500 20800 21100
ESR (mm/hours) 153 63 87
CRP (mg/L) 297 330 267
AST (U/L) 38 174 178
ALT (U/L) 100 398 140
RF ) ) )
ANA ) ) )
Ferritin (ng/L) 7361 7500 616
Abstracts
706
of this regional, national and world problem, some intense
preventive measures must be applied rigorously.
R2127
Determination of Mycobacterium tuberculosis
drug resistance in Mazandaran province, Iran –
2002
M. Ahanjan, M. Vahedi, M. Nasrollahie (Sari, IR)
Objectives: Tuberculosis (TB) is one of the most important
infectious disease and the main cause of mortality in the
developing countries (4). Drug resistant leads to failure in
treatment which is followed by unaffordable expenses (6).
Administrators of Iran to plan necessary educational pro-
grammes, and as soon as possible eradicate tuberculosis in Iran.
Methods: Sputums from the individuals referring to health
centre suspected of having TB were collected in sterile contain-
ers, decontaminated by PETROPH method and concentrated,
supernatant was removed and collected in container having
disinfectant then sediment was inoculated onto the Lowenstein–
Jensen medium and incubated at 37 (C for 4 weeks. Smears
were prepared from the collected samples, Zeihl-Neelsen
staining was performed and looked for the presence of myco-
bacterium for 10 min growth on the medium 4 weeks after the
inoculation it was transferred to the partment of mycobacteri-
ology Culture media were observed for the growth of mycobac-
terium tuberculosis (TB). The results were recorded. At Masih
daneshvari TB centre in Tehran, to be conﬁrmed for the growth
of TB and performing antibiogram.
Results: In this study, on 45 TB growth cultures, drug sensitivity
was done for 4 essential drugs that are Izoniazid (INH), refampin
(Ref), ethambotol (Eth) and stereptomycin (ST) hich are used
against TBCases resistant to Izoniazid and 37 sensitive as result
26.66% resistant. For rifampin 37 cases sensitive and 8 cases
resistant, that is 26.66% resistant. For Ethambitol 5 cases resistant
and 40 cases sensitive, as a result 16.66% resistant. In case of
streptomycin 17 cases resistant and 28 sensitive, with 37.77%
resistant. Also two simultaneous resistant to rifampin and
streptomycin was observed, and one case with simultaneous
resistant to Izoniazid, rifampin and streptomycin was noticed.
Conclusion: The results of this study indicate that, resistant to
INH, Rif, Eth, and ST is 26.66%, 16.66% and 37.77% respectively,
which reveals an increasing pattern of TB drug resistant. Hence,
increase in educational training of the physicians and paramed-
ical personals for the proper short course treatment and
implementation of directly observed treatment short course
(Dots) strategy considered as prior.
R2128
Haemorrheological alterations in Nigerian
pulmonary tuberculosis patients
O. Ajayi, A. Famodu, J. Onyemairo, C. Iyere, V. Onaghise,
C. Adogun (Benin City, NG)
Objective: Pulmonary tuberculosis (PTB) is a major infectious
disease with very high incidence in developing countries and
this is expected to rise with the incidence of HIV infection.
Despite the known consequences of PTB on blood ﬂow,
rheologic properties have not been viewed with any serious
research attention. This study was designed therefore, to
investigate the possible haemorheological effects of the infec-
tion.
Methods: Haemorheological parameters were studied in 40 (17
males and 23 females) and 10 (5 males and 5 females) newly
diagnosed PTB patients but conﬁrmed to be HIV negative. Their
ages ranged between 25 and 45 years. Also, 50 apparently
healthy controls with age and sex matched were compared.
Haematocrit (HCT), plasma viscosity (PV), erythrocyte sedi-
mentation rate (ESR) and plasma ﬁbrinogen concentration (PFC)
were estimated with standard methodologies while student
t-test was used to compare the data.
Results: Patients (treated and untreated) show statistically
signiﬁcant increase in PFC, PV and ESR (P<0.01 respectively)
while there was a statistically signiﬁcant decrease in the HCT
(P<0.01). However, treated patients show an improved rheolo-
gical values than the untreated ones (i.e. reduced ESR and PV
with an increased PCV, P<0.01 respectively). There was no
established male and female differences amongst the patients.
Conclusion: Hyperﬁbrinogenaemia with hyperviscosity are
possible consequences of PTB infection and coupled with
reduced PCV and increased ESR indicates chronic signals of
altered haemorheology which may predispose the patients to
increased cardiovascular risks. The inclusion of haemorheolog-
ical parameters in the monitoring of patients on treatment is
hereby emphasized.
R2129
Challenges of M. tuberculosis drug resistance in
Russia
E.V. Sevastyanova, V.I. Golyshevskaya (Moscow, RUS)
Despite some stabilization and even decrease in TB incidence,
epidemic situation for TB in Russia remains difﬁcult. Aggrava-
tion of the epidemic situation for TB is primarily caused by
proliferation of multi-drug resistance among new cases and
prevalence of HIV-infection. The major condition of TB control
both among civilians and prisoners is bacteriology veriﬁcation
and imperative drug resistance determination, especially MDR.
In 2003 MDR was 8.0% among new cases (newly-detected
patients) in Russia; primary MDR among prisoners reached
17.8%. In different Russian regions frequency of drug resistant
cases signiﬁcantly ranged. This was mainly caused by non-
standardized drug resistance determination methods, also by
disadvantages or impediments, such as lack of substances for
drug resistance determination, lack of equipment, lack of
reagents and lack of professional staff, no regular external
quality control, other. Recently a number of Russian laboratories
have implemented rapid methods of drug resistance determin-
ation along with traditional absolute concentrations. Only
quality and degree of standardization of such studies, as a
major condition, will assure reliability and repeatability of
results.
R2130
Serum total adenosine deaminase activity in
active pulmonary tuberculosis in comparison to
other infectious diseases in Iran
Ma. Keshtkar Jahromi, B. Haghighat, Mi. Keshtkar
Jahromi (Tehran, Shiraz, IR)
Objective: In order to have an acceptable rapid test helping the
clinicians in the diagnosis of active pulmonary tuberculosis, we
evaluated the importance of elevated serum adenosine deami-
nase in active pulmonary tuberculosis versus other infectious
diseases.
Methods: We measured serum total adenosine deaminase
level in 3 groups: 1. Cases of active pulmonary tuberculosis
who were conﬁrmed by positive sputum smears for acid fast
bacilli in association with compatible clinical and radiologic
ﬁndings.
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2. Cases of other infectious diseases including Brucellosis,
Endocarditis, Salmonellosis, meningitis conﬁrmed by clinical
ﬁndings and related laboratory tests.
3. Healthy controls.Serum adenosine deaminase levels were
measured before treatment was started. Data analysis was
performed by Chi square, ANOVA and LSD. The signiﬁcance
level was evaluated for P value of less than 0.05.
Results: We evaluated 51 (21 females and 30 males aged
47.7 ± 19 years) cases of active pulmonary tuberculosis, 11 (6
females and 5 males aged 44.7 ± 21 years) cases of other
infectious diseases and 50 (14 females and 36 males aged
48.4 ± 11 years) cases of healthy individuals. Mean serum total
adenosine deaminase level in pulmonary tuberculosis (42.4 ±
21.5 IU/ml) and other infectious diseases (38.3 ± 23.4 IU/ml)
was meaningfully more than controls (26.6 ± 8.2 IU/ml,
p < 0.0001 and p < 0.03 respectively), but the difference in
pulmonary tuberculosis and other infectious diseases was not
statistically signiﬁcant. There was no signiﬁcant difference in
age and gender between the above groups.
Conclusion: We conclude that serum total adenosine deami-
nase increases in infectious diseases but it cannot differentiate
pulmonary tuberculosis from other infectious diseases. This
project has been supported by Infectious Diseases and Tropical
Medicine Research Centre of Shaheed Beheshti University of
Medical Sciences, Tehran, Iran.
R2131
Tuberculosis and diabetes: risks and realities
I.C. Bygbjerg (Copenhagen, DK)
The vicious combination of tuberculosis (TB) and HIV is now
well-established, though not well-controlled. More unnoticed is
the meeting between TB and diabetes, predominantly type 2
(DM2,) particularly in low-income countries in fast transition. In
India, e.g., about 10% of adults have DM2 and another 10% pre-
stages (impaired glucose-tolerance), while 1% may have active
TB and 30% have are at risk of (re-)activating TB. In Mexico, the
risk for reactivating TB in patients with DM2 was increased 4–6
times, which is comparable with increased risk for TB among
HIV-infected. The World Health Organisation preview that by
year 2025 about 350 mio. may have DM2, more than 70% in
developing countries. It remains to be seen if TB may double or
quadruple in the wake of the DM2 epidemic, as has been the
case with TB in HIV. The mechanism(s) behind the increased
risk for re-activation of TB in DM is poorly understood. Present
knowledge (and lack thereof) will be highlighted and sugges-
tions given for future research and possible measures to control
this emerging health problem.
R2132
Meningo-encephalo-mielo-polyradiculonevritis
with Mycobacterium tuberculosis: case report
C. Jianu, R. Iubu, I. Ciutica (Cluj-Napoca, RO)
Objectives: Tuberculosis still represents a public health prob-
lem in developing and underdeveloped countries. We report a
case of central nervous system tuberculosis.
Methods: A 17 year-old female was admitted in our hospital for
fever, headache, loss of weight and progressive disability to
walk. She presented: fever, later cervical lymphadenopathy and
the objective neurological signs were: coma, nuchal rigidity,
Kernig signs were positive, lack of abdominal cutaneous reﬂexes
and osteotendinous reﬂexes, paraplegia, convergent strabismus.
We performed: CT brain scan, routine hematological and
chemical tests, chest X-ray, lumbar puncture, CSF culture, blood
culture.
Results: CT brain scan revealed cerebral edema. Routine
hematological and chemical tests showed leukocytosis (17100/
mm3). Chest X-ray was normal. Blood culture was negative.
Lumbar puncture revealed opalescent CSF with 122 WBC/mm3
(lymphocytes), increase in protein level (200 mg%), decrease in
glucose level (10 mg%); culture was positive for Mycobacterium
tuberculosis. She received antituberculosis chemotherapy with
isoniazid, rifampin, pyrazinamid, and streptomycin for 41 days.
After 30 days of treatment the CSF parameters returned into
normal values and the clinical evolution was very good.
Conclusions: Our case shows that Mycobacterium tuberculosis
infection can affect the entirely central nervous system in
absence of systemic infection.
R2133
Tuberculous meningitis: a 5-year review
E.G. Miftode, D. Leca, A. Teodor, R. Scurtu, D. Teodor, M. Radu,
V. Luca (Iasi, RO)
Objectives: To assess the present epidemiology, clinical pres-
entation and outcome of patients with tuberculous meningitis
(TBM).
Methods: A retrospective study was conducted including 118
cases of tuberculous meningitis hospitalized in the Department
of Infectious Diseases Iasi between January 1999 and January
2004.
Results: Among the 118 patients with tuberculous meningitis
children (5 months–15 years) accounted 29% and elderly (>65
years) – 6% of the cases. Clinical condition at the time of
admission was: coma in 13.5% of the cases, other consciousness
abnormalities – 50%, cranial-nerve palsies – 18.6%, hemi/
monoparesis – 8% of the cases. A history of contact with
tuberculosis or prior tuberculosis was documented in 36% and
21% of the cases, respectively. In 60% of the patients antituber-
culous therapy was initiated in the ﬁrst day after admission, 23%
of patients received adequate treatment in the second day and
12% were treated after 48 hours. In 52% of the cases other
location of tuberculosis was revealed: pulmonary TB (42%),
lymph nodes (8%), bones and joint (5%), etc. A positive CSF
culture resultM. tuberculosis was available in 17% of the patients
and 12% of patients were smear positive. The CSF albumin level
was very high (>3 g/l) in 18% of the patients and glucose level
was markedly low (<0.3 g/l) in 47% of the cases. Complications
occurred in 49% of the patients: hydrocephalus (15%), tubercu-
loma (4.2%), hemi/monoparesis (12%), and cranial nerve palsies
(18.6%). Ninety-ﬁve patients recovered (80%), 10 patients (8%)
required neurosurgery procedures for complications of TBM
and 13 patients (11%) died.
Conclusions: The prognosis was generally poor for patients
with CSF glucose level at the time of admission and for those
presenting late, with stage 2 and 3 disease even when treatment
was begun on the day of admission.
R2134
Evaluation of molecular assays for detection of
Mycobacterium tuberculosis multi drug resistant
strains and genotyping this isolates by
spoligotyping
J. Oles, M. Koziol-Montewka, F. Drobniewski, V. Nikolaevsky,
A. Gibson, M. Dabrowska (Lublin, PL; London, UK)
Objectives: The increasing incidence of tuberculosis and multi-
drug resistance (MDR) among Mycobacterium tuberculosis strains
remains one of the major public health problems in Poland. The
geographical position of Lublin means that potentially MDR
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strains from former Soviet Union countries are more likely to be
present. Rapid detection of MDR can optimize the efﬁcacy of
antituberculosis therapy and control their transmission. The aim
of the study was to compare current methods of drug suscep-
tibility testing with two molecular assays.
Methods: The Inno-Lipa Rif. TB was applied to detect muta-
tions in rpoB gene conferring rifampicin resistance and a non-
commercial low-density macroarray (MDRTB screening array)
detecting mutations in rpoB and kat G, inh A genes responsible
for rifampicin and isoniazid resistance, respectively. Differenti-
ation of M. tuberculosis complex species was conﬁrmed using
biochemical analyses, niacin accumulation test and spoligotyp-
ing based on polymorphism of the chromosomal direct repeats
(DR) locus, which contains a variable number of short DR
interspersed with non-repetitive spacers.
Results: 18 MDR strains cultured from patients with pulmon-
ary and extrapulmonary tuberculosis in the laboratory of
Public Hospital were subjected to susceptibility testing for
rifampicin and isoniazid by the resistance ratio method on L–J
medium. All these strains were analysed by the Inno-Lipa Rif,
MDRTB screening array and spoligotyping. Phenotypic testing
established that 17 of 18 isolates were rifampicin and isoniazid
resistant using the resistance ratio method – the gold standard
to compare with. By the Lipa assay 17 of 18 strains (94.4%)
were scored as rifampicin resistant. The MDRTB screening
array had the same results for both rifampicin and isoniazid
resistance – 15 of 18 strains (83.3%); 2 of the 18 isolates
demonstrated unusual pattern of hybridisation in the MDRTB
screening array. Among the 18 isolates identiﬁed as M.
tuberculosis by conventional methods, 17 strains (94.4%) were
conﬁrmed as M. tuberculosis whereas 1 strain was identiﬁed
(5.6%) as M. bovis using spoligotyping. The M. bovis strain had
the absence of the spacers 39 to 43 in DR region, characteristic
of all M. bovis strains.
Conclusion: Our study shows that rapid commercial and non-
commercial molecular methods may be useful tools to detect
MDR strains and to distinguish M. tuberculosis and M. bovis
which is often difﬁcult by traditional methods.
R2135
Comparison of BacT/ALERT and Lo¨wenstein–
Jensen media and rapid differentiation of
Mycobacterium tuberculosis complex from other
mycobacteria using para-nitrobenzoic acid from
clinical specimens at a chest disease hospital in
Istanbul, Turkey
C. Guney, M. Partal, A. Suel, T. Karagoz, H. Yorulmaz,
H. Calisir (Istanbul, TR)
Objectives: To evaluate the performance of BacT/ALERT 3D
(bioMerieux, France) for isolating of mycobacteria in compar-
ison with the Lo¨wenstein–Jensen medium. Additionally, a series
of studies were conducted to detect the sensitivity of p-nitro-
benzoic acid test for differentiation of Mycobacterium tuberculosis
complex with other mycobacteria at Social Security Institute
Sureyyapasa Chest Disease Hospital, Istanbul.
Methods: During our investigation, a series of different
samples such as sputum, bronchial aspiration, pleural ﬂuid,
bronchoalveolar lavage, gastric lavage, urine, periton ﬂuid and
lenfadenopathy drenage recovered from patients in the three
major services, were treated with N-acetyl-L-cysteine-3%
NaOH decontamination and concentration procedure. Each
sample was then cultivated in BacT/Alert 3D MP bottle and
Lo¨wenstein–Jensen medium in 37 C. Acid-fast staining was
employed for smear preparation. Time and presence of
growth on BacT/Alert 3D MP bottle was monitored and
recorded. Additionally, we have evaluated efﬁciency of BacT/
Alert MP medium in rapid differentiation of mycobacteria by
adding PNB.
Results: Among the smear-positive and smear-negative spec-
imens, more Mycobacteria grew on BacT/ALERT MP then L–J
media. In smear-positive samples, BacT/ALERT 3D system
showed a few days earlier then in smear negative samples.
Contamination ratios for BacT/Alert 3D and L–J were 3 and
4%, respectively. The total mean time of detection of BacT/
ALERT MP bottles were approximately 19 days shorter than
Lo¨wenstein–Jensen media. It has been determined that all
bottles with Mycobacterium tuberculosis complex showed no
growth or late growth compared to bottles containing
p-nitrobenzoic acid. But other mycobacteria bottles showed
same type of growth as the bottles containing p-nitrobenzoic
acid. Mean time of p-nitrobenzoic acid test for other mycobac-
teria and Mycobacterium tuberculosis complex have not exceed
more than 5 days.
Conclusions: It has been showed that the performing of
p-nitrobenzoic acid test in BacT/ALERT MP bottles is sensitive
and rapid. Thus total testing time of mycobacteria at the
system provides the ability to meet the 21 days target for
detection and identiﬁcation of M. tuberculosis complex as
recommended by the Centers for Disease Control and Preven-
tion, Atlanta, GA, USA.
R2136
Early diagnosis of lung tuberculosis by automatic
system probetec ETTH (Becton-Dickinson)
N. Montiel, J.L. Prada, I. Lopez, A. Del Arco, F. Fernandez,
J. De La Torre, M. Hortas (Marbella, E)
Introduction: To study the sensibility and speciﬁcity of the
strand displacement ampliﬁcation (SDA) technique compared
with baciloscopies (BC) by automatic system Probatec ETTH
(Becton–Dickinson) in patients with high potentiality of lung
tuberculosis (LTB).
Method: A total of 195 samples from respiratory origin (spu-
tums, bronchial aspirates, broncoalveolar lavages, induced
sputums) from patients with high clinical likelihood of LTB,
from the General Internal Medicine and Neumology depart-
ments of our centre. All the samples underwent (1) a decon-
tamination process; (2) were homogeneizated and concentrated
by the method of N-acetil-cisteine-NaOH; (3) BC was made in all
the samples; (4) culture in liquid medium (BactAlert 3D, Bio-
Merieux) and solid (Lo¨wenstein–Jensen, Becton–Dickinson); (5)
M. tuberculosis complex (MTC) DNA was tested in all the
samples by SDA technique and by the automatic system
Probatec ETTH (Becton–Dickinson) following the trader instruc-
tions.
Results: A total of 61 (31.3%) samples were positives for MTC
DNA, of these samples 49 (80.3%) were BC positives and 12
(19.7%) were negatives. In those 3 samples (1.5%) with BC
positive and MTC DNA negative, atypical mycobacteria were
presented in 2 cases and in the other one a culture contamin-
ation eluded its identiﬁcation. MTC DNA positive and BC
negative were in 12 samples (6.1%), in these MTC only could be
demonstrated in 4 (33.3%), in the others the half were from
patients with LTB therapy started.
Conclusions: SDA method is quickly, efﬁcient and easy to the
early diagnosis of LTB (4–6 h) overall in cases with BC positives.
We have achieved a sensibility of 94.2% compared with BC and
a speciﬁcity of 91.6%. We consider that this technique cannot be
used by LTB therapy monitorization.
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R2137
Drug resistance pattern of Mycobacterium
tuberculosis in a technical university medical
faculty in Turkey, 2000–2004
O. Bayraktar, I. Ko¨ksal, K. Aydin, R. Caylan, D. Ozen, O. Yu¨cel,
N. Sucu (Trabzon, TR)
Multidrug-resistant tuberculosis, a disease caused by Mycobac-
terium tuberculosis strains that are resistant at least to rifampin
and isoniazid, entails extended treatment, expensive and toxic
regimens, and higher rates of treatment failure and death. To
document the presence of multidrug-resistant tuberculosis
(MDR-TB) strains in patients from Turkey on Black Sea region
between January 2000 and October 2004. We retrospectively
analysed the outcomes in 249 patients treated and untreated ,
and tests of primer and seconder resistance to isoniazid,
rifampicin, streptomycin, ethambutol and multi drug resistance
on their specimens were performed using the Bactec TB-460
system. The most commonly encountered culture-positive spec-
imens were sputum (67%) and BAL ﬂuids (14.4%). The drug
resistance pattern of M. tuberculosis among these isolates was as
follows: 249 strains were resistant to 22.9% isoniazid, 14.8%
rifampin, 20.9% ethambutol, 7.6% streptomycin, and 13.2%
isoniasid and rifampin drugs.
R2138
Cerebellar abscess and syringomyelia due to
isoniazid resistant Mycobacterium tuberculosis
Y. Ersoy, O. Ates, S. Cayli, A. Dinc But, Y. Bayindir, C. Onal,
R. Durmaz (Malatya, TR)
Objectives: Tuberculous brain abscess (TBA) is a rare clinical
entity, even in endemic areas. These lesions may occur
during the treatment of tuberculous meningitis. Drug resi-
stances were not well deﬁned in Central Nervous System
tuberculosis.
Case report: A 19 years-old, immunocompetent, young man
was admitted with diplopia, nausea, vomiting and a change in
mental status. The patient had a history of tuberculous
meningitis diagnosed before six months in another hospital
and given anti-tuberculosis treatment with isoniazid (INH),
rifampicin (RF), pyrazinamide (PRZ) and ethambutol (ETB) for
two months and followed by two drugs treatment with INH
and RF for four months. Computed tomography (CT) scan of
the brain showed a non-communicating hydrocephalus. The
patient was operated for hydrocephalus and placed a ventri-
culo-peritoneal shunt. Two mounts later, the patient was
hospitalized again for fever, dysfagia and left hemiparesis.
Cranial CT scan was within normal; however magnetic
resonance imaging (MRI) examination revealed irregular mul-
tiloculer peripheral contrast enhancement lesion with hypo-
intense necrotic centres within the left cerebellar hemisphere
extended to the upper posterior cervical subarachnoid space
through left medullacerebellar ﬁssure. The abscess was drained
by surgical operation. Acid resistant bacillus (ARB) was
demonstrated in the abscess material by Zeihl-Neelsen stain
and polymerase chain reaction (PCR). Isoniazid resistant
Mycobacterium tuberculosis was grew on Lowenstein–Jensen
culture medium. One month after the operation quadryparezi
was developed. Cervical MRI was revealed cervico-thoracic
syringomyelitic cavity. The treatment was given with four
drugs (INH, RF, PRZ, and ETB) for 10 months and it was
continued with three drugs until 24 months.
Conclusions: The patients with tuberculous meningitis should
be observed closely for complications like brain abscess and




Pneumocystis jiroveci in patients with pulmonary
infections
L. Nimri, J. Amer (Irbid, JOR)
Objectives: In patients with acute or chronic respiratory prob-
lems mainly tuberculosis (TB) suspected cases, there is a concern
that other opportunistic infections apart from TB, such as
Pneumocystis jiroveci, may be missed owing to lack of diagnostic
facilities. The aim of this study was to investigate the extent of
P. jiroveci pneumonia in patients with respiratory tract infections
especially in TB patients registered for smear-negative.
Methods: Three hundred specimens, included bronchoalveolar
lavage, and sputum collected from patients having different pul-
monary infections were tested by nested PCR for P. jiroveci and TB.
Results: P. jiroveci was detected in 15 (5%) patients, 7 (46.7%)
were TB negative by both acid fast-smear and PCR, the other 8
(53.3%) had dual infections with TB. These patients included old
patients, alcoholic, heavy smokers, and post primary TB
patients. Results suggest that these might be risk factors for
Pneumocystis pneumonia (PCP). Patients with PCP had some-
how different clinical presentation and radiographic appear-
ances from patients with TB. The PCP infections might be
overlooked due to concurrent infections with TB, which makes
the diagnosis difﬁcult.
Conclusions: The use of sensitive diagnostic methods for the
diagnosis of PCP in patients with respiratory tract infections
who are not responsive to treatment is recommended.
R2140
Susceptibility testing of pathogenic fungi with
ﬂuconazole and tea (Camellia sinensis) on
Candida albicans PTCC-5027
Z. Nasrolahi (Tehran, IR)
Tea (Camellia sinensis) has recently been shown to inhibit growth
of a range of bacteria and microfungi. In my study Candida
albicans standard strain PTCC-5027 were tested for in-vitro
susceptibility to ﬂuconazole and tea containing whole extract of
Lahijan fresh tea leaves and black tea, Chinese green tea and tea
polyphenols and caffeine. A rapid reversed phase HPLC
method for the determination of polyphenols, using a binary
gradient system, was developed. At the present research, which
is aiming at determining the minimum inhibitory concentration
of tea extract and tea polyphenols and caffeine at concentration
(6.26–200 mg/ml) on (500, 1000, 2000 cells Candida albicans
PTCC-5027) at two period 24 and 48 h. The macrodilution broth
test technique was performed to do this. Fluconazole was used
for comparing in this study, and we found resistance of that
strain with ﬂuconazole and MICs > 64 lg/ml. The 100% mini-
mum inhibitory concentrations (MFC) calculated in our study
are evidence of antifungal activity of polyphenols against
ﬂuconazole-resistance Candida albicans PTCC-5027. The obtained
results conﬁrmed that caffeine in rather than polyphenols
produced better treatment outcomes. The obtained MFC for
polyphenols in comparison to the whole extract of tea has better




Aspergillosis of the maxilla sinus in patients
from maxillofacial surgery clinic in Cracow,
Poland, between 1998 and 2004
Budak, A. Dzierwa, B. Bogusz, J. Zapala, P. Nowak (Cracow, PL)
Objectives: The aim of the paper was to analyze the occurrence
of the aspergillosis of maxilla sinus among patients hospitalized
in Maxillofacial Surgery Clinic connected with the estimation of
the results of laboratory-clinical diagnostics applied and
together with therapeutical procedure.
Methods: The subject of the analysis was the group of 398
patients with chronic inﬂammation of the maxilla sinus hospit-
alized in the clinic between 1998 and 2004. The diagnosis of
aspergillosis was performed on the basis of interview, object,
subject studies, radiological studies, mid-operation estimation of
the state of mucous membrane and inside of sinus, and on the
basis histological and mycological examinations. Aspirates
taken during operation from maxilla sinus were subject to
mycological investigation. Diagnostics included: direct micro-
scopic examination, culture on Sabouraud agar, microculture
and estimation of MIC for itraconazole and voriconazole using
E-tests.
Results: Aspergillosis of maxilla sinus was diagnosed in 12
patients (5 males, 7 females) in age from 19 to 74, respectively in
years: 2000: 2, 2001: 1, 2002: 2, 2003: 5 and 2004: 2 cases. In
mycological examinations in 5 patients the presence of septate
mycelium was proved in direct preparations and in one case the
presence of Aspergillus conidiophores was also stated. In 3
persons positive result from preparation was proved by culture.
Moulds from genus Aspergillus was identiﬁed. In 2 patients
isolates were recognized as Aspergillus niveus and A. candidus. In
histological examination in 9 patients the presence of foreign
body was also stated in lumen of sinus and numerous septate
mycelium was also identiﬁed in preparations. All patients were
treated with combined surgical and antifungal therapy using
itraconazole and in one patient ambisone.
Conclusions: Applied therapeutical procedure caused signiﬁ-
cant improvement of local and general condition of patients,
which was conﬁrmed by the results of mycological investiga-
tions and by the interview which took place along time after
surgical operation. In one patient invasive form of aspergillosis
was observed together with the expanding inﬂammation pro-
cess to eye-socket and to lower part of front skull.
R2142
Adverse events and outcomes in patients with
fungal infections treated with amphotericin B
deoxycholate
J. Garbino, D. Lew, R. Matulionyte, L. Markham, V. Rives,
J. Arduino, W. Gerth (Geneva, CH; Whitehouse Station, USA)
Objectives: Amphotericin B deoxycholate (AmBd) has been a
standard therapy for most systemic mycoses. It is associated
with signiﬁcant adverse events (AEs) including nephrotoxicity
(NT). Objectives were to describe AmBd therapy, AmBd related
AEs, and clinical outcomes.
Methods: Retrospective chart review was undertaken in an
academic centre in Geneva, Switzerland, on patients with IFI
receiving AmBd as initial therapy. Data abstracted included:
AmBd mean daily doses (MDD), AEs, clinical/microbiologic
response to antifungal treatment (AFT), and mortality. NT: 50%
increase in baseline serum creatinine (SCr) or if baseline
SCr > upper normal limit, an absolute increase of 1 mg/dL.
Successwas deﬁned as complete or partial clinical response to the
AFT. Wilcoxon rank-sum test was used for continuous variables
and the Mantel–Haenzel chi-square test for proportions.
Results: Twenty nine patients were abstracted from 1990 to
2000 (62% male, 28% solid tumor, 24% AIDS, 14% leukaemia;
94% Candidiasis). Average MDD: 0.57 ± 0.26 mg/kg. Mean
duration of treatment: 18 ± 16 days. Nine patients (35%) were
switched to alternative AFT (35% azoles; 3% lipid formulation of
amphotericin B). Eighteen patients (62%) experienced AmBd
related AEs. Eight patients (33%) experienced NT. Solid tumor
rate was higher in NT patients (50% vs. 13%, p = 0.05).
Nephrotoxic medications distribution was not different in NT
and non-NT patients. NT patients showed higher MDD than
non-NT patients (0.72 vs. 0.48 mg/kg; p = 0.04). Non-signiﬁcant
numeric differences were observed between NT and non-NT
patients for success rate (25% vs. 56%), hospital length of stay
(HLOS) (33 vs. 23 days), and mortality rate (63% vs. 50%).
Conclusion: Patients with IFI, treated with AmBd had high AEs
and mortality rates. Descriptive analyses suggest how AmBd
related NT could have negative impact on clinical outcomes,
and HLOS. This adds to the body of knowledge and highlights
need for less toxic, more effective AFT.
R2143
Candida albicans endocarditis in a human
immunodeﬁciency virus infected patient
successfully treated with caspofungin and
vegetectomy: a case report
V. Bacak, B. Biocina, B. Starcevic, J. Begovac (Zagreb, HR)
History: A 22-year-old male i.v. drug user acquired acute HIV
infection in September 2003. At that time he was admitted to a
hospital outside Croatia and treated for mixed bacterial (Strep-
tococcus sanguis) and fungal (Candida albicans) sepsis with
tricuspid valve endocarditis. His hospitalization was complica-
ted by pulmonary embolism, femoral thrombosis and bilateral
pneumonia that required bilateral thoracic drainage. His Candida
albicans infection was treated with liposomal amphotericin B for
3 weeks followed by oral ﬂuconazole. He was discharged in
December 2003 in a stable condition and given ﬂuconazole
(400 mg/day) and methadone maintenance therapy.
Case presentation: The patient was admitted to our hospital in
March 2004 because two blood cultures taken in the outpatient
setting grew Candida albicans despite continuous ﬂuconazole
therapy. Echocardiography was performed and a vegetation
2 cm in diameter was found on the tricuspid valve, and there
was also a thrombotic mass 0.5 cm in diameter in the right
ventricle. A 2-week course of liposomal amphotericin B with
intravenous ﬂuconazole (400 mg/day) was given, followed by
oral ﬂuconazole (400 mg/day). The patient became afebrile,
however, a blood culture taken in May 2004 grew Candida
albicans again. On June 2nd surgery was performed with
excision of the vegetations on the tricuspid valve and in the
right ventricle. One the day prior to surgery treatment with
intravenous caspofungin (70 mg on day 1 followed by 50 mg/
day) was started. Candida albicans grew from the cultured
vegetations, it was susceptible to ﬂuconazole and amphotericin
B. Intravenous caspofungin was given for 4 weeks followed by
oral ﬂuconazole (400 mg/day). In the following 4 months no
recrudescence of endocarditis was observed. Antiretroviral
treatment was started in April 2004 with a combination of
stavudine, lamivudine and lopinavir/ritonavir. It was given
throughout the course of illness and was well tolerated.
Conclusion: Initial caspofungin treatment followed by ﬂucon-
azole maintenance therapy, in addition to vegetectomy, was
successful in the treatment of Candida albicans right-sided
endocarditis in our HIV infected patient.
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R2144
Survey of the prevalence and identiﬁcation of
dermatophytosis in Northern Iran, 2003–2004
J. Hashemi, A. Nasrollahi Omran (Tehran, Tonekabon, IR)
Objective: For 15 months in the period from June 2003 to
September 2004, we experimented 400 patient suspected to
dermatophytosis refer to clinics medical mycology to have
itching and irritation.
Materials and methods: Skin samples were taken by scraping
from patients and collected. Diagnosis was conﬁrmed by direct
microscopy carried out with a 20% KOH preparation and culture
were performed in Petri dishes on mycobiotic agar and dermat-
ophyte medium (DTM), and dermatophyte diagnosis tests for
taxanomic identiﬁcation of species. Thus after to complete
questionnaire, we analysis prevalence of dermatophytosis.
Results: Our results showed that: Totally, that 210 cases of them
suffered from dermatophytosis, that disease conﬁrmed by
microscopic examination and culture positive. %70 (147 case)
of this patients suffered from disease were male and rest were
female 30% (63 case). Age groups between 10 and 50 were effect
by this disease, with a lightly higher incidence in the age group
was 20–30 (57%). Seventy per cent (147 case) of patients living in
the cities rest 30% (63 case) were villager. Majority of the
patients were driver 30% (63 case), rest were student 20% (42
case), ofﬁcer 20% (42 case), collar worker 20% (42 case) and 10%
(21 case) farmer. The frequency of clinical types according to the
anatomic site involvement of dermatophytosis was groin, thus
tinea cruris 50% (105) was the predominant clinical form of all
ring worm infection see, rest were 20% (42 case) of cases were
tinea manum, 17.6% (37case) tinea pedis, 4.76% (10 case) tinea
capitis. 4.76% (10 case) tinea corporis, 1.9% (4 case) tinea
unguium. Ninety ﬁve per cent (2 case) tinea barbae. Eighty per
cent of tinea capitis was ectothrix rest were 5% endothrix and
15% tinea favosa. Epidermophyton ﬂoccosum was most common
etiological agent 28.5% (60 case) rest encountered dermatophy-
tosis including: T. rubrum 23.8% (50 case); T. violaceum 7.14% (15
case); T. mentagrophytes 14.28% (30 case); T. verrcosum 4.76% (10
case); T. schoenleinii 11.9% (25 case); T. sonsudens 4.76% (10 case);
M. canis 476% (10 case). We found that anthropophilic infections
85.72% (180 case) appeared to be six time frequent than
zoophilic ones 14.28% (30 case)
Conclusion: Statistical evaluation of obtained data indicated the
decreased trends towards frequency of tinea capititis and the
growing trends toward tinea cruris. This study highlights a
common problem in many areas of the northern Iran and
suggests that further measures regarding public health and
specially personal hygiene must be undertaken in order to
reduced the risk of dermatophytosis.
R2145
Colonisation of oral cavity by Candida species
I. Glazar, M. Abram, S. Pezelj-Ribaric, B. Ticac, M. Muhvic Urek,
D. Maricic (Rijeka, HR)
Objectives: The aims of the study were to assess the coloniza-
tion of oral cavity in otherwise healthy individuals with oral
symptoms (dry mouth and burning mouth syndrome) by
Candida species and to determine their susceptibility to
antimycotic drug nystatin. Nystatin is frequently used for
topical prophylaxis or treatment of oral candidiasis.
Methods: This study examined the oral yeast colonization in
104 participants. Samples were collected with tongue swabs and
cultured on Sabouraud’s dextrose agar at 37 C for 48 h. All
isolates were identiﬁed by germ tube production, chlamydo-
spore development on cornmeal agar with 0.5% Tween 80
(Difco, Detroit, USA) and ID 32 Candida identiﬁcation kit (bio-
Merieux, Marcy-l’Etoile, France). The susceptibility proﬁle was
evaluated by disk diffusion method for nystatin (NeoSensitabs,
Taalstrup, Denmark) on Mueller–Hinton agar.
Results: At the time of sampling, 30 (28, 84%) individuals were
positive on colonization by Candida species. 27 (90%) of isolates
corresponded to Candida albicans while two isolates (6.6%) were
identiﬁed as C. kefyr (C. pseudotropicalis) and one (3, 3%) as
C. glabrata. All the isolates were susceptible to nystatin.
Conclusion: Candida albicans was the main Candida species that
colonized oral cavities while non-C. albicans species were rarely
detected. Since all isolates were susceptible, nystatin can be
safely used for prophylaxis of oral candidiasis in patients with
oral symptoms such as dry mouth or burning mouth syndrome.
R2146
Conﬁrmation of C. dubliniensis from other
Candida spp.
B. Matica, I. Kosalec, A. Mlinaric-Dzepina, N. Jarza-Davila,
J. Granic, T. Marijan, T. Maretic, S. Pepeljnjak (Zagreb, HR)
Objectives: C. dubliniensis (CD) is often identiﬁed as C. albicans
(CA) specially in routine mycological practice because two
species shares characteristics, they are germ-tube positive and
produce chlamydospores. The aim of this study was to distin-
guish CD from other Candida spp. in immunocompetent and
immunodeﬁcient patients clinical specimens.
Methods: All Candida spp. isolates were tested using algorithm-
tolerance at 45 C, osmotic resistance in broth containing 6.5% of
NaCl and phenotypic features on CHROM agar and Pal agar.
For quality control we used C. albicans ATCC9028 and
C. dubliniensis CBS7988.
Results: One hundred and twenty three strains of Candida spp.
isolated from genitourinary tract of immunocompetent patients
were tested for CD and was no such strain conﬁrm. In 93
Candida spp. from oral cavity in haematological patients and 10
swabs from HIV positive persons we conﬁrm only one strain as
CD. CD growth on Sabouraud-agar at 37 C and do not at 45 C
does not growth in broth with 6.5 % NaCl, on Pal agar colonies
have characteristic pseudo-hyphal roots (with chlamydospores
under 400·). On CHROMagar CD have dark blue-green colour
distinguishable from light-blue CA colonies.
Conclusions: Using algorythm (germtubes) and chlamydo-
spore formation together with two methods: growth at 45 C
and cultivation on Pal agar present easy methods for distinguish
C. dubliniensis from C. albicans and other Candida spp. in clinical
laboratory specimens.
R2147
Candidosis due to Candida guilliermondii: an
analysis of eleven cases
A.C. Pasqualotto, A.G.V. Antunes, L.C. Severo (Porto Alegre, BR)
Objectives: In the attempt to separate colonization from infec-
tion, we reviewed the clinical records of patients who had
Candida guilliermondii identiﬁed on clinical specimens.
Methods: Retrospective study of all positive cultures for
C. guilliermondii obtained during October 1997 to August 2003
at Santa Casa Complexo Hospitalar, Brazil. The records of the
Mycology Laboratory were reviewed attempting to identify
positive cultures to C. guilliermondii. Clinical records of these
patients were also reviewed. Candidemia was diagnosed if a
peripheral positive blood culture was temporally related to
signs and symptoms. Histopathologic or cytopathologic
examination showing C. guilliermondii from specimens of needle
Abstracts
712
aspiration or biopsy, excluding mucous membranes, were
considered evidence of invasive infection, as well as positive
culture result on sample obtained by sterile procedure from
normally sterile site.
Results: Eleven patients were included in this study. Specimens
corresponded to blood (n = 5), ascitis ﬂuid (n = 2), pericardial
ﬂuid (n = 1), urine (n = 1), colon biopsy (n = 1), and esophagus
mucosa (n = 1). Patients were mainly male (54%), and age
ranged from 19 days to 73 years. Six patients were immuno-
suppressed (3 transplant recipient, 2 AIDS, and 1 cancer), and 4
had been exposed to invasive procedure (2 peritoneal dialysis,
and 2 abdominal surgery). For the 5 patients with candidemia,
there was a favorable response with amphotericin B treatment.
Only one case, an immunocompetent patient, received no
antifungal therapy. Two cases were presented of C. guilliermon-
dii peritonitis, associated to dialysis catheter; both had favorable
evolution after antifungal therapy and catheter removal.
Conclusions: In this series of 11 patients, we demonstrated that,
although C. guilliermondii can be associated with invasive
disease, its presence may represent colonization or even infec-
tion with low pathogenicity, mainly in immunocompetent
patients. There was a frequent association between C. guillier-
mondii and catheter use (intravenous, peritoneal or urinary),
which is common to Candida species infections. Aseptic
technique should be rigorously performed during the process
of blood sampling, to avoid further mistakes in the interpret-
ation of the isolation of C. guilliermondii from clinical specimens.
R2148
Importance of the coexistence of Candida fungi
and bacteria Helicobacter pylori
E. Karczewska, M. Zwolinska-Wcislo, D. Trojanowska,
A. Budak (Cracow, PL)
Objectives: Except of well known role of Helicobacter pylori (Hp)
in the pathogenesis of ulcer disease (UD) and chronic gastritis
(CG), the role of the presence of Candida (C.) fungi in the
stomach is now evaluated. The problem of the coexistence of
Candida and Helicobacter pylori in the gastric mucosa and their
inﬂuence on ulcer healing and the course of chronic gastritis has
not been explained. The aim of study was to (1) evaluate the
frequency of C. in patients with gastric ulcer (GU), duodenal
ulcer (DU) and CG; (2) estimate the frequency of Hp in GU, DU
and CG; (3) evaluate the frequency of coexistence of C. and Hp
in above patients; (4) identify the C. species, isolated from
patients with GU, DU and CG; (6) evaluate the inﬂuence of Hp
eradication on the frequency of the presence of C. in the
stomach.
Methods: We examined the group of 63 patients, including14
patients after Hp eradication therapy, aged from 18 to 72 years,
with dyspeptic and ulcer symptoms. Clinical investigation
included: clinical history, gastroscopy with biopsies for urease
test, histopathology, mycology and evaluation of the Hp
presence. Also brush smear from changed gastric mucosa and
aspirate of gastric juice were taken for mycological investigation.
Bacteriological investigation included: (a) Hp culture in the
incubator with CO2 ﬂow, (b) identiﬁcation of Hp species by
evaluation of urease, catalase and oxydase activity. Mycological
investigation of examined material was evaluated on the basis of
qualitative and quantitative investigation. In the identiﬁcation of
isolated fungi: Albicans ID2, ID 32C ATB System (bio Merieux)
was used.
Results: (1) Presence of C. in the stomach was found in 47% and
57% patients before and after Hp eradication therapy respect-
ively. (2) We did not ﬁnd C. and Hp in 53% and 29% in not
eradicated and eradicated patients respectively. (3) Coexistence
of C. and Hp in the stomach was found in 10% of cases. (4) C.
albicans was the most frequently isolated species.
Conclusions: (1) C. and Hp coexistence was found in 10% of
cases. (2) Hp eradication therapy containing proton pump
inhibitor and antibiotics may increase the frequency of fungal
colonization of stomach mucosa.
R2149
Molecular characterisation of GTP-binding
protein gene in dermatophyte pathogen
Trichophyton rubrum
S. Rezaie, F. Nourbakhsh, F. Fallahyan (Tehran, IR)
Trichophyton rubrum (T. rubrum) is an anthropophilic dermat-
ophyte. Infections caused by the fungus are mostly conﬁned to
the keratinized epithelial layer. T. rubrum is the most common
cause agents of dermatophytosis in human skin and nail tissue.
Some properties of T. rubrum have been investigated in
molecular level, however, no information is available regarding
the GTP-Binding protein in this dermatophyte. GTP-Binding
proteins regulate a variety of processes including sensual
perception, protein synthesis, various transport processes, and
cell differentiation. In the present study, we try to characterize
the GTP-Binding protein gene in this dermatophyte pathogen.
T. rubrumwas obtained from patients with dermatophytosis and
cultured in appropriate conditions. Nucleic acids (DNA and
RNA) were isolated from obtained mycelial mass by standard
methods. Pairs of 21 nt primers were designed from highly
conserved regions of the GTP-binding protein genes in other
eukaryotic cells. Mentioned primers were utilized in PCR by
using isolated genomic DNA as well as cDNA template of
T. rubrum. Predicted molecules have been ampliﬁed and were
sequenced. By the time 350 nucleotides of this gene are
sequenced. The characterization of this PCR fragments which
revealed signiﬁcant homology with other GTP-binding protein
in GenBank (NCBI, NIH, USA) is still under investigation.
R2150
Molecular characterisation of vacuolar-ATPase
gene in dermatophyte pathogen Trichophyton
rubrum
S. Rezaie, H. Khodadadi, H. Mirhendi, K. Zomorodian,
P. Kordbacheh (Tehran, IR)
Trichophyton rubrum (T. rubrum) is one of the dermatophyte
fungi which invade the skin of human. Several properties of
this fungus have been investigated so far. However a few
studies were carried out in the ﬁeld of molecular biology of
this fungus. In the present study we tried to identify the
vacuolar ATPase proteins (V-ATPase) in this fungus. Pairs of
21 nt primers were designed from highly conserved regions of
the same gene in other fungi. Mentioned primers were utilized
in PCR by using isolated genomic DNA as well as cDNA
template of T. rubrum and the PCR fragments were then
sequenced. By the time, 568 nucleotides have been sequenced
from this new gene which encodes a polypeptide with 119
amino acids. Nucleotide sequence comparison in gene data
banks (NCBI, NIH) for both DNA and its deduced amino acid
sequence revealed signiﬁcant homology with V-ATPase genes
and proteins from other eukaryotic cells. The molecular
characterization of this gene as well as deﬁnition of its possible
role in the physiological function of T. rubrum are still under
investigation. The new gene has been submitted to the
international GenBank (NCBI, NIH, USA).
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R2151
Aspergillus arthritis in an immunocompetent
patient
A. Azap, O¨. Demir, A. Kaya, D. Yagci, E. Tekeli, H. Gu¨riz,
N. Numanoglu (Ankara, TR)
Case: Aspergillus is an opportunistic pathogen that causes
severe clinical diseases in immunosuppressive patients. It is
widely distributed in nature and rarely causes disease in
immunocompetent patients. A 69 year-old immunocompetent
female patient was admitted to our hospital one and a half
month after implantation of bilateral knee prothesis. She had no
other underlying disease. Her complaints were fever, cough,
hemoptysis, pleuritic chest pain and dyspnea on the 5th week
after operation. She was hospitalized with the suspicion of
pulmoner thromboembolism and anticoagulant therapy was
started. The purulan drainage from both knees was noticed
during the follow up. Polymorphonuclear leukocytes and Gram-
positive cocci were seen in the microscopic examination of the
joint ﬂuid. Teicoplanin treatment was begun. She improved,
fever resolved but necrotic areas appeared during teicoplanin
treatment. The pathological examination of the necrotic material
demonstrated fungal hyphae and the culture grew Aspergillus
niger. Amphotericin B was started along with debridman and
the patient improved dramatically. After 42 days of amphoter-
icin B therapy, both knees and the patient were well without
prothesis replacement. She was still in good health three months
after discharge.
Conclusion: Prosthetic joint infections are troublesome
complications of orthopedic surgery. Usually Gram-positive
microorganisms cause such infections but in descending order
Gram-negative bacilli or Candida spp. may be the causative
agents. Aspergillus arthritis is a rare clinical entity especially in
immunocompetent patients. Other interesting side of this case is
the rescument of the prothesis with medical therapy and
debridman only.
R2152
Fungaemia by yeasts in a Portuguese university
hospital: epidemiology and susceptibility proﬁle
over a 2-year period
C. Pina-Vaz, A. Gonc¸alves-Rodrigues (Porto, P)
Fungaemia is reported as the 4th cause of septicemia in the
international literature, with inherent serious morbidity and
signiﬁcant mortality. No local epidemiological data on this
problem are yet available.
Objectives: To deﬁne the prevalence of Fungaemia due to
yeasts, respective risk factors, reservoirs, distribution by species
and its susceptibility antifungals pattern.
Methods: All the yeasts isolated from blood cultures during
24 months (2002–2004) at an university hospital of Porto were
collected. Data like demographical aspects, hospital department,
presence of central venous catheter or other indwelling medical
devices, concomitant diseases, as well as antimicrobial therapy
were collected.Additionally, concomitant isolation of yeasts from
distinct body sites was also registered. The nosocomial nature of
such infections was investigated. Following biochemical charac-
terization of isolates, performed by Vitek system (BioMe´rieux),
the susceptibility pattern to antifungals like amphotericin B,
ﬂuconazole, itraconazole, voriconazole and caspofungin, was
determined according to NCCLS protocol M27-A2.
Results: A total of 160 blood yeasts strains were identiﬁed,
representing 0.3% of all positive blood cultures; 31% from
Internal Medicine, 24% from Surgical Departments, 18% from
Hematology/Oncology and 17% from Infectious Diseases
Department. C. albicans and C. parapsilosis were isolated in
similar percentage, 33.5%; 12.8% were C. tropicalis; 7.7%
C. glabrata; 6.9% Cryptococcus neoformans; 2.5% C. guillermondii
and 1.25% C. lusitanea. All the strains were susceptible to
amphotericin B except C. lusitanea; 20% of isolates were
resistant (R) to ﬂuconazole, 7% being susceptible dose-depend-
ent (S-DD); 26% were R to voriconazole (MIC > 1 lg/ml); 22% R
to itraconazole while 30% S-DD; 41% were R to caspofungin
(MIC > 1 lg/ml).
Conclusion: Fungaemia due to yeasts represents is an important
concern among us, being non-albicans species of Candida
prevalent comparing with other international studies. Due to this
fact, resistance to antifungals was found in a signiﬁcant extent.
R2153
C. krusei showed promoted resistance to oxidative
stress
S. Costa-de-Oliveira, C. Pina-Vaz, A. Gonc¸alves-Rodrigues,
P. Ludovico (Porto, Braga, P)
The increase of invasive infections by non-albicans species of
Candida is of great concern as such isolates are more resistant to
antifungals. C. krusei is a paradigma example, whose pathogen-
icity is not yet full understood, being often negative for
mechanisms like germ tube formation or production of enzymes
like coagulase (1). Recent studies have implicated a role for
adaptative responses to oxidants in pathogenesis. The reactive
oxygen species (ROS) are produced mainly by phagocytic cells
of the host immune system, its microbial effect leading to the
destruction of potential pathogens.
Objectives: To study the response of C. krusei to some oxidative
stress agents.
Methods: Blastoconidea of 10 clinical strains of C. krusei and 10
strains of C. albicans were stained with 50 lg/ml of MitoTracker
Red CM-H2XRos (Molecular probes) during 15 min and
exposed to oxidant stress agents: 0.4 mM of H2O2, 0.5 mM of
menadione and 3 lM of plumbagine, all from Sigma, during
different periods of time (15, 30 and 60 min). After treatment the
cells were analysed in a ﬂow cytometer (Beckman Coulter XL-
MCL). MitoTracker Red CM-H2XRos does not emit ﬂuorescence
until entering an active respiratory cell, where is oxidized by
agents of ROS. Strains affected by those agents, ROS, will show
an increase in intensity of ﬂuorescence.
Results: All C. albicans showed an increase of the intensity of
ﬂuorescence after being exposed to oxidative stress agents,
which increased with the time of incubation. Conversely, minor
variations of the intensity of ﬂuorescence were seen in all
C. krusei strains tested.
Conclusions: C. krusei are relatively protected to agents of ROS
compared to C. albicans strains. Further work is need to clarify its
importance and role regarding pathogenicity
(1) Rodrigues AG et al. J. Clin. Microbiol. 41: 5792–5793, 2003.
R2154
Species distribution and antimycotic
susceptibility of Candida strains isolated from
pulmonary tuberculosis patients
Kulko, S. Mitrokhin (Moscow, RUS)
Objectives: To determine species of Candida fungi inducing
respiratory tract infections in pulmonary tuberculosis (TB)
patients and analyze their resistance to antimycotics.
Methods: Culture (inoculation onto Sabouraud medium with
chloramphenicol) and microscopy of bronchoalveolar lavage,
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sputum (we estimated quantitative concentration of Candida
spp. in specimens), samples from lung cavities and pleural
cavity (aspirates, biopsies), lung tissue samples (resection);
identiﬁcation of isolated strains (morphology on corn-meal agar
and CandiSelect medium, Auxacolor test-system, Bio-Rad);
antimycotic resistance determination (using microdilution
method validated with NCCLS M27-A reference method –
Fungitest test-system, Bio-Rad).
Results: During 2002–2004 we studied 502 patients with differ-
ent forms of pulmonary TB. Inoculation of clinical samples
revealed strains of Candida spp. in 163 patients (32.5%). In 89.2%
from this group culture results were conﬁrmed by positive
microscopy of clinical samples. We detected 8 species of
Candida. Detection rate of C. albicans strains was 64%, C. glabrata
– 11%, C. krusei – 9%, C. tropicalis – 8%, C. parapsilosis – 4%,
C. kefyr – 2%, C. guilliermondii – 1%, C. lusitaniae – 1%.
Susceptibility to antimycotics (ﬂuconazole, itraconazole, amph-
otericin B, ketoconazole, miconazole, 5-ﬂuorocytosine) was
tested in 328 Candida strains (211 strains of C. albicans, 41 –
C. glabrata, 27 – C. tropicalis, 24 – C. krusei, 16 – C. parapsilosis, 5 –
C. kefyr, 3 – C. guilliermondii, 1 – C. lusitaniae). Resistance to
ﬂuconazole was detected in 5% of all studied strains (in 2%
strains of C. albicans, 15% – C. glabrata, 21 % – C. krusei and 4% –
C. tropicalis). Resistance to itraconazole was in 7% strains (in 6%
strains of C. albicans, 17% – C. glabrata and 15% – C. tropicalis).
We also found strains resistant to miconazole (1% strains),
ketoconazole (3% strains) and 5-ﬂuorocytosine (2% strains).
Strain of C. lusitaniae was resistant to amphotericin B.
Conclusions: Pulmonary TB patients administered long-term
adequate course of chemotherapy (4–7 antituberculosis drugs)
compose a risk group for candidosis. Considering the experi-
mental data on Candida clinical strains resistance, we deem that
before administration of speciﬁc treatment for pulmonary cand-
idosis with ﬂuconazole and itraconazole it is advisable to identify
the strain and determine its susceptibility to antimycotics.
R2155
Candida species isolated from blood and other
sterile ﬂuids: distribution and susceptibility
K. Masselou, A. Mitroussia-Ziouva, D. Mylona-Petropoulou,
L. Zerva, H. Malamou-Lada, N. Legakis (Athens, GR)
Objective: During the last decades yeast infections have
emerged as important causes of nosocomial infections. As
Candida infections are associated with signiﬁcant morbidity and
mortality, monitoring of Candida species distribution among
signiﬁcant isolates and their resistance is required.
Material and methods: All consecutive strains of Candida spp.
isolated from blood and other normally sterile ﬂuids cultures at
the General Hospital of Athens G. Gennimatas during a 5.5-year
period (1999–2004) were examined. Isolates were speciated by
the Vitek II system (BioMerieux, France). Susceptibility testing to
amphotericin B, ﬂuconazole, ﬂucytosine, itraconazole and vor-
iconazole was performed by the E-test (AB Biodisk, Sweden);
result interpretation was according to NCCLS.
Results: A total of 81 Candida spp. strains were isolated from a
respective number of patients hospitalized in Surgery (n = 27,
33.5%), Internal Medicine (n = 39, 48%) or ICU (n = 15, 18.5%);
18 persons (22%) had received ﬂuconazole prophylaxis previ-
ously. Sixty ﬁve (80%) strains originated from blood and 16
(20%) from other sterile ﬂuid cultures. Nine Candida species
were identiﬁed. C. albicans represented the most common
(n = 32, 39.5%) followed by C. parapsilosis (n = 19, 23.5%), C.
glabrata (n = 14, 17.3%) and C. tropicalis (n = 8, 9.9%). However,
C. albicans isolation rates decreased steadily from 1999 to 2004
(from 58.3% to 22.2%), while C. glabrata isolation rates increased
(from 8.3% to 33.3%). All strains were susceptible to amphoter-
icin B (MIC, <1 mg/l) and a single C. krusei strain (1.2%) was
ﬂucytosine resistant (MIC, 332 mg/l). Resistance to ﬂuconazole
(MIC, 364 mg/l) and itraconazole (MIC, 31mg/l) was observed
in 15 (18.5%) and 24 (29.6%) strains, respectively. C. glabrata and
C. kruseiwere the species more often resistant to the azoles (9 out
of 14 and 2 out of 2 strains, 64.3% and 100%, respectively), while
C. albicans was the least resistant (1 out of 32 strains, 3.1%).
Resistance to voriconazole (MIC, >1 mg/l) was detected among
6 (7.4%) isolates, 3 strains of C. glabrata and 2 strains of C.
parapsilosis.
Conclusion: Similarly to data from other countries, our results
from Greece show increasing isolation rates of species other than
C. albicans in blood and other sterile ﬂuid cultures. Increased
frequency of C. glabrata strains resistant to conventional azoles
was detected, but voriconazole demonstrated good in vitro
activity against Candida species.
R2156
Epidemiology and in vitro antifungal
susceptibilities of Blastoschizomyces capitatus:
a 14-year overview
T. Pela´ez, L. Alcala´, J. Martı´nez-Alarco´n, J.A. Go´mez-Rodrı´guez,
N. Garcı´a-Escribano, J.V. Guinea, M.J. Goyanes, P. Mun˜oz,
E. Bouza (Madrid, E)
Background: Blastoschizomyces capitatus (BC) is an uncommon
but frequently fatal cause of invasive infections in immunocom-
promised patients, particularly those with hematological malig-
nancies. Data on its antifungal agent susceptibilities are limited.
We evaluated the epidemiology and antifungal susceptibilities
of Blastoschizomyces capitatus in our hospital during a 14-year
period.
Methods: From 1990 to 2003, 80 isolates of Blastoschizomyces
capitatus (44 patients) were recovered. The in vitro activities of
amphotericin B (AMB), ﬂucytosine (FC), ﬂuconazole (FZ),
itraconazole (IZ), ketoconazole (KZ), voriconazole (VZ) and
anidulafungin (AL) were determined by the microdilution
method (NCCLS M27-A2).
Results: The ratio of isolates to patients with B. capitatus during
the study period was: 1990–1996 (5/5), 1997–2003 (75/39).
Among the clinical isolates of BC, 23 were collected from deep
sites (9 blood, 7 lower respiratory tract, 5 sterile ﬂuid, 1 biopsy
and 1 abscess) and 67 were recovered from mucosal sites with
no systemic involvement. The overall MIC90 (mg/l) of AMB,
FC, FZ, IZ, KZ, VZ and AL against 45 available BC were: 0.5, 1,
32, 1, 1, 0.5 and 8. There were no differences in susceptibility
between isolates from deep and mucosal sites.
Conclusions: A clear increase in the rate of isolation of
B. capitatus occurred during the second period of the study in
our institution. Although there are no established breakpoints to
deﬁne antifungal susceptibility to BC, voriconazole and amph-
otericin B appeared to be the most active antifungal agents. Our
data shows the reduced susceptibility of BC to ﬂucytosine,
ﬂuconazole, itraconazole, ketoconazole and anidulafungin.
R2157
Evaluation of Candiselect4 a chromogenic
medium for yeasts differentiation
U. Nawrot, K. Wlodarczyk, J. Skala, A.P.M. Przondo-Mordarska,
N. Nolard (Wroclaw, PL; Brussels, B)
Objectives: Candiselect4 (BioRad) is a chromogenic medium
recommended by manufacturer for selective isolation of
yeasts, direct identiﬁcation of Candida albicans and presumptive
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identiﬁcation of C. glabrata, C. tropicalis and C. krusei. The
identiﬁcation is based on the species speciﬁc color and colony
morphology, namely: pink-purple for C. albicans, dark turquoise
and smooth for C. tropicalis, dark turquoise and rough for
C. krusei and pale turquoise for C. glabrata. In this study we
evaluated the performance of Candiselect 4 for the identiﬁca-
tion of clinical yeasts isolates.
Methods: A total number of 204 strains included 57 C. albicans,
43 C. glabrata, 18 C. krusei, 13 C. tropicalis, 23 C. parapsilosis, 7
C. inconspicua, 6 C. kefyr, 6 C. guilliermondi, 4 C. dubliniensis,
2 C. rugosa, 1 C. norvegensis, 1 C. lusitaniae, 1 C. lipolytica, 19 S.
cerevisiae, 2 C. neoformans, and 1 P. anomala. 13 strains were
obtained from BCCM IHEM Collection and 191 were a clinical
isolates collected in Department of Microbiology Medical
University of Wroclaw and identiﬁed previously using standard
methods (e.g. ID-32C tests, BioMe´rieux) and on the base of
rDNA restriction fragment length polymorphism. As a quality
control six typical Candida strains from ATCC and 34 bacterial
isolates were used. The yeasts cultures on Candiselect 4
medium were incubated at 37 (C for 4 days. The colony
morphology and pigmentation were read visually after every
24 h.
Results: A pink-purple colonies were found in C. albicans and C.
dubliniensis only. After 48 h a color of C. dubliniensis colonies
became purple-bluish and differ from C. albicans, which were
purple-violet with a pink halo around. The color and colony
morphology of all strains of C. tropicalis, C. krusei and C. glabrata
were in agreement with manufacturer description. Among the
remain investigated Candida and non-Candida species the color-
less or white colonies were very seldom and different shades of
blue and green were observed. There was a problem with
discrimination between C. glabrata and some C. inconspicua,
C. parapsilosis, C. kefyr, and C. norvegensis. The sensitivity
and speciﬁcity values for C. albicans were 98% and 87%, for
C. tropicalis 100% and 98.4%, for C. krusei 100% and 100%, and
for C. glabrata 100% and 90%.
Conclusion: Candiselect 4 could be regarded as a useful
medium for presumptive identiﬁcation of most commonly
isolated Candida species, including ﬂuconazole resistant.
R2158
In vitro activity of amphotericin B against
Aleuriconidia derived from Aspergillus terreus
C. Lass-Flo¨rl, A. Rief, A. Mayr (Innsbruck, A)
Aspergillus terreus is an uncommon but emerging fungal
pathogen, which causes lethal infections often refractory to
amphotericin B (AMB). It has been suggested that aleuriconidia
might be the source of AMB resistance. This study used
aleuriconidia as inoculum and compared the minimal inhibi-
tory concentration (MIC) of AMB and voriconazole (VRZ) to
those obtained for conidia of 31 A. terreus strains using a broth
microdilution method. In addition, we examined the in vitro
susceptibility of hyphae derived from aleuriconidia and con-
idia of A. terreus. The MIC ranges of AMB for conidia and
aleuriconidia were 1.25–5 lg/ml and MIC90 was 2.5 and 5 lg/
ml, respectively. The MIC ranges of VRZ for conidia and
aleuriconidia were 0.25–1 and 1–2 lg/ml, and MIC90 was 1
and 2 lg/ml, respectively. The MIC ranges of AMB for hyphae
of conidia and aleuriconidia were 1.25–5 lg/ml, and MIC90
was 2.5 lg/ml; the MIC ranges of VRZ were 1–2 lg/ml, and
MIC90 was 2 lg/ml. In conclusion, our data conﬁrm that AMB
MICs from A. terreus aleuriconidia do not differ dramatically in
comparison to MICs obtained from conidia. VRZ was signiﬁ-
cantly more active against aleuriconidia and showed consis-
tently lower MICs.
R2159
Clinical evaluation of Aspergillus-PCR for
detection of invasive aspergillosis in
immunosuppressed patients
C. Lass-Flo¨rl, G. Gastl, M.P. Dierich, A. Petzer (Innsbruck, A)
We evaluated the value of Aspergillus PCR as a tool for
diagnosing invasive aspergillosis in patients at risk. Aspergillosis
was assessed according to European Organization for Research
and Treatment of Cancer/Mycosis StudyGroup deﬁnitions. Nine
and 17 patients with proven and probable aspergillosis were
evaluated. Whole blood samples prior (n=101) and during
antifungal treatment (n=267), and tissue specimens (n=9) and/
or bronchoalveolar lavage ﬂuids (n=17) were investigated. In
patients with proven infections the sensitivities of PCR of lung
samples were 100%, of blood samples prior treatment were 66%,
during treatment 55%. Clearance of fungal DNA from blood was
associated with resolution of clinical symptoms in 2 of 4 patients
with proven infection. Consecutive positive PCR results for
Aspergillus are associated with fatal outcome as 2 of 5 patients
died. In patients with probable infections the sensitivities of PCR
of lung ﬂuids were 85%, of blood samples prior treatment were
57%, during treatment 42%. The beneﬁts of PCR diagnosing and
screening of whole blood is limited if sampling takes place once
treatment has started. The performance of Aspergillus PCR from
tissue samples should be recommended in addition to micro-
scopic examination and culture technique for sensitive detection
of fungal infection.
R2160
Identiﬁcation of dermatophytes using partially
digested ITS2-PCR
T. De Baere, T. Boekhout, B. Theelen, R. Summerbell, G. Claeys,
M. Vaneechoutte (Ghent, B; Utrecht, NL)
Objectives: The routine identiﬁcation of dermatophytes is a
time-consuming process, depending on morphology. The forms
of the spores are very informative, but this is mostly pending on
the expertise of the researcher. The objective is to design a fast,
easy and robust identiﬁcation technique which allows the
identiﬁcation to species level from cultured dermatophytes.
Methods: Internally transcribed spacer region 2 (ITS2)-PCR
followed by fragment analysis (De Baere et al., 2001) has been
shown to be a fast and reliable identiﬁcation technique for yeasts.
The used primers are universal for all fungi, so also molds and
dermatophytes. The dermatophytes are however consisting of a
variety of species of which some are highly related and ITS2-
length is identical. Therefore we added a partial restriction
digestion to increase the discriminatory power.
Results: In total 29 species (each represented by 1–5 strains)
were tested. For 16 of those species a unique ﬁngerprint was
obtained, which was different from all other species and which
was constant for all members of that species, except for 3 species
for which minor intraspeciﬁc differences were obtained. For
other species we found different ﬁngerprints, some of them
unique, some also found for other species, which leads only for
some members to a precise identiﬁcation up to species level.
Finally, a number of species had identical ﬁngerprints so that
ﬁnal identiﬁcation could not be obtained.
Conclusion: Partially digested ITS2 fragment lengths analysis
enables the identiﬁcation of dermatophytes up to species level
(for most of the species) or to a cluster of 2–4 species (which are
sometimes highly related by other methods as well). Observed
discrepancies might in part be explained but not yet resolved
taxonomy and may indicate the existence of not yet described
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species or the need for reclassiﬁcation of strains. The technique
can be seen as a fast identiﬁcation technique for most of the
routinely encountered dermatophytes. It worked especially well
for the genera Arthroderma, Epidermophyton, Microsporon
while Trichophyton species were more difﬁcult to identify.
R2161
Successful use of posaconazole in a paediatric
case of necrotising fasciitis caused by Rhizopus
K. De Decker, S. Van Poucke, M. Wojciechowski, M. Ieven,
C. Colpaert, P. Jorens (Edegem, B)
Objectives: Victims of severe trauma are susceptible to oppor-
tunistic fungal infections such as zygomycosis, a rare but life-
threatening infection commonly caused by Rhizopus species. We
describe the case of a child with necrotizing fasciitis caused by
Rhizopuswho was successfully treated with posaconazole (POS),
an investigational triazole antifungal agent with in vitro activity
against Zygomycetes.
Case Report: A 12-year-old girl sustained bilateral haemorrha-
gic contusions of the temporal brain lobes, fractures of the skull
and left tibia, and deglovement of the left leg after being hit by a
truck. Drug-induced coma was initiated to control resistant
intracranial hypertension. Initial treatment of the leg injury
included almost daily removal of necrotic skin and muscle tissue
and hyperbaric oxygen therapy. Thirteen days after the accident,
Rhizopus spp and Trichosporon oviodes were cultured from
multiple wound swabs. Subsequently, therapy with liposomal
amphotericin B (LAMB) at 200 mg/d was initiated. Three days
later, several areas of necrotic black ulcerations suggestive of
invasive zygomycosis were observed, and the patient showed
signs of sepsis. To avoid leg amputation, all suspected sources of
infection were excised, daily hyperbaric oxygen treatment was
given, and POS oral suspension (800 mg/d in divided doses)
was added to the LAMB therapy. POS was given via nasogastric
tube for the ﬁrst 28 days and orally thereafter. After 2 days,
most signs of sepsis disappeared, though the patient continued
to experience fevers for the next 2 weeks. LAMB was discon-
tinued after 9 days because drug-associated toxicity was antici-
pated. Necrotizing fasciitis responded gradually to antifungal
treatment. Two weeks after initiation of POS, Rhizopus was no
longer detected histologically or by culture of superﬁcial tissue
or muscle specimens. After 6 weeks, cultures were negative for
Trichosporon. POS was continued for 3 months. After 8 months,
neither local nor systemic fungal infection was observed. The
patient is continuing physiotherapy and can walk. Despite signs
of frontal-lobe syndrome, her neurologic status is improving.
Conclusion: POS demonstrated activity against Rhizopus and
appears to have prevented limb amputation and systemic
spread of infection. It is noteworthy that POS, as an oral
suspension, was successfully administered to an unconscious
patient. The successful outcome of this case further supports the
activity of POS against zygomycosis.
R2162
Subtyping and susceptibility testing of
Microsporum canis isolates from preadolescent
tinea capitis to four oral antifungal agents by
broth microdilution and E-test
A. Makri, M. Arabatzis, E. Alexopoulos, A. Voyatzi,
A. Velegraki (Athens, GR)
Tinea capitis, a dermatophyte infection involving the scalp hair
shaft, is primarily affecting preadolescent children. Across 19
European countries a survey conducted by the European
Confederation of Medical Mycology (ECMM) revealed that the
commonest agent of tinea capitis remains Microsporum canis
(Hay et al. J. Eur. Acad. Dermatol. Venereol. 2001;15: 229–33).
Objectives: To identify the M. canis subtypes prevailing among
isolates from preadolescent tinea capitis and determine their
susceptibility to the newer antifungals that are currently shown
to be effective, safe and of shorter treatment duration than oral
griseofulvin.
Methods: Twenty-six isolates were delineated by PCR ﬁnger-
printingwith a decamericminisatellite oligonucleotide sequence.
Broth microdilution (BMD) susceptibility testing against terbin-
aﬁne (Novartis, Basel, Switzerland), itraconazole (Janssen Phar-
maceutical NV, Beerse, Belgium), ﬂuconazole and voriconazole
(Pﬁzer Inc., Sandwich, Kent, UK),was performed according to the
NCCLSM38Aguidelines. E-test (ABBiodisk, Solna, Sweden)was
performed supplementing the RPMI 1640 mediumwith zinc and
thiamine to support M. canis growth and facilitate 48–72 h
minimum inhibitory concentration (MIC) reading.
Results: PCR ﬁngerprinting disclosed the same discrete M.
canis subtypes. The BMD range of MIC50 (mg/l) of terbinaﬁne
was 0.03-equal or greater than 0.5, itraconazole 0.03-equal or
greater than 0.25, ﬂuconazole 0.25-equal or greater than 64,
voriconazole 0.03–0.5. The overall agreement between BM and
E-test was 85–90%.
Conclusions: The proposed RPMI-1640 solid medium can
adequately support growth of M. canis for recording 48–72 h
concordant BMD and E-test MICs. Regular conventional and
molecular epidemiological surveillance and testing for antifun-
gal susceptibility to the newer oral antifungal agents is an
essential component in the management of tinea capitis.
R2163
Enzymatic proﬁle of Cryptococcus neoformans
isolates from patients with AIDS and
lymphoproliferative diseases
A. Trpkovic, S. Mitrovic, I. Radonjic, L. Petkovic,
D. Milobratovic, V. Arsic-Arsenijevic (Belgrade, CS)
Objectives: Cryptococcus neoformans is an important pathogen in
patients with impaired cell-mediated immunity and is the most
common cause of fungal meningoencephalitis. C. neoformans is a
facultative intracellular pathogen with several well-deﬁned
virulence factors that include the production of a polysaccharide
capsule, melanin and growth at 37 C. Identiﬁcation and
characterization of enzymes produced by C. neoformans are
important because of their potential role in virulence, induction
of host immune response and for epidemiological typing.
Methods: Thirty-nine strains were included in the study, 29
obtained from patients with AIDS and 10 from patients with
lymphoprolipherative diseases. The enzymatic proﬁles of
C. neoformans isolates were obtained by using the API-ZYM
system (bioMe´rieux, France) as a whole-cell assay with an
inoculum of 106 cells/ml. The phospholipase activity was tested
using the egg-yolk plate method. The ratio of colony diameter to
the diameter of the colony plus the pericolonial precipitation
zone on agar (Pz) correlated with phospolipase activity.
Results: All tested strains were identiﬁed as grubii or neofor-
mans variety by standard methods. The API-ZYM system is a
screening test for the activity of 19 enzymes. Eleven of the 19
enzymes were found to be positive and no signiﬁcant difference
between two groups of isolates was observed. The activity of
butyrate esterase was detected in 38 strains and activities of
caprylate esterase lipase, leucine arilamidase and acid phospha-
tase were registered in 37 isolates. The activities of following
enzymeswere negative: lipase, cystine arilamidase, trypsin, chym-
otrypsin, alpha-galactosidase, N-acetyl-beta-glucosaminidase,
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alpha-mannosidase and alpha-fucosidase. Seventeen enzymatic
patterns were identiﬁed according to the proﬁles obtained by
API-ZYM system. Only one strain, isolated from an AIDS
patient, was detected as phospholipase negative. There was no
signiﬁcant difference in phospholipase production between
isolates obtained from patients with AIDS and lymphoproliph-
erative diseases (mean Pz, 0.52 vs. 0.55; p>0.05).
Conclusion: We found no difference in the enzymatic activity
between strains infecting two different groups of immunocom-
promised patients. Each enzymatic activity has its own path-
way, which could be separately related to C. neoformans
virulence, and it was recently demonstrated that extracellular
phospholipase activity is a virulence factor for this fungus.
R2164
The epidemiology and antifungal sensitivity
results of nosocomial infections caused by
Candida species
B. Kurtaran, A.S. Inal, F. Kibar, A. Yaman, Y. Tasova,
N. Saltoglu, H.S.Z. Aksu (Adana, TR)
Objective: To determine epidemiologic and antifungal sensi-
tivity patterns of nosocomial Candida infections in C¸ukurova
University Research Hospital where antibiotic consumption and
nosocomial infection rate are high.
Materials and methods: Between January and June 2004, 160
patients with nosocomial candida infections according to CDC
criteria were involved. Identiﬁcation of candida isolates anti-
fungal susceptibility tests by ID 32C (bioMerioux, France) and
by ATB Fungus 2 (bioMerioux, France) respectively.
Results: In patients with candidiasis, the site of infection and
their frequency were determined as bloodstream, urinary tract
and other sites, 42 (26.3%), 104 patients (65.0%), and 14 patients
(8.7%) respectively. Risk factors statistically signiﬁcant for
bloodstream infection were determined as total parental nutri-
tion, central venous catheter and prior antibiotic use (p < 0.05).
Of all patients 77.5% and 76.2% of patients with candidemia
were hospitalized in intensive care units. C. albicans (50.6%) the
most prominent Candida species was followed by C. glabrata
(16.3%), C. tropicalis (16.3%), C. parapsilosis (10.0%), C. krusei
(3.1%), C. lusitaniae (1.2%) and C. kefyr, C. sake, and C. pulcherr-
ima. All isolates were sensitive to amphotericin B (MIC ‡ 1).
Fluconazole resistance was 4.3% and 15.6% for all C. albicans
and other species respectively. Resistance to itraconazole was
found to be higher, which was 11.4% for C. albicans, and 26.5%
for other species. Cross-resistance to itraconazole was deter-
mined in 12 of 13 (92.3%) isolates which were resistant to
ﬂuconazole.
Conclusions: The high resistance to azoles which can be
considered as indicator of inappropriate antifungal usage
should be paid attention. Empiric antifungal treatment by
azoles which is routinely used by clinicians without differenti-
ation between infection, colonisation and contamination, espe-
cially for Candida species isolated from urinary tract, threatens
the efﬁcacy and safety of antifungal therapy. Antifungal sensi-
tivity tests should be used to determine the regional antifungal
sensitivity patterns, to follow up of the patients with invasive
infections like candidemia who need long term therapy and for
determining the resistance and to choose alternative antifungal
drug for those unresponsive and have recurrent mucosal
disease.
Tropical and parasitic diseases
R2165
Loiasis with eyeworm and microﬁlaremia
M. Cosculluela, M.J. Revillo, M.L. Aisa, C. Marne, P. Palacia´n,
A. Ruiz (Zaragoza, E)
Objectives: Loiasis is a nematode parasitic infection endemic to
sub-Saharan Western Africa. Native people from endemic areas
emigrated to developed countries are often infected with this
worm. We report a case of conjunctival loiasis in a young black
male born in Guinea.
Case report: Patient was living in Spain for the last 2 years. He
complained of eye pain and noticed a worm passing through
the left eye. He was attended in the ophtalmologic emergency
care. Moderate eosinophilia (21%) was present in peripheral
blood. Inﬂammatory reactions (Calabar swellings) were not
present. After surgical and medical treatment, the patient was
discharged from the hospital. At the present time, 10 months
latter, he remains asymptomatic.
Results: The presence of migrating subconjunctival worm was
observed, and removed surgically. It was identiﬁed as a female
adult of Loa loa (55 · 5 mm). In blood samples collected during
day-time, 300 lm long microﬁlariae were observed in direct wet
smear. Hematoxylin stain showed the external sheath and
Giemsa stain the nuclei extended to the end of the tail.
Microﬁlariae discharged by the female worm were preserved
in destilled water in the laboratory at room temperature. On day
seven both free forms and eggs were present.
Conclusions: 1. The main interest of the case reported is the
observation of all forms of Loa loa cycle in humans. 2. Country
of origin and length of stay in the new residence will facilitate
correct diagnosis and treatment.
R2166
Immunisation of Arabian sheep against
haemonchosis with Haemonchus contortus
intestinal homogenate
H. Nayebzadeh, M. Seyﬁ Abadshapouri, N. Hoghooghi
Rad (Khorram Abad, Ahwaz, IR)
Haemonchosis, a disease caused by Haemonchus contortus is of
considerable economic importance in sheep cattle and goats
throughout the world. Severe infections in sheep may cause
considerable morbidity and mortality rates; even more, moder-
ate infections in lambs, may give rise to body weight reduction
and in adults cause various degrees of anaemia and decrease the
animal products. Control depends on repeated application of
anthelmintics and therefore there have been many attempts to
develop a vaccine against this disease.In a trial, in Ahwaz area,
the ability of an experimental vaccine made from the whole gut
homogenate of Haemonchus contortus was evaluated. A group
of 5 Arabian female lambs were immunized twice with 100 lm
whole gut homogenate (WGH) of Haemonchus contortus
diluted in 1 ml PBS and emulsiﬁed in 1 ml Freund’s adjuvant.
The other group (5 Arabian female lambs) received 1 ml PBS
emulsiﬁed in 1 ml of the same adjuvant. The ﬁrst immunization
was performed intra muscularly in the semi-membranous
muscles of each hind leg. Booster immunization administered
subcutaneously on day 21. On day 33 each lamb was challenged
with approximately 10,000 Haemonchus contortus third-stage
larvae. From the ﬁrst immunization until challenge the animal
were bled with an interval of 10 day and then weekly from
challenge until the end of study. Sera were tested by ELISA and
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western-blotting. Lambs were necropsied 6 week post-challenge
for recovery of nemetodes.Vaccinated lambs showed a 77%
reduction in mean EPG, 75% reduction in mean male worm
numbers, 80% reduction in mean female worm numbers and
78% reduction in mean total worm numbers. A signiﬁcant
difference in means optical density of sera in ELISA was noticed
(p = 0.001). Proteins of Hemonchus contortus gut were seperat-
ed by SDS-PAGE. Then sera of vaccinated group indicated a
high reactivity in western-blotting.
R2167
Clinical features and therapy of trichinosis in
Belarus
A. Kachanka, I. Karpov (Minsk, BLR)
Objectives: Trichinosis is a rare helminthiasis, caused by the
tissue-dwelling nematode Trichinella spiralis. The typical symp-
toms are acute onset, fever, myositis with myalgia, periorbital
edema, eosinophilia and other allergic manifestations. We
reviewed the cases observed at the Reference Center for
Infectious Diseases of the Belarus Ministry of Public Health.
Methods: The observation group consisted of 15 patients with
either mild or severe clinical trichinosis, admitted to the
Infectious Diseases Hospital of the Medical State University
over the years 2002–2004.
Results and Conclusion: The likelihood of the clinical diagnosis
was enhanced by both anamnestic and epidemiological data, and
serological conﬁrmationwas obtainedby testing IgMwithELISA.
90% of the patients presented with a typical clinical picture of
trichinosis, including fever, periorbital edema, myalgia (usually
affecting the gastrocnemius muscle), and eosinophilia in the ﬁrst
days of disease. However, 5% of the patients showed eosinopenia
(down to 2%) within the ﬁrst days, which correlated with the
severity of the disease. The clinical features of these latter patients
also included myocarditis, neurologic disorders and respiratory
failure.Treatment of trichinosis is known to be not satisfactory. In
prescribing the antiparasitic therapy, attention should be paid to
the phase of the disease, its severity and the eosinophyl blood
count. Our approach was highly individualised and consisted of
both etiologic and pathogenetic (or symptomatic) therapy. The
etiologic therapy aimed at destructing intestinal worms, prevent-
ing the development of cyst walls around the larvae, and
destructing the Trichinella larvae in the muscle ﬁbers. We used
mebendazol 0.3 g every 8 h for 10 days. This etiologic therapy
was most effective in the incubation phase or in the ﬁrst days of
disease, when localisation of Trichinella still remained intestinal.
Vice-versa, therapywithmebendazol during themuscular period
of disease not only was less effective but could also lead to a
further exacerbation of the symptoms. The symptomatic therapy
included antihistaminic and non-steroid anti-inﬂammatory
drugs. In the most severe invasive forms, we used glucocortico-
steroids (prednisolon 20–80 mg/day for 5–7 days).
R2168
Intestinal parasites in native and foreign citizens
of Athens during a two-year period
V. Skandami, C. Kotsi, C. Achilleos, C. Kontou-
Castellanou (Athens, GR)
Objectives: To determine the incidence of intestinal parasites in
citizens of Athens and analyze the difference between the
natives and immigrants coming from developing countries.
Methods: During a 2-year period (2003–2004), 1680 feacal
samples (1399 from natives and 281 from foreigners) were
examined in our hospital laboratory for the presence of parasitic
pathogens. Of them, 592 were treated in the hospital and 1088
were outpatients. The 86.9% of outpatients were workers who
were examined in order to obtain a health clearance certiﬁcate.
All specimens were examined in direct microscopy using wet-
mount and formalin-ether concentration methods.
Results: Of the 1680 specimens examined, 24 (1.4%) were found
positive for pathogen intestinal parasites: Giardia lamblia 15,
Enterobious vermicularis 5, Heterophyes heterophyes 1, Ancylostoma
duodenale 1, Entamoeba histolytica/dispar 2. In 15 specimens (0.9%)
Blastocystis hominis were detected and in 2 non pathogenic
Amoebae (Entamoeba coli and Iodamoeba butschlii). The incidence
of pathogen parasites was 0.7% for the Greeks and 5.0% for the
foreign population.
Conclusion: The frequency of intestinal parasitic infection in
Greece, is relatively low but not rare, especially during the
recent years because many immigrants coming from developing
countries have introduced new parasites. The alertness of public
health services is critical in order to prevent parasite spreading
from the carriers to the healthy population.
R2169
Control of coccidiosis in poultry
K.K. Hayat (Dera Ghazi Khan, PAK)
An egg adapted gametocytes, E. tenella, vaccine(s) were used
against coccidiosis in chickens. On day ﬁve chicks were divided
into four groups and administered vaccine(s) orally viz; Vaccine
I (gametocytes), Vaccine II (gametocytes inactivated), Vaccine III
(gametocytes sonicated inactivated) and fourth group was
served as control given normal saline. On day 15 immunized
chicks were challenged with 60,000–70,000 sporulated oocysts of
mixed species of Eimeria. A total of 126 birds were used in this
study out of them 94 birds were scariﬁed and 32 chicks died
during challenge response. On day 21st post vaccination birds
were subjected to postmortem and their lesions score were
recorded. A maximum of 46 birds having lesions in intestine
and caeca of Group-IV birds were observed while a minimum of
17 birds having lesions in intestine and caeca were observed in
Group-III. There was non-signiﬁcant difference (P > 0.05) in
lesions score of Group-I, II and IV. Lesions scores in Group-III
were signiﬁcantly different (P > 0.05) from Group-I, II and IV.
R2170
Molecular characterisation of a HSP70 gene from
Entamoeba dispar
S. Rezaie, M. Rezaian, A. Bairami (Tehran, IR)
Entamoeba histolytica infects more than 480 million people
annually worldwide which cause the mortality of about
50–110 thousand patients every year. Resent studies revealed
that the agents of Amoebiasis which isolated from infected as
well as non-infected individuals can be classiﬁed as two species;
Entamoeba histolytica as infectious and Entamoeba dispar as non
infectious. As these two species are morphologically similar to
each other, the differentiation of them will need speciﬁc tests
regarding iso-enzyme as well as modern molecular methods
including PCR. In the present study, we tried to characterize the
70 kDa Heat Shock Protein of Entamoeba dispar at molecular
leveland compare it with that from Entamoeba histolytica. With
these ﬁndings, we will be able to gain more information about
this protozoon and the new methods for distinguishing it from
the infectious Entamoeba histolytica. For this purpose, we have
isolated genomic DNA from Entamoeba dispar and used it as
template in the PCR. This has been performed by using
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designed primers from highly conserved parts of other HSP70
genes in eukaryotic cells. The result indicated some DNA
binding patterns in agarose gel which may be some parts of
HSP70 gene from Entamoeba dispar. The analyses of these
genomic parts are still under investigation.
R2171
Experimental amoebiasis: immunological aspects
A. Zavgorodyaya, K.O. Hovnanyan, A.G. Mkhitharyan,
L.V. Karabashyan, A.M. Arzumanyan, K.G. Karageuzyan
(Yerevan, ARM)
Cellular immunity was studied in the course of immunization
of animals and during their conseguent infection with Ent-
amoeba histolytica, 81 reedleswe albino rats being employed. 4
strains of polyxenic culture Ent.histolytica were used isolated
from patients and carriers. For immunization of rats, the killed
antigen composed 50,000 trophozoies per 1 ml of the medium
was administered subcutaneously 5 times at a weeks interval.
A week following the immunization the rats were infected
through caecum with 0.5 ml of the live culture containing
about 100,000 trophozoites. On days 6–9 p.i. all the rats
appeared to be infected. On days 14–21 and 28 p.i.(the end of
the observation ), 93 and 97% of infected animals were
registered respectively. The control animals were not infected.
Up to the 6th day, 75% of young rats were infected. In most of
the infected adult (91.3%) vegetative forms of Ent.histolytica
were found in the caecum and moderate morphological
changes were observed in 72.8% of these (hyperemia, oedema,
haemorrhage, ulcer). In the submucous membrane of almost all
the experimental animals vascular perivascular mononuclear
inﬁltration was observed. With the help of the migration
inhibition reaction of macrophages, it has been established that
in the process of immunization and subseguent infection
lymphocytes sensible to amoebic antigen appear in the rat’s
body. The danger the observation the higher the degree of
body sensibilization. The evidence presented shows that the
cellular mechanisms of immunity the of great signiﬁcance in
the pathogenesis of amoebiasis.
Sexually transmitted diseases (except HIV)
R2172
Study of Chlamydia trachomatis and Chlamydia
pneumoniae as a cause reactive arthritis
K. Themeli-Digalaki, E. Orcopoulou, J. Miriokefhlitakis,
S. Varveraki, M. Economou, L. Spaliara, C. Koutsia Carouzou
(Athens, GR)
Objective: To study the role of Chlamydia trachomatis (Ct) and
Chlamydia pneumoniae (Cp) in patients with reactive arthritis
(ReA).
Methods: We examined 72 patients with ReA aged 22–
774 years (45 women & 27 men) during January 2002 to October
2004. The control group consisted of 25 healthy persons same
age with patients but without any arthritis problems. All
specimens from urethra were tested by direct immunoﬂuores-
cence (DAF), while serum samples by MIF test for speciﬁc IgA
and IgG antibodies to Chlamydia.
Results: Chlamydia trachomatis and Chlamydia pneumoniae in 28
of 72 patients (38.7%) were detectived fulﬁlled diagnostic
criteria of ReA. From the control group, Ct was found in only
one case. Analytically, in three patients (4.1%) with acute ReA
after an upper respiratory tract infection with Cp. The serolog-
ical ﬁndings were as follow: IgA antibodies titres >1/20 and IgG
>1/512. Chlamydia trachomatis was diagnosed in 25 patients
(34.6%). Nineteen out of them had retinitis prior to arthritis. The
diagnosis by DAF in 23 patients and in 2 by MIF.
Conclusions: (1) The data suggest that Ct and Cp were
diagnosed in nearly a half (40%) of Rea patients. (2) Prior
respiratory or urogenitical infection with the clinical presenta-
tion of arthritis and detection of Chlamydia may lead to the
etiological agent of Reactive arthritis.
R2173
The genital infection as the trigger of
development of a myoma of the uterus
A. Tikhomirov, S. Sarsaniya (Moscow, RUS)
Objectives: The estimation of efﬁciency anti-inﬂammatory
therapies in complex treatment of a myoma of an uterus.
Methods: There were surveyed 320 patients with a myoma of
an uterus. The clinical, bacteriological, immunohistochemical,
pathohistological, PCR-researches myometrium, endometrium,
a serous cover of a uterus, myomatous units were carried out.
The studying of anamnestic material by method ’’the case-
control’’.
Results: The inﬂammatory diseases of genitals were preceded
and accompanied in half of the patients of leiomyoma. In 60%
various combinations of pelvic inﬂammatory disease. The
method ’’the case–control’’ has revealed a high risk of
development of a myoma of an uterus (the relative risk of
occurrence by a parameter of the attitude of chances is 1.75)
in patients with inﬂammatory diseases of genitals. The
bacteriological research of 80 myomatous units, has revealed
the associated microbic ﬂora in them, in comparison with non
changed fabrics of a uterus. Identiﬁcation of ﬂora by carrying
out 400 PCR testiﬁes to presence Chlamydia trachomatis (mainly
in submucous) and Ureaplasma urealyticum (in intermuscular-
subserous) myomatous units, even at their absence before
operation in underlying departments of sexual ways. Patho-
histological research of non struck with a myoma uteruses,
removed concerning endometritis in a combination with
purulent tubo-ovarian formations in three women of 24–
25 years old, has shown formation of the reclaiming rudi-
ments consisting from proliferated, concentrically located
smoothly-muscular cells (SMC) around the inﬂammatory
inﬁltrates in myometrium-leiomyomatoz. Immunohistochemi-
cal researches with PCNA have established its accumulation
in nucleus SMC in inﬂammatory mononuclear inﬁltrates zones
in myometrium at endometritis, that is considered by us as
the trigger of a myoma of an uterus.
The conclusion: In our opinion, uterin ﬁbroid embolization
(UFE) is a prime method of a choice in treatment of a myoma
of a uterus. In some cases there is a risk of secondary
infection in degradation of unit or allocated myomatous
detritus, that can demand hysterectomy. Taking into account
all set forth above, before carrying out UFE, in our practice,
we used: Fromilid 500 mg twice a day during 10 days +
Tiberal 500 mg twice a day during 10 days. Using the given
circuit, in complex treatment of a myoma of an uterus, has





Comparative evaluation of effectiveness of
urogenital clamidiosis treatment with antibiotics
and ozonotherapy
N. Sarapulova, N. Guryanova, T. Kolesova (Perm, RUS)
Objectives: The aim of this study is to examine the comparative
evaluation of urogenital clamidiosis treatment with antibiotics
and ozonotherapy in women of childbearing age.
Methods: were two groups of women of childbearing age from
20 to 45 years old with urogenital clamidiosis under investiga-
tion. I group of 37 patients were treated with classical antibiotics
treatment regimen. II group of 31 got ozonotherapy as intra-
venous introduction of ozonized physiological solution 200 ml
with concentration 2–3 mg/l, N. 7–12 and ozonized oil was
used locally. Estimation of the therapy results in both groups
was held twice with the month interval with the use of enzyme
immunodetection (EI) (diagnostic antibody titre 1:32 and more)
and direct immunoﬂuorescence (DI).
Results: Both groups of patients had identical results by
serologic and bacterioscopic methods before the treatment.
87% of women in I group and 90% in II had positive results of
DI. Median geometric of titre (MGT) in EI in I group was 6.224,
in II – 6.006 (P > 0.05). Diagnostic antibody titres had 91.9%
patients in I group and 93.6% in II (P > 0.05).After treatment,
during the ﬁrst control of DI positive results were noticed in 73%
of patients in I group and 84% in II (P £ 0.05). During the second
control of DI elementary bodies of C. trachomariswere deﬁned in
16.2% women in I group and II group they didn’t revealed.
Dynamic estimation of the serum examinations by EI during the
ﬁrst control discovered not authentic lowering of MGT in I
group from 6.224 to 5.324 (t = 1.84) and authentic lowering of
MGT in II group in 1.3 (t = 2.57). Second control showed lack of
antibodies titres lowering dynamic in I group: MGT before
treatment 6.224, MGT of second control –5.958 (P > 0.05) and
positive dynamic patients of II group – MGT before treatment
6.006 and during second control 4.655 (P £ 0,05). Control
laboratories examinations discovered C. trachomatis eradication
in 30% of patients in I group and in 67.7% in II (t = 3.36).
Conclusion: Classical antibiotics treatment of urogenital cla-
midiosis undoubtedly gives positive results. However, high
effectiveness of ozonotherapy in urogenital clamidiosis treat-
ment showed the possibility of using this method like alternat-
ive treatment.
R2175
Diagnosis of Chlamydia trachomatis infection in
a sexually transmitted disease clinic using
polymerase chain reaction in endocervical,
urethral and rectal swab
C. Nocales, M. Ramirez, I. Pueyo, R. Claro, L. Perez,
E. Martin-Mazuelos (Cadiz, E)
Objectives: The aim of this study is to show the incidence and
the most important characteristic of C. trachomatis (CT) infection
in a group of patients with sexual risk behaviours who are
followed in a sexually transmitted disease clinic (STD).
Methods: Our study included 2412 patients, aged 30.1 (55%
women and 44%men) attending in STD clinic from January 2002
at December 2003. Of all the patients attending, 50% have sexual
risk behaviours (47% female commercial sex workers (FCSWs),
45% men who have sex with men (MHM), 8% men and women
with a new sexual partner or more than one partner during the
previous 3 months. All of them were attending for symptoms,
periodic revisions and epidemiology control of sex partner. A
total of 3136 specimens (1645 endocervical, 1189 urethral, and
302 rectal swab) were analysed. The samples were recovered
following the STD system (Swab specimen Collection and
Transport kit, Roche diagnostic system). The diagnosis was
performance using PCR techniques with COBAS Amplicor CT
system (Roche Molecular System). The patients with CT positive
had come for follow-up examination 4 weeks after treatment for
CT infection with a single oral 1.0 g doses of azithromycin.
Results: There were 139 patients with a positive results for CT.
Of all samples, 155/3136 (4.5%) were positive [55 female (40%)
and 84 male (60%)]. The incidence of CT was 5.7% (4.1% female
and 7.8% male). The endocervical swabs were positive in 3.3%.
Sexual risk behaviours were: 54.6% FCSWs, 40% women who
did not have any risk factors for sexual transmitted infection,
4.5% promiscuous women. The 78.2% were asymptomatic. The
urethral swabs were positive in 6%, and rectal swabs in 7%.
Sexual risk behaviours were 52.4% MSM, 22.6% without risk
factors, 25% promiscuous men. The 42.8% were asymptomatic.
The detection of the CT infection was performance by screening
programme for STD clinic.
Conclusion: 1. PCR is an sensitive and speciﬁc test for the
detection of CT infections. 2. We recommended the rectal swab
with the other samples (endocervical and urethral) in patients
with sexual risk behaviors. 3. To reduce CT infections we
recommended screening programme in STD clinic to asympto-
matic infections.
R2176
Detection of Chlamydia trachomatis infection
using leucocyte culture
T. Saralidze, T. Shvelidze, P. Gabunia, L. Mohchevishvili,
G. Saralidze, K. Kiladze (Tbilisi, GEO)
Complications of latent and chronic chlamydial infection is
continuing to be a problem in medicine. The clinical onset of
these cases is unexpectedly wide while the origin of complica-
tions is often concealed and detection of Ch. trachomatis plays
important role to work out the problem-based treatment. The
bone marrow and blood leucocytes culture system was adjusted
to the investigation of Ch. trachomatis in vitro. This method helps
to reveal concealed infection in chronic cases and observe
behavior and kinetic of bacteria in cells and estimate the activity
of infection according to the cell damage and dissemination of
bacteria in cells. We investigated Ch. trachomatis infection in 25
active sportsmen with different unclear symptoms and revealed
this infection in 20 of them. Besides in 15 sportsmen immune
reactivity of organism according to the macrophage–lymphocyte
rosette formation in vitro was signiﬁcantly decreased while in
the rest this index fell in the low range of the normal values. The
sportsmen were treated by the combination of modern chem-
otherapeutical drugs (Josamycin, Asitromycin, Doxacyclin etc.)
and immunomodulators. After clinically effective treatment
immune reactivity of organism was improved and Ch. tracho-
matis bacteria was detectable in culture in 8 cases (though in
some cells) pointing to the existence of bacteria in organism
pointing to the necessity of further antichlamydial treat-
ment.Our studies show that blood leucocyte culture is useful
for the detection of chlamydial infection and for the estimation
of immune reactivity of organism as well especially in clinically
unclear cases.
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R2177
Micro-organisms isolated from urethral exudates
from males in a Spanish teaching hospital
D. Monclu´s Arroyo, D. Domingo, A Pe´rez de Ayala, J. Azcona,
J. Dı´az-Regan˜o´n, M. Lo´pez-Brea (Madrid, E)
Objectives: The purpose of this study is to determine the most
commonly isolated microorganisms from urethral exudates
from male patients in a teaching Hospital of Madrid over a
three-year period.
Material and methods: We performed a retrospective study
from January 2001 to December 2003 of 595 urethral exudates
from male patients with an average age of 39.57 years. Urethral
samples were processed by conventional methods: a gram stain
and a culture in an appropriated solid media (blood agar,
chocolate agar, Tayer–Martin agar and a commercials kit for
detection of mycoplasma) were performed. Isolates were
identiﬁed by conventionals test and an automated system
(Micro-Scan. Dade-Behring) or manual biochemical systems:
API Strep, API 20NE, API NH (bio Merieux).
Results: Two-hundred and thirteen (36%) out of the 595
patients, were positive (average age: 38.95). Seventy-one
(33%) were immigrants,118 patients (55%) came from primary
care and 95 (45%) from Hospital. The microorganism most
frequently isolated was Ureaplasma urealyticum, in 70 cases
(33%), followed by Neisseria gonorrhoeae in 47 cases (22%).
Other species commonly isolated were: Streptococcus agalactiae
(12%), Haemophilus spp. (8%), Escherichia coli (5%), Candida
albicans (4%), as well as other species of microorganisms.
(15%).
Conclusion: An important number of patients with suspicion of
sexual transmitted disease showed positive cultures. Ureaplasma
urealyticum and Neisseria gonorrhoeae were the most commonly
isolated microorganisms in urethral exudates.
Molecular virology (incl. diagnostics)
R2178
Automated DNA extraction inﬂuences the
sensitivity of PCR-based molecular diagnostics
T. Schuurman, A. van Breda, R.F. de Boer, M. Beld,
P.H.M. Savelkoul, A.M.D. Kooistra-Smid, R. Boom (Groningen,
Amsterdam, NL)
Objectives: Direct detection of microbial DNA in clinical
samples like blood or cerebrospinal ﬂuid (CSF) requires a
reliable DNA isolation procedure and a sensitive PCR ampliﬁ-
cation, due to low microbial loads in these clinical samples. In
this respect optimal recovery of target DNA during extraction is
necessary. In this study we compared the performance of DNA
recovery of the automated Roche MagNA Pure Total Nucleic
Acid Isolation Kit (M-extraction) and the manual Boom extrac-
tion method (Si-extraction).
Methods: DNA recovery experiments were conducted with
PBS, CSF, plasma and whole blood (4–8 replicates for each
sample matrix) for both methods. Other reconstruction experi-
ments were performed with positive control DNA’s for EBV and
VZV (2 dilutions, tested in 5-fold) in PCR negative blood and
analysed by PCR. Also serial diluted CMV was spiked in CMV
negative blood (4 dilutions tested in 8-fold) and analysed by
CMV PCR. Finally clinical blood samples were tested for EBV
(n = 23) and CMV (n = 16) by both methods.
Results: Recovery experiments showed reduced recovery for
M-extraction (~20%) compared to Si-extraction (>80%) for all
matrices tested. Part of the missing DNA from the M-extraction
could be retrieved from binding (~20%), washing (~5%) and
silica matrix (~15%), leaving ~40% of the DNA irretrievable.
Positive control DNA’s showed between 7.6 and 14.2 and 1.9
and 7.9-fold lower PCR signals after M-extraction, compared to
Si-extraction for EBV and VZV respectively. PCR analysis of
spiked CMV showed reduced recovery and loss of sensitivity for
M-extraction, resulting in 0% (0/8) and 88% (7/8) hit rates for
the lowest spiked CMV loads, whereas Si-extraction obtained
50% (4/8) and 100% (8/8) hit rates. In clinical blood samples this
resulted in 11 false negative and 1 invalid result(s) for M-
extraction, compared to 1 false negative result for Si-extraction.
Similar results have been obtained with other lots of the M-
extraction reagents over a 4 year time period and with 2 MagNA
Pure LC instruments.
Conclusion: The M-extraction seems to have a substantial lower
DNA recovery compared to Si-extraction, leading to reduced
sensitivity and possible false negative results with low microbial
loads in molecular diagnostic methods. Before implementing the
M-extraction the clinical consequences of the loss in sensitivity
should ﬁrst be considered, especially when maximal sensitivity
is required. The quality of the DNA from both methods seems
identical.
R2179
RT-PCR analysis of fulminantly dead Iranian
patients with Crimean- Congo haemorrhagic
fever symptoms and without antibody response
to CCHF
S. Chinikar, R. Mirahmadi, V. Mazaheri, F. Ahmadnejad,
A. Niknam Asl, M. Bouloy, R. Flick, H. Feldmann, A. Lundkvist,
A. Mirazimi, M. Nilsson (Tehran, IR; Paris, F; Galveston, USA;
Winnipeg, CAN; Stockholm, S)
Objectives: CCHF is one of the most important zoonoses. The
virus is from Bunyaviridae family and Nairovirus genus and has
an RNA genome with 3 segments. CCHF is an arboviral disease
transmitted by tick bite or by handling of infected blood, tissues
or nosocomially. After the foundation of our lab in 2000, we
worked on this matter in Iran and found 20, 62, 99, 49 and 17
IgM positive cases in 2000, 2001, 2002, 2003 and 2004, respect-
ively. On the other hand as many patients died fulminantly with
haemorrhagic syndromes and negative serological results and
the cause of death was unknown for the physicians, so we
decided to clear up the main cause of death by RT-PCR analysis
for detection of CCHF genome in order to diagnose and treat the
disease precisely.
Methods: In this study, from 7 June 2000 to 15 October 2004
three sequential serum samples were collected from each of 682
suspected patients throughout the country. In these sera, speciﬁc
IgM and IgG antibodies against CCHF, Yellow Fever (YF), Rift
Valley Fever (RVF) and Dengue2 (D2) have been quantiﬁed by
Elisa method. Also by using RT-PCR method, the presence of
the 2 fragments (226 and 536 bp)in the S segment of CCHF
genome has been tested.
Results: The results show that among 682 suspected cases, 247
were IgM positive and had enough time for antibody generation
because they died later or survived. By studying 83 fulminantly
dead cases, 27 were IgM positive and from 56 cases who died
fulminantly without enough time for IgM generation, 17 were
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RT-PCR positive. This result shows the importance of molecular
analysis because if only serological tests had been done on them,
they had been considered negative but now we know that
30.35% (17/56) of them are RT-PCR positive. All of the sera were
negative for YF, RVF and D2.
Conclusion: Our results show that CCHF is the most important
agent of Viral Haemorrhagic Fevers in Iran. The great number of
IgM positive cases indicates that the patients have been infected
recently by the virus. As many patients die fulminantly and
have no time for antibody generation, by using RT-PCR in all of
these IgM negative dead cases, we can determine the cause of
death of these suspected patients. The rapid diagnosis of the
disease by detection of virus genome is an effective help for the
physicians to start on time supportive and antiviral treatment
and prevent predictable deaths. Our work shows the cause of
some unknown deaths and regards its beneﬁts and importance
we decide to continue this research.
R2180
Rapid identiﬁcation of human T-cell leukaemia
virus type I using a PCR method
N. Ortiz, M. Basaras, J. Beltran, E. Arrese, R. Cisterna (Bilbao, E)
Background: The human T-cell leukaemia virus type I (HTLV-
I), is the etiological agent of adult T-cell leukaemia–lymphoma
(ATLL) and HTLV-I associated mielopathy/tropical spastic
paraparsis (HAM/TSP). In HIV coinfected patients only rare
cases of cutaneous T-cell lymphoma. HTLV-I infect T cells and
reverse transcribe its RNA into DNA, witch integrates into the
host cell genoma. The aim of our study was to evaluate a PCR
technique for the diagnosis of HTLV-I infection in clinical
samples of peripheral blood mononuclear cells (PBMCs).
Materials and Methods: A PCR approach was adopted to
detect HTLV-1 infection in clinical samples of peripheral blood
mononuclear cells (PBMCs) from subjects with leukaemia and/
or lymphoma from Basurto Hospital. The PCR was designed
using primers from the pol and tax genes of human T cell
leukaemia virus type I. The assay reliably detected a single copy
of HTLV-I proviral genome in DNA from 1 x 105 PBMCs. We
also included in each sample the HLA DQ alpha gene to check
the presence of PCR inhibitors and the quality of DNA
extraction. As positive control we used HTLV-I infected MT-2
cell line maintained in RPMI, supplemented with FBS, gluta-
mine, penicillin and streptomycin.
Results: After analyzing 30 patients, all of then presented the
band of the HLA DQ alpha gene (242 bp), indicating that the
PCR had been carried out under good conditions. Our results
showed that the PCR quickly solved the diagnostic query,
detecting the presence of proviral HTLV-I DNA in two of 30
patients in both genes (188 bp for pol gene, and 156 bp for tax
gene).
Conclusion: The main advantage of this method is the rapidity
(5–6 hours) of the performance of the assay and its sensitivity is
comparable with other HTLV-I PCR formats. Both genes, pol
and tax, could be used to evaluate HTLV-I viral infection in
PBMCs clinical samples.
R2181
Quantitation of CMV, EBV and HBV using new
sensitive real-time PCR assays
N. Finnstrom, A-M. Jonsson, M. Nygren, S. Palm, V. To¨rma¨nen,
A. Hedrum (Bromma, S)
Objective: New therapeutic options have led to considerable
improvements in viral infection management and it is also clear
that such treatment requires careful consideration and follow-
up. Monitoring of viral load in immuno-compromised patients
applying a pre-emptive disease management strategy is
important to manage opportunistic infections and prevent
disease. In order to meet the growing clinical demand for
these patients, three sensitive assays have been developed for
measuring CMV, EBV and HBV viral DNA in serum, plasma or
whole blood.
Method: Real-time PCR quantitation utilising the Scorpion
technology provides sensitive and rapid methods for determin-
ation of CMV (afﬁgene CMV trender), EBV (afﬁgene EBV
trender) or HBV (afﬁgene HBV trender). An internal control
(IC) is included in each sample to indicate for the effects of
inhibition, and control for sample preparation, ampliﬁcation and
detection. A manual sample preparation protocol with input
volumes from 50 to 1000 ul (serum, plasma or whole blood) is
used.
Results: Performance testing demonstrated: afﬁgene CMV
trender: assay sensitivity (95% positivity-rate) of ~100 copies/
mL and at least 6-log dynamic range for CMV clinical speci-
mens. Equivalent quantitation of CMV strains has been shown
using clinical specimens.afﬁgene EBV trender: assay sensitivity
(95% positivity-rate) of <500 copies/mL and at least 6-log
dynamic range for EBV clinical specimens. Equivalent quantita-
tion of EBV genotypes A and B has been shown using clinical
specimens. afﬁgene HBV trender: assay sensitivity (95%
positivity-rate) of <4 U/mL and a 8-log dynamic range for HBV
clinical specimens. Equivalent quantitation of HBV genotypes
A–H has been shown using clinical specimens and quantitated
genotype plasmids. Normal blood donors were negative for
HBV by serology. No cross-reactivity for potential cross-reactive
pathogens has been observed in any of the assays. Correlation
between titers generated with all three assays correlate well with
the 2002–2004 QCMD/VQC sample panels.
Conclusion: The afﬁgene trender tests provide robust meth-
ods for monitoring viral DNA levels in immuno-compromised
and transplanted patients. The assays performance is well
suited for monitoring patients being treated with the new
efﬁcacious therapies for viral diseases and for studies designed
to determine the relationships between viral load and the
disease state of the emergence of drug resistance.
R2182
Development and validation of the ﬁrst open
system CE marked real-time PCR kit for the
detection and quantitation of hepatitis B virus
P. Herzog, S. Wach, M. Hess, T. Laue (Hamburg, D)
Objectives: Artus GmbH has developed and established the
ﬁrst CE marked quantitative Hepatitis B Virus (HBV) detection
Kit for use with the LightCycler Instrument (Roche). The assay
was validated utilizing an efﬁcient, CE marked viral DNA
isolation system (QIAamp DSP Virus Kit, Qiagen). One of the
objectives was to establish a highly sensitive and reliable in vitro
diagnostic Kit, which can be run on open systems.
Methods: All validation experiments were done by using
plasma samples, spiked with known amounts of HBV particles.
Extraction and ampliﬁcation were done using the QIAamp
DSP Virus Kit and the LightCycler Instrument, respectively.
For the determination of the viral load the HBV LC PCR Kit
quantitation standards were calibrated against the 1st Interna-
tional Standard preparation (WHO 97/746). Therefore, the
quantiﬁcation results are deﬁned as international units (IU).
Genotype detection studies were done with the HBV Genotype
Panel (15 Member, Teragenix). Each genotype was tested in a
0.5 log dilution series 4 times. The correlation of quantiﬁcation
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results was determined by analysing 117 clinical samples with
the Cobas Amplicor HBV Monitor System (Roche) and the
HBV LC PCR Kit in parallel.
Results: The detection limit was determined to be 5.8 IU/ml at
a detection rate of >95%. The linear range of the assay was
determined to cover concentrations from 20 IU/ml to at least
4 x 10 E9 IU/ml. In contrast to other HBV detection systems
(e.g. Cobas TaqMan, Roche) the HBV LC PCR Kit was able to
detect all members of the HBV Genotype Panel with a sensitivity
below 100 IU/ml. The diagnostic sensitivity and speciﬁcity were
determined to be >99%. The quantitative correlation (1.0 log
range) with the Cobas Amplicor HBV Monitor system was
determined to be 95.91%.
Conclusion: It has been shown, that the HBV LC PCR Kit
developed and established by artus GmbH performs in respect
of sensitivity, speciﬁcity, quantiﬁcation, reliability and turn-
around time (about 3 hours) at least as good or better than all
other currently available HBV detection and quantiﬁcation
assay.In addition the HBV LC PCR Kit is the ﬁrst HBV detection
and quantitation assay designed to work on open systems,
demonstrating the usability of research grade sample prepar-
ation systems and real-time PCR instruments for clinical in vitro
diagnostics. The HBV LC PCR Kit is in complete accordance to
the EU IVD Directive 98/79/EC.
Viral diseases (not HIV, Herpes, Hepatitis)
R2183
Parainﬂuenzae tybe B meningitis with autonomic
nerve involvement: a case report
K.K. Yasar, G. Sengoz, S. Gulduren, G. Ergin, F. Yildirim,
D. Berzeg, O. Nazlican (Istanbul, TR)
Objective: The most frequent causes of aseptic meningitis are
viral meningitis. The causative agent cannot be shown by
routine methods of staining and culturing of cerebrospinal ﬂuid
in viral meningitis, lymphositic pleocytosis with increase in
protein levels and decrease in glucose levels may be seen.
Mumps virus, enteroviruses, HSV are frequent causes of viral
meningitis, while parainﬂuenzae virus is a rare cause.
Methods and results: In this study, a 26 year-old male patient
who applied with fever, headache, and disuri, and had lympho-
sitic pleocytosis, increase in protein, and decrease in glucose
levels of his cerebrospinal ﬂuid, and who was diagnosed by
determining speciﬁc antibodies against parainﬂuenzae virus
type B as viral meningitis, is reported. He had symptoms like
globe vesicale, hypertension resistant to therapy, tachycardia,
hyperthermy, and dry skin which showed involvement of the
autonomic nerve system. Autonomic nerve system pathologies
like acute pandisautonomic neuropathy can be seen following
infections like rubella, infectious mononucleosis. In order to
show autonom neuropathy MUAP (Motor Unit Analysing
Potential) test was performed. Cardiac autonom nerve involve-
ment was shown by determination of loss of changeability in
P-R interval by breathing.
Conclusion: The patient recovered spontaneously and was
discharged from the hospital after 40 days.
R2184
Epidemiology of human metapneumovirus in
Western Austria
C. Larcher, H.P. Huemer (Innsbruck, A)
Human Metapneumovirus (HMPV) is a newly discovered
Paramyxovirus which causes respiratory infections. In this
study we tested 266 respiratory samples from the local paedi-
atrics department and from adult transplant patients for active
replication of HMPV by a combined cell culture/PCR method.
Most of the HMPV cases clustered within 2 major outbreaks in
October/November and March, whereas only few isolations
were obtained from December to the end of February, in most
cases from immunosuppressed patients. Sequencing analysis of
the isolated viruses revealed that a single strain predominated
the 2 outbreaks whereas a clearly different genotype was
detected in the interepidemic period. As the same strains were
detected in small children (< 2a) and immunosuppressed adults,
active transmission within the population can be assumed.
Prolonged HMPV shedding was observed in some patients after
lung transplantation, although also these patients despite
immunosuppression seemed to be able to clear the virus after
some months.
R2185
Cytomegalovirus infection and biliary atresia in a
newborn infant
K. Mandraveli-Hatzikosta, M. Pape-Chrisaﬁ, M. Fotoulaki,
D. Papadopoulou, S. Alexiou-Daniel (Thessaloniki, GR)
A 2-month-old female infant was admitted to the paediatric
clinic because of progressive and unexplained jaundice and light
coloured stools. Symptoms began 20 days before admission. On
examination, pediatricians found distened abdomen, hepato-
megaly and enlargement of the spleen. The ultrasound test
detected a tiny gall bladder, while during the HIDA scan test the
radioactive dye could not ﬂew through the billiary system.
Blood tests showed the following: PT and PTT times were
prolonged, repeatedly blood cultures were negative and sero-
logic tests ruled out an acute infection with A, B, C and E
hepatitis viruses, HIV, HSV, VZV, EBV, Rubella viruses,
Toxoplasma gondi and Coxiella burnetii. CMV serologic study
was based on the perfomance of ELISA ( DiaSorin s.r.l.) and IFA
( PANBIO, inc ) methods. Sera samples were collected on the 1st,
5th, 8th day after admission. CMV IgG antibodies were found
positive by ELISA test (54 Au/ml, 60 Au/ml, 66 Au/ml,
respectively ). In all the tested samples CMV IgM antibodies
were found positive by both ELISA (+) and IFA tests ( 1:40, 1:80,
1:80 respectively ). At the same times, PCR analysis was carried
out (COBAS AMPLICOR CMV MONITOR test) and detected
CMV-DNA in blood and urine samples. Only the ﬁrst blood
sample was positive (5.2 · 102 copies/ml), while two urine
samples were CMV positive (3.45 · 103, 2.69 · 104 copies/ml). The
baby’s mother was CMV-IgG (+) 236 Au/ml and CMV-IgM (-).
CMV-DNA has not been detected in her blood and urine
samples. Under antiviral treatment with ganciclovir ﬁrst the
blood on the 5th day, and then urine samples on the 8th day
became negative. However, this did not affect the progressive
damage of the liver. Portal hypertension and hepatic coma
eventually occurred.
Conclusion: CMV perinatal or congenital infection may
participated in the etiopathogenesis of the the neonatal
cholestasis. The cause is difﬁcult to be determined, since
there was no history of maternal CMV infection and the
serology of the mother was unknown before and during
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pregnancy and at the time of the birth. At that time, the
serology of the infant was also unknown and CMV-DNA was
detected 2 months later.
R2186
Seasonal distribution of gastroenteritis viruses in
Bosnia and Herzegovina during 2002/2003
I. Salimovic- Besic, M. Hukic, E. Dervovic (Sarajevo, BIH)
Objective: The relative importance of the different enteropath-
ogens depends on a variety factors. Some of them are geo-
graphical location and season of study.
Methods: 547 stool specimens of patients with acute gastroen-
teritis were examined for viruses by direct electron microscopy
using negative staining method and by qualitative direct EIA for
the detection of rotaviruses group A, adenoviruses and astro-
viruses.
Results: Data were analysed monthly from July 2002 till June
2003 (included). During the Summer- Autumn time (July–
September 2002) the major viral causative agent of gastroen-
teritis was the diverse group of caliciviruses. The peak of
calicivirus infection we observed in August (68.4%). In
October, the rotavirus infection reached the same percentage
as infection caused by calicivirus (40%). In the next months,
especially in the Winter–Spring time, the rotavirus infection
was the most common and the peak of infection was in
March (82.6%). In this study the rotavirus infection was
observed in a 52.3%, calicivirus in 28.1%, adenovirus in 14%,
astrovirus in 13% and coronavirus infection in 10% of positive
samples.
Conclusion: In Bosnia and Herzegovina, analysis of seasonal
distribution of gastroenteritis viruses for 2002/03 has shown to
be important for rotavirus and calicivirus infections. In Sum-
mer–Autumn period the calicivirus infection was the major
causative agent of virus gastroenteritis while in Winter–Spring
time it was rotavirus infection. Annual 2002/03 results for our
country have shown the rotavirus infection as the most common
causative agent of gastrointestinal tract infection.
R2187
Enterovirus meningitis: study from 1995 to 2003
A. Betra´n, M. Omen˜aca, L. Torres, M.J. Revillo (Zaragoza, E)
Objectives: The aim of this report is to analyze the evolution of
the clinical and epidemiological characters of Enterovirus
meningitis in the Miguel Servet University Hospital in Zaragoza
during the period 1995–2003.
Methods: Since 1995 until 2003, 65 cases of Enterovirus men-
ingitis were detected in Miguel Servet Hospital. Samples of
cerebrospinal ﬂuid (CSF) were performed on ﬁbroblast
MRC-5 and human rhabdomiosarcoma cells. Positive cultures
were identiﬁed with monoclonal antibodies and since 2000
Enterovirus RNA was detected through RT-polymerase chain
reaction. Sixty three clinical records were revised.
Results: Isolation of Enterovirus in CSF was positive in 65 of
926 of the samples studied in our laboratory (7.0%). Forty-eight
(74%) of these patients were males and 17 were females (26%).
Most patients were under 14 years and 11 of them (17.2%) were
infants younger than one year. Enterovirus was isolated only in
three adults (4.8%).The evolution time until hospital admission
was less than 24 h in 57 cases (90.5%) and longer than two days
in 6 patients (9.5%). Hospitalization was required in all the
patients. Six of them were discharged before 48 h (9.5%) and 26
remained in the hospital more than 5 days (41.2%).The most
common symptoms were fever, headache and meningeal symp-
toms. Antibiotic treatment was given to 39 patients (61.9%) and
only in 6 cases (9.5%) it was removed before of the fourth day.
The rest of the patients received antibiotic treatment until viral
culture result was known. The evolution of the patients was
favourable without sequels.
Conclusions: Enterovirus are the most important cause of viral
meningitis in our environment with a high incidence in infants.
A seasonal distribution has been found in Enteroviruses men-
ingitis; the highest incidence was recorded from May to June
(Spring). The knowledge of this seasonal distribution is a
diagnostic indicator, which can help to predict infection in
these months and adequate the treatment.
R2188
Telomerase activity in cutaneous and anogenital
warts: a preliminary study
D. Kilic, M. Kocak, O. Bozdogan, C. Agalar, A. Birol,
S. Kaygusuz, Y. Alpay (Kirikkale, TR)
Objective: To evaluate telomerase activitiy in cutaneus and
anogenital warts.
Methods: Normal skin, genital and cutaneous lesion specimens
were collected from 6, 9 and 14 patients, respectively. Telom-
erase activity was detected by classical immunohistochemstry
by using telomerase catalytic unit (hTERT) antibody. Specimens
were stained with monoclonal antibody (Novocastra).
Results: Staining pattern was located in basal and suprabasal
location in normal skin specimens. However, telomerase activity
in basal, supra basal and spinose layers was detected in all
anogenital wart specimens but this staining pattern was detec-
ted only 7of 14 cutaneous specimens. Mean telomerase activity
of the specimens was 66.9%, 61.7%, 27.6% in anogenital wart,
cutaneus wart and normal skin specimens, respectively. No
association in telomerase activity was determined between
anogenital and cutaneus warts. The telomerase activity was
signiﬁcantly higher in HPV infection groups (cutaneus and
anogenital) than in normal skin.
Conclusion: The increase in the activation of telomerase by
HPV found in this study is consistent with all other proliferative
lesions.
AIDS and HIV infection
R2189
Efﬁcacy of acute HCV treatment with peg-
interferon and ribavirin in HIV infected patients
A. Kruk, N. Polovinkina (Moscow, RUS)
Objectives: Mortality related to HIV infection has signiﬁcantly
decreased due to the implementation of highly active anti-
retroviral therapy (HAART). But, morbidity associated with
Hepatitis C (HCV) is increasingly affecting the HIV/HCV co-
infected population. It’s essential to perform clinical studies to
identify the efﬁcacy, safety and tolerability of interferon and
ribavirin in the co-infected population.
Methods: Efﬁcacy, safety and tolerability of peg-interferon
1.5 mcg/kg/weekly and ribavirin 800–1000 mg/d for 24 weeks
was assessed in a prospective open labeled study in HIV patients
with acute Hepatitis C. Quantitative HCV RNA, HIV RNA and
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CD4countaswell asbloodcountand liver enzymeswereassessed
at baseline and at weeks 4, 12, 24, 48. All patients had a CD4 count
>200 · 10/ml and HIV viral load <200 cp/ml. Recruitment of
patients is ongoing with 17 patients enrolled to date.
Results: Infection was predominantly acquired through intra-
venous drug usage (87%). Other groups were heterosexuals (8%)
and homosexuals (5%). The majority was virologically stable on
HAART (53%); the remainder did not require HAART. 31%
patients were infected with genotype 1/4 and 69% with
genotype 2/3. 79% were male and mean age was 29 years
(range 19–39). At 4 weeks early biochemical and virological
response (normalization of liver transaminases and negative
HCV RNA) was observed in 11 (65%) patients, and at 12 weeks
15 (88%) patients were HCV RNA negative. Two patients (12%)
did not complete therapy up to 12 weeks due to severe
depression. At the end of treatment 15 (88%) patients were still
HCV RNA negative, and 9 (53%) patients who overcame
48 weeks are always HCV RNA negative.
Conclusion: After 24 weeks of acute HCV treatment with peg-
interferon and ribavirin 15(88%) of treated patients were HCV
RNA negative. Peg-interferon and ribavirin show good antiviral
efﬁcacy in HIV/HCV co-infected patients. Discontinuation rate
is low, but depression is a major problem in this cohort with a
high proportion of drug users.
R2190
Infective endocarditis in a group of patients at
risk for HIV infection: analysis of 63 episodes
M.E. Valencia, V. Moreno, A. Enrı´quez, J. Guinea,
J. Gonzalez-Lahoz (Madrid, E)
Objectives: To study epidemiological, clinical, microbiological
and evaluative characteristics of infective endocarditis (IE) in a
group of patients at risk for HIV infection and to determine the
inﬂuence of HIV virus in the patients‘ evolution.
Methods: All IE (deﬁned according Durack criteria) diagnosed
between 1996 and 2004 have been studied. Data were collected
with regard to the clinical, laboratory and demographics
characteristics of patients as well as results of blood cultures
and data on clinical outcome. Statistical study was done with
SPSS program (11.0).
Results: There were diagnosed 63 episodes of IE between 55
patients. Only one of them was not intavenous drug adict
(IVDA) and most were men (81%). Mean age was 33 years (20–
49) and 20 (32%) had had a previous episode of IE. There was
HIV infection in 56 patients (89%), 26 of them had AIDS and
mean CD4+ was 248 mm3 (4-810). Only 12 (19%) were receiving
highly active antiretroviral therapy (HAART) and 49 (78%) had
also HVC infection. The onset was acute in 43 cases (68%). All
the patients were febrile, 48 (76%) had respiratory symptoms
and 33 (52%) cardiac murmur. Chest X-ray was normal only in
nine cases (14%) and septic embolisms were observed in 28
(44%). The vegetations were detected by two-dimensional
echocardiography and tricuspid was the most frequent affected
valve (53 cases; 84%). Mitral valve endocarditis was diagnosed
in ﬁve cases (8%), aortic in 6 (9.5%) and pulmonary in 3 (5%).
There was valvular insufﬁciency in 39 cases. Blood culture was
negative in 28 episodes (44%), there was three cases of
polymicrobial IE (4.8%) and S. aureus was the most frequently
isolated organism (19 episodes; 30%). Patients were treated with
antibiotics during 2–4 weeks, but 7 (11%) needed treatment for
6 weeks. Therapy was depended on the organism‘s susceptibil-
ity but initially the subjects were empirically treated with
cloxacillin with or without tobramycin. Ten patients, all with left
sided IE (16%), developed cardiac insufﬁciency, 7 (11%) renal
insufﬁciency, 2 (3%) arterial emboli and 8 (12.7%), all with HIV
infection, dead.
Conclusions: Most of the cases of IE in patients with HIV
infection are seen in subjects without HAART, probably because
IE is more related with drug abuser than with HIV, CD4+
lymphocyte count or HAART use. For this reason IE may be an
important disease with an elevated mortality rate in patients
with HIV infection, overall they will probably be active IVDA
without HAART.
R2191
Global trends in infectious diseases in
HIV-infected patients in HAART era
J. Guardiola, L. Matas, A. Lacal, S. Herrera, M. Mateo, A. Mauri,
H. Corominas, M. Puig, M. Gurgui, S. Benito, P. Domingo
(Barcelona, E)
Background: The incidence and prevalence of different micro-
organisms and infection sites in HIV-infected patients remains
controversial. The aim of this study was to evaluate the global
presence of infectious diseases during the HAART era.
Methods: We retrospectively studied all HIV-AIDS records
from 1996 to 2003 at a teaching-urban hospital in Barcelona
(Spain). All microbiological positive cultures and infection sites
were reviewed from 1996 to 2003. Contamination was ruled out
based on clinical grounds. Statistical analysis was performed
with standardized methods.
Results: We analysed 1502 HIV infected patients. A total of 623
(41%) patients showed one or more infections, with 1681
positive microbiological cultures (371 patients had more than
one infection). 429 (68.8%) were men. Mean age was 40 + 9
(range: 18–79). 89% of patients were on highly active antiretro-
viral therapy. The most frequent isolates were: E. coli 159 (9.5%),
M. tuberculosis 132 (7.9%), S. aureus 106 (6.1%), Herpes simplex 84
(5.0%), S. pneumoniae 74 (4.4%), Campylobacter sp 72 (4.3%),
Pneumocystis carinii 68 (4.0%), Pseudomonas aeruginosa 59 (3.5%),
S. epidermidis 56 (3.3%), Salmonella sp 50 (3.0%). The most
frequent clinical syndromes were: Bacteremia 262 (15.5%) cases
(S. epidermidis 16%, E. Coli 13%, S. pneumoniae 12%), respiratory
infections (whit positive BAL culture) 213 (12.7%) cases (Pneu-
mocystis carinii 32.5%, Candida sp 17.7%, M. tuberculosis 7.2%,
S. pneumoniae 5.3%), urinary infections 231 (13.7%) (E. coli 47%,
Enterococcus sp 11.4%) and diarrhoea was present in 200 (11.9%)
cases (Campylobacter sp 37.9%, Entamoeba 14.9% Cryptosporidium
14.4%, Giardia 13.8%, and Salmonella sp 12.1%).
Conclusions: 1. Almost half the patients suffered one infection
during the study period. 2. The most frequent isolated micro-
organisms were E. coli and M. tuberculosis and S. aureus. 3. The
most frequently involved sites were blood, respiratory, urinary
and gastrointestinal tracts.
R2192
Post-kala-azar dermal leishmaniasis during
highly active anti-retroviral therapy in an
HIV-infected patient. Case report
E. Boumis, P. Chinello, C. Della Rocca, M.G. Paglia,
M.F. Proietti, N. Petrosillo (Rome, I)
Introduction: Post-kala-azar dermal leishmaniasis (PKDL) is a
complication of visceral leishmaniasis (VL) and manifests as
multiple hypocromic macules, erythematous papules or nodules
arising in the skin during or most often after treatment of VL.
PKDL is very uncommon in HIV-positive patients and just few
cases have so far been documented. We describe the occurrence
of PKDL in an HIV-infected patient unresponsive to liposomal




Case report: An HIV infected patient in HAART with ddI-d4T-
Lop/Rit in June 2003 started complaining of asthenia and failure
to gain weight. The blood tests showed: CD4 50/mm3, unde-
tectable HIV-RNA, PMN 680/mm3, Hb 9.4 g/dL and PLT
161,000/mm3. The search for opportunistic infection was neg-
ative, but a serologic test (IFI) for Leishmania spp. was positive
at a titre of 1:2560 and a PCR on peripheral blood was positive
for Leishmania infantum. The patient refused bone marrow
aspiration. A presumptive diagnosis of VL was made. Lipo-
somal amphotericin B at a 3 mg/kg dose was administered
daily for 12 days and weekly later on, with initial beneﬁt.One
month later, a maculopapular, nonpruritic, pink rash on the
trunk appeared. The rash gradually worsened over time and in
October 2003 a skin biopsy was performed. A granulomatous
inﬁltrate was seen, with histiocytosis, PMNs, plasmacells, and
amastygotes. The PCR performed on the skin sections was
positive for Leishmania infantum. A diagnosis of PKDL was
made. The patient continued to receive liposomal amphotericin
B 3 mg/kg once a week. Because of the rash worsening, in
January 2004 a new course of liposomal amphotericin B at a
5 mg/kg qd dose for 10 days was tried, unsuccessfully. In April
a course of Glucantim was started, at the dose of 100 mg/kg
i.m. qd. After a transient increase in amylase and lipase plasma
levels, the dose was adjusted to 75 mg/kg daily and was
administered for4 weeks. The treatment was well tolerated. At
stop therapy the skin lesions were ﬂattened and began to turn
pale. The patient is still in good conditions after a 6 months
follow-up.
Conclusions: Although very uncommon, PKDL must be con-
sidered in HIV-positive patients treated for VL and presenting a
skin rash, especially during HAART. Even liposomal ampho-
tericin B, which is considered the most effective anti-Leishmania
drug, can sometimes need to be substituted by antimonials for
PKDL treatment.
R2193
Temporal pattern of infectious complications in
HIV-infected patients
J. Guardiola, L. Matas, M. Mateo, A. Lacal, S. Herrera, J. Montiel,
J. Arroyo, H. Corominas, A. Mauri, I. Diaz, M. Puig, S. Benito,
M. Gurgui, P. Domingo (Barcelona, E)
Background: The aim of this study was to determine and
evaluate pattern changes over the last 9 years regarding the
presence of infectious diseases in HIV infected patients during
the HAART era.
Methods: We retrospectively analysed all infectious episodes in
all HIV infected patients from 1996 to 2003. Infectious disease
was deﬁned as isolation of a pathogenic bacteria together with
consistent clinical ﬁndings. No serological data were assessed.
We analysed the temporal trend of the most prevalent infec-
tions, in search of signiﬁcant differences to compare their annual
prevalence using contingency tables mediating Chi-square
analysis
Results: 1677 infectious samples in 628 patients were analysed
during this period. Signiﬁcant results are shown in the following
table:
YEAR 96 97 98 99 00 01 02 03 Total P value
Candida 38 37 34 29 33 30 39 23 263 0.3
E. coli 6 21 18 12 24 29 24 25 159 0.001
H. simplex 19 9 8 10 9 8 11 10 84 0.3
M. tuberculosis 13 24 16 30 17 13 17 2 132 0.001
Aspergillus 8 2 2 11 1 1 2 2 29 0.001
YEAR 96 97 98 99 00 01 02 03 Total P value
Campylobacter 12 12 4 8 8 8 10 10 72 0.8
Citomegalovirus 20 7 5 0 2 3 1 6 44 0.001
Cryptosporidium 7 3 2 6 4 3 2 0 27 0.1
Enterococo 3 6 5 3 7 5 5 6 40 0.8
Klebsiella 0 2 1 0 2 1 4 6 16 0.05
Pnemocystis 7 12 5 11 8 8 8 9 68 0.9
P. aeruginosa 19 8 4 7 4 5 6 6 59 0.003
S. pneumoniae 5 11 9 10 8 8 14 9 74 0.7
Salmonella sp. 10 7 4 6 3 7 7 6 50 0.7
S. epidermidis 7 7 4 9 7 5 7 10 56 0.9
Pyogenes 0 0 2 1 0 2 8 3 16 0.001
M. xenopi 3 6 4 3 5 2 3 5 31 0.8
Conclusions: E. coli , Klebsiella sp, and Streptococcus pyogenes
showed an increasing prevalence over time, whereas prevalence
of. M. tuberculosis, Aspergillus sp, Citomegalovirus and P. Aerugi-
nosa, showed a progressive and signiﬁcant decrease.
R2194
Potential risk factors and speciﬁc management of
pancreatic abnormalities in HIV-infected patients
taking combination antiretroviral therapy
R. Manfredi, L. Calza, F. Chiodo (Bologna, I)
Introduction: Epidemiological-clinical features of pancreatic
abnormalities are expected to change after the introduction of
highly active antiretroviral therapy (HAART).
Methods: The frequency, risk factors and clinical-therapeutic
features of pancreatic alterations were assessed in an observa-
tional case–control study.
Results: 920 patients (p) were evaluated for pancreatic abnor-
malities in a case–control study including the entire follow-up
period of each considered p;128 p with high and prolonged
laboratory anomalies were assessed to outline the proﬁle of
pancreatic disease before and during the HAART era. Com-
pared with controls, the 334 p (36.3%) who experienced >1
episode of conﬁrmed pancreatic laboratory abnormality had a
longer duration of seropositivity, exposure to protease inhibi-
tors, a more frequent immunodeﬁciency, AIDS diagnosis, liver-
biliary disease, and hypertriglyceridemia, while no relation was
found with antiretroviral use, and the duration of nucleoside
analogue use. Among these 334 p, high and prolonged labor-
atory alterations eventually associated with signs of organ
involvement occurred in 128 p, and were related to the
administration of ddI, d4T, 3TC, pentamidine, cotrimoxazole,
or antitubercular therapy, substance or alcohol abuse,
opportunistic infections, liver-biliary disease, a protease inhib-
itor-based HAART, and hypertriglyceridemia. However, no
difference was noticed between the 32 p with clinical and/or
imaging evidence of pancreatic involvement and the remaining
96 asymptomatic p, as to the same risk factors. Although
recurrences of enzyme alterations involved >70% of p, in only
33.8% of cases a change of antiretroviral or antimicrobial therapy
became needed. An acute but uncomplicated pancreatitis
occurred in 7 p of 26 overall symptomatic ones. A 2–4-week
gabexate and/or octreotide administration (performed in 59 p of
128), achieved a signiﬁcant laboratory, clinical, and imaging
cure or improvement in 71.2% of p, with a better success rate of
combined vs single therapy; a reduced tendency to disease
recurrences, and an ameliorated tolerability of antiretrovirals,
were also noticed.
Conclusion: Epidemiological and pathogenetic studies are nee-
ded to assess pancreatic abnormalities especially in the HAART
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era and their consequences on continued anti-HIV and antimi-
crobial therapy. The antiretroviral management and the indica-
tion to gabexate and/or octreotide administration in the
different clinical-laboratory situations, deserves extensive, con-
trolled studies.
R2195
Occurrence of cholangiocarcinoma after
AIDS-related cholangitis
C. Charlier, M. Lecuit, A. Furco, J.M. Estavoyer, A. Lafeuillade,
B. Dupont, O. Lortholary, J.P. Viard (Paris, Besanc¸on, Toulon, F)
Objective: Increased survival among patients with AIDS has
led to a recent increase of neoplasms. Cholangiocarcinoma (CC)
is a rare form of malignancy arising from the bile duct
epithelium, that may be associated with history of chronic
inﬂammation of the biliary tract. We describe here the ﬁrst series
of ﬁve patients with AIDS-associated CC.
Methods: Retrospective multicentric study among all 54
Departments of Infectious Diseases of French University Hos-
pitals.
Results: All patients were men of Caucasian origin. At CC
diagnosis, median age was 48 yrs (range 38–61 yrs), median
known duration of HIV infection was 13 years (range 0–17).
Four patients were at CDC stage C of infection, with a median
time between AIDS and CC diagnoses of 13 years (0–17). Three
patients were treated by HAART with a median duration of 1
year (range 0–8 years). Median CD4+ lymphocyte count was
170/mm3 (range 1–600/mm3) and median viral load was 32,000
copies RNA/ml (range <50–47, 700). All ﬁve patients were
lacking the most important risk factors for CC (sclerosing
cholangitis and liver ﬂuke infection), but three had an history of
AIDS-related cholangitis (including one related to cytomegalo-
virus). Median survival was 7.5 months (range 2 month-9 yrs).
Only one patient could have complete tumour resection with
prolonged survival (9 years).
Conclusions: 1. Patients with AIDS may develop CC, especially
those with long lasting infection and previous AIDS-related
cholangitis; 2. Patients with history of AIDS-related cholangitis
should therefore be closely monitored, since early diagnosis is
key for surgical excision which is associated with increased
survival.
R2196
Outcome of invasive pulmonary aspergillosis
under highly active antiretroviral therapy in a
HIV-infected patient without appropriate
antifungal drugs
R. Iubu, C. Jianu, D. Tatulescu (Cluj-Napoca, RO)
Background: Invasive pulmonary aspergillosis (IPA) is the
most common manifestation of aspergillus infection in HIV
patients, associated with an extremely high mortality rate.
Aim: To present IPA in a HIV infected patient recovered by
immune reconstitution under antiretroviral therapy, without
appropriate antifungal drugs.
Case report: A 15-years teen-ager, male, was admitted in our
hospital for a 2 months history of weight loss, weakness,
anorexia, fever, persistent cough and thoracic pains and related
more previous episodes of pneumonia, diarrhoea and allergy.
He had fever, height and weight deﬁcit, labial herpes, white
plaque tongue, tachycardia, normal pulmonary sounds, inﬂam-
matory syndrome (ESR = 85–110/h, ﬁbrinogen = 560 mg%,
CRP = 6.5 mg/dL), high values of Ig G (2200 mg/dL), leuco-
cytes and lymphocytes count decreased (3800/mm3, respect-
ively 570/mm3). Chest radiograph showed an inhomogeneous
opacity with a poorly deﬁned nodular appearance, about 4–5 cm
diameter in left upper pulmonary lobe, extended to hila by
multiple micro nodules, 5–10 mm, and high-resolution chest
computed topography indicated a 4.5/5.2 cm parenchyma
nodule with a surrounding halo of ground glass, suggesting
an IPA. High levels of the Aspergillus antigen galactomannan
detected by enzyme-linked immunosorbent assay (ELISA) in
two consecutive serum samples conﬁrmed the diagnosis. ELISA
and Western Blot tests for HIV were positive, CD4 count
140 cells/mm3, HIV-RNA levels 68,000 copies/mL and he was
diagnosed as nosocomial-transmitted HIV infection, CDC stage
C3. HAART was started with lamivudine + efavirenz + indina-
vir with a very good adherence to the treatment. He did not
receive any antifungal therapy because he presented intolerance
to Amphotericin B and no another antimycotic drugs were
available at that moment. After 3 months of HAART, re-
evaluation showed weight growth, inﬂammatory syndrome
absented, WBC count 6500/mm3, lymphocytes count 1855/mm3
(27%), CD4 count increased 612/mm3, viral load <400 copies/
mL, radiographic and CT abnormalities resolution; 2 months
later radiological manifestations absolutely disappeared and
Aspergillus antigen galactomannan levels was undetectable.
The patient remained stable for 5 years with the same HAART
regimen.
Conclusions: We obtained IPA recovery by immune reconsti-
tution after 5 months of HAART, even in absence of any
antifungal treatment. HAART starting may improve the clinical
outcome in HIV-infected patients with IPA.
R2197
Prediction of potential antigenic domains of
HIV-1 Pol protein and evaluation their
immunoreactivity
V. Puzyrev, N. Savel’eva, E. Baranova, O. Van’kova, V. Pimenov,
A. Obriadina, A. Burkov, T. Ulanova (Nizhniy Novgorod, RUS)
Objectives: The aim of this study is prediction and evaluation
diagnostic relevance of potential antigenic epitopes of HIV-1
polymerase protein (protease; reverse transcriptase; integrase).
Methods: Five potential antigenic epitopes of HIV-1 pol protein
have been predicted by bioinformatics analysis. Recombinant
genes encoded selected amino acids sequences have been
assembled by PCR from synthetic oligonucleotides and
expressed in E. coli as hybrid proteins with Glutathione
S-transferase. Proteins were tested by enzyme immunoassay
against a panel of human serum specimens positive for anti HIV
(n = 228) and specimens from normal blood donors (n = 200).
Status of samples has been conﬁrmed by New Lav Blot (Bio-
Rad, USA).
Results: Potential antigenic determinants were predicted at
position 1–51 aa, 198–347 aa, 242–347aa, 352–411 aa and 922–
1002 aa pol protein. Only protein comprising 922–1002 aa of pol
protein (integrase) was immunoreactive and detected IgG
antibody in 87% anti-HIV positive serum samples. Average of
signal to cutoff ratio is 8.5. None of specimens from normal
blood donors were tested as positive with this recombinant
protein. Other theoretically selected amino acids sequences
demonstrated no immunoreactivity. This may be connected
with the conformational nature of other predicted epitopes.
Conclusion: The results indicated that recombinant protein
comprising one of the theoretically predicted antigenic epi-
tope(s) of HIV-1 pol protein demonstrated a signiﬁcant diag-
nostic potential and can be used for the development EIA for the




A progressive study of mycobacterium isolations
in HIV+ patients (1991–2004)
S. Nikolaou, S. Kanavaki, A. Skroubellou, S. Karabela,
I. Raftopoulou, A. Papavassiliou, V. Tamvakis (Athens, GR)
Objectives: We studied the mycobacterium isolation frequency
and resistance to antituberculous drugs in HIV+ patients,
examinated in National Mycobacterium Reference Laboratory
of Athens, during the years 1991–2004.
Methods: From 1212 HIV+ patients studied, 156 mycobacteri-
um strains were isolated from various clinical sources. Labor-
atory testing included Ziehl Neelsen strain, cultures performed
classically and automatically by the use of Bactec and MGIT
systems, detection of M. tuberculosis rRNA in clinical specimens
by the Ampliﬁed Mycobacterium Tuberculosis Direct Test
AMTD (Gen Probe), identiﬁcation by the nucleic acid hybrid-
ization method of Accuprobe (Gen Probe) and Innolipa V2,
(Immunogenetics) and ﬁnally, susceptibility testing, by the
method of proportion on solid medium Lo¨wenstein Jensen and
in liquid medium by the use of Bactec and MGIT automated
systems Innolipa RTF TB (Immunogenetics) for the detection of
rpo B gene was also performed.
Results: From 1212 HIV+ patients examinated for TB, 1029
(84.9%) were men and 183 (15.1%) women. Mycobacterium was
isolated in 156 (12.8%) patients. In 91 (58.3%) patients
M. tuberculosis was isolated, while in 65 (41.7/%) M. avium. In
particular, M. tuberculosis was isolated in 77 (58.8%) men and in
14 (56%) women, while M. avium in 54 (41.2%) men and in 11
(44%) women. M. tuberculosis was mainly isolated from lower
respiratory tract, urine and CSF, whileM. avium from blood and
bone marrow. Among the 91 M. tuberculosis isolations, 87
(95,6%) were susceptible to all antituberculous drugs.
Conclusions: Mycobacterium isolation frequency in HIV+
patients is progressively decreasing. M. tuberculosis is predom-
inating in comparison to M. avium. In M. tuberculosis isolations
not any signiﬁcant resistance to antituberculous drugs was
detected.
R2199
Clinico-evolutive aspects of tuberculosis in
horizontally HIV-infected patients
A. Cupsa, F. Dumitrescu, F. Romanescu, L. Giubelan,
G. Peftidis (Craiova, RO)
Objectives: Evaluating the incidence, clinical forms and evolu-
tion, of tuberculosis (TB) in horizontally HIV/infected
patients.Materials and methods: Retrospective study 01
Nov1994–01 Nov 2004 on a cumulative lot of 305 HIV+ patients
in evidence of Regional Center of Monitoring and Evaluation
HIV/SIDA Infection Craiova, Romania. The assessment was
clinical, immunological, imagistic, bacteriological and histopath-
ological.
Results: 87 cases with TB (28.55%): 68 pulmonary forms
(88.3%), 7 ganglionary forms (8%), seven cases meningoen-
cephalitis (8%), 4 bacillary pleurisy (4.6%), three cases intestinal
TB (3.4%), 2 TB pericarditis (2.3%); three patients with multiple
determinations. In 18 cases (20.7%) of TB, the diagnosis of HIV
infection was established concomitantly with TB diagnosis.
Pulmonary forms were: primary – 35 cases (51.4%), miliary – six
cases (8.8%), inﬁltrative-ulcerative – seven cases (10.3%), inﬁl-
trative-nodulary – ﬁve cases (7.4%). Bacteriologic conﬁrmation
was found in 10.7% and histopathological in all cases with
ganglionary TB. Main characteristics of patients with HIV-TB co-
infection: average age: 16.9 years, average CD4 = 176.4 cells/
mmc; M/F = 48/39. Evolutions with tuberculostatic and anti-
retrovirals treatments: favorable in 65 cases (74.7%), recidives –
nine cases (20.7%), paradoxal reactions – nine cases (20.7%),
deceases – 13 cases (14.9%).
Conclusions: TB remain one of most frequent opportunistic
infections in HIV+ patients with advanced immunodepression
having a potential severe evolution.
R2200
Atazanavir early access programme: safety data
from an HIV infected Greek population
P. Tserpe, N. Tsogas, N. Mangafas, A. Lioni, M. Chini, G. Tsekes,
M.C. Lazanas (Athens, GR)
Objectives: To report our experience regarding safety from the
Atazanavir early expanded programme ran in our clinic from
March 2003 to October 2004. We registered Grades 3 and 4
toxicities according to ACTG table of Grading Severity of Adult
Adverse Experiences.
Methods: We enrolled 19 patients (CDC stage: 9A, 4B, 6C),
84.2% male, median age 43 years, median time on prior ART
95 months, median CD4 564 cells/ml, 36.8% with undetectable
VL and 84% placed on a TDF-containing regimen. Reasons for
starting on ATV/RTV were 47.4% hyperlipidemia, 26.3% viro-
logical failure and 26.3% toxicities. 10.5% were coinfected (1
HBV, 1 HCV). 4/19 initially received ATV 400 mg daily
according to the protocol, changing 6 months later to ATV /
RTV. Median time on ATV was 6.5 months.
Results: 5/19 patients had mild to moderate bilirubin eleva-
tions (2/5 were on IDV) before enrollment. After the initiation of
ATV/RTV 15/19 patients (78.9%) experienced grade 3 or 4
hyperbilirubinemia (due to elevation of indirect bilirubin), of
whom 7 grade 3 (36.8%) and 8 grade 4 (42.1%). Jaundice/scleral
icterus was noticed in 10/19 (52.6%). 14/15 patients (93.3%)
manifested hyperbilirubinemia within 12 weeks. 4/19 patients
(21%) discontinued ATV: 3/4 due to protocol requirements, and
1/4 due to patient’s request (scleral icterus, esthetic reasons). No
other side effects were noted (transaminase elevations, rash,
gastrointestinal disorders, dizziness, myalgia or ECG changes).
Total bilirubin was returned to normal in all four patients after
discontinuation of ATV.
Conclusions: ATV was safe and well tolerated. Almost 8/10
patients experienced severe hyperbilirubinemia (4/10 grade 4).
1/2 patients experienced jaundice/ scleral icterus. No relation
between the above side effects and coinfection with HBV and
HCV was noted. 1/5 discontinued ATV, mainly due to protocol
requirements. ATV seems to be a more potent inhibitor of the
uridine diphosphate-glucoronosyl-transferase than IDV. These
data in our study revealed a signiﬁcantly higher percentage of
severe hyperbilirubinemia and jaundice from ATV use than
previous studies.
R2201
The epidemiologic and clinical characteristics of
HIV/AIDS patients in a tertiary hospital, Turkey
A. Celikbas, O¨. Ergonul, N. Baykam, S. Eren, H. Esener,
B. Dokuzoguz (Ankara, TR)
Objective: To describe the epidemiological and clinical ﬁndings
of 87 Acquired Immune Deﬁciency Syndrome (AIDS) patients
from Turkey.
Methods: All the patients had been followed in Ankara Nu-
mune Education and Research Hospital between 1993 and 2004.
Results: Seventy-two per cent of the patients were male, mean
age at the diagnosis was 36 (min 13, max 71). Mean years of
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survival was 3.4, and maximum years of survival was 11. Thirty-
one of the patients died, of those 26 died at their ﬁrst admission.
The most common professions were, drivers and workers.
Eighty per cent of the women were housewives. Only one of the
patients was university graduated. Heterosexual intercourse
was the most common (86%) route of transmission. Blood
transfusion, and IV drug use was the other routes. One male
patient declared men with men sexual relation at the ﬁrst
interview, and 5 did after more detailed interview. Median CD4
count at the diagnosis was 198 (min 5, max 1051), and the mean
viral load at the diagnosis was 122, 000 (min 400, max 107), 36%
of the patients were grouped in C3 category at their ﬁrst
admission. The most commonly detected opportunistic infec-
tions were Candidal infections (0.1 per patient year), Mycobac-
terium tuberculosis (0.034 per patient year), and CMV (0.015 per
patient year).
Conclusions: Considering the low education status among the
patients, the role of the education in preventing HIV infection
should be re-emphasized. Appropriate education programmes
should be developed to prevent the transmission of HIV
infection. A signiﬁcant number of patients were diagnosed at
very late stages. The physicians and other health care workers
should be educated on the clinical pictures of HIV/ AIDS to
diagnose the cases earlier.
R2202
AIDS, a risk disaster for the African Great Lakes
region
J.L. Mangala Miherule (Nairobi, KEN)
Africa bears the heaviest burden of HIV/AIDS. According to the
UNAIDS (2003), more than 28 millions are contaminated. The
prevailing remains stable.African states already faced with
many developmental difﬁculties must by all means avoid the
total explosion of this bomb ( HIV/ AIDS).Southern African still
has this disaster. The African Great lakes region constitutes
countries such UGANDA, Tanzania, Kenya, Burundi, Rwanda,
Zambia and DRC. These Countries are noticing new infections
following a massive displacement of (refugees) population due
to ethnic conﬂicts, political, economic and social crisis (lands,
poverty, identity and other problems).According to research
conducted by UMHE/GREAT LAKES, ANDA-ONLUS for
Central And Eastern Africa, out or 12,000 young students
(boys/girls) of the sub-regions, +20% of girls agreed to have
succumbed to sexual violence from soldiers from one or another
regime.+80% have no idea on voluntaring testing and antiret-
roviral , +70% are engaged in unprotected sexual relations +75%
fear being pregnant than HIV/AIDS . +2% accepted tocontribute
towards funds for solidarity for students and young HIV/AIDS
victims.No one ignores that the Great Lakes region is led by
Armies, Warlords, troops that 40% are infected by HIV/
AIDS.+50% Of other young girls did not want to testify in
sexual violence from the men in uniform fearing stigmatization
and reject.+60% of young would like to know their status but
there is lack of appropriate structures.A study conducted in the
East of DRC ( North–South Kivu and Maniema), for about
10,000,000 habitants, there exist six structures of voluntary
testing but with a weak capacity of less than 500 volunteers per
year.In south –Kivu for example, there is only one existing
structure taking care of patients of HIV/AIDS with a capacity of
20 Patients per year out of a population of +4,500,000 habit-
ants.Rape is part of principal causes of HIV/ AIDS expansion in
the sub-region. Sexual Violence have become a current deno-
mination in the region for a decade now.The African Great
Lakes Region is undergoing a disaster without precedent.The
future of the region might be auctioned. Efforts for a stable
development risk being trapped by the explosion of HIV/ AIDS.
We are requiring once more, action for all in order to save
human lives in danger in the great region.
Hepatitis
R2203
Prevalence of serum HBV markers among 13,581
women of child-bearing age in Greece
I.S. Elefsiniotis, I. Glynou, I. Magaziotou, K.D. Pantazis,
M. Psyrouki, C. Sofoudis, H. Kada (Athens, GR)
Objectives: To evaluate the seroprevalence of hepatitis B
surface antigen (HBsAg) in a large multinational group of
women at gestational age and to examine the presence of
hepatitis B e antigen (HBeAg), antibody to hepatitis B e antigen
(anti-HBe) as well as antibody to hepatitis C virus (anti-HCV) in
HbsAg(+) ones.
Methods: Between August 2003 and August 2004 a total of
13,581 women at gestational age (range 16–45 years) were
prospectively evaluated. HBsAg, HBeAg, anti-HBe as well as
anti-HCV were detected using routine commercially available
enzyme immunoassays (Abbott Laboratories, Abbott Park,
Illinois, USA). All women of the study population were screened
for HBsAg whereas the rest serum markers were evaluated only
in HBsAg(+) ones.
Results: The majority of the study population were from
Greece (70.31%) whereas 15.96% of them were from Albania,
7.06% from countries of Eastern Europe (Russia, Romania,
Bulgaria), 4.09% from countries of Africa, 0.69% from coun-
tries of Asia, 0.99% from countries of Northwestern Europe,
0.46% from Australia and 0.43% from countries of North
America. Overall, 157 of 13581 females (1.156%) were
HBsAg(+) and the vast majority of them (112/157, 71.3%)
were Albanian. None of the females from countries of North
America, Northwestern Europe and Australia were HbsAg(+).
Among women from Albania the seroprevalence of HBsAg
was 5.1%, representing the higher rate among the national
groups of the study population, followed by 4.2% in Asian
women and 1.14% in women from Eastern European coun-
tries. The prevalence of HbsAg among African (0.36%) and
Greek women (0.29%) was very low. Overall, only 4.45% of
HbsAg(+) women were also HbeAg(+) whereas the vast
majority of them were HbeAg(-)/antiHbe(+).Only 3 of 157
women (1.91%) with chronic HBV infection were HBV/HCV
coinfected.
Conclusion: The overall seroprevalence rate of HBsAg is
relatively low among women at gestational age in Greece but
is higher enough among speciﬁc populations (Albanian,
Asian). The HBeAg())/antiHBe(+) status is a ﬁnding observed
in the vast majority of HBsAg(+) women of our study
population, suggesting possibly that only a small subgroup of





A comparative study of C-reactive protein serum
values in chronic hepatitis Band C and correlation
with the progression of the disease
V. Karabassi, M. Pouyiouka, C. Milonas, C. Petrochilou,
N. Alexandropoulos, C. Kontou-Castellanou (Athens, GR)
Objectives: Our study was conducted to control hospitalized
patients for chronic hepatitis infection B and C and to estimate
the clinical signiﬁcance of C-reactive protein (CRP) serum levels,
the relationship between CRP and alanine aminotransferase
(ALT) concentrations in serum and the correlation of CRP with
the hepatic inﬂammation and damage in these patients.
Methods: During a ten month interval 100 hospitalized patients
were found with chronic viral hepatitis. There were two groups
of patients, Group A: 70 patients with chronic hepatitis B and
Group B: 30 patients with chronic hepatitis C. Serum samples
from them were examined for the determination of CRP and
ALT levels. The detection of surface antigen HBsAg and HCV-
antibodies was performed by MEIA methodology (AXSYM-
ABBOTT) and the diagnosis proved by liver’s biopsy. The CRP
values were determined using the nephelometric method (Dade-
Behring) taking as normal values 0–5 mg/lt and ALT values
were determined by IFCC method (Technicon RA 1000 Med-
icon) taking as normal values 5–40 U/L.
Results: In Group A of the 70 patients, 24 (34.3%) had
pathological CRP levels that ranged from 15 to 174 mg/lt,
23(32.8%) had high ALT levels that ranged from 58 to 6110 U/L
and in 18 of them (79.7%) were found high CRP concentrations
ﬂuctuated simultaneously with ALT serum levels and ranged
from 35 to 174 mg/lt.In Group B of the 30 patients, 6 (20%) had
high CRP levels that ranged from 13 to 83 mg/lt, 7 (23.3%) had
high ALT levels that ranged from 56 to 89 U/L and in all of
them (7/7) the CRP concentrations were normal.
Conclusion: This study showed a signiﬁcant association
between elevated CRP and ALT serum levels in chronic
hepatitis B. In contrast no correlation was observed in chronic
hepatitis C. In conclusion the combination of CRP and ALT
values could be a useful marker for the progression of the
disease in chronic hepatitis B but not in chronic hepatits C.
R2205
Treatment of chronic hepatitis C in haemophiliac
patients
P. Husa, L. Roznovsky, P. Smejkal, L. Husova, M. Penka
(Brno, Ostrava, CZ)
Objectives: Chronic hepatitis C infection is very common
among haemophiliacs in the developed World.
Methods: Retrospective evaluation of the treatment results in
haemophiliacs with chronic hepatitis C, all infected with
genotype 1b. Twelve patients were treated with interferon-alfa
monotherapy, 21 patients with interferon-alfa and ribavirin, and
3 patients with pegylated interferon and ribavirin, all for
48 weeks.
Results: Sustained virologic response (deﬁned as an undetect-
able serum HCV RNA level 24 weeks after treatment was
completed) was not achieved in any of 12 patients treated with
interferon-alfa alone. Combination therapy with interferon-alfa
and ribavirin was associated with better results: 4/10 (40%)
patients still untreated with interferon-alfa, 2/4 (50%) relapsers,
and 2/7 (29%) non-responders to previous interferon-alfa
monotherapy achieved sustained virologic responses. Combi-
nation therapy with pegylated interferon and ribavirin has been
used in 3 patients. Sustained response was achieved in one
patient who had relapsed after treatment with interferon-alfa
and ribavirin and in 1 of 2 non-responders to this combination
therapy. There were no serious adverse events and it was not
necessary to reduce dosages or even cease therapy prematurely.
Conclusions: The efﬁcacy and tolerability of antiviral treatment
in haemophiliacs did not differ from other patients with chronic
hepatitis C.
R2206
Prevalence of hepatitis B virus genotypes in
chronic infected patients
A. Sua´rez, E. Vazquez, C. Sa´nchez, J.J. Picazo (Madrid, E)
Objectives: Hepatitis B Virus (HBV) genotypes have been
associated with speciﬁc patterns of liver disease and treatment
response. The aim of this study were to determine the preval-
ence of HBV genotypes, serum HBV-DNA level and severity of
liver disease in chronic infected patients.
Methods: A total of 87 HBV infected patients were enrolled, 63
males and 24 females. The mean age was 46 years (range 28–
77 years). Fourteen of them were co-infected with human
immunodeﬁciency virus (HIV). Sera were tested for HBV
genotyping by reverse hybridization line probe assay INNO-
LiPA HBV Genotyping (Innogenetics) after a PCR sensitive
ampliﬁcation protocol. Quantitative HBV-DNA levels were
determined using Cobas Amplicor Monitor kits (Roche). Detec-
tion of Hepatitis B e antigen (HbeAg) in patient serum samples
also was performed using the ETI-EBK enzyme-linked immu-
nosorbent assay (DiaSorin).
Results: All HBV genotypes (A–G) were found. The genotypes
A, D, E and F were common and constituted 22%, 36%, 8% and
12% of the total patient population. Genotypes B, C and G were
uncommon and represented less than 2% each one. Fifteen
patients were infected with two HBV genotypes. On the HIV co-
infected patients genotypes A, D and mixed (A + G) were
prevalent. Only in 14 of the 87 patients was detected the
presence of serum HbeAg, ten of them were HIV-infected, and it
was associated with HBV genotypes A (30%), D (20%) and
mixed genotype A + G (30%). Among the patients HbeAg
negative genotypes D, A and F were more frequent 37%, 20%
and 12% respectively. Analysis of baseline serum HBV–DNA
levels in HBeAg positive patients revealed that were higher than
106 excepted in two of the three mixed genotypes. Genotypes B,
C and G were associated with high levels of serum HBV-DNA.
The lower level of serum HBV–DNA was detected in a patient
with genotype D and negative HbeAg.
Conclusion: Our data indicate that HBV genotypes A, D and
mixed A + G were associated with a higher prevalence of
HbeAg, and HIV-infected patients. Genotypes B and C presen-
ted higher serum HBV-DNA levels in HbeAg negative patients.
R2207
Molecular phylogenetic analysis of Iranian HDV
complete genome
F. Behzadian, F. Sabahi, M. Karimi, R. Sarrami-Forooshani,
N. Maghsoudi, M. Sadeghi Zadeh (Tehran, IR)
Objectives: Hepatitis D (delta) virus (HDV) is a subviral
pathogen agent and a satellite of Hepatitis B virus. Three
distinct genotypes of HDV are described. So far at least 60 full
genome HDV sequencing have been reported from all over the
world. There is limited genetic information on Middle East’s
HDV isolates and no data about isolates from Iran where delta
infection is endemic. In this study complete HDV genome
sequences isolated from an Iranian patient has been reported.
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Methods: RNA extraction was done on serum sample from an
IVDU who was chronic HBsAg carrier and anti-HD ELISA
positive. Twelve pairs of primers were used to amplify six
partially overlapping fragments, covering the entire HDV
genome by RT-nested PCR. PCR products were puriﬁed and
subjected to automatic cycle-sequencing procedure. Editing of
raw data was accomplished by the Generunner and Chromas
softwares. Alignment analysis of complete genome and HDAg
amino acid sequences were carried out on IR-1 and eleven
reference sequences. These analyses were done by ClustalW
method, ClustalX software and subjected for phylogenetic
analysis by applying neighbour-joining model for tree construc-
tion.
Results: This new isolate (IR-I) contained 1676 nucleotides
encoding 214 a.a. of HDAg and belongs to genotype I. IR-I
revealed the most sequence similarity to an Italian isolate
(92.6%) whereas IR-I HDAg showed the most homology with
those of Lebanese isolate. Tree branching and bootstrap values
conﬁrmed these ﬁndings. In addition IR-1 showed the same
pattern of diversity throughout complete genome and its
deduced HDAg shown by other HDV isolates.
Conclusion: In this study, the location of an Iranian HDV
isolate was determined among other worldwide isolates for the
ﬁrst time. It might be explored that IR-I, Italian and Lebanese
HDV isolates are from same origin. Data analysis also conﬁrmed
genetic variability and heterogeneity of HDV species isolated
from different geographical areas.
R2208
Immunocomplexes in HCV-infected patients
E. Riva, F. Maggi, F. Bambacioni, S. Meschi, F. Bellomi,
R. Burioni, M. Clementi, E. Spada, E. Piccolella, F. Dianzani,
G. Antonelli (Rome, Pisa, Milan, I)
Hepatitis C virus infection is widespread and considered the
main cause of chronic hepatitis in Western countries. Many
studies conducted in the last decade have shown that the
outcome of HCV infection is determined by the interaction
between the virus and the host immune system. Recent
acquisitions suggest that in persistent HCV infection the
immune response may contribute to hepatocellular injury. To
this regard HCV-directed antibodies (Ab) might be involved in
the development of immunocomplexes (IC), that may favour the
infection of usually not susceptible cells, and of immunocorre-
lated diseases. The present study is aimed at evaluating the
development of IC and, eventually, their relevance in HCV-
infection clinical outcome.
Methods: The presence of IC was evaluated in 44 chronic and in
6 acute naı¨ve HCV-infected patients with different genotypes.
To verify the presence of IC, patient’s plasma samples were
sequentially absorbed on protein A coated beads and then
analysed to quantify the number of HCV-RNA copies absorbed
(or not) to the beads. HCV-RNA was monitored using the
Amplicor HCV Monitor kit, while HCV genotype was obtained
by INNO-LIPA HCV II assay. The study of the Ab was carried
out by INNO-LIA HCV Ab III and the reactivity for E2 protein
was also monitored by in house-made ELISA.
Results and conclusions: The results suggest that in chronic
HCV patients most of the HCV-RNA (ranging from 80 to 99.9%)
is bound to Ab in IC with a higher percentage in patients
infected with 1b genotype. No correlation between baseline
plasma viral load and IC development was observed suggesting
that the frequency of IC does not depend on plasma viraemia
levels. The analysis of antibodies revealed that the IC do not
contain anti-E2 Ab, even if these antibodies can be detected in
the plasma of all subjects. In contrast newly HCV-infected
patients developed no or low amount of IC that, interestingly,
increases within time (0, 1, 3 and 5 months of follow-up) only in
patients who developed chronic infection. Again this phenom-
enon does not seem to be related to the presence on anti-E2
antibody. These data suggest that the presence of IC is a
peculiarity of HCV chronic infection; the pathogenetic relevance
of such a phenomenon is now under study.
R2209
Identiﬁcation of mutations in hepatitis B virus
under lamivudine therapy
K. Mandraveli-Hatzikosta, M. Pape-Chrisaﬁ, D. Papadopoulou,
M. Giannousis, S. Alexiou-Daniel (Thessaloniki, GR)
Objective: The aim of this study was to determine the preval-
ence of HBV genotypes and viral loads in the serum of patients
with chronic hepatitis B and also the variants that may appear in
the HBV polymerase region (in and around YMDD region) due
to prolonged lamivudine treatment.
Methods: A group of 100 patients from Northern Greece (70
men, 30 women, mean age 45.5 ± 10.0 year) with chronic
hepatitis B was tested. All patients were treated with lamivudine
for more than six months. The mean duration of the antiretro-
viral therapy was 15 (±2.3) months. Serum HBV-DNA levels
(viral load) were measured with quantitive PCR (COBAS
TaqMan HBV Test), genotypes and polymerase gene mutations
were determined using the reverse hybridization in a line probe
assay (INNO-LiPA HBV genotyping, INNO-LiPA HBV DR kits,
respectively). Three kind of mutations were examined in and
around YMDD region.1st substitution of leucine by methionine
at position 180 (L180M), 2nd substitution of methionine by
valine or isoleucine at position 204 (M204V/I) and 3rd substi-
tution of valine or leucine or methionine by isoleucine at
position 207 (V/L/M207/I ).
Results: The majority of patients (90%) showed infection with
genotype D, genotype A was the second most common (9%) and
only 1 patient had mixed type (D and G). Polymerase mutants
were identiﬁed in 49 patients (78%).The M204V/I mutant was
observed in all (100%) YMDD variants of both genotypes D and
A. The L180M mutant was detected in 4/43 (8%) patients with
genotype D and in 3/5 (60%) patients with genotype A. There
were no patients in whom mutation V/L/M207/I occurred.
HBV-DNA was detectable in 64% of patients (baseline > 35 cop-
ies/ml). The prevalences of variants and viral loads were
respectively the following: low viral load (102–103 copies/ml)
25% mutants 75%, medium viral load (104–105 copies/ml) 30%
mutants 60%, high viral load (>105 copies/ml) 45% mutants
90%.
Conclusions: Genotype D is the most common in the area of
Northern Greece. The M204V/I mutation is the most frequent
among genotypes D and A. Although the appearance of mutants
seems to have no correlation with HBV genotypes and viral
load, the type of change is propably relayed.
R2210
Phylogenetic analysis of hepatitis A virus
isolated in Korea
M.-O. Song (Seoul, KOR)
The test was conducted to ﬁnd infection of Hepatitis A virus
(HAV) and the genotypes against twenty-six of the patients with
fatigue and nausea. Fifteen isolates (57.7%) were ampliﬁed by
RT-PCR using HAV speciﬁc primer, and then compared to
168 bp nucleic acid sequences in VP1/2A junction region for the
genotypes. Based on 79% similarity, 13 out of 14 isolates were
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clustered with genotype IA and 1 out of 14 isolate was separated
to IIIA. Above 13 isolates found in genotype IA were sporadic to
Japan, China, and Korean strains which are grouped determined
by it’s geographic region with over 95% similarity. The history
of patients informed the high relationship of endemic or family
transmission, and it also showed the changes according to risk
age group followed by the economic growth as 14~46 years-old
patients.
R2211
Secondary acute viral hepatitis
C.S. Cambrea, S. Rugina, M. Ilie, C.N. Rugina (Constanta, RO)
Introduction: There are some diseases caused by viruses that
secondary affect liver. These viruses are: Epstein Barr, Cyto-
megaloviruses, adenoviruses, Echo, Coxsachie, herpes simplex,
varicella zoster, and rubella virus.
Objective: To evaluate the clinical and biological evolution of
some secondary acute hepatitis.
Material and method: Study about 53 patients hospitalizedwith
secondary acute viral hepatitis in Children Infectious Diseases
Department of Clinical Infectious Diseases Hospital of Constanta
during a period of one year (2003). The etiological diagnosis was
establishedon clinical andparaclinical data (serologicalmarkers –
ELISA method). In order to establish a complete diagnosis we
checked the following syndromes: cytolitic, hepatoprive and
billiary retention. Also we studied parameters such as age, sex,
residence and period of hospitalization.
Results: From the total of 53 patients the most of the cases
with secondary acute viral hepatitis were patients with
infectious mononucleosis – 25 cases, followed by patients
with rubella – 17 cases, by patients with cytomegalovirus
infections – 9 cases, and by varicella zoster – 2 cases. Patient’s
age was between 2 and 17 years. Sex ratio shown a predom-
inant feminine injury (M:F = 1:2.53). For residence point of
view the majority of children were from urban area (31
patients from 53). The cytolysis syndrome was presented with
a slight elevation of ALT (2–5 N) in majority of cases (except
one case with infection with a severe form of hepatitis), such
as billiary retention syndrome. The hepatoprive syndrome
was light and medium in all cases except the patient already
mentioned with varicella zoster infection in an immunode-
pressed person. There were no colestatic forms and no
chronically cases or deceases.
Conclusions: The secondary acute viral hepatitis presented a
favorable evolution in almost all our cases. In the context of
some viral diseases hepatic injury is frequent but slight,
sometimes asymptomatic. In these diseases generally the liver
affection is underestimated in our area.
R2212
Hepatitis B virus genotypes in Belgium
M. Micalessi, L. De Cock, R. Vranckx (Brussels, B)
Objectives: Several studies have demonstrated that pathogenic
and therapeutic differences exist among hepatitis B virus (HBV)
genotypes. It appeared sensible, therefore, to establish the
prevalence of the different HBV genotypes in Belgian patients
with chronic hepatitis B.
Methods: The study population consisted of two groups of
patients: Flemish blood donors and patients whose sera were
collected at the gastro-enterology units of three university
hospitals in Antwerp, Brussels and Ghent. HBV genotyping
was carried out with the Inno-Lipa HBV Genotyping assay
(Innogenetics NV, Belgium) on 128 samples where chronic
hepatitis B infection and HBV DNA were detected.
Results: Of the 93 serum samples from blood donors 49 (53%)
samples were infected with genotype A and 34 (37%) samples
were infected with genotype D. Mixed genotypes A and D were
found in 7 (8%) samples. In the group of patients from the gastro-
enterology units, 19 (54%) of the 35 were infected with genotype
A and 11 (31%) patients had genotype D. Here also, mixed
genotypes A and Dwere found, speciﬁcally in 3 (9%) samples. In
total, only 2 samples could not be genotyped by the Inno-Lipa
assay, despite the detection of HBV-DNA. No signiﬁcant differ-
ence was observed with respect to the distribution of the
genotypes A, D and A/D between the 2 groups of patients.
Conclusion: The results indicate that genotypes A and D are the
predominant genotypes in Belgian patients with chronic hepa-
titis B infection.
R2213
Response to interferon-alpha in chronic hepatitis
B with and without precore mutant strain
S. Akhan, E. Azak Karali, Z. Yulugkural (Kocaeli, TR)
Objectives: Chronic hepatitis B is an important public health
problem worldwide and in Turkey. In Turkey chronic hepatitis
B were mostly precore mutant strains. We investigated whether
the presence of precore mutant affects the response to inter-
feron-alpha in patients with chronic hepatitis B.
Study: Chronic hepatitis B patients who were admitted to the
Infectious Diseases and Clinical Microbiology polyclinic in the
last eight months were included in this study. Thirteen with
hepatitis B e antigen-positive, hepatitis B e antibody-negative
and ten with hepatitis B e antigen-negative, hepatitis B e
antibody-positive (precore mutants) chronic hepatitis patients
were treated with natural interferon-alpha 24 months. Before
treatment, all patients had liver biopsy to grade and stage liver
disease. Liver biopsy showed chronic hepatitis (necroinﬂamma-
tory score 4), there was no cirrhosis and nobody had interferon
therapy before. Serum HBV DNA level criteria to begin the
therapy was 104 copies/ml for precore mutant strains and
105 copies/ml for non-mutant strains.
Results: SerumHBVDNA level before treatment was not differ-
ent between the two groups (p = 0.053). At the end of treatment,
serumHBV-DNAwas decreased to undetectable levels in 30% of
mutant group and 23% of the non-mutant group. The decrease of
serum HBV-DNA level was found signiﬁcant (z = )2.66;
p = 0.008) in mutant group and not signiﬁcant (z = )1083;
p = 0.279) in non-mutant group. Six months after treatment, the
percentage of cases with a decrease in the transaminase level to
Distribution of genotypes among blood donors and patients
from the gastroenterology units, with chromic hepatitis B.
Genotype H could not be assessed with the line-probe assay





N % N %
Total 93 100 35 100
Genotype A 49 53 19 54
Genotype B 1 1 0 0
Genotype C 0 0 0 0
Genotype D 34 37 11 31
Genotype E 0 0 1 3
Genotype F 1 1 0 0
Genotype G 0 0 0 0
Genotype A/D 7 8 3 9
Unclassiﬁed 1 1 1 3
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within the normal rangewas signiﬁcantly higher inmutant group
(p = 0.028) than in non-mutant group (p = 0.108).
Conclusions: Chronic hepatitis with precore mutant strain
seems more responsive to IFN-alpha. The reason of not
expecting result may be the serum HBV-DNA of four patients
in non-mutant group showed increase in spite of the treatment
and none of the patients in the mutant group.
R2214
Neutrophil oxidative metabolism in children
with chronic hepatitis C
T. Wozniakowska-Gesicka, M. Wisniewska-Ligier,
P. Lewkowicz (Lodz, PL)
A growing number of data suggest the role of reactive oxygen
species (ROS) in the pathogenesis of chronic type c hepatitis.
Activated neutrophils, macrophages and Kupffer cells are basic
sources of ROS in the course of the inﬂammatory process in the
liver. The aim of the study was to assess the metabolism of
neutrophil oxygen in children with chronic hepatitis C.
Material and methods: The study comprised 14 children with
chronic hepatitis C (group I), 4 children with positive serum anti-
HCV antibodies and negative HCV-RNA as well as normal ALT
activity (group II) and 6 healthy children 9 (group III). Produc-
tion of reactive oxygen species by neutrophils using the method
of chemiluminescence (CL) with luminol (MLX Microtitier Plate
Luminometr, Dynex, USA) was assessed. We estimated chemi-
luminescence response (CL max and CL total) of neutrophiles
both unstimulated and stimulated by formyl-methionyl-leucyl-
phenyloalanine (fMLP), opsonized zymosan (OZ), phorbol-
myristate-acetate (PMA) without and after priming with tumor
necrosis factor alpha (TNF-?) was estimated.
Results: CL max f MLP stimulated without preactivation was
signiﬁcantly lower in group I and II than in group III (p < 0.04,
p < 0.06, respectively). CL max OZ stimulated was signiﬁcantly
higher in group I in comparison to group II (p < 0.04) and it
tended to be higher in group I than in group III. CL max PMA
stimulated was lower in group I compared to group III
(p < 0.08). CL total fMLP stimulated was lower in group II
(p < 0.07) compared to group I and it tended to be lower in
group I and II compared to group III. CL total OZ stimulated
was signiﬁcantly higher in group I than in group II (p < 0.05)
and group III (p < 0.03). CL max and CL total OZ stimulated
and preactivated with TNFa was signiﬁcantly lower in group I
compared to group III (p < 0.02 and p < 0.04, respectively).
Summing up: In the course of chronic hepatitis C in children,
both neutrophil preactivation and inhibition of neutrophil
release of reactive oxygen species, which occur as a result of
different mechanisms, are observed.
R2215
One year combined treatment with ribavirine and
intron A in children with chronic hepatitis C
T. Wozniakowska-Gesicka, J. Kups, M. Wisniewska-Ligier
(Lodz, PL)
The aim of the study was to assess the effect of 12-month
therapy with IFN-a and Ribavirine in children with chronic
hepatitis C.
Material and methods: The study comprised 22 children
treated with Intron A administered subcutaneously at a dose
of 3 M.U. Three times a week and Ribavirine orally 15 mg/kg
body weight daily forthe period of 12 months. In the course of
the treatment, ALT activity, haemoglobin, leucocyte and throm-
bocyte were determined. HCV-RNA in serum was performed at
the beginning, after 6 month and after the therapy.
Results: After 12 months of combined treatment with IFN-
alpha and Ribavirine the elimination of HCV-RNA and nor-
malisation of ALT activity were observed in 14 children. In 2
children the normalisation of ALT activity without elimination
of HCV-RNA was observed. Six children did not respond to 12-
month combined therapy. A lower mean activity of ALT at the
beginning of the treatment was observed in children who fully
responded to the combined therapy as compared to those who
did not respond to the treatment. The following side effects were
found in all the treated children: fever, headache, abdominal
pain loss appetite, hair loss, myalgia and hypersomnia. In 12
children transient leucopenia, in 6 thrombocytopenia and in 5
anaemia were detected.
Conclusions: 1. Full response to the combined therapy (HCV
RNA elimination and ALT normalisation) was obtained in about
64% of the treated children.
2. Numerous side effects observed in the course of the




Human herpesvirus 8 and associated neoplasms
M. Hemmersbach-Miller, M.A. Ca´rdenes Santana, M.E. Arkuch
Saade, J.C. Rivero Vera, M. Mathias Gutie´rrez, P. Betancor Leo´n
(Las Palmas de Gran Canaria, E)
Objective: Human herpesvirus 8 (HHV-8) is the etiologic agent
of Kaposi sarcoma. HHV-8 has been associated to other diseases
such as primary effusion lymphoma, Castleman disease, bone
marrow failure and oral cavity plasmablastic lymphomas (PBL)
in HIV+. Epstein-Barr virus (EBV) is known as a cofactor in
AIDS-related lymphomas. We report the case of an HIV+ male
which presented with two HHV-8 related neoplasms: a colonic
PBL and a sigmoid Kaposi sarcoma. To our knowledge this is
the ﬁrst case of colonic PBL in the literature, as well as the ﬁrst
case where these two malignancies are associated.
Case: A 41-year-old male had a 3-month history of liquid
diarrhoea, fever and malaise. He was known HIV+ for 11 years
and had not previously received HAART. Physical examination
was normal except for a facial lipoatrophy and small cervical
lymphoadenopathies (<1 cm). Hemoglobin 9.9 g/dl, WBC
5030/mm3, platelets 227000/mm3, ESR 29 mm/h, creatinine
0.89 mg/dl, GOT 61 U/l, GPT 55 U/l, LDH 545 U/l, beta-2-
microglobuline 3.58 mcg/ml, CRP 4.82 mg/dl; CD4 135/mcl,
HIV-1 viral load 302,000 copies/ml. PCR for EBV in the
cerebrospinal ﬂuid was positive. A colonoscopy showed a
purplish lesion in the sigmoid colon and an ulcerated mass in
the caecum; both were biopsied. The ﬁrst one was informed as a
Kaposi sarcoma and the second one as a PBL. A bone marrow
biopsy showed lymphomatous inﬁltration. D4T, 3TC and
lopinavir/ritonavir was started, as well as CHOP chemother-
apy. The latter was stopped after the third course due to
progressive deterioration. The patient developed a palsy of the
III and VII cranial nerves. Opportunistic infections were ruled
out and a spinal tap revealed lymphomatous meningeal
involvement. He died 6 months after the initial referral.
Abstracts
734
Conclusion: HHV-8 is involved in the pathogenesis of both
malignancies, Kaposi sarcoma and PBL. Nevertheless, neither
this association nor the peculiar localization of the PBL (right
colon) have been described. Only few other extra-oral sites have
been found: nose, lung, mediastinum, stomach, testicle, bone
and ano-rectum. Diagnostic procedures with regard to HHV-8
infection are not routinely performed. Repeated detection of
HHV-8 has been described to increase the risk of active Kaposi
sarcoma. We hypothesize that extra-oral PBL might also be
related to HHV-8 as a cofactor, similar to EBV. We suggest that a
better understanding of the mechanisms of the infection could
provide prevention and treatment strategies.
R2217
Epstein-Barr virus infection in patients with
gastric carcinoma
A. Szkaradkiewicz, W. Majewski, M. Wal, M. Czyzak, A. Kuch,
J. Bierla. (Poznan˜, PL)
Objective: The studies aimed at evaluation of serological
markers of Epstein-Barr virus (EBV) infection and presence of
EBV DNA in the gastric carcinoma (GC) material.
Methods: The studies were performed on 21 patients, aged 42–
68 years, in whom advanced GC was diagnosed by histological
methods. Sera of the patients were tested for EBV DNA (Sharp
Signal System; Digene), IgG-anti-EA antibodies (ETI-EA-G;
DiaSorin), antibodies directed to VCA (ETI-VCA-M, ETI-VCA-
G; DiaSorin) and IgG-anti-EBNA antibodies (ETI-EBNA-G;
DiaSorin). In parallel, in the GC material EBV-encoded small
RNA (EBER) particles were detected using in situ hybridization
(ISH) and ISH Detection Kit (DakoCytomation).
Results: Basing on serological markers (serum IgG-anti-VCA
and IgG-anti-EBNA antibodies), past EBV infection was docu-
mented in 20 patients. In one patient no anti-EBV antibodies
were detected. In 12 of the patients positive reaction for EBER
was documented in the nuclei of carcinoma cells, while 11 of
them demonstrated presence of EBV DNA in the serum. The 9
remaining patients manifested neither positive signals in EBER-
ISH nor presence of EBV DNA in the serum.
Conclusions: The obtained results point to involvement of EBV
in development of GC conﬁrming a multifactorial etiology of the
disease.
R2218
The prevention and treatment of neonatal
herpesviruses infections
D. Bartosova (Brno, CZ)
Objectives: In this report, the authors have presented clinical
picture, course and therapy used in 13 infants with congenital
VZV infection, 12 infants with congenital herpes simplex
infection and 18 infants with CMV infection hospitalised at the
Department of Paediatric Infectious Diseases in Brno within
January 2000–November 2004.
Methods: The diagnosis of congenital HSV, VZV and CMV
infection was established partly clinically on the base of typical
symptoms of congenitally acquired disease, in a part of infants
even from personal anamnesis (mother’s disease during preg-
nancy) and especially veriﬁed by isolation of viruses from skin
lesion, urine or occasionally from cerebrospinal ﬂuid, detection
of VZV, HSV and CMV DNA in the CSF, blood, or surface
specimen, and/or by detection of viral antigen and by means of
serological examinations.
Results: There were no death in HSV and VZV study group. In
the set of 18 newborns with conﬁrmed congenital CMV
infection, 11 of them have permanent neurological consequences
involving motor of psychomotor problems. Five of them suffer
from sensoric affection (4· disturbance up to loss of hearing, 1·
strabism).
Conclusion: The early diagnosis and management of congenital
and perinatal infectious in neonate is important and this will
depend on the clinical recognition of the condition. Unfortu-
nately, early diagnosis is problematic. Many of these conditions
have non-speciﬁc manifestations. As most maternal infections
are asymptomatic, repeated serological screening of all suscep-
tibile seronegative women would be required throughout
pregnancy. This difﬁculty exempliﬁed by neonatal herpes
infection when early diagnoses and treatment is essential to
prevent possible adverse consequences. Early initiation of
therapy is of outmost importance every case of herpesviruses
infection should be treated as soon as possible. Antiviral
therapies have dramatically improved survival rates.
R2219
Evaluation of herpes simplex virus-1 latency in
trigeminal ganglia of ocular and systemic
infected mice
A. Ghaemi, H. Soleimanjahi, T. Bamdad, E. Areﬁan,
M. Jamalidoust (Tehran, IR)
Objective: Experimental herpes simplex virus type 1 infection
in mice parallels that which occurs in humans. During primary
infections, viral replication at the surfaces mucosal is detectable
for a 10- to 12-day period. Within 24 h post infection (p.i) HSV
infections are common and produce not only a primary
infection, but also latent and recurrent infections. Following
primary infection of herpes simplex virus type-1, the virus gain
access to the termini of sensory neurons, transported in
retrograde direction to the neuron cell bodies in sensory ganglia,
replicates, spreads to other neurons, and establishes a lifelong
latent infection in a portion of the neurons.
Method: In this study we used PCR analysis for detection of
HSV-1 latency in inoculated BALB/c mice. Thirty ﬁve to forty
days after intraocular (IO) and intraperitoneal (IP) challenges in
different groups, the surviving mice were euthanized, trigemi-
nal ganglia (TG) were harvested, mouse TG was individually
homogenized and cell pellet was used to detect viral DNA by
PCR analysis .The TG pellet after washing with PBS, were
suspended in Tris-EDTA containing .1%SDS and protienase K.
After incubation in 55 for 5 h, viral DNA was extracted and PCR
performed using two primers of thimidine kinase gene of HSV-1
that generated a 398 bp product.
Results: We show that the rate of virus latency in IO infected
mice is signiﬁcantly higher than IP infected mice.
Conclusion: Primary HSV infection of any of the 3 branches
(ophthalmic, maxillary, mandibular) of cranial nerve V can lead
to latent infection of nerve cells in the trigeminal ganglion then,
after IO challenge we have more per cent of latency in
comparison to IP challenge.
R2220
Evaluation of the antigenaemia assay in early
diagnosis of active cytomegalovirus infection in
hospitalised patients
K. Themeli-Digalaki, E. Orcopoulou, T. Karonis, L. Poutilina,
D. Kairis, C. Carouzou (Athens, GR)
Objective: To evaluate the detection of Cytomegalovirus
(HCMV) pp65 antigen and serologic response in patients with
active HCMV infection.
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Methods: We examined 36 hospitalized patients with suspect
HCMV infections (8 children and 28 adults) and 25 blood donors
as control group. HCMV pp65 antigen in blood leukocytes were
detected and speciﬁc IgM and IgG antibodies in sera wera
determined by DF and EIA, respectively. The number of blood
leukocytes was >2000/ml.
Results: Active HCMV infection was diagnosed in22 adults and
6 children (77.7%) by pp65 antigen detection ,while in control
group antigenaemia not found. In all cases IgM antibodies were
positive in 31 patients (86.1%), IgG antibodies were positive . In
5 children (13.8%) was found seroconversion of IgG .In control
group, Igm antibodies were negative, while in 18 of them (72%)
igG antibodies were found positive. From the 6 children with
active HCMV infection 2 had mononucleosis-like syndrome and
4 acute febrile infection. Adults in respectively from the 22
patients, 6 had mononucleosis-like syndrome, 4 acute febrile
infection and 12 undergoing immunosuppressive therapy. The
speciﬁcity and the sensitivity of antigenaemia assay for diagno-
sis active infection were 100% and 87.5%, respectively.
Conclusions: In this study the pp65 antigen assay seems to be
simple, rapid, inexpensive test for early diagnosis of active
HCMV infection.
R2221
Identiﬁcation of two major human
cytomegalovirus gB genotypes in Taiwan
Y.-J. Chan, Y.-W. Ma, C.-Y. Liu, Y.-C. Liu, W.-T. Liu
(Taipei, Kaohsiung, TW)
Objectives: Genotypic preference of human cytomegalovirus
(HCMV) can be found in a certain geographic area. To determine
the predominant CMV genotype(s) in Taiwan, an island located
in the southeastern Asia, we performed this study.
Methods: We used restriction fragment length polymorphism
(RFLP) analysis to determine the subtypes of the HCMV gB
gene, which encodes a viral membrane glycoprotein. A total of
101 clinical HCMV isolates collected island-wide were tested to
determine their genotypes.
Results: We found two major CMV gB genotypes, gB1 (52%)
and gB3 (33%), in the paediatric patients. There were 9% of
mixed gB types 1 and 3 and 6% of unknown types. None of them
belonged to gB types 2 and 4. The reason that results in the
signiﬁcant difference of gB genotypic preference is unclear.
Conclusions: Two major HCMV gB genotypes, gB thpe 1 and 3,
are found. RFLP may serve as a convenient method for
genotypic analysis of CMV clinical isolates.
R2222
IgG response to herpes simplex virus type 2 gG
and gD recombinant proteins among adults and
children
S. Klimashevskaya, V. Puzyrev, T. Ulanova, T. Volkova,
A. Burkov, A. Obriadina (Nizhnij Novgorod, RUS)
Objectives: Recent studies have shown that both HSV-2 glyco-
protein D (gD2) and glycoprotein G (gG2) have high potential as
diagnostic reagents for the reliable detection of the type-speciﬁc
IgG. The purpose of this study was to evaluate speciﬁc IgG
response to HSV-2 gG2 and gD2 among child and adult
populations and to investigate the protein-speciﬁc pattern of
low avidity IgG reactivity.
Methods: A total of 160 serum samples from adults (normal
blood donors) and 55 serum samples from children (age range
2–3 years-old) were analysed by type-speciﬁc HSV2 IgG enzyme
immunoassay (DS-EIA-ANTI-HSV2-IgG, Russia), based on
recombinant HSV 2 gG2 (525–578aa) and gD2 (266–394 aa)
proteins. All HSV-2 IgG positive samples were additionally
tested for presence of IgG to gD2 (anti gD2) and gG2 (anti gG2)
individually. The determination of IgG avidity was performed
with 8M urea as a dissociative agent.
Results: 73 out of 160 (45.6%) serum samples from normal
blood donors (adults) and 14 out of 55 (25.5%) serum samples
from children were positive for HSV2 antibodies by EIA.
Protein-speciﬁc distribution of IgG activity was signiﬁcantly
different in terms of both IgG level and IgG avidity for two
investigated groups (Table 1, Table 2).
Conclusion: Speciﬁc IgG response to HSV 2 gG2 and to gD2
differs among various age groups. Frequency of low-avidity
antibodies in children signiﬁcantly exceeds frequency of low-
avidity antibodies in adults. Furthermore, low-avidity anti gG2
was found predominant in children, and low-avidity anti gD2 in
adults.Serologic assay based on the only protein (gG2 or gD2)
has a potential for false negative result. It may be especially
important for primary HSV2 infection detection.
R2223
Qualitative DNA PCR for early detection of
symptomatic CMV infection after renal
transplant
V. Kanapeckiene, R. Valinteliene (Vilnius, LT)
Objectives: One of the most perspective methods in CMV
infection diagnostics is detection of viral DNA by the polym-
erase chain reaction PCR. It is very actual for early differential
diagnostics of the arising acute rejection crisis and CMV clinical
syndrome after transplantation. Treatment strategy of these
clinical syndromes is different: in the crisis of acute rejection,
immunosuppressive treatment is intensiﬁed, while on the onset
of the CMV clinical syndrome-minimised with additional
administration of speciﬁc antiviral treatment.
Methods: There was carried out a prospective laboratory-
clinical study of patients after renal transplantation (duration –
3 months). Blood samples for the CMV serological tests were
collected once every 10–14 days. In a retrospective way, for the
tests by the DNA PCR there were selected 24 kidney recipients
with manifesting clinical symptoms over the all ﬁrst months
following transplantation. By the repeated serological tests
(ELISA, indirect immunoﬂuorescence), for the patients with
manifesting clinical symptoms there was found a diagnostic
increase in antibody titres indicating active CMV infection.
Results: The CMV clinical syndromemanifesting in self by fever
and other typical clinical signs was determined for 13 persons. In
11 cases the CMV infection was asymptomatic. A positive PCR












Adults (n = 160)
73 50 (68.5%) 5 (6.8%) 18 (24.7%)
Children 2–3 years (n = 55)
14 9(64.3%) 3(21.4%) 2(14.3%)















Adults (n = 160)
73 12 (16.4%) 11 (15%) 1 (1.4%) 0
Children 2–3 years (n = 55)
14 6 (42.9%) 2 (14.3%) 3 (21.4%) 1 (7.1%)
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test was obtained for 12 recipients out of 13 with symptomatic
CMV infection and only for 5 out of 11-with asymptomatic
infection.A negative PCR testwas obtained for 6 patientswith the
asymptomatic infection and only for 1 with the clinical manifes-
tation of the CMV infection. Thus, using the qualitative PCR
method when only a positive or negative result is obtained
without estimation of the amount of viral nucleic acids, the
symptomatic CMV infectionwith early onset may be identiﬁed in
92.3% of cases (sensitivity of methods), though a positive result in
also obtained in 29.4% of cases of the asymptomatic CMV
infection. Therefore, speciﬁcity of method in as low as 54.4%.
Conclusion: The positive prognostic value of the PCR test
while seeking to have early detection of the symptomatic CMV
infection requiring appropriate treatment is as low as 70.6%.
Somewhat more valuable is the negative prognostic value of
the PCR test-in the presence of a negative result, in 85.5% of
cases there is no clinical manifestation of the CMV infection,
and in such cases a speciﬁc antiviral treatment is not needed.
Emerging infectious diseases
R2224
Serological evidence of coinfection with Borrelia
burgdorferi and agent of human granulocytic
ehrlichiosis in forestry workers in north western
Poland
J. Niscigorska, I. Maczynska, I. Moranska,
A. Boron-Kaczmarska (Szczecin, PL)
Objectives: Tick-borne diseases-Lyme disease (L.d.)and human
granulocytic ehrlichiosis (HGE) can be a cause of high morbidity
in some groups of population, especially in forestry workers,
exposed for tick bites. Accordingly to some papers, coinfection
with Borrelia burgdorferi (B.b.) and agent of HGE may alter the
immune response and severity of L.d. The aim of this study was
to assess prevalence of anti-B.b. and anti-HGE antibodies in
serum of forestry workers in North Western Poland.
Methods: Eighty three samples of sera of forestry workers were
tested to detect anti-B.b. and anti-HGE antibodies using ELISA
(anti-B.b.) and IFA (anti-HGE) tests.IgG class of antibodies anti-
HGE and IgG and IgM classes of antiborrelial antibodies were
examined.
Results: Presence of anti-HGE IgG antibodies were conﬁrmed
in 15 tested serum samples (15/83, 18.1%). Anti-B.b.antibodies
were found in 13/83 samples (15.7%). Among 13 patients
infected with B.b. 10 (77%) had IgG class of antiborrelial
antibodies and 3 (23%) had IgM class antibodies. In analysed
group there were only 2 serum samples with presence of both
anti-B.b. and anti-HGE antibodies (2/83, 2.4%)
Conclusions: 1. Conducted study revealed presence of infec-
tion with B.b. and agent of HGE among examined forestry
workers in North Western Poland.
2. Serological study conﬁrmed possibility of coinfection with
these two pathogens.
3. Patients with L.d.should be tested to detect potential coin-
fection with HGE.
R2225
Brucellosis in municipality of Ke¨rc¸ove¨ during
1983–2000
I. Mehmedi, G. Mehmeti, R. Mehmedi (Kercove, MK)
Objective: To present clinical features and serological data of
brucellosis in the municipal of Kercove, Republic of Macedonia.
Methods: patients with brucellosis followed between January
1983–December 2000 were retrospectively evaluated. Initial
evaluation included complete blood count urinalysis and sero-
logical tests (standard tube Brucella agglutination test-STA).
Diagnosis of brucellosis was made by following criteria: (a)
history of exposure, (b) compatible clinical picture of disease, (c)
brucella serum agglutination titre more then 1/160. The method
of work is statistical method.
Results: In the above mentioned period were registered 133
cases with brucellosis, 28 of which are female and 105 male. The
average age was 41 ± 30 years. The most frequent features in the
patients disease of acute Brucellosis are: fever 92 (69.17%); joints
pain (mostly in the spine and in the hips) 107 (80.45%); sweat 91
(68.42%); loss of appetite 60 (45.11%); headache 68 (51.12%);
hepatosplenomegaly 14 (10.52%). In the diagnosis of human
brucellosis the best results were shown with the Rose Bengal
test, which was positive 100% of patients with acute brucellosis,
then with the Coombs test positive in 96.99%. The test by Wright
with 93.23%.
Conclusion: Brucellosis remain a major zoonosis worldwide.
The most frequent features in the patients disease of acute
Brucellosis are: joint pain(80.45%), fever (69.17%), sweat
(68.42%). In the diagnosis of human brucellosis the best results
were shown with the Rose Bengal test, which was positive 100%
of patients with acute brucellosis.
R2226
Prevalence of antibody against varicella zoster
virus in Iran
Z. Shariﬁ (Tehran, IR)
Objectives: Varicella zoster virus is a highly contagious virus
that affects people worldwide. The seroepidemiology of infec-
tion due to varicella-zoster (VZV) was investigated in 426
Iranian children aged from under 2 to 14 years and adults
(healthy male blood donors and pregnant women).
Methods: The enzyme linked immunosorbent assay (ELISA)
method was used to assess the presence of anti-VZV antibody.
Results: Age-speciﬁc prevalence of IgG antibodies VZV showed
a progressive increase with age in both males and females with
no obvious sex-related variation in the level. The overall
prevalence of antibodies was 51% for VZV in children whereas
about 88% of the adults.
Conclusion: These data show that almost 50% of the children in
Iran have not been infected with VZV. The differences in age-
speciﬁc prevalence of varicella may be due to the climate that
may also decrease the survival of virus in tropical regions.
R2227
Risk factors of Crimean-Congo haemorrhagic
fever outbreak in Central Anatolia: a case control
study
M.A C¸evik, R. Uzun, N. Yilmaz, M. Ugurlu, N. Elaldi, H. Bodur,
M. Bakir, H. Vahaboglu (Ankara, Sivas, Kocaeli, TR)
Objectives: An outbreak of CCHF evolved through 2002–2003
in Central Anatolia in Turkey. To demonstrate the risk factors
and potential sources or dissemination vehicles of this outbreak
a case control study in the region was undertaken.
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Methods: Cases were the patients those admitted to tertiary
care hospitals in 2003 with an illness consistent with CCHF and
a positive IgM or RT-PCR test result. Two controls per case were
selected randomly among those living in the same villages but
not experienced a similar illness during the last 3 years. As
being potential confounding parameters, age (+10 years) and
gender were controlled. A questionnaire was ﬁlled by home
visits at the region while a blood sample was obtained for
serologic screening of speciﬁc IgG and IgM antibodies.Statistical
analysis was performed by the software NCSS (Number Crun-
cher Statistical Systems, ver. 2004). Dichotomous variables were
compared by Chi-square or Fisher’s Exact Test where applic-
able. Statistical comparisons were always two tailed.
Results: A total of 62 cases were reachable. Accordingly, 124
controls were selected. Among the risk factors compared only
tick exposure before the unset of disease was signiﬁcant (OR,
13.33; CIs, 6.39–27.81). Cases those experienced ticks bites
mostly described domestic animals and rural areas out of
villages for tick exposure (data not shown). Serologic screening
between cases and controls were signiﬁcant, as well. These
comparisons and demographic characteristics, such as age and
gender were shown in Table 1.
Table 1. Some demographic features and one signiﬁcant risk
factor (tick bite) and serologic torts between cases and controls
Cases (n=52) Controls (n=124) P
Age (mean [SD]) 42.4 (17.0) 43.9 (16.9)
Male sex 29 (46.8) 58 (46.8)
Animal keeping 56 (90.3) 99 (79.8) 0.0943
Tick bite 43 (59.4) 13 (14.5) <0.001a
IgG 59 (96.7) 15 (12.1) <0.001b
IgM 47 (78.3) 3 (2.4) <0.001
Discussion: This study demonstrated that tick bite was the
single signiﬁcant risk factor responsible for this outbreak.
Animal keeping, buying and selling is widespread in the region
(83.3%). Domestic animals could be a source for tick exposure.
However, some cases described certain areas out of villages for
thick exposure, as well. One important point was that, cases
were mostly scattered. Except few examples, they were mostly
from different houses. If the live stocks are the source of infected
ticks we would found clusters from same houses. The signiﬁcant
difference in the serologic survey between cases and controls
supported this view as well. This study, in other words,
indicated that rural areas with a heavy tick infestation must be
the most likely source of this outbreak. However, more studies
in the region are warranted to explore the source of this
outbreak and eventually to control it.
R2228
High prevalence of Helicobacter pylori infection
in Tunisia
A. Amor, M.R. Bouali, M. Ben Moussa, F. Khediri Montﬂeury,
TN
Objectives: Helicobacter pylori (HP) infection is widespread in
developing countries. We performed a survey to evaluate the
prevalence of this infection in a Tunisian population including
all age brackets.
Methods: During February and Mars 2002, patients (414)
referred to our hospital laboratory for blood tests were asked
to reply to a questionnaire and give a blood sample for a test
measuring out the anti-HP antibodies (anti-HP EIA QUANT,
Cobas Core II, Roche).234 asymptomatic volunteer blood donors
(AVBD) were also included (mean age: 22 yr).
Results: 414 patients were included (52 % male) with mean age
of 31 yr (extr: 1–80).94% of these patients were of average social
standing. 9.2% were complaining of dyspepsia and 14.2%
reported symptoms of dyspepsia in the household.The sero-
prevalence of HP antibodies was 9% in the young children
(1–5 yr), 40% in the older children (6–15 yr) and 60% in patients
between 16 and 20 yr of age. In patients older than 20 yr,
seroprevalence was 88% (279/317) comparable to AVBD: 86.3%
(202/243). Except for the age, there was no other factor (gender,
origin, social standing, dyspeptic symptoms) inﬂuencing the HP
infection seroprevalence.
Conclusions: Seroprevalence of HP infection is high (79.3%) in
our mainly asymptomatic population. Infection increases during
childhood and adolescence, reaching 88% in adults. This high
prevalence raises the question of whether we should continue to
systematically look for HP infection in patients with upper
gastroenterological disorders.
R2229
A case of acute melioidosis in a traveller
N. Liassine, R. Lucchini, M.C. Descombes, O. Guinand
(Geneva, Breganzona, CH)
Burkkolderia pseudomallei is the causative agent of melioidosis
and a potential biological weapon. This anthropozoonosis is
endemic in regions of southeast Asia and northern Australia and
sporadic in Europe. Bacteraemia in melioidosis is associated
with high mortality.We report a case of acute melioidosis in a
traveler. A 52-year-old man was admitted to hospital with fever,
asthenia and vomiting. He had recently traveled in Bangladesh
and Vietnam. He had a documented non-insulino-dependent
diabetes. On clinical examination he presented fever and
abdominal pain. The diagnostic of malaria was excluded after
laboratory investigation. CT abdominal scan showed hepatic
and splenic abscesses and the diagnosis of visceral amebiasis
was discussed although amebic serology was negative. Of four
blood-culture bottles, one aerobic bottle was positive with
Gram-negative bacilli identiﬁed as Burkholderia cepacia by
Vitek 2 (very good identiﬁcation, T-index 0.66). In regard to the
doubtful diagnosis of visceral amebiasis and the unusual
susceptibility of the isolate to imipenem, a new identiﬁcation
was made by 16S RNAr sequencing and API20-NE that
identiﬁed a Burkholderia pseudomallei. An appropriate antimi-
crobial treatment was then prescribed for a total duration of
12 weeks (ceftazidime i.v and association of trimethoprim-
sulfamethoxazol/doxycycline). Clinical outcome was favora-
ble.This case emphasizes: 1/the possibility of misidentiﬁcation
of Burkholderia pseudomallei in laboratories that are unfamiliar
with this microorganism; 2/the importance of an acute diagno-
sis of melioidosis to treat correctly this severe disease and to
prevent relapses; 3/the necessity to consider the diagnosis of
melioidosis in travelers.
R2230
Acute gastroenteritis caused by Aeromonas
jandaei – importance of identiﬁcation to the
species level
E. Durnova, A. Andelova, I. Porazilova, J. Kulhavy,
I. Sedlacek (Ostrava, Brno, CZ)
Objectives: Aeromonads have recently been accounted into a
new emergent pathogens. They can cause wound infection or
septicaemia as well as gastroenteritis. Until now, the epidemi-
ology is not known too much and lately described species still
appear. According to our experience the identiﬁcation of clinical
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isolates of mesophilic aeromonads only asA. hydrophila,A. caviae,
or A. sobria complex is no longer accurate. With proper
identiﬁcation system even so-called rare species can occur in
clinical samples.
Methods: 160 isolates of aeromonads originated mostly in stool
samples. Biochemical identiﬁcation was done by ENTEROtest24
(Pliva-Lachema), results were assumed by software TNW for
oxidase positive fermenting rods. Cellular fatty acid analysis
was performed by MIS Sherlock (MIDI, Inc., USA).
Results: Genus speciﬁc tests such as resistance to vibriostatic
agent O/129 (150 lg) and growth in broth culture with addition
of NaCl (0%,1%,6%) conﬁrmed, that ENTEROtest24 ensured
good distinction of genera Vibrio and Aeromonas. In combina-
tion with TNW software ENTEROtest24 was useful for identi-
ﬁcation of common aeromonads. Nevertheless, due to
permanent changes in taxonomy the supplementary conven-
tional biochemical tests are recommended. Routine species
identiﬁcation of Aeromonas isolates by biochemical testing and
fatty acid analysis proved the presence of species from com-
plexes A. hydrophila (A. hydrophila, A. bestiarum), A. caviae
(A. caviae, A. eucrenophila, A. media) and A. sobria (A. veronii,
A. sobria). Beside these common ones we noticed also Aeromonas
jandaei isolate from stool sample. Diagnosis of acute gastroen-
teritis was evident (vomiting, watery dirrhoea. Isolate was
identiﬁed by ENTEROtest24 as excellent (T index 0.882, ID
91.39%) and comparison of cellular fatty acid proﬁle conﬁrmed
the identiﬁcation. The same major and also minor fatty acids as
by A. jandaei CCM 4355T (C16:1w7c alcohol, C16:0N alcohol,
C17:0 10 methyl) were presented by our isolate.
Conclusion: There are enough aeromonads in clinical samples
and there are also less frequent Aeromonas species occuring in
our region. Use of an appropriate identiﬁcation system can easily
warn microbiologist of a rare species. Only proper identiﬁcation
of each isolate will provide us with information, whether all
described mesophilic Aeromonas species are involved in diar-
rhoeal disease.Our project is being supported by IGA of Ministry
of Health of the Czech Republic, Id.code: NR/8011-2.
R2231
Q-fever febrile illness and pneumonia in a rural
town in the Balkans
M. Tiholova, G. Kamenov (Soﬁa, BG)
Objectives: In the spring of 2004 an increase was noted
inpatients with acute fever and pneumonia in a small rural
town in the Balcans. The diagnosis Q fever was established and
the epidemics was limited. 51% of the outbreak cohort had
speciﬁc antibody titres to phase II C.burnetii antigen >1:64, that
conﬁrmed a recent infection. The objectives of our study were to
establish the clinical, epidemiological and laboratory parameters
of Q fever in this part of Bulgaria and to draw conclusions
concerning the early diagnosis, treatment and prevention of the
infection in the endemic regions.
Methods: To establish the diagnosis of Q-fever all patients had
a complete physical examination, epidemiological data were
collected. Atypical pneumonia was documented. Seroconvertion
was considered in patients demonstrating titres of antibody
(IgG > 200 and IgM > 50) to phase II C.burnetii.
Results: 51% of seropositive cases presented acute self-limited
illness, 39%-atypical pneumonia. Common clinical symptoms
were found and appropriate antibiotic regiments indicated.
Conclusions: The apparent reason for the outbreak was the
inhalation of infected aerosols. The large number of infected
domestic animals in the town may have been the cause. The
character of ﬂue-like illnesses and pneumonias during May
implies a point source. The early diagnosis of Q fever in risk
regions can be helped by epidemiological data on morbidity due
to inﬂuenza-like illnesses and atypical pneumonia. In such
conditions, physicians must treat with appropriate antibiotics
before serological conﬁrmation of the diagnosis of Q fever. The
public health, veterinary and municipal authorities must work
together to educate the population about the basic principles of
Q fever prevention which includes restricting contact between
people and cattle and improving infection control in the places
where animals are bred.
Discussion: The apparent reason for the outbreak of atypical
pneumonia due to C. burnetii was the inhalation of infected
aerosols.The large number of infected domestic animals in the
town may have been the cause. The early diagnosis of Q fever
in risk regions can be helped by epidemiological data on
morbidity due to inﬂuenza-like illnesses and atypical pneu-
monia. In such conditions, physicians must treat with appro-
priate antibiotics before serological conﬁrmation of the
diagnosis of Q fever.
Vaccines
R2232
Production, extraction and evaluation of Neisseria
meningitidis serogroup B outer membrane vesicle
containing PorA
S.D. Siadat, Q. Behzadian Nejad, B. Tabaraie, S. Najar Peerayeh,
H. Ahmadi, A. Kazemnejad, M. Nejati (Tehran, IR)
Capsular polysaccharides from Neisseria meningitids groups A,
C, W135 and Y induce protective bactericidal antibodies in
humans, having been used as vaccines for almost two decades.
In contrast, group B capsular polysaccharide vaccines have
proven to be essentially nonimmunogenic and for this reason’s
serogroup B is presently the major cause of meningococcal
disease in most developing countries and this, combined with
the lack of immunogenicity of the B polysaccharide, has
necessitated development of alternative vaccines based upon
the outer membrane proteins and lipooligosaccharides. Major
surface components, such as the outer membrane porin PorA
(class 1 protein), are nowadays considered as potential vaccine
candidates. Sergroup B N. menigitidis strains CSBPI, G245
obtained from the Collection of Standard Bacteria Pasteure
Institute of Iran for farther investigation the cultivation medium
was meningococci medium according to Frantz, with main
compotent: L-glutamic acid, L-cystein, glucose and yeast extract.
Cell’s were cultivated at 36oC for 18h.Outer membrane vesicle-
containing class1(PorA) were prepared and puriﬁed according
to the Deoxycholate Ultracentrifuge-Differentiation Technique
(DUDT) of fermenter grown bacteria. Brieﬂy N. meningitides
CSBPI, G245 Was cultivated in Frantz medium supplemented
with 0.2% yeast extract dialysate in 40 l fermenter contact-Flow
b.v. Bilthoven unit system until early stationary phase and
OMV-PorA extract by tris-buffer, EDTA and 0.5% w/v
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deoxycholate. Puriﬁcation was done by sequential centrifuga-
tion steps at 20,000 g for 30 min. Following ultracentrifugation
at 125,000 g for 2 h, the pelleted OMV-PorA were homogenized
in PBS. OMV-PorA were ultrasonically treated to disperse the
vesicles and were attached to Formvar/Carbon coated Nickel
Grids. After preparation step’s, the Grids were examined in a
Zisse CEM 902A electron microscope. In negative contrast
staining and electron microscopy size of OMV-ProA ranged
50–150 nm. Intactness of vesicles in these preparation ranged
70–90% of the vesicle.Protein concentration was measured
according to method of lowry et al. The samples were analysed
on 10% poly acrylamide gels in the presence of 2% (w/v) SDS.
After electrophoresis protein were stained by 0.1% (w/v)
coomassie Brilliant Blue staining and the relative amount of
OMV-PorA were determined. The results of lowry method was
6 mg protein per 1 ml of sample. When analysed on SDS-PAGE
can be separated and their MW can be calculated.
R2233
Immunological evaluation of OMP-F vesicle of
native Iranian Pseudomonas aeruginosa CSBPI:
16-190 as a protective vaccine in mice model
H. Ahmadi, B. Tabaraie, M. Nejati, S.D Siadat,
F. Pormirzagholi (Tehran, IR)
300 Pseudomonas aeruginosa strains were isolated from patients
admitted in four Tehran hospitals. Using standard O-speciﬁc
typing sera, they were all grouped in 16 serotypes out of 17
known Pseudomonas aeruginosa. The serotypes were lyophilized
and each was given a code according to the Collection of
Standard Bacteria Pasteur Institute of Iran (CSBPI) for farther
investigations. Among all clinical samples, CSBPI: 16-190 was
the most prevalent Pseudomonas aeruginosa serotype which
showed a high agglutination titre (4+, 320) against homologous
O-speciﬁc typing sera. This serotype was selected for extraction
of Pseudomonas aeruginosamajor outer membrane vesicles (OMP-
F). OMP-F vesicles were extracted and puriﬁed according to the
Deoxycholate Ultracentrifuge-Differentiation Technique. Purity
and molecular weight of OMP-F was determined by SDS-PAGE
and ability of OMP-F vesicles to induce high titre of antibody in
rabbit was shown as a sharp antibody-antigen precipitation line
in gel double diffusion test. Passive immunization of mice with
anti-rabbit OMP-F antisera, induced a high level of protection
when the mice were post-challenged with 2·LD50 of live
Pseudomonas aeruginosa CSBPI: 16-190. Besides, active immun-
ization of mice with 50 lg of OMP-F, could protect mice against
2·LD50 of live homologous (100% protection) and 15 heterol-
ogous native Iranian Pseudomonas aeruginosa serotypes with 50–
100% level of protection. OMP-F was Pyrogen-free in rabbit
pyrogenic test and did not produce any detectable abnormal
toxicity in mice and guinea pigs. Moreover, OMP-F did not
show any skin sensitization when 25, 50, 100, 250 and 500 lg
were injected intradermally.The above investigations indicate
that puriﬁed OMP-F of CSBPI: 16-190 can be regarded as a safe
protective immunogen in vaccinothrapy against all Pseudomonas
aeruginosa immunotype isolated in Iran.
R2234
Expression and puriﬁcation of Herpes simplex
virus type 2 glycoprotein D in insect cells using
the Baculovirus expression system
F. Fotouhi Chahooki, M. Roostaee, H. Soleimanjahi (Tehran, IR)
Objectives: Herpes simplex virus type 2 (HSV-2) infects muco-
cutaneously and causes genital infection in humans, followed by
the establishment of a latent infection in the sensory ganglia and
can reactivate for life. A need for effective vaccine remains the
preferred strategy for control of HSV-2 infection. Glycoprotein D
(gD) of HSV has been focused on as subunit vaccine due to its
primary role in inducing cellular and humoral immune
responses to a herpes infection. In this study, HSV-2 gD was
expressed in insect cells using the Bac-to-Bac Baculovirus
Expression System in order to apply as a subunit vaccine in
animal models.
Methods: The HSV-2 gD of an Iranian isolate was ampliﬁed by
PCR and cloned into pFastBac plasmid. The recombinant
plasmid was transformed into E. coli DH10Bac cells containing
bacmid, a baculovirus shuttle vector, for the site-speciﬁc
transposition of the gD2 gene. The recombinant bacmid was
conﬁrmed by PCR, transfected into Sf9 cells, cultured in serum-
free Grace’s medium at 27 C and monitored daily for observa-
tion of cytopathic effects. After 72 h, the baculovirus was
harvested from the cell culture medium. The viral stock was
ampliﬁed by reinfecting insect cells and titrated as pfu. The Sf9
cells were infected with gD2-baculovirus and incubated at
27 ordm;C for various times to express the recombinant protein
of interest. The cells were pelleted by centrifugation, lysed and
subjected to SDS-PAGE before and after puriﬁcation. The gels
were analysed by western blotting using a monoclonal anti-gD2
antibody.
Results: The gD gene of HSV-2 was cloned after conﬁrming by
sequencing. The protein production in insect cells was shown
by western blot analysis. The results revealed that
Glycosylated and nonglycosylated forms of gD2 were expressed
in insect cells as cell-associated proteins by 72 hours post
infection.
Conclusion: Baculovirus expression system provides correct
folding of recombinant protein as well as disulﬁde bond
formation, oligomerization and other important post-transla-
tional modiﬁcation. Consequently, the expressed protein exhib-
its the proper biological activity and function. The pure gD2 can
be used as a subunit vaccine in animal models.
R2235
Seroprevalence of Rubella antibodies among
young population in Tehran, Iran
H. Soleimanjahi, T. Bamdad, F. Fotouhi Chahooki, M. Roostaee,
S.D. Siadat (Tehran, IR)
Objectives: Congenital rubella is a preventable disease, which
has largely been controlled through immunization. The aim of
this study is to examine the prevalence of antibodies against
rubella in Iran, before and after the largest mass campaign for
measles and rubella (MR) vaccination of 33,000,000 people with
an age rang of 5–25 years-old in 2004.
Methods: A total of 400 serum samples before and after
vaccination were collected and assayed using hemagglutination
inhibition test (HIT). HIT considered as a reliable index of the
immunity level to RV infection.
Results: The data revealed that 95% of target population
becomes seropositive after vaccination, while 94.25% of them
had rubella antibodies before MR vaccination.
Conclusion: Rubella is an infectious viral disease, which is
endemic in Iran. The more detailed epidemiological studies are
still needed to perform a national immunization programme.
Based on the results, rubella virus is circulating among popu-
lation in Iran, so it is recommended to selective vaccination of




Analysis of anti-ﬂu vaccinations among patients
of a family practice: four-year observation
I. Szymczyk, W. Lukas, E. Wnuk-Bialas (Zabrze, PL)
Objectives: Estimation of anti-ﬂu vaccinations, accomplishment
in chosen groups of patients.
Material and methods: Retrospective analysis included case
records of FP patients vaccinated agains the ﬂu in 2000–2003.
Basing on WHO recommendations assessment involved: (1)
patients over the age of 50, (2) patients over the age of 65, (3)
diabetic patients, (4) patients suffering from chronic, obturative
respiratory tract diseases, (5) children and adolescent patients
under the age of 18, and (6) the other parients over the age of 18.
Results: Among 3430 patients of FP over the age of 50, 81 (i.e.
2.29%) were vaccinated in the year 2000. In the following years:
3.38%/4.97%/4.17%, respectively. In 2000, 39 out of 959 patients
over the age of 65 i.e 2.76% were vaccinated. In 2001–2003 this
percentage was: 7.71%/12.06%/12.48%. Among diabetic
patients, in 2000–2003 were vaccinated: 5.3%/9.6%/11.38%/
12.83%. Patients suffering from asthma and chronic, obturative
respiratory tract diseases were vaccinated in:4.8%/8.02%/
8.78%/7.91%. In 2000, among 1553 patients under the age of
18, 42 were vaccinated i.e 2.7%. In 2001/2002/2003 this per-
centage was: 2.42%/4.11%/2.60%. Among patients over the age
of 18, in whom anti-ﬂu vaccination is not recommended,
percentage of vaccinated patients was: 3.11%/1.85%/3.23%/
2.27%. Among vaccinated agains the ﬂu at least three times
during 2000–2003, we vaccinated: 22% of patients over the age of
50, 59% over the age of 65, 67% of diabetic patients, 90% of those
suffering from astma, 32% of patients under the age of 18 and
28% over the age of 18%.
Conclusion: Hitherto existing system of anti-ﬂu vaccination
promotion is not efﬁcient enough, despite the advertisements in
media and information in FP.
R2237
Comparison of two types of recombinant live-
attenuated Salmonella strains expressing HBc-ag
in experiments
M. Donin, M. Boychenko, A. Ilytchev, L. Karpenko,
T. Veremeyko, A. Vorobiev (Moscow, Novosibirsk, RUS)
Objectives: One of the method of approach for chronic hepatitis
B treatment is activation of T-cell immunity. For this purpose
therapeutic vaccine containing HBc-ag can be used. Live-
attenuated Salmonella are able to deliver both HBc-ag, encoded
in prokaryotically expressed plasmid, and HBc-ag, encoded in
eukaryotically expressed plasmid. Therefore such mentioned
above two types of recombinant Salmonella strains were exam-
ined in experiments in mice and cell culture of human
monocytes in vitro.
Methods: Attenuated cya (lack adenylatecyclase) suppressor
(CRP) mutant of Salmonella Enteritidis was used as a vechicle
for both HBc-ag encoded in prokaryotically expressed plasmid
pKHBc (vector’s vaccine), and HBc-ag encoded in eukaryotically
expressed plasmid pcDNA3.1pKHBc (DNA-vaccine carried in
Salmonella). Mice were inoculated per rectum with suppositor-
ies containing 1,000,000 cells of examined Salmonella strains.
Salmonella multiplication in Payer’s patches, spleen, liver,
lungs, and determination the titre of speciﬁc anti – HBc-ag
antibodies were examined. Culture of human monocytes in vitro
was used for examination of interaction Salmonella strains with
phagocytes.
Results: All strains possessed ability to multiply in Payer’s
patches more then 7 days. In contrast to other Salmonella
strains, strain carrying pcDNA3.1pKHBc (DNA-vaccine in
Salmonella) did not possessed ability to multiply in parenteral
lymphoid tissue. It did not also induce production of speciﬁc
anti HBC-ag antibodies. Examination of interaction Salmonella
strains with culture of human monocytes in vitro was shown
that strains free from HBc-ag synthesis possessed ability to
multiply in phagocytes. The number of Salmonella cells reached
40 cells per phagocyte. Synthesis of HBc-ag limited Salmonella
multiplication. Effect was more expressed in Salmonella carry-
ing DNA-vaccine.
Conclusion: Salmonella strain carrying DNA-vaccine expres-
sing HBc-ag , possesses limited persistence in mice. HBc-ag
increases bactericidal activity of phagocytes.
R2238
Humoral response to Staphylococcus aureus
polypeptides in patients treated with autovaccine
A. Szkaradkiewicz, A. Kuch, A. Korzeniowska-Kowal,
A. Kuzma, A. Gamian (Poznan˜, Wroclaw, PL)
Objectives: The studies aimed at evaluation of anti-S. aureus
humoral response in patients treated with autovaccine, prepared
from killed S. aureus strains isolated from the patients.
Methods: The studies were performed on 15 strains of S. aureus
isolated from patients with chronic inﬂammatory processes in
the throat and/or skin and demonstrated to be of staphylococcal
aetiology. Surface proteins were isolated by Laemmli buffer and
were electrophoretically separated (SDS-PAGE), stained with
Coomassie blue or transferred onto nitrocellulose membrane for
immunoblotting with patient sera, obtained in two time points,
i.e. before and after applying the autovaccine. The antigen/
antibody reactions were visualized employing the alkaline
phosphatase method. Protein proﬁles for individual S. aureus
strains and immunobloting results were analysed using GelD-
OK software (Syngen Biotech).
Results: Using Western-immunoblotting, the IgG lass anti-
bodies were fund to react to S. aureus surface proteins of 14–
140 kDa molecular weight while IgM class antibodies reacted
with proteins of molecular weight of 25–94 kDa. In studies on
the autovaccines IgM antibodies were detected directed
toward individual polypeptides in 12 patients while no IgM
class antibodies could be detected in the remaining 3 patients.
In the subsequent time point of the study (after administra-
tion of autovaccine), in 12 patients IgM class immune
response was found to resemble that documented before
while the remaining, previously negative 3 patients this time
carried IgM antibodies speciﬁc toward individual polypep-
tides. As far as IgG class humoral reaction was concerned,
the response was comparable in the two time points of the
study.
Conclusion: The obtained results suggest that therapeutic effect
of S. aureus autovaccine is not related to the respective humoral
response.
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Infection in transplant recipients
R2239
Bacterial and fungical colonisation of the
bronchial tree in outpatient lung donors. An
advance in lung transplantation
J. Lobera, F. Alfageme, T. Marco, A. Parra, M. Linares,
C. Lopez-Feijoo, J. Sanz, P. Mendaza (Madrid, E)
Objectives: Out hospital non-heart-beating lung donors
(NHBLD) may be advantageous in terms of microbiological
colonization of the bronchial tree because of limited ventilation
time and no ICU environment exposure.
Methods: Microbiological results of 8 out hospital NHBLD
and 31 brain-dead lung donors (BDLD) performed in the
same period of time (november 2002–may 2004) were system-
atically reviewed in three categories: donor’s bronchial swabs
and bronchial aspirates (BAS) and receptor’s BAS prior and
after transplantation. Any microbiological isolated microor-
ganism was considered signiﬁcant excluded upper airways
ﬂora.
Results: Only 1 out of 8 (12.5%) cultures of the out hospital
NHDLD a signiﬁcant microorganism could be isolated. In the
case of the BDLD 17 cultures out 31 donors (54.8%) were
positive for signiﬁcant colonization. Colonization was statisti-
cally different in both groups (p = 0.049).Respect to the
recipient’s results, in 5 of the 8 NHBLD (62.5%) signiﬁcant
colonization was evidenced compared with the 8 of 31 (25.8%)
microbiological isolates in the case of BDLD receptors. No
statistically signiﬁcative differences could be found in recip-
ients colonization (p = 0.09). BAS after transplantation was
microbiologically signiﬁcant in 5 of the 8 (62.5%) cases of
transplantations from a NHBLD. In the case of the transplan-
tations from BDLDs 19 of 31 (61.2%) presented a signiﬁcant
isolate.In the case of BDLD transplantation a statistically
signiﬁcative (p = 0.012) increase in the colonization after
transplantation was found due to BDLDs (from 25.8% to
61.2%) in contrast with NHBLD transplantation in which
NHBLD did not increase the proportion of signiﬁcant cultures
(62.5% in both cases).
Conclusions: According to our series NHBLD are statistically
less colonized than BDLD. A difference in the proportion of
colonization in out hospital NHBLD in the era of prophylactic
antibiotherapy could be adventageous in terms of decreasing
infections after transplantation, using less prophylactic antibi-
otics, and avoiding the appearance of antibiotic resistant
microorganisms.
R2240
PTLD following allogeneic HSCT: a single-centre
experience in Korea
W.S. Shin, S.H. Park, S.M. Choi, D.G. Lee, J.H. Choi, J.H. Yoo,
M.W. Kang (Seoul, KOR)
Objectives: Post-transplant lymphoproliferative diseases (PTLD)
is a well recognized complication after HSCT. However, it has
been difﬁcult to characterize because the incidence is <1% and
clinical presentation is diverse. Incidence and characterisitcs of
PTLD after HSCT have not been reported in Korea. This study is
aimed to evlauate and characterize PTLD after HSCT in a single
institution.
Methods: Medical records of adult patients who underwent
allogeneic HSCT in the Catholic HSCT centre from in January
1993–December 2003 were retrospectively analysed.
Results: There were 7 patients who had PTLD for 10 years. The
mean age was 33 ± 11.6 years, male to female ratio was 6–1. The
underlying hematologic diseases were 3 chronic myeloid le-
ukaemia, 2 acute myelocytic leukaemia, 1 myelodysplasic
syndrome, 1 severe aplastic anemia. The types of HSCT were
4 of matched sibling donor (MSD) HSCT, 2 of matched unrelated
donor (MUD) HSCT, and 1 of haploidenticl HSCT. Five of these
patients (71.4%) experienced episodes of acute GVHD and
received steroid therapy. PTLD developed at mean 145.3 days
(range, 83  244) after HSCT. Clinical symptoms were diverse
depending on the involved sites, but cervical lymphadenopathy
was frequently observed (5 out of 7). Theincidence of PTLD has
been increasing: no proven cases before 1996, 1 case in 1996, 3 in
2001, 1 in 2002, 2 in 2003. The pathology review showed that 6
cases had B-cell origin PTLD and one patient had T-cell origin,
who had haploidentical HSCT and rapidly progressed to death.
In situ hybridization for EBER was positve in 4 cases. Treat-
ments of PTLD were 1 acyclovir therapy, 2 reduction of
immunosuppressants plus acyclovir therapy, 2 reduction of
immunosuppressants plus donor lymphocyte infusion (DLI), 2
reduction of immunosuppressants plus acyclovir therapy plus
DLI. Five of seven patients (71.4%) reponded to the treatment.
Three patients died, and 2 of them died patially or directly due
to PTLD, which developed in 2003 in these cases.
Conclusion: The incidence of PTLD is low in allogeneic HSCT
patients, but has been increasing recently probably because the
rate of HLA mismatched HSCT or MUD HSCT, which needs
more profound immunosuppression, has increased. Therefore,
we should be careful of development of PTLD in patients after
HSCT, who have risks of PTLD.
Paediatric infections
R2241
The prevelance of respiratory viruses in
hospitalised children in Amman, Jordan
R.M. Al-Toum, S. Al-Bodour, H.A. Ayyash (Amman, JOR)
Objectives: To detemine the prevelance, seasonal distribution
and to draw out the clinical signs and symptoms associated with
the following respiratory viruses:Respiratory syncytial
virus(RSV),Human parainﬂuenza viruses (PIV) type 1,2 and
3,Inﬂuenza viruses A&B and Adenoviruses(Ad).
Methods: A total of 200 nasopharyngeal aspirates were
obtained from hospitalized children (below 2 years old), admit-
ted to Islamic hospital in Amman-Jordan, between september
2002 and March 2004. These specimens were analysed for the
presence of some respiratory viruses using the direct and
indirect immunoﬂouresence techniques.
Results: 27% of enrolled patients have proved viral respiratory
infection. The etiological agents associated with these infections
were RSV(12%), Ad.(11.5%) and PIV-3(3%). Seasonal distribu-
tion of respiratory viruses and their correlation with the climatic
factors (temperature, rainfall, and humidity) were determined.
The peak of RSV incidince was during February 2003 and
January 2004 and showed a signiﬁcant correlation with the
climatic factors. Ad infections peaked during December of2002
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and 2003, and PIV-3 infections restricted to march 2003 and
January 2004.However,both Ad andPIV-3 did not show any
signiﬁcant correlation with the cilamatic factors.Males were
affected more than females, and most infections were associated
with lower age groups(less than 1 year). Croup (laryn-
gotracheobronchitis) was only associated withHPIV-3,Bronchio-
litis with RSV, bronchopneumonia, pharyngitis and tonsillitis
were mostly associated with Ad infections. According to the
clinical and radiological ﬁndings, RSV infection can be distin-
guished clinically fromPIV-3 and Ad infections by the higher
rates of hypoxemia, retractions, tachypnoea, hyperinﬂation, and
interstitial inﬁltrates.however.PIV-3and Ad infections cannot be
distinguished on the same basis.
Conclusion: This study has demonstrated the prevelance of
three othe major respiratory viruses infecting Jordanian children
below the age of 2 years, and causing their hospitalzation. The
study stated the seasonabilty of repiratoy viruses and their
associted illnesses, as well as the major clinical manifestations
associated with each virus. The knowledge of local climatic
factors together with the characterstic pattern of these viruses
may help in the prediction of the beginning and end of
epidemics and thus also help in the planninig of preventive
programmes.
R2242
Tuberculous meningitis in sucklings
C.M. Luca, A. Vata, C. Manciuc, D. Leca, O. Dorneanu,
V. Luca (Iasi, RO)
Objective: To study the tuberculous meningitis in sucklings,
from the clinical , laboratory ﬁndings and therapy point of view.
Material and Method: retrospective study of tuberculous men-
ingitis of 23 infants under 1 year of age, admitted in the
Infectious Diseases Hospital of Iasi-Romania, in the period 2000–
2004.
Results: The were identiﬁed in medium 29% new cases in
children per year, comparatively with adults (14.8%). From
these 23 cases,60% were boys and 26% of the group of age 1–
4 months. The onset was incidious in 72,84% , with meningeal
syndrome in 91% cases and conscience troubles in 8% cases. The
CSF was clear in 95% cases, with high values of proteins and low
values of glucose and chlorus. M. tuberculosis was isolated in
culture in 28% cases and 14.66% by directly exam. The therapy
was then with quadruple association of antituberculous drugs,
with favourable evolution 65% cases, 8 deaths being recorded.
The factors of bad prognoses still remain: the little age, the
hydrocephalus (5 cases), malnutrition (3 cases), and coma from
the beginning (2 cases).
Conclusion: Tuberculous meningitis still remain a disease with a
high incidence and severe evolution in sucklings, despite the
progress of diagnostic methods and therapy.
R2243
Clinical course of urinary tract infections in early
infancy
M. Christodoulaki, E. Balomenaki, D. Athanasopoulos,
A. Basiliadi, F. Barabouti, A. Alexopoulos (Chania, GR)
Objective: Urinary tract infections are the most common
bacterial infections in infants. The aim of the study was the
clinical analysis of infants younger than 60 days of age with
urinary tract infection.
Methods: We reviewed the medical records of 54 infants
younger than 60 days-old hospitalized with a urine tract
infection at our hospital during a 2 year period. Diagnosis was
conﬁrmed by positive urine culture. All urine specimens
obtained by suprapubic aspiration. Clinical presentation, labor-
atory data, management, imaging studies and outcome were
reviewed.
Results: Forty six of patients were males (85%). The most
common symptom was fever (65%). Other clinical manifesta-
tions were: weight loss (11%), vomiting (9.2%), failure to thrive
(7.4%), diarrhoea (3.7%) and jaundice (3.7%). The most common
pathogen was Escherichia coli (60%). Other isolated microorgan-
isms included Klebsiella pneumoniae (24%), Enterobacter cloacae
(11%) and proteus (5%). Abnormal urinalysis results were noted
in 65% of infants. Leucocytosis, high C-reactive protein concen-
tration and elevated erythrocyte sedimentation were noted in
45%, 58% and 43%, respectively. 24 infants had abnormal renal
ultrasound results (46%). In all cases intravenous treatment with
a combination of ampicillin or cephalosporin and aminoglyco-
side was efﬁcient. Voiding cystourethrogram detected vesico-
ureteral reﬂux in 13 infants(24%). Renal scanning revealed
scarring in 3.7%.
Conclusion: Early diagnosis and prompt management of urine
tract infection in infants are very important to prevent serious
complications and preserve renal function.
R2244
Colonisation of bronchial secretions in intubated
patients in paediatric intensive care unit in
Athens, Greece
H. Papavasileiou, I. Varzakakos, L. Papavasileiou, Z. Beka,
L. Sianidou, A. Vogiatzi (Athens, GR)
Endotracheal intubation is generally performed to facilitate the
treatment of respiratory failure or to control the airways during
shock, sepsis, status epilepticus or cranioencephalic trauma.
Intubated patients present frequently colonization and infec-
tions of the lower respiratory track.
Aim: The aim of our study was to determine the frequency and
etiology of infections or colonization of the lower respiratory
tract in intubated children in intensive care unit.
Material and method: 22 intubated children (15 boys and 7
girls) were studied, aged from 2 months to 16 years-old, treated
in I.C.U. during the year 2002. From the study were excluded the
chronic cases with frequent re-admissions. The clinical and
laboratory infection indexes were evaluated, such as culture of
bronchial secretions, C.R.P., procalcitonine, blood culture, chest
X-R, high fever and acrocyanosis.Bronchial secretions were
taken for culture, by means of endotracheal suction the ﬁrst day
of intubation and after second day and ﬁnally the day of
removal of the tube.The samples cultured quantitatively in
blood, M.C., chocolate and Sabouraux agar, in aerobic and
anaerobic conditions.
Results: From the 22 children, infection developed in 6 (26%).
Infection appeared in the 3rd day of intubation, whereas
colonization after the ﬁrst 24 h.The bacteria isolated the ﬁrst
24 h of intubation were mainly H. inﬂuenzae 9 srains (25%),
M. catarrhalis 6 (17%) and S. aureus 5 (14%), whereas in 48 h
predominated S. aureus with 10 strains (30%), Pseudomonas spp.
7 (21%), A. baumanii 4 (13%) and Candida spp. 4 (13%).
Conclusions: 1. Children intubated for more than three days
are prone to infection. 2. Colonization of bacteria of the
environment may happen the 2nd 24 h of intubation. 3. Chil-
dren of I.C.U. colonized mainly by Gram-bacteria, S. aureus and
Candida spp. 4. Knowledge of factors contributing to pulmon-
ary infection in intubated patients is important for more
effective treatment.
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R2245
Nasopharyngeal colonisation in healthy children
in Greece
H. Papavasileiou, A. Makri, L. Papavasileiou, X. Agathokleous,
I. Andrianopoulou, M. Varveri, T. Kanaki, A. Vogiatzi (Athens,
GR)
Colonization of nasopharynx by potential respiratory pathogens
is established in early childhood, although this varies greatly
according to locality, individual and social factors.
Aim: The aim of this study was to investigate the prevalence of
the nasopharyngeal carriage of respiratory pathogens and
identify factors affecting colonization in healthy children in an
area of Athens inhabited mainly by ethnic minorities.
Material and method: From January 2003 up to May 2004 with
exception of summer months, 392 nasopharyngeal swabs from
equal in number healthy children were obtained. 38 of the
children were under the age of 6 (group A) and the rest (354)
from 6 to 10 years-old (group B). 45% of the above children
either had not been or incompletely vaccinated against H.
Inﬂuenzae type b (Hib). The samples were cultured in blood and
chocolate agar for 48 h. Identiﬁcation of the isolates and
sensitivity to antibiotics was performed by disk diffusion
method following the guidelines of NCCLS.
Results: Out of 392 swabs, 285 (73%) were found positive to one
or more pathogens. From these in 74 (26%) were isolated 2
bacteria and in 8 (3%) three. The pathogens isolated were 307
(71%) H. inﬂuenzae, 38 (8,8%) M. catarrhalis, 24 (5,5%) Candida
spp., 15 (3,5%) S. pyogenes (GAS), 8 (1,8%) Neisseriae spp., 4
(0,9%) S. aureus, 1 (0,2%) Streptococcus Group C and 36 (8,3%)
Gram-bacteria. From the 38 group A children, 27 (59%) were
found positive for H. inﬂuenzae, 6 (13%) for M. catarrhalis, 1
(2%) for GAS, 1 (2%) for Candida spp., 1 (2%) for S. aureus and 10
(22%) for Gram-bacteria. 9 swabs (24%) were positive for two
pathogens and 1 (5%) for three. Signiﬁcant resistance had H.
inﬂuenzae to Cotrimo (31%), M. catarrhalis to Ampicillin (76%)
and S. aureus to Penicillin (100%).
Conclusions: H. inﬂuenzae is the prevalent colonist in the
nasopharynx of the examined children, possibly due to the fact
that these had not been at all or partially vaccinated against Hib.
Group A children had been colonized in higher frequency by
Gram-bacteria. Rhinopharyngeal colonization by respiratory
pathogens on these children might have a strong relationship
with the socioeconomic level and the way of living of these
populations. Therefore, antimicrobial restrictive guidelines
should be tailored to local microbiologic sceneries.
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